Division of Extramural Activities

Annual Report 2003

National Institutes of Health

National Cancer Institute
Chemical Genetics and New Treatments for Cancer

The NCI has a long history of involvement and support for the discovery and development of new cancer therapies. Recently, the NCI initiated programs in chemical genetics to increase the availability of small molecules

as probes of biological systems and to increase interactions between biologists and chemists. The term chemical genetics denotes the use of small molecules derived through modern synthetic organic chemistry, rather

than gene mutations, to alter the functions of gene products. Protein functions that can be specifically targeted and activated or inactivated by small molecular probes could result in anti-tumor activity and provide new

therapeutic approaches for cancer.

The NCI created the Initiative in Chemical Genetics (ICG) to accelerate the discovery of potential drug targets

in academic laboratories. The ICG has promoted the development and application of diversity-oriented organic synthesis (DOS) as a means to create small cell-permeable molecules that can modulate the circuitry of cancer cells. DOS allows chemists to synthesize stereochemically and skeletally diverse small molecules that anticipate the need for followup chemistry after screening through the use of combinatorial synthesis. This endeavor also has led to the development of a high-throughput, miniaturized, whole-cell immunodetection assay,

termed a cytoblot assay, for screening small-molecule libraries derived from DOS. The cytoblot assay is adaptable for screening numerous protein modifications because the only requirement is a specific primary antibody

directed against the cellular molecule of interest.

The cover image depicts the results of screening small molecules in the cytoblot assay for their ability to cause

hyperacetylation of tubulin (left) and histone (right) proteins in lung epithelial cells. Acetylation of these two

proteins was measured by immunofluorescence using antibodies against acetyl-tubulin (red/left), which is

detected in the cytoplasm and acetyl-histone (blue/right), which is detected in the nucleus. The image also

depicts the structures of two powerful small-molecule probes of cancer that emerged from the screen: tubacin

and histacin. Currently, clinical cancer trials are underway with nonselective histone deacetylase (HDAC)

inhibitors. By contrast, tubacin and histacin are the first selective deacetylase inhibitors to be discovered.

Indeed, tubacin, which is highly selective for the inhibition of HDAC6 (a tubulin deacetylase), has been demonstrated to induce p53-independent apoptosis in a mouse model of multiple myeloma (Ricky Johnstone, ICG,

unpublished). In contrast to nonselective HDAC inhibitors, tubacin does not inhibit transcription or cell division in normal cells grown in culture. The ICG has made the results of small-molecule screens from many laboratories nationwide freely available to the public via ChemBank, a small-molecule and assay-data analysis environment (http://chembank.med.harvard.edu). These efforts provide illustrations of how chemical genetics and

the ICG are having a direct effect on the development of new cancer strategies and therapies.

Cover Illustration:

Courtesy of S.J. Haggarty, Ph.D., and S.L. Schreiber, Ph.D., Director, ICG, Harvard University.

References:

S.J. Haggarty, K.M. Koeller, J.C. Wong, C.M. Grozinger, and S.L. Schreiber. Domain-selective small molecule

inhibitor of HDAC6-mediated tubulin deacetylation. Proc Natl Acad Sci 2003;100:4389-4394.

R.L. Strausberg and S.L. Schreiber. From knowing to controlling: a path from genomics to drugs using small

molecule probes. Science 2003;300:294-295.

S.J. Haggarty, K.M. Koeller, J.C. Wong, R.A. Butcher, and S.L. Schreiber. Multidimensional chemical genetic

analysis of diversity-orientated synthesis-derived deacetylase inhibitors using cell-based assays. Chemistry &

Biology 2003;10:383-396.
Division of Extramural Activities

Annual Report 2003

National Institutes of Health

National Cancer Institute

September 2004
NCI/DEA Annual Report 2003

ii
Contents

Foreword. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . v

Introduction. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

Grant Referral: DEA as the First Point of Contact with the NCI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3

Peer Review—The Next Step . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5

Supporting Peer-Review Consultants . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17

DEA’s Role in Advisory Activities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19

Committee Management Activities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21

Extramural Policy and Program Development . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23

Information Resources Management . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25

Portfolio Tracking and Analysis. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27

Special Activities in the Office of the Director, DEA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29

Organizational Structure of the Division of Extramural Activities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31

Appendix A: Glossary of Acronyms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 45

Appendix B: List of Chartered Committees, FY2003 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 47

Appendix C: NCI Initial Review Group Consultants, FY2003 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 63

Appendix D: Activities of the National Cancer Advisory Board . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 115

Appendix E: Activities of the Board of Scientific Advisors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 117

Appendix F: NCI Grant Guidelines and Descriptions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 119

Appendix G: Cancer Information Sources on the Internet . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 127

Table 1. Applications Received for Referral by the NCI/DEA (by Mechanism), FY2003. . . . . . . . . . . . . 129

Table 2. Applications Reviewed by the NCI/DEA (by Mechanism), FY2003. . . . . . . . . . . . . . . . . . . . . 131

Table 3. Applications Reviewed by NCI IRG Subcommittees for NCAB Meetings, FY2003 . . . . . . . . . . 132

Table 4. Summary of Investigator-Initiated P01 Applications Reviewed for 

Each NCAB Meeting, FY2003 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 133

Table 5. Summary of Review Formats for Unsolicited Program Project 

Applications Reviewed, FY2003 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 133

Table 6. Summary of Unsolicited P01 Applications Reviewed by NCI Program Division, FY2003 . . . . . . 133

Table 7. Requests for Applications (RFAs) Published by the NCI, FY2003. . . . . . . . . . . . . . . . . . . . . . 134

Table 8. Program Announcements (PAs) Published by the NCI, FY2003. . . . . . . . . . . . . . . . . . . . . . . 135

Table 9. Program Announcements with Special Referral (PARs) Published by the NCI, FY2003 . . . . . . . 136

Table 10. Requests for Applications (RFAs) Reviewed by the NCI/DEA, FY2003 . . . . . . . . . . . . . . . . . . 137

Table 11. PA/PAR SEP* Applications Reviewed by the NCI/DEA, FY2003 . . . . . . . . . . . . . . . . . . . . . . 139

Table 12. Non-RFA PA SEP Applications Reviewed by the NCI/DEA, FY2003 . . . . . . . . . . . . . . . . . . . . 143

Table 13. Average Total Cost and Number of RPG† Awards by Division, 

FY1999 - FY2003 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 143

Table 14. Summary of NCI Grant Awards (by Mechanism), FY2003 . . . . . . . . . . . . . . . . . . . . . . . . . . 144

Table 15. NCI Special Interest Category (SIC) Dollars for FY2003—Percent Change from FY2002. . . . . 147

Table 16. NCI Organ Site-Specific Dollars for FY2003—Percent Change from FY2002 . . . . . . . . . . . . . 150

Table 17. Requests for Proposals (RFPs) Reviewed by NCI/DEA in FY2003 . . . . . . . . . . . . . . . . . . . . . 152

* Special Emphasis Panel. 

† Research Program Grant.

NCI/DEA Annual Report 2003

iii
NCI/DEA Annual Report 2003

iv
Foreword

Since Congress passed the National Cancer Act in 1971, we have been

experiencing exponential growth in our knowledge of cancer. That scientific knowledge base, which is a primary responsibility of the National

Cancer Institute (NCI), is the first stage along a continuum of discovery,

development, and delivery that will ultimately take us to the goal I have

challenged myself and the entire cancer community to reach by the year

2015—the elimination of suffering and death from cancer. The knowledge that we discover, whether at the level of the gene, molecule, cell, tissue, organ, individual, or population, feeds development—the process of

creating tools and interventions to reduce the cancer burden—with the end result being delivery, the

process of disseminating, facilitating, and promoting evidence-based prevention, detection, diagnosis, and treatment practices and policies.

The NCI is committed to exploiting that discovery-development-delivery strategy to achieve the

2015 challenge goal. In large measure, this will be accomplished through the efforts of outstanding

NCI extramural scientists who have and will continue to enhance the scientific knowledge base. 

The NCI Division of Extramural Activities (DEA), carries a major responsibility for strengthening

the scientific knowledge base by conducting the scientific review of applications for support of

extramural research; managing and coordinating the Institute’s advisory activities, including the

Presidentially appointed National Cancer Advisory Board and the Board of Scientific Advisors; 

formulating, coordinating, and disseminating operating policies pertaining to extramural programs;

and analyzing and reporting on all extramural research programs funded by the NCI.

The DEA Annual Report provides a comprehensive look at each of the major areas of responsibility within the DEA, including program coordination, referral, review, advisory activities, information resources, portfolio tracking and analysis, management, and extramural policy.

I am pleased to present this annual report, which not only describes the DEA’s activities and accomplishments and its work in the context of achieving the NCI’s overall scientific goal of reducing the

burden of cancer, but also gratefully acknowledges the hundreds of researchers who have contributed

to the success of our peer-review and advisory activities.

Andrew C. von Eschenbach, M.D.

Director, National Cancer Institute

NCI/DEA Annual Report 2003

v
NCI/DEA Annual Report 2003

vi
Introduction

The mission and responsibilities of the NCI Division of Extramural Activities (DEA) affect, in some

way, all extramural scientists receiving research or training support from the NCI. The DEA is centrally involved in all aspects of grant development and tracking, from original conception of research

and training programs for introduction in the extramural community, to issuance of announcements

of such programs, to receipt and referral of incoming applications, to review and final approval of

the applications, to coding and tracking awards after disbursement of funds. In brief, the DEA was

established to:

y Provide advice and guidance to potential applicants

y Coordinate and assist in the development of extramural research funding initiatives

y Refer incoming grant applications to appropriate programs within the NCI

y Provide the highest quality and most effective scientific peer review and oversight of extramural grant and contract research

y Coordinate and administer advisory committee activities, such as the National Cancer

Advisory Board (NCAB) and Board of Scientific Advisors (BSA), as they relate to the various

aspects of the NCI mission

y Establish and disseminate extramural policies and procedures, such as requirements for inclusion of certain populations in research, actions for ensuring research integrity, budgetary limitations for grant applications, policies to expedite funding and changes to the application and

award process

y Track the NCI research portfolio (more than 6,670 research and training awards) using consistent, budget-linked scientific information to provide a basis for budget projections and to serve

as an NCI resource for the dissemination of information about cancer.

In essence, the DEA is the organizational component of the NCI that coordinates the scientific

review of extramural research before funding and provides systematic surveillance of that research

after awards are made. In this latter role, the DEA assists the NCI in its goal of achieving a balanced

portfolio of research in biology, behavior, epidemiology, and cancer control, prevention, detection,

diagnosis, and treatment, as well as long-term survival/survivorship, rehabilitation, and end-of-life

issues. In addition, the DEA serves as a focal point for information about the NCI’s peer-review and

grants policies. DEA maintains a comprehensive Web site providing detailed information and links

to application procedures and to announcements regarding funding opportunities—see http://

deainfo.nci.nih.gov/funding.htm.*†

* See Appendix A for a glossary of acronyms used in this report. 

† A directory of Cancer Information Sources on the Internet, including selected DEA and NCI Web sites, is included in Appendix G.

NCI/DEA Annual Report 2003

1
NCI/DEA Annual Report 2003

2
Grant Referral: DEA as the First Point of Contact with the NCI

In Fiscal Year (FY) 2003, the NCI received more than 11,000 grant applications for referral (see

Table 1). These included applications for 50 different types of funding award mechanisms (see

Appendix F), including Career Development Awards (K awards), Research Program Projects (P01),

Cancer Center Support Grants (CCSGs)-[P30], Research Projects (R01), and Small Business

Innovation Research (SBIR) Grants (R43/44). During FY2003, the Program Coordination and

Referral Branch (PCRB) in the DEA was responsible for receipt, referral, and assignment of applications, as well as other program development functions.

The past 5 years have seen a significant increase in grant applications coming to the NCI for referral. The increase in all applications has been 43 percent, while increases in R01, R21, and R03 have

been 27 percent, 219 percent, and 73 percent, respectively (see Figure 1).

All applications submitted to the NIH are assigned to an Institute program and receive a review

assignment. Upon receipt of a primary or secondary assignment to the NCI by the National

Institutes of Health (NIH) Center for Scientific Review (CSR), the DEA Referral Officer (RO)

assigns all incoming applications to one of the 45 NCI extramural research program areas. The RO

NCI/DEA Annual Report 2003

3

Figure 1. Receipt and Referral of NCI Applications

12,800

12,000

11,200

10,400

9,600

8,800

8,000

7,200

6,400

5,600

4,800

4,000

3,200

2,400

1,600

800

0

1999 2000 2001 2002 2003

All Applications Received and Referred by NCI

Total R01 Applications

Total R21 Applications

Total R03 Applications

11,894

9,660

8,769 8,629 8,323

5,977

5,206

4,525 4,373 4,694

1,677

1,035 931 922

525 175 191 232 250 303

Calendar Year

All NCI Applications
also must track, in real time, the review status of all applications assigned to the NCI. The RO distributes all of the applications directly reviewed by the DEA for the NCI. These applications include

P01 Program Projects, P30 Centers, P20 Planning Grants, P50 Specialized Centers, R13 Conference Grants, R03 Small Grants, T32 Training Grants, certain R01 Research Project Grants, and

U series Cooperative Agreement applications. This includes distribution of advance copies of applications from investigators submitting P01s or responding to Requests for Applications (RFAs) and certain Program Announcements (PAs). These applications are sent to one of the three DEA Review

Branches for assignment to individual Scientific Review Administrators (SRAs) and to one of the

eight subcommittees of the NCI Initial Review Group (IRG) or to a Special Emphasis Panel (SEP),

as described later.

The DEA is often the first point of contact for applicants and the recipient of Letters of Intent from

potential applicants for multiproject Program Grants (P01) and Conference Grants (R13). It is also the

only point of receipt for distribution to program staff of Research Supplements for Underrepresented

Minorities, Supplements to Promote Reentry Into Biomedical and Behavioral Research Careers,

Research Supplements for Individuals with Disabilities, and Supplements for the Continuous Umbrella

of Research Experience (CURE) program for underrepresented minorities (available for R25, K12, and

P30 parent grants). 

DEA ROs serve as primary NCI contact persons for members of the extramural scientific community in need of information on a broad range of subjects, including application information, new initiatives announced as RFAs or PAs, and the review process. The ROs also provide “one-stop shopping” for applicants who are uncertain about whom to contact and direct them to appropriate

Program Directors or SRAs for information on the status of the review and award of their grants. In

addition, the ROs assist members of the extramural community in navigating NIH and NCI Web

pages to obtain current information, forms, and guidelines.

NCI/DEA Annual Report 2003

4
Peer Review—The Next Step

Once applications are referred to the NCI and the appropriate program, they must be reviewed. The

high caliber of NCI-sponsored research is maintained through peer review and a quality control

process in which experts in the field review and score proposals for research. The peer-review mechanism helps ensure that the NCI uses its resources wisely and funds research that has the potential

to make a significant contribution to science and medicine. The NCI’s extramural programs and

activities are funded primarily through peer-reviewed grants and cooperative agreements. Programs

that are funded through research contracts are also subject to peer review, including contract-supported projects conducted within the intramural research program.

The dual peer-review system of the NIH consists of two sequential levels of review mandated by

statute. The first level of review is performed by either an NIH CSR study section, an NCI Initial

Review Group (IRG) subcommittee, or Special Emphasis Panel (SEP) whose primary purpose is to

review and evaluate the scientific merit of research grant and cooperative agreement applications.

The second level of review for program relevance is conducted by the NCAB.

Most investigators are familiar with the NIH CSR study sections, which have primary responsibility for investigator-initiated Research Project (R01) grants and fellowships. It is less widely known,

however, that applications representing more than 50 percent of the NCI’s extramural budget are

reviewed by groups that are directly formed and managed within the NCI by the DEA. Routing for

review to either the CSR or the DEA is usually decided by the choice of award mechanism. In either

case, the NCAB, also managed by the DEA, has statutory responsibility to perform the second level

of review, which considers additional factors of NCI’s mission and relevance.

The NCI has no direct input into the selection of reviewers who serve on CSR study sections. In contrast, members of the NCI IRG are selected by NCI review staff and approved by the Director, 

NCI, based on their knowledge of the various disciplines and fields related to cancer. The DEAmanaged NCI IRG has eight specialized subcommittees for review of scientific areas. For example:

Subcommittee A reviews Cancer Centers; Subcommittee D reviews Clinical Program Projects; and

Subcommittee H reviews Clinical Cooperative Groups. (The current charter and membership of subcommittees may be found in Appendix B and at the following Internet address: http://deainfo.

nci.nih.gov/advisory/irg.htm). IRG members are appointed for varying terms of service, which may

be up to 4 years on specific subcommittees. SEPs may be formed by the DEA to review RFAs or

unique applications. Members of such panels are selected on a one-time, as-needed basis to review

specific applications, contract proposals, or proposed solicitations. (Additional information about 

the NCI SEPs can be accessed at the following Internet address: http://deainfo.nci.nih.gov/

advisory/sep.htm.) In addition, applications for Cancer Center, Cooperative Group, or Program

Project support may require a site visit to the applicant institution by members of the appropriate

IRG subcommittee and ad hoc consultants.

Both the SEPs and the IRG advise the Director, NCI, on the scientific and technical merit of applications for grants for research and research training, as well as for research-related grants and cooperative agreements and contract proposals relating to scientific areas that are relevant to cancer.

Government-employed SRAs within the DEA manage the scientific review of applications, including the selection of peer reviewers and the overall administration of the peer-review process.

NCI/DEA Annual Report 2003

5
In FY2003, the DEA organized, managed, and reported the review of a total of 2,164 grant and cooperative agreement applications (see Table 2) and 404 contract proposals (see Table 17). Twenty-two

meetings of the NCI IRG subcommittees were convened to review and evaluate grant applications

of various types (see Table 3). In addition, there were 78 SEP meetings for review of grants or contracts, and 186 site visits (43 SEP and 143 IRG).

In FY2003, 2,424 reviewers served on 286 occasions on either the parent IRG subcommittees or SEPs

to review applications (see Appendixes B and C). Members are selected because they are authorities

in relevant fields of biomedical research or because they represent informed consumer perspectives.

Bypass Budget Goals

Each year, the NCI identifies several broad priority areas that serve as the framework for strategic

planning and budget development. Extraordinary Opportunities for Investment are areas of discovery that build upon the most important recent developments in knowledge and technology and

hold promise for making significant progress against all cancers. NCI Challenges are areas of

emphasis that focus investment on improving the resources and mechanisms that are available to

support research, furthering the preparation of the people needed to conduct research, enhancing

access to research information and technology, and maximizing the sharing of discovery and collaboration among researchers and clinicians. The “opportunities” and “challenges” are articulated in

the NCI Bypass Budget that is sent to the President each year. For the FY2003 Bypass Budget, the

Institute identified the following:

Six areas of NCI extraordinary opportunities (o): # of RFAs/PARs

1. Genes and the Environment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .2/0

2. Cancer Imaging . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .2/2

3. Defining the Signatures of Cancer Cells: Detection and Diagnosis . . . . . . . . . . . . . . . . . . . .0/1

4. Molecular Targets of Prevention and Treatment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .2/6

5. Research on Tobacco and Tobacco-Related Cancers . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .2/2

6. Cancer Communications . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .1/1

In addition, eight NCI challenges (c) also were highlighted:

1. Enhancing Investigator-Initiated Research . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .1/0

2. Centers, Networks, and Consortia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .5/9

3. National Clinical Trials Program . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .4/1

4. Informatics and Information Flow . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .0/3

5. Studying Emerging Trends in Cancer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .0/0

6. Cancer Research Training and Career Development . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .1/6

7. Quality of Cancer Care . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .0/0

8. Reducing Cancer-Related Health Disparities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .0/0

As indicated above, in FY2003 these “opportunities” and “challenges” translated into a variety of

specific RFA or PAR initiatives, not only for academic research centers, but also for the small business community. Depending on the scientific discipline, reviews of initiatives tied to “opportunities” and “challenges” are managed and conducted by SRAs in one of the three review branches

NCI/DEA Annual Report 2003

6
NCI/DEA Annual Report 2003

7

of DEA: RTRB, RPRB, and SRLB. These review functions are highlighted in the narrative for

each branch that follows and shown in Tables 10 and 11.

Peer Review Functions

The review units in the DEA are responsible for organizing, managing, and reporting the scientific

peer review of applications for a wide variety of grant mechanisms. Three branches within the DEA

manage peer-review activities for NCI-reviewed applications. The Resources and Training Review

Branch (RTRB) has primary responsibility for review of applications for cancer centers, cancer training and career development, and cancer clinical trials, as well as for managing the corresponding five

subcommittees of the NCI Initial Review Group (IRG) (see Table 3). The Research Programs

Review Branch (RPRB), with primary responsibility for review of unsolicited applications for program project grants (P01s), for applications for Special Programs of Research Excellence (SPOREs)

in various organ sites, and for conference grant applications. The RPRB also manages the three subcommittees of the NCI IRG that are responsible for review of program project grant applications and

the internal NCI R13 Review Committee. These branches are primarily responsible for the peer

review of a variety of unsolicited multiproject and career development grant applications (see Table

2) and together manage the eight subcommittees of the NCI IRG (see Appendix B). The Special

Review and Logistics Branch (SRLB) organizes and manages peer review primarily for grant applications in response to specific RFAs, Program Announcements with special receipt dates and Institute

review (PARs), and contract proposals submitted in response to specific Requests for Proposals

(RFPs); all of these reviews are conducted by the SEPs. The review units in the DEA prepare the summary reports of the evaluations and recommendations for each site visit or review committee meeting

and distribute these reports to program officials, the NIH data management system, and NCI’s

Records Management Center. Details of the summary statements also are provided to the NCAB, as

required. Each primary Principal Investigator applicant receives a report in the form of the summary

statement.

Many of the reviews conducted by the RPRB and the RTRB involve complex, multidisciplinary

applications. The review format for these applications usually involves a two-tier review. The first

tier of the review is usually either a site visit to the applicants’ institution, an applicant interview in

the Washington, DC area, or a teleconference by an expert review panel; these provide an opportunity for the reviewers to question the applicants directly to clarify issues in the application, thereby

enhancing the review process. The review panel members prepare a draft review report, which is

then considered, along with the application, by the relevant subcommittee of the NCI IRG. Five of

the eight NCI subcommittees of the NCI IRG serve as the “parent committees” for final scoring of

applications after expert panel reviews: Subcommittee A is the “parent committee” for Cancer

Center Support Grant (P30) applications; Subcommittees C, D, and E are the “parent committees”

for Program Project (P01) grant applications; and Subcommittee H is the “parent committee” for

review of Cooperative Clinical Trials (primarily U10) applications. The other three subcommittees,

Subcommittees F, G, and I, review all of the career development, training, and education grant applications submitted to the NCI.

During FY2003, the eight subcommittees of the NCI IRG reviewed a total of 757 applications of various types with requests for a total of $511,104,255 in direct costs for the first year, and more than

$2,732,860,191 billion for all years (see Table 3). The FY2003 workload of the subcommittees

therefore represents an increase of approximately 13 percent in the number of applications reviewed
by the subcommittees, due mainly to the increased number of program project applications for

Subcommittee C and career development applications for Subcommittees F, G, and I.

Research Programs Review Branch

A significant proportion of the effort of the Research Programs Review Branch during FY2003 was

associated with the review of unsolicited P01 applications. The SRAs in the RPRB organized and

managed the review of 135 new, recompeting, amended, and supplemental P01 applications (see

Table 4). This represents a 15 percent increase over the number of P01 applications in FY2002, and

continues the growth trend in P01 workload that NCI has seen since 1999 (see Figure 2). The 135

applications requested more than $280 million in direct costs for the first year (see Table 6), an 86

percent increase over the P01 budget requests in FY2002. There were 123 program project applications reviewed by IRG Subcommittees C, D, and E, the three P01 subcommittees of the NCI IRG,

and 12 were reviewed by Special Emphasis Panels, due mainly to member conflicts with the IRG.

Seventy-three of the reviews involved site visits for new and recompeting applications (see Table 5).

In all, about 1,500 reviewers with expertise from the most basic cellular and molecular biology to

the most clinical cancer research areas were required for all of the individual P01 review panels

organized by RPRB SRAs.

During FY2003, the RPRB successfully continued several initiatives to improve review procedures

for applications for program projects. The Deputy Chief of the Research Programs Review Branch,

who is the P01 review coordinator for the DEA, and the SRAs for the IRG Subcommittees (C, D,

and E) responsible for program project review, organized the third annual joint orientation session

for new members of the committees in late July 2003. An orientation notebook, with policies, procedures, suggestions, and case studies, was provided for each new subcommittee member. This new

member orientation was followed by a plenary session of all of the reviewers on these three subcommittees; this session featured several exercises, led by the subcommittee SRAs, which were designed

to help the reviewers establish consistent scoring calibration standards that are applicable across the

three committees, regardless of scientific discipline. The outcomes of this plenary session were

more consistent review practices and scoring patterns across the three subcommittees and, therefore,

better information for NCI program staff to base funding decisions for program project applications.

This is important, because support of P01s accounted for approximately 11 percent of the entire NCI

extramural budget in FY2003.

During FY2003, RPRB senior staff and SRAs also were key participants in the NCI P01 Working

Group. As the P01 review workload reached record levels, this group was convened by DEA with

representation from DEA and the four NCI extramural program Divisions, to consider review

options for P01s for the future that would conserve reviewer time and effort, decrease the total number of reviewers required for the review panels, improve scoring consistency, decrease scoring compression, and reduce NCI costs associated with P01 review. RPRB staff first surveyed the members

of the three P01 review subcommittees and NCI program directors with significant P01 grant portfolios to identify the most important factors in peer review of P01s. There was overwhelming consensus among both reviewers and program directors that the expertise of the reviewers, the ability of

the reviewers to meet together face-to-face, and the ability to ask questions of the applicants, were

the most important aspects of the P01 review process. 

The P01 Working Group considered two options, streamlined site visits and clustered review of P01

applications, in depth. The streamlined site visit format included a set amount of time for presentaNCI/DEA Annual Report 2003

8
tions by applicants and questions by reviewers for each project and core proposed, and theoretically

allowed many of the site visits to be concluded in a day and a half. RPRB staff developed a streamlined agenda for P01 site visits, and pilot tested it for all site visits for the May 2003 NCAB review

cycle to prove feasibility. 

The cluster review option involves review of two to four P01 applications on closely related topics

by one review panel constituted with appropriate expertise; the review panel meets together and contacts each applicant group by teleconference to ask questions, but site visits and formal presentations

by applicants are discontinued. To address the feasibility of clustering applications, RPRB SRAs performed retrospective and prospective clustering exercises with P01 applications submitted for five

consecutive NCAB review cycles. In addition, RPRB SRAs also conducted a pilot cluster review of

three P01 applications proposing similar drug discovery research, and then surveyed the reviewers

and program staff afterward to determine their satisfaction with the process. RPRB staff also modeled the impact of adopting each of these potential review options on the number of reviewers

required and review costs. 

Although the streamlined site visit option saved reviewer time at most site visits, and was actually

adopted as the standard for site visits for the rest of FY2003, it would not reduce the number of

reviewers required, improve scoring consistency across review panels, or address scoring compression. The cluster review model addressed all of these issues more effectively. The analysis was presented to the P01 Working Group members, and culminated in a recommendation by the Working

Group to implement a 1-year trial of clustered review of P01s beginning with the February 1, 2004,

P01 application receipt date. This recommendation was approved by the NCI Executive Committee

in late July 2003, and was presented to the NCAB at its September 2003 meeting. As FY2003 came

to a close, RPRB SRAs therefore were revising the NCI P01 Guidelines and all P01 review instructions in preparation for implementing the new cluster review format in FY2004.

During FY2003, RPRB also had responsibility for the peer review of the applications received for

the NCI Special Programs of Research Excellence (SPORE) program. These large, complex multidisciplinary P50 research center applications focus on translational research directly applicable to

human disease in various organ sites. The SPOREs address the NCI Challenge for Centers, Networks, and Consortia by supporting multipronged approaches to cancer research in various organ

sites. During FY2003, the RPRB organized and managed Special Emphasis Panels for the review of

a total of 57 SPORE applications for research in leukemia, myeloma, genitourinary, prostate, lung,

pancreatic, skin, ovarian, and breast cancer. These 57 applications requested almost $138 million in

direct costs for the first year of support. As shown in Figure 2, the number of SPORE applications

reviewed by RPRB has grown by 470 percent since 1999 as awards in new organ sites were added,

but is beginning to level off as the program has almost reached its target number of awards and the

NCI prepares for smaller budget increases in the future. The SRAs who organize the SPORE reviews

routinely conduct orientation conference calls with all of the reviewers before the applications are

sent to the reviewers to explain the special features of the SPORE program and the special review

criteria for SPORE applications. Two RPRB SRAs also were key participants, with SPORE program

staff in the NCI Organ Systems Branch, in planning and facilitating the annual SPORE Investigators

Workshop. 

During FY2003, the RPRB also continued to conduct the reviews for R13 applications for support

for a wide variety of scientific conferences. The Chief of the RPRB organized the review of 76 applications by the NCI R13 Review Committee, which is composed entirely of NCI extramural staff.

NCI/DEA Annual Report 2003

9
This committee uses an innovative “virtual review” format to accomplish an accelerated review of

the conference grant applications four times a year, so that conference organizers can plan more

effectively. The 18 percent reduction in the number of R13 applications that were submitted for

review in FY2003 compared to FY2002 largely reflects the aggressive outreach efforts of the Chief,

RPRB, to educate the applicant organizations supporting conferences that NIH policy had changed

to allow multi-year requests for support of established annual and biennial conferences. Therefore,

rather than submitting applications to support such conferences every year, the organization can save

time and effort by submitting a request for support for 5 years. 

DEA also maintained a leadership role in the design and implementation of the Peer Review Module

of the new, central NIH extramural database, called IMPAC II, during FY2003. The Chief of the

RPRB, an SRA from the SRLB, and a support staff member from the RPRB served on the IMPAC

II Review Users’ Group (RUG) to test new programming for uploading final summary statements

into the database. An RPRB SRA served on the task force to design and test a new Internet-assisted review module that will be part of IMPAC II. This module allows reviewers to log in through the

NIH eRA Commons and post their preliminary critiques and preliminary scores on a secure Web site

prior to the review meeting. This system allows reviewers to preview the other critiques for their

assigned applications and helps to focus the discussions during the review meeting more effectively. In addition, an RPRB support staff member continues to serve on the trans-NIH User Group for

the Committee Management (CM) Module in the new NIH IMPAC II database system, and on the

working group designing a Web-based upgrade to the CM module. The CM module is a critical element in preparing for and reporting on peer reviews, and the User Group has identified resolutions

for problems and suggested several enhancements to the system. 

NCI/DEA Annual Report 2003

10

Calendar Year

Total P01 Applications Reviewed

Total P50 Applications Reviewed

145

125

105

85

65

45

25

5

1999 2000 2001 2002 2003

135

124

94

114

116

57 49

28

19

10

Number of P01 & P50 Applications

Figure 2. Number of P01 & P50 (SPORES) Applications Reviewed, 

1999-2003
NCI/DEA Annual Report 2003

11

Finally, RPRB staff contributed substantively to both NIH-wide and NCI DEA management studies

and initiatives. During FY 2003, the NIH initiated its first two large competitive-sourcing studies, as

required under OMB Circular A76: extramural support and facilities management. The Chief of the

RPRB served on the small team of senior NIH staff that developed and wrote the functional requirements, quality and timeliness standards for the competitive-sourcing study of support for all extramural program, review, and grants management offices at the NIH. This study involved the work

performed by more than 950 Full-Time-Equivalent government and contractor support staff and was

completed in less than one-half of the usual time. The resulting performance work statement was

included in the Request for Proposals, which was the basis for both the government staff’s Most

Efficient Organization proposal and for outside contractors to bid on the important support functions

that allow all NIH Institutes to accomplish their missions.

Resources and Training Review Branch

The Resources and Training Review Branch (RTRB), which administers five NCI IRG subcommittees (A, F, G, H, and I), has the responsibility for multidisciplinary cancer centers, cooperative clinical trials, institutional training and education grants, and career development awards. Staff members

from this branch also participate in the review of other funding mechanisms within the DEA. 

The reviews conducted by the committees within RTRB are of two types. For the complex, multidisciplinary applications, such as cancer center support grants (P30s) and multi-institutional clinical

trial cooperative group statistical center cooperative agreements (U10s), the review format generally involves a two-step initial review. The first step of the review has involved either a site visit to the

applicant institution or a presentation to a committee in the Washington area. Each group of experts

serves as a fact-finding body to update the application and to clarify issues in the application based

on discussion with the applicants. This first committee prepares a draft report that is presented,

together with the full application, for discussion, evaluation, and final scoring by the appropriate parent committee; NCI IRG Subcommittee A for cancer centers and Subcommittee H for clinical trials.

The U10 applications for support of the operational aspects of the clinical trial cooperative groups

are reviewed by applicant interview at the parent committee meeting, which eliminates a separate

trip for reviewers and, thus, reduces the reviewer burden. Scoring by a parent committee provides

for a more uniform evaluation of applications than scoring by individual review teams.

Shortly after his appointment as NCI Director, Dr. von Eschenbach established a P30/P50 Working

Group composed of leaders of the cancer research community, who are sensitive to issues facing both

peer reviewers and applicants. The purpose of the Group was to study the P30 Cancer Center Support

Grant (CCSG) together with the P50 SPORE award to determine how to continue supporting these

important methods of funding translational research in a more restricted funding environment. A final

report was presented to the NCAB in February 2003, and included some recommendations for reducing the burden on applicants and reviewers by decreasing the number and duration of site visits for

cancer centers. RTRB staff members who were involved in the review of P30 applications have discussed possible means of implementing these recommendations. In addition, the SRA for Subcommittee A made a presentation to the Cancer Centers Administrators’ Forum to obtain further

input on ways to streamline cancer center reviews. Implementation of any changes in response to the

Working Group Report awaits the development of an implementation plan. RTRB review staff have

instituted some modifications to the review process to reduce the burden on peer reviewers, including

poster sessions for shared resource presentations, uniform time limit for individual program presentations, staff selection of protocols for review, and simplified review of core budgets. The SRAs
NCI/DEA Annual Report 2003

12

involved in CCSG review will continue to interact with staff of the Cancer Centers Branch and will

be involved in the process for implementating the recommendations of the Working Group to help

revise the Guidelines, and improve the review of CCSG applications, while maintaining the rigor

needed for this important program. Review staff worked with staff of the Cancer Centers Branch on

modifications of the existing Guidelines for the CCSG, issued in September 2003, to incorporate

clarifications of language and changes in NIH policy.

During 2003, Subcommittee A reviewed 11 CCSG applications and 6 Cancer Center P20 Planning

Grant applications that fall within the focus of the second NCI Challenge for Centers, Networks,

and Consortia.

In September 2002, the NCI Office of Centers, Training, and Resources, Cancer Centers Branch, and

the National Institute on Aging (NIA) Geriatrics Clinical Oncology Program, Geriatrics Branch,

announced the availability of planning and development grants, through RFA CA-03-504, to develop and establish formal programs directed at the aging/cancer research interface within the NCI-designated Cancer Centers. The purpose of the research solicitation was to expand the capacity of the

NCI-designated Cancer Centers to engage in research that concentrates on aging- and age-related

aspects of human cancer in persons 65 years and older, which is the age group at highest risk for cancer as well as that in which the major tumors primarily occur. In response to the Request for

Applications, Planning and Development (P20) Grants Integrating Aging and Cancer Research in

NCI-Designated Cancer Centers, 24 applications were received. These applications were evaluated

by a multidisciplinary Special Emphasis Panel review team, consisting of 33 members with clinical,

basic science, and population-based research expertise in cancer and/or aging research. Subcommittees F and G had been reviewing all education, training, and career development grant applications within the DEA. These applications include a large number of different funding mechanisms

divided between Subcommittee F (T32, K01, K08, K22) and Subcommittee G (R25, K05, K07, K22,

K23, K24). Each of these sets of applications was reviewed in one meeting by the chartered committee supplemented by temporary reviewers with appropriate expertise to ensure that every application is evaluated by experts in its field.

The number of institutional training grant and individual career development applications being

reviewed continued to grow (see Figure 3). Between 1999 and 2003, the number of career development applications reviewed in DEA increased by 56 percent (261 to 417), while the number of

training and education grant applications increased 20 percent (136 to 165). The first-year direct

costs for these applications similarly increased from $23.9 million in 1999 to $48.4 million in 2003

for career development and from $26.1 million to $50.0 million in 2003 for training and education.

This is due, in part, to the increased number of mechanisms available and to the increased information disseminated about them. To reduce the burden on the Subcommittee F reviewers, who had an

extremely high number of applications at each review meeting, a third committee was formed. To

provide for continuity in process and scoring, the membership of the existing Subcommittee F was

split between the ongoing Subcommittee F and the newly formed Subcommittee I. Similarly, the

review responsibilities were divided so that Subcommittee F now focuses on T32 and K01 applications and Subcommittee I focuses on K08 and K22 applications. The number of applications continues to grow demonstrating the wisdom of creating the new committee. In addition, the number of

applications submitted to Subcommittee G has reached new highs increasing by 21 percent from

FY2002 to FY2003, creating a severe review load for the members of the committee. RTRB staff

are exploring ways to address this issue.
NCI/DEA Annual Report 2003

13

The many applications for training, education, and career development awards support the NCI

Challenge for Cancer Research Training and Career Development. It is of particular interest

to note that among the applications reviewed are those that were submitted in response to four

ongoing initiatives for minority candidates, clearly within the NCI Challenge for Reducing

Cancer-Related Health Disparities.

Another issue of concern with regard to the applications reviewed by Subcommittees F and G was

the compression of scores. This made it more difficult for funding decisions to be made because many

applications received scores that were very close to each other. In addition, it was misleading to applicants because scores that appeared numerically to be very favorable may in fact have been ranked in

a low percentile of all the applications of its type. To address this concern, a new scoring paradigm

was developed in which reviewers were asked to rate, across the full rating scale, each application on

its merit relative to the full population of applications of its type. Reviewers also were encouraged to

rate as unscored any application that they judged to be in the lower half of applications of its type.

These unscored applications received the reviewers’ comments, but the meeting duration was shortened by not discussing them at the meeting. Using these new procedures, the median score for the

committees improved significantly, with a fuller range of scores used. Fewer applications were rated

as better than 150, and a sufficient number were rated as unscored to reduce the meeting’s length.

The SRA for Subcommittee H (Clinical Cooperative Groups) continues to work closely with the staff

of the Clinical Investigations Branch of the NCI Clinical Trials Evaluation Program (CTEP) to update

the Clinical Trials Cooperative Group Program Guidelines. All the activities of this subcommittee

Figure 3. Number of Career Development (CD) and Training and Education (T&E) 

Applications Reviewed, 1999-2003

Calendar Year

1999 2000 2001 2002 2003

Total CD Applications Reviewed

Total T&E Applications Reviewed

450

400

350

300

250

200

150

100

261

312

338

395

417

165 160

185

147

136

Number of CD & T&E Applications
NCI/DEA Annual Report 2003

14

support the NCI Challenges for the National Clinical Trials Program and Improving the

Quality of Cancer Care.

To reduce the reviewer burden of the prior review format, the SRA has been actively involved in the

pilot of a new review format for the Clinical Cooperative Groups. The pilot review format involves

a direct presentation by the group under review to Subcommittee H, after an onsite review of their

statistics and data management centers. The pilot was viewed as a success by all parties: reviewers, applicants and NCI program staff. Financial evaluation of the pilot project is underway.

During this year, four competitive Clinical Cooperative Groups were reviewed, and components/

committees from two other Clinical Cooperative Groups that had received less than excellent evaluations at their initial review were evaluated.

Special Review and Logistics Branch

The Special Review and Logistics Branch (SRLB) has a prominent role in the outcome of NCI

opportunities and challenges, because it organizes and manages peer review primarily for grant

applications submitted in response to specific NCI RFAs and most special PARs, as well as for contract proposals submitted in response to specific Requests for Proposals (RFPs); most of these

reviews are conducted by SEPs.

Following approval by the NCI Executive Committee and BSA (unlike RFAs, PAs are not approved

by the BSA), program staff—assisted by the Program Coordination and Referral Branch—generate

the initiatives that are published in the NIH Guide for Grants and Contracts.* In an RFA, a specific, published dollar amount is set aside by the Institute, while in an Institute PAR (Institute Reviewed

Program Announcement) there is no dollar set-aside and no requirement for BSA review. Tables 7

through 12 summarize the NCI RFAs, PAs, and PARs published and the RFAs and PAs reviewed by

DEA in FY2003. SRLB reviewed the RFAs identified in Table 10. Tables 11 and 12 represent those

applications submitted in response to PAs or PARs, the review of which is shared by SRLB, RPRB,

and RTRB. In these tables, the title of the initiative is tied to one of the specific opportunities (o)

or challenges (c) identified on page 6.

In February 2003, the NCAB concurred with the review results of 26 SRLB-reviewed initiatives, 22

of which were directly related to the Bypass Budget; in June 2003, 18 of 20 RFA/PAR initiatives

were related to the Bypass Budget; and in September 2003, 29 of 36 RFA/PAR initiatives were related to the Bypass Budget. SRLB professional staff contacted 3,394 potential reviewers and had 1,120

of them accept.

Breadth of Peer Review

A general theme that has been applied to all recent NCI initiatives—PAs, RFAs, and Broad Agency

Announcements (BAAs)—is that the widest possible net should be cast in the search for quality science. NCI IRG subcommittees increasingly serve as the locus for peer review of applications

assigned to the NCI. In the past, most PAs for single-project research grant mechanisms (R01, R03, 

R21) were directed to the CSR for evaluation. Over the last several years, however, increasingly specialized requirements of NCI initiatives have led to the need for specific kinds of expertise not routinely found in depth on the standing CSR study sections. This has led to the issuance of more PARs,

* Because of the importance of allowing adequate time for the applicant community to respond to NCI’s initiatives, it is to be expected that the results of some initiatives may be funded (or reviewed by the NCAB) in subsequent fiscal years.
for which ad hoc peer-review groups with discipline-appropriate expertise (as provided by SEPs) are

specifically recruited. Considerable effort is required to recruit a wide range of individuals with the

expertise to cover all aspects of an initiative.

Many of the NCI extraordinary opportunities and challenges involve the development of New

Technologies for Cancer Imaging, and Initiatives for Informatics and Information Flow. The

NCI developed a new grant mechanism, the R21/R33 phased application awards, for the support of

innovative exploratory/developmental studies, which can rapidly move to proof-of-principle

research studies if the stated milestones are met. This grant mechanism is well suited for technology development, and the number of Program Announcements and grant submissions for these initiatives have greatly expanded in the past 5 years. In 2003, 234 R21/R33 grant applications were submitted under five Program Announcements, which was a growth rate of 119 percent as compared to

1999 when the grant mechanism was first started. In addition, SBIR/STTR Program Announcements

in these same research areas saw an increase in the number of grant applications from 57 to 142,

which was a growth rate of 149 percent (see Figure 4).

Additional highlights of SRLB reviews for FY2003 include two major initiatives. The first was the

Loan Repayment Program (LRP), that generated 244 applications for the May 2003 NCAB (See

Table 17). The LRP is a Congressionally mandated program whose intent is to forgive outstanding

loan balances for clinician scientists who intend to pursue careers in general clinical or pediatric

research. Applications are submitted electronically to the NIH Loan Repayment Office, which then

NCI/DEA Annual Report 2003

15

 R21/R33 Applications Reviewed

SBIR/STTR Applications Reviewed

234

209

188

123

107

142

145

144

115

57

1999 2000 2001 2002 2003

250

230

210

190

170

150

130

110

90

70

50

Calendar Year

Figure 4. Technology Initiatives (Phased Innovation and SBIR/STTR) 

Applications Reviewed, 1999-2003

Number of R21/R33 and SBIR/STTR Applications
refers the proposals to the individual Institutes. This initiative is unique, in that all of the proposals

are submitted electronically and are classified as contracts. Instead of conducting a face-to-face

meeting to review these proposals, SRLB staff conducted a virtual meeting in which assigned

reviewers submitted their evaluations and scores electronically. A total of 138 potential reviewers

were contacted and 84 actually served. Of the 244 proposals reviewed, 92 clinical and 25 pediatric

proposals were funded by the Institute.

The other significant project was the BAA (a contract initiative) for Novel Technologies. This initiative was modeled after the long-range research projects of the Defense Advanced Research Projects

Agency (DARPA), one of which developed into the Internet. To elicit participation of technologyoriented firms, measures were applied in accordance with the Procurement Integrity Act regarding

the confidentiality of the information submitted. This made the initiative a hybrid—part investigator-initiated research and part contract—which complicated the review process and necessitated the

use of a waiver from the usual conflict-of-interest provisions.

In addition to the BAA and LRP described above, the SRLB reviewed 19 RFPs (contract initiatives).

Eleven of those 19 RFPs were part of the Omnibus Solicitation for Small Business Innovation Research (SBIR). RFPs are proposals in which several elements of each proposal are individually evaluated and scored, with the combined score indicating the overall merit. After negotiations, contract

awards result from the RFP solicitation. The list of RFPs reviewed in FY2003 is shown in Table 17.

Grant Funding Trends

In Table 13, a comparison is made of the average cost and number of NCI R01 and P01 grants

awarded in FY1999 through FY2003 according to extramural division. Table 14 presents a summary for FY2003 of total funding of NCI grant awards by mechanism. Trends in grant funding

according to scientific discipline and organ site are described on page 27 and in Tables 15 and 16.

NCI/DEA Annual Report 2003

16
NCI/DEA Annual Report 2003

17

Supporting Peer-Review Consultants

Ensuring that highly qualified individuals are available for expert review of grant applications and

contract proposals requires an efficient administrative support system. The DEA’s Scientific Review

and Evaluation Award (SREA) Office, residing within the Committee Management Office (CMO),

supports the NCI peer-review process by compensating consultants for their services on the NCI IRG

subcommittees or SEPs and by reimbursing them for their travel and other expenses (see Appendixes B and C). The SREA Office also approves and processes payments for other activities related

to review, including contract-supported ticketing services. During FY2003, the SREA Office authorized 4,308 consultant reimbursement vouchers and 739 nonconsultant vouchers for travel ticketing,

meeting room rental, and teleconferences.

During FY2003, the SREA Office continued to work with a contractor to further develop the program that allowed retrieval of Financial Operating Plan (FOP) data from IMPAC II (an NIH-wide

committee management database). The IMPAC II Committee Management Voucher Module is now

fully operational, and the SREA Office utilizes IMPAC II for the generation of all consultant and

nonconsultant voucher reimbursements, FOPs, and Internal Revenue Service Form 1099 reports.

Also, during FY2003, the SREA Office worked with the contractor to develop a program that will

allow retrieval of financial and consultant reimbursement information from IMPAC II, established

the new checkwriting process for NCI, and streamline the reconciliation process.

The SREA Office took over checkwriting activities and began processing checks with the new 2003

Fiscal Year, anticipating processing checks two times per week, to allow quicker voucher reimbursement to consultants.

The SREA Coordinator continues to join other NIH Institute SREA Offices to participate in the

ongoing NIH SREA Coordinating Committee. This group meets bimonthly to discuss SREA procedures and has finished working on the first Standard Operating Procedure (SOP) for the NIH SREA

community to standardize procedures and provide guidance and consistency within the SREA offices

and among all of the Institutes. Also, the committee revised and published an update to the NIH

Manual Issuance 4705, which is the first update in 20 years.

In addition, the SREA Office advises consultants, NCI staff, and the SREA trustee on policies and

procedures; performs the administrative tasks related to setting up, managing, monitoring, and closing out accounts; and prepares expenditure reports, including those required by the NIH Office of

Financial Management for 1099 tax forms and those requested by the CMO for the NCI FOP, consultant services, and financial management reports for IRG, SEP, and SREA.

This little-known administrative function is critical to the success of the peer-review system because

any error, inconvenience, or delay in reimbursement that reviewers experience is likely to discourage their future service. Excellent customer service remains a constant goal of the NCI SREA staff,

whose Vision Statement is: “We take ordinary requests and provide extraordinary results.” 
NCI/DEA Annual Report 2003

18
NCI/DEA Annual Report 2003

19

DEA’s Role in Advisory Activities

Beyond its central role in coordinating the peer review and referral of grants, perhaps the most farreaching role the DEA plays across the NCI is the coordination and administration of NCI’s eight

chartered Federal advisory committees (see Appendix B). The activities of these advisory bodies are

coordinated by the Office of the Director, DEA, and the Committee Management Office, DEA. A

primary responsibility of the DEA is coordination of the activities of the NCAB, whose members are

appointed by the President and whose responsibilities include conducting the second-level review of

grants and cooperative agreements, as well as advising the NCI Director on policy for the conduct

of the National Cancer Program. The DEA also coordinates administration of the BSA, the body

responsible for the oversight and concept review of the extramural programs and initiatives of the

NCI. As such, the DEA plays a major role in the development and issuance of PAs, PARs, and RFAs,

the major extramural program initiatives used by the NCI. The DEA Director serves as Executive

Secretary to the NCAB, and the Deputy Director, DEA, serves as Executive Secretary to the BSA.

(See Appendixes D and E for highlights of the activities of these Boards in FY2003.)

Each year, the NCI relies on thousands of individuals with special expertise to advise and support

staff in its mission to win the war against cancer. These individuals provide advice and guidance to

NCI staff on countless research projects, scientific concepts, and programmatic and administrative

issues relating to its research initiatives and priorities. During FY2003, a total of 2,553 consultants

were asked to serve as standing, temporary, and ad hoc members on NCI’s chartered advisory committees, panels, site visits, and work groups. Under the various chartered committees, working

groups were formed to address several important areas of cancer research related to diverse populations, and cancer advocacy, treatment, prevention, communication, and education. (See Appendix B

for a list of chartered committee members and Appendix C for a list of consultants.)

Major NCI Advisory Bodies Administered by the DEA

National Cancer Advisory Board. NCI’s principal advisory body is the Presidentially appointed NCAB.

The Board advises the DHHS Secretary and the NCI Director on issues related to the entire National

Cancer Program and provides a second level of review for grant applications referred to the NCI.

Board of Scientific Advisors. The BSA represents the scientific community’s voice in NCI-supported

extramural science. The Board, composed of distinguished scientists from outside the NCI and representatives from the advocacy community, advises the NCI leadership on the progress and future

direction of the Institute’s Extramural Research Program. The Board evaluates NCI extramural programs and policies and reviews ideas for new research opportunities and solicitations, to ensure that

a concept is meritorious and consistent with the Institute’s mission.

The BSA believes it is important to interact with and receive feedback from the clinical, population

science, and laboratory research communities that are affected by NCI policies. To this end, the NCI

has established BSA-sponsored “NCI Listens” sessions at national association meetings (see Appendix B, page 51). BSA members and NCI staff invite conference participants to join them for these

sessions. A brief presentation is given by NCI staff emphasizing the status of grant funding, the

Bypass Budget, and the status of several new initiatives. The brief presentation is followed by an

open question-and-answer period. The NCI is committed to providing a written response to the scientific society hosting the meeting concerning issues raised during the session. The BSA hopes that

conference participants will take advantage of this opportunity to raise their concerns.
NCI/DEA Annual Report 2003

20

Board of Scientific Counselors. The BSC, managed through the Office of the Director (OD), NCI,

advises the Institute leadership on the progress and future direction of NCI’s Intramural Research

Program residing in the Center for Cancer Research (CCR) and the Division of Cancer

Epidemiology and Genetics (DCEG). This group of scientific experts from outside the NCI evaluates the performance and productivity of NCI staff scientists through periodic site visits to intramural laboratories and provides evaluation and advice on the course of research for each Laboratory and

Branch.

NCI Initial Review Group. The IRG, composed of eight subcommittees, reviews grant and cooperative

agreement applications for centers, research projects, and research training activities in the areas of

cancer cause, diagnosis, treatment, and prevention, as well as contract proposals relating to all facets

of cancer. Members may be appointed as standing committee members with overlapping terms of up

to 4 years, or as “temporary” members with all the rights and obligations of committee membership,

including the right to vote on recommendations in which the individual fully participated as a

reviewer for a specific meeting. Consultants also may be invited to serve as special experts or ad hoc

members, to provide information or advice. These individuals generally serve in site visit groups,

providing critical information to the chartered advisory subcommittees responsible for initial peer

review.

NCI Special Emphasis Panels. The SEPs advise the Director, NCI, and the Director, DEA, regarding

research grant and cooperative agreement applications, contract proposals and concept review relating to basic and clinical sciences, and applied research and development programs of special relevance to the NCI. Membership of an SEP is fluid, with individuals designated to serve for individual meetings rather than for fixed terms. These individuals have all of the rights and obligations of

committee membership, including the right to vote on recommendations.

Program Review Groups. As part of an ongoing process of review and revitalization, the NCI instituted a series of external reviews to guide it in strengthening major research support programs. Program

Review Groups, coordinated by the DEA as an activity of the BSA, examine the NCI extramural programs and their infrastructures to evaluate whether changes are necessary for the Institute to be in a

position to effectively guide and administer the needs of the science in the foreseeable future. (See

http://deainfo.nci.nih.gov/advisory/bsa/bsa_program/bsaprgr.htm.)

Progress Review Groups. As part of its overall responsibilities for committee management functions

and coordination of advisory groups, the DEA assists other NCI offices with additional types of oversight activities. Progress Review Groups, managed by the Office of Science Planning and Assessment within the OD, NCI, are created to provide their expertise, biomedical research information,

and assistance to NCI chartered advisory committees in defining and prioritizing the national

research agenda for particular cancers—including breast, prostate, colorectal, brain, pancreatic,

leukemia, lymphoma, myeloma, and lung—by: (1) identifying new or unmet scientific opportunities; (2) reviewing an NCI analysis of its current research program; and (3) using the ongoing activities as a baseline, providing expert opinions on how to address the research opportunities and hasten progress against the disease. These groups report to the NCI through a chartered Federal advisory committee. (See http://deainfo.nci.nih.gov/advisory/pog/progress/index.htm.)
NCI/DEA Annual Report 2003

21

Committee Management Activities

The Committee Management Office (CMO) is the DEA administrative unit that coordinates the

general administration of the NCI’s chartered Federal advisory committees. The CMO provides

advice related to the provisions of the Federal Advisory Committee Act (FACA) and other Federal,

Department of Health and Human Services (DHHS), and NIH regulations governing the actions of

NCI staff who manage advisory committees. It coordinates the activities of advisory committees

across the NCI and ensures that NCI staff comply with Federal advisory committee policy.

Additionally, the Office of the Director (OD), DEA, and the CMO provide guidance and information to staff and external groups on specific NIH policies related to the operation of working groups

and ad hoc consultants operating under the direction of some of NCI’s chartered Federal advisory

committees. NCI working groups provide scientific expertise through chartered committees to the

NCI Director and Division Directors on a range of matters related to the National Cancer Program.

The Office works closely with the other DEA offices to coordinate activities with NCI advisory committees; implements policies and procedures designed to avoid conflicts in the nomination and selection of board members; implements policies and procedures to ensure compliance with DHHS and

NIH regulations governing the operation of chartered advisory bodies; advises on issues related to

conflicts of interest, selection and recruitment of viable committee members, and management of

committee records; provides logistical support for NCAB and BSA meetings; and facilitates committee-related travel.

CMO staff continue to participate in various NIH-wide Information for Management, Planning,

Analysis, and Coordination (IMPAC II) software application user group meetings and pilots, including participation on the NIH Committee Management-Joint Application and Development Group

(CMJAD) slated to provide advice on the redesign of the Committee Management Module. The

IMPAC II Module is being redesigned as a Web-based application and will be a more user-friendly and

intuitive system. In FY2003, the CMO continued to develop in-house IMPAC II training information,

developed new guidelines geared towards assisting NCI staff in efficiently using the IMPAC II system,

and conducted training for users of the system. Additionally, CMO and SREA staff gave presentations

to NCI staff on management of Federal Advisory Committees and the Scientific Review and Evaluation

Award and they participated in the revision of NIH Manual Policy 1810-1, Procedures for Avoiding

Conflict of Interest for NIH Special Government Employee (SGE) Advisory Committee Members.

The CMO also became a Committee Management Service Center and is providing committee management services to the Office of Biotechnology Activities (NIH Office of the Director) for the Secretary’s

Advisory Committee on Genetics, Health and Society. This committee reports to the DHHS Secretary.

CMO staff also participated in a stringent review of committee management support staff functions for

an A-76 review. 

In concert with the automation of the NIH-wide committee management functions, the CMO continued to work closely with other DEA staff to streamline general committee management and

review procedures related to member travel, vouchering, mail review, and teleconference reimbursements. The same procedures were used to facilitate more effective management of all other NCI

chartered advisory committees.

In addition, the DEA CMO continued to conduct briefings with the NCI Divisions, the Offices of

Liaison Activities, and NCI management on the use of working groups associated with chartered

committees. The CMO was actively involved in the guidance and support of various NCI working
NCI/DEA Annual Report 2003

22

groups and NIH employee working groups related to the IMPAC II Module, the Data Quality and

Control Initiative, and the SREA Coordinating Committee. Additionally, CMO staff participated in

NIH Committee Management work groups and the Committee Management Users Group charged

with redesigning the IMPAC II Module. 
NCI/DEA Annual Report 2003

23

Extramural Policy and Program Development

An important part of the DEA’s mission is to provide effective and timely coordination of program

initiatives from the initial concept stage through publication of RFAs, PAs, and RFPs, and finally,

through the peer review of grant applications and contract proposals. The NCI’s activity in this arena

has grown, in proportion to the generous budget increases received by the Institute, to the point

where a central unit, the Office of Referral, Review, and Program Coordination (ORRPC), was

established within DEA for coordination of NCI program development, issuance, and review activities. ORRPC is responsible for: (1) coordination and management of review activities for grants,

cooperative agreements, and contracts for the Institute; (2) development of NCI policies and procedures as related to review of grants and contracts; (3) coordination of the second level of review with

the National Cancer Advisory Board; (4) development of referral guidelines and grant referral to NCI

programs; and (5) coordination of the development, preparation, clearance, and issuance of special

NCI initiatives, including program announcements, requests for applications, and extramural policy

statements through the NIH Guide to Grants and Contracts. ORRPC coordinates the activities of the

Program Coordination and Referral Branch and the three review branches, Special Review and

Logistics Branch, Resources and Training and Review Branch, and Research Programs Review

Branch. At each stage of the development of new initiatives, DEA’s ORRPC facilitates this coordination across the NCI’s extramural Divisions, other NIH Institutes, and other relevant agencies of

the Federal Government.

The DEA manages and coordinates the BSA, which is charged with the concept review of all new

and reissued RFAs and RFPs (see Appendix E). In addition, the DEA tracks new initiatives proposed

by other Institutes and agencies to consider possible NCI participation. The success of this operation

is dependent on the development of clear Institute referral guidelines, also a DEA responsibility.

Before the publication of an initiative, the DEA negotiates with the CSR, DEA review units, and

other offices to coordinate scheduling, timelines, and workloads. Concepts for PAs do not require

BSA approval, but are considered instead by the NCI Extramural Division Directors Committee.

Through the OD, the DEA conducts continual evaluation of program initiatives and coordinates policies and procedures to ensure that all aspects are as clear and accessible as possible to staff, advisory groups, and applicants. To facilitate this evaluation, the ORRPC, with the technical assistance of

Applied Information Systems Branch (AISB), manages Web-based information systems to provide

key information on new initiatives. This Web-based information system includes early notice of

approved concepts, listings of active PAs and recently published RFAs, and policies related to the

clearance of new program initiatives. This information is provided in both public Internet and NCI

limited-access Intranet versions (http://deainfo.nci.nih.gov/funding.htm).

Tracking and Coordinating Program Activities

The program coordination responsibilities of the DEA, in cooperation with NCI Extramural Program

Divisions, extend to the development of all new extramural program guidelines. The DEA manages

this activity in communication with the originating NCI program and the NIH Office of Extramural

Research. To maintain consistency and completeness, all new NCI guidelines are centrally edited

and cleared through the DEA before being forwarded for NIH approval and publication in the NIH

Guide for Grants and Contracts. Because most program staff have limited experience in crafting an

initiative in the precise format required by the Public Health Service (PHS) rules and regulations, the
NCI/DEA Annual Report 2003

24

services provided by the DEA in preparing such announcements materially speeds their release,

often shortening the process by a month or more. Another program coordination activity is the development of referral guidelines for assignment of grant applications to the NCI. These guidelines, included in the Referral Guidelines for Funding Components of PHS, are critical to the development of program initiatives across the NIH, as well as to the prompt referral of unsolicited grant applications to the

NCI. These guidelines differ from the internal referral guidelines, which also are coordinated by the

ORRPC. The internal referral guidelines are vital to the prompt referral of grant applications to the

appropriate NCI program areas.

In addition to program coordination, the DEA has developed and maintained a Web-based information tracking system to provide NCI staff with all essential information on program initiatives, from

concept through publication of the full text, with the ultimate goal of tracking outcomes. In addition

to the Intranet version for NCI staff, extramural scientists have access to an Internet version of published initiatives.
NCI/DEA Annual Report 2003

25

Information Resources Management

The Applied Information Systems Branch (AISB) provides integrated computer support, applications, and information systems development to the DEA. The AISB monitors the DEA Web Site, supports the Division’s Intranet server, designs and maintains Division-specific software applications, provides oversight of hardware and connectivity, and serves as liaison with the Center for Information

Technology (CIT) and NCI central units. Its mission is critical to the future of the Division in communicating both internally and externally current information technology activities and new developments

with all components of the NCI, NIH, and reviewer and applicant communities.

All of the Division’s Information Technology and Information Systems contracts are consolidated

under the AISB. The AISB has a computer support team to track staff requests, manage the Division’s

computer equipment inventory, and provide computer-related training, as needed. Specific projects

utilizing the technologies and services provided by the AISB are described under the appropriate functions of the DEA throughout this report. For FY2003, the following specific accomplishments are

highlighted:

y Implemented a new search engine for the DEA Internet Web Site. This search engine is provided by FirstGov.gov. Enhanced the existing search engine for the DEA Intranet Web Site.

y Developed a prototype version of the A-Z Extramural Policies Web Site. This Web site provides

a comprehensive alphabetized list of links and references to various sources of extramural policies and procedures.

y Developed a prototype version of the Glossary and Definitions Web Site. This Web Site provides cross-reference among terms, definitions, and acronyms used in the NIH/NCI extramural

activities arena.

y Enhanced and upgraded the Fiscal-Linked Analysis of Research Emphasis (FLARE) by adding

new features. Started consolidation and reorganization of about 125 reports generated by the

FLARE application.

y Completed the production version of a Web-based software application for DEA review staff to

enable the merging of IMPAC II data into MS Word or Corel WordPerfect documents and

labels.

y Consolidated and reconfigured database and Web servers and DEA Web Sites, and reorganized

the DEA server room to improve access and maintainability.

y Performed enhancements, upgrades, and maintenance on the following production systems:

Extramural Science Administrator Training Tracking System (ESATTS); Reviewer CDs; BSA

(Board of Scientific Advisors) Reports; DEA Annual Reports Web Site; Program Coding

System; IRG (Initial Review Group) Books Reports; NCAB (National Cancer Advisory Board)

Early Concurrence Web Site; and the DEA Computer Inventory and Tracking System.

y Started development of an enhanced concept-tracking system for the NCI that will combine the

functionality of the existing RFA/PA Tracking System and the BSA Concept Reporting System.
NCI/DEA Annual Report 2003

26

y Began conversion of batch data transfer programs and DEA staff reports to the Java programming language. This will result in more reliable and maintainable programs.

AISB staff are involved with many NCI and NIH information systems and information technology

groups and organizations, including:

y NCI Office of Information Systems and Computer Services

y NCI Information Systems Advisory Group

y NCI Change Management Group

y NIH Electronic Council Book Steering Committee

y IMPAC II Joint Applications Development and Critical Design Review Groups

y NIH Architecture Review Board

y NIH Automatic Data Processing Extramural Coordination Committee.
NCI/DEA Annual Report 2003

27

Portfolio Tracking and Analysis

The DEA’s Research Analysis and Evaluation Branch (RAEB) serves as the officially designated

locus and contact for scientific information that is associated with NCI-supported research. The NCI

needs consistent budget-linked scientific information across all of its scientific programs to facilitate

analysis of the Institute’s portfolio, provide a basis for budget projections, and serve as a resource

for the NCI to disseminate information about cancer. The DEA conducts analyses to project future

NCI research expenditures and to provide budget justifications to Congress. The work of the RAEB

allows the DEA to respond immediately to daily requests for information from NCI staff, the broader NIH community, and requesters nationally and even sometimes worldwide. The Branch also performs specialized custom searches on request. 

These capabilities are based on a sophisticated system of indexing, in which Research Documentation

staff analyze grant applications to classify each project for its degree of relevance to Special Interest

Category (SIC) and Organ Site Codes. The number of categories assigned to an individual grant varies

from fewer than 10 to more than 50. SIC Codes are meant to describe in a consistent way the major

scientific disciplines that are of stated or growing interest to the NIH, DHHS, Congress, and the public. SIC Codes are added throughout the year to retain currency with these interests.

In FY2003, RAEB added new SIC Codes for Tissue Engineering and Physical Activity. The Branch

assumed responsibility for indexing all AIDS projects with AIDS Mason Codes, Special Interest

Categories, and Strategic Planning Codes. In FY2003, RAEB indexers profiled more than 2,900

unfunded applications. The process of indexing unfunded applications, begun in FY1999, has greatly expanded the potential for analysis of the major categories found in these applications. RAEB

Research Documentation staff profiled more than 2,200 funded grants and contracts in FY2003. A

critical characteristic of these data is comparability from one fiscal year to the next. Changes in funding between FY2002 and FY2003 for selected SIC Codes and organ sites are presented in Tables 15

and 16.

In FY2003, RAEB Technical Operations staff continued to work with contractors and AISB to refine

the FLARE computer application, and managed the FLARE module for computerized calculation of

indexing for Clinical Cooperative groups, Community Clinical Oncology Program, P30 Centers

grants, and U01 Clinical Trials. The staff oversaw the elimination of paper grant handling and now

almost exclusively use E-Grants online documentation. Staff also managed the integration of

GENIUS mainframe files from ’62-’89 into the FLARE database and the upgrade of microfiched

archive files to CDs. 

Highlights of FY2003 include:

y RAEB indexers profiled more than 2,900 unfunded applications.

y RAEB staff indexed more than 2,200 funded grants and contracts.

y RAEB added new Special Interest Categories for Tissue Engineering and Physical Activity.

y RAEB assumed responsibility for indexing AIDS Mason Codes, Special Interest Categories,

and Strategic Planning Codes.
NCI/DEA Annual Report 2003

28

y RAEB eliminated use of paper grant applications, and now index from electronic files available

on E-Grants.

y RAEB managed the integration of GENIUS mainframe files dating from ’62-’89 into the

FLARE database.
NCI/DEA Annual Report 2003

29

Special Activities in the Office of the Director, DEA

In addition to managing and coordinating the various activities described in this report, the DEA’s

Office of the Director (OD) has specific additional responsibilities to the NCI. First, the OD serves

as a focal point and repository of information related to various funding mechanisms for grants, staff

and awardee responsibilities, eligibility requirements, receipt dates for all granting mechanisms, and

special programs. The DEA serves as the coordinating center for submission of applications for special NIH-wide awards, such as the James A. Shannon Director’s Award, the Academic Research

Enhancement Awards (AREAs), the Institutional Development Awards (IDeAs), and the Research

Enhancement Awards Program (REAP).

Second, the DEA OD plays a critical role in the NCI’s efforts to promote increased participation of

women, children, and members of minority and medically underserved populations in the research

areas of cancer cause, prevention, control, diagnosis, and treatment. The NCI Revitalization Act of

1993 mandates that women and members of minority groups be included as subjects in each research

project, unless there are clear scientific or ethical reasons that inclusion is inappropriate with respect

to the health of the subject or the purpose of the research. Administrative procedures allow NCI staff

to resolve inclusion problems after initial review of applications that are otherwise highly meritorious. In the event a grantee believes the proposed study does not warrant or require inclusion of

women or minority groups, he or she can apply for a waiver of this requirement. The Director of the

DEA has the authority to grant this waiver. In FY2003, 65 applications with preliminary bars to

award were received by the DEA. Through corrective action, all were brought into compliance

before award decisions were made.

Third, the DEA Director serves as the locus for implementation and oversight of NCI policies concerning extramural research integrity and serves as a resource to all NCI staff with questions in this

area. In this role, the DEA OD works to address concerns about extramural scientific misconduct,

misuse of human and animal research subjects, financial mismanagement, and financial conflict of

interest involving NCI-supported research. Thus, the DEA Director functions as the NCI Research

Integrity Officer and receives from the appropriate sources all documents related to misconduct for

transmittal and reporting to relevant sources. In FY2003, five cases of alleged scientific misconduct

were opened by the Office of Research Integrity and referred to the Director, DEA. Five cases were

closed, and one was found to involve misconduct.
NCI/DEA Annual Report 2003

30
NCI/DEA Annual Report 2003

31

Organizational Structure of the Division of Extramural Activities

Office of the Director

y Directs and administers the operations of the Division, including those activities relating to grant

review and administration and contract review, as well as Advisory Committee and Board activities.

y Coordinates and manages the NCAB and the BSA.

y Initiates, coordinates, and implements Institute policies and procedures relating to grants and

contracts review.

y Implements NCI policies regarding extramural research integrity.

y Represents the NCI on extramural policy issues to the NIH.

y Advises the Executive Committee, NCI, on extramural implementation strategies.

y Coordinates with the NIH for all NCI extramural staff training requirements.

y Represents the NCI on the NIH Institute-wide Extramural Program Management Committee

(EPMC) with responsibility for development of extramural policy and procedures across all NIH

Institutes and Centers.

Marvin Kalt, Ph.D.* . . . . . . . . . . . . . . . . Director

Paulette Gray, Ph.D. . . . . . . . . . . . . . . . Acting Director

Deputy Director and Associate Director, 

Extramural Applications

Diane Bronzert . . . . . . . . . . . . . . . . . . . Associate Director, Referral, Review, and Program Coordination

Cedric Long, Ph.D. . . . . . . . . . . . . . . . . Assistant Director

Elise Kreiss . . . . . . . . . . . . . . . . . . . . . . Senior Program Analyst

Patricia Marek . . . . . . . . . . . . . . . . . . . . Program Analyst

Carlene Neil-Allman† . . . . . . . . . . . . . . . . Program Analyst

Carolyn Craig . . . . . . . . . . . . . . . . . . . . Program Analyst

Bernadette Monacelli . . . . . . . . . . . . . . . Secretary

Donyelle Parrish* . . . . . . . . . . . . . . . . . . Secretary

Wendy Jones . . . . . . . . . . . . . . . . . . . . . Secretary

Lisa Verikios† . . . . . . . . . . . . . . . . . . . . . Secretary

Jasen Converse*. . . . . . . . . . . . . . . . . . . Receptionist

Joshua Rhoderick . . . . . . . . . . . . . . . . . . Receptionist

* Left in 2003.

† Joined in 2003.
NCI/DEA Annual Report 2003

32

Office of Referral, Review, and Program Coordination, OD

y Coordinates program concept development; publication functions; and receipt, referral, and assignment of all applications.

y Coordinates activities of the SRLB, RTRB, RPRB, and PCRB.

Diane Bronzert . . . . . . . . . . . . . . . . . . . Associate Director

Catherine Battistone . . . . . . . . . . . . . . . Program Analyst

Alma Carter . . . . . . . . . . . . . . . . . . . . . Technical Assistant

Angela Collick . . . . . . . . . . . . . . . . . . . . Secretary
NCI/DEA Annual Report 2003

33

Committee Management Office, OD

y Coordinates functionally related advisory activities across the Institute and manages a DHHS

committee to ensure that appropriate policies and procedures are in place to conduct its mission

and ensure the synthesis, integration, and documentation of these activities.

y Provides committee management services to the Office of Biotechnology Activities, Office of the

Director, NIH, and established the Committee Management Office as an NCI Service Center.

y Provides consultation services to NCI staff on administrative and technical aspects of Federal

Advisory Committees; coordinates activities with all other NCI advisory committees; implements policies and procedures designed to avoid conflicts in the nomination, selection, and

recruitment of board members; implements CM IMPAC II guidelines and procedures to ensure

that all committee-related data are correctly entered into the database for preparation and submission of required annual reports to the President of the United States, DHHS, and NIH; provides

logistical support for NCAB and BSA meetings; and facilitates NCAB and BSA committee-related travel.

y Provides administrative support for the peer-review system by compensating consultants for their

services on NCI IRG subcommittees and SEPs; reimburses consultants for travel and other

expenses; and approves and processes payments for other activities related to review, such as

meeting room rental and teleconferencing.

Claire Harris . . . . . . . . . . . . . . . . . . . . . Committee Management Officer

Andrea Collins . . . . . . . . . . . . . . . . . . . . Deputy Committee Management Officer

David Alperin . . . . . . . . . . . . . . . . . . . . Program Analyst

Linda Coleman . . . . . . . . . . . . . . . . . . . . Committee Management Specialist

Earline Jackson . . . . . . . . . . . . . . . . . . . Committee Management Assistant 

Hing Lee . . . . . . . . . . . . . . . . . . . . . . . . Committee Management Specialist

April Mellinger . . . . . . . . . . . . . . . . . . . . Committee Management Specialist

Kerry Peasland . . . . . . . . . . . . . . . . . . . . Program Specialist

Lisa Rustin . . . . . . . . . . . . . . . . . . . . . . Committee Management Specialist
NCI/DEA Annual Report 2003

34

Special Review and Logistics Branch

y Plans, manages, and assists in the scientific merit review of special grant and cooperative agreement applications (RFAs and PAs) and the technical merit review of contract proposals (RFPs).

y Arranges for and participates in onsite assessments of the research capabilities and facilities of

selected applicants.

y Identifies and recommends appropriate review committee members and site visitors, as required

for the review of assigned applications and proposals.

y Provides the SRA and other support staff to the technical review committees.

y Serves as the information and coordination center for all grant applications and contract proposals pending review by the Branch.

y Provides input and advice on grant and contract review policy and procedures, application and

proposal patterns, and research trends and other related information, as required.

y Coordinates secondary-level review activities of the NCAB with staff of other NCI Divisions,

other Branches of the Division, the Research Contracts Branch, and the Grants Administration

Branch.

y Provides logistical support for primary- and secondary-level review activities in support of other

Division and Institute units.

Kirt Vener, Ph.D. . . . . . . . . . . . . . . . . . . Chief

Special Review Unit

Thomas Vollberg, Ph.D. . . . . . . . . . . . . . Deputy Chief

Kenneth Bielat, Ph.D. . . . . . . . . . . . . . . . Scientific Review Administrator

Jennifer DeGroff . . . . . . . . . . . . . . . . . . . Program Support Assistant

Juana Diaz . . . . . . . . . . . . . . . . . . . . . . . Program Support Assistant

Paul Gallourakus . . . . . . . . . . . . . . . . . . . Program Support Assistant

Sherwood Githens, Ph.D. . . . . . . . . . . . . Scientific Review Administrator

Marcus Johnson‡ . . . . . . . . . . . . . . . . . . Review Technical Assistant

C. Michael Kerwin, Ph.D., M.P.H. . . . . . . Scientific Review Administrator

Sarah King-Mitchell . . . . . . . . . . . . . . . . . Contracts Technical Assistant

Allonda Lord . . . . . . . . . . . . . . . . . . . . . . Program Support Assistant

Gerald Lovinger, Ph.D. . . . . . . . . . . . . . . Scientific Review Administrator

Timothy Meeker, M.D. . . . . . . . . . . . . . . Scientific Review Administrator

‡ Contractor.
NCI/DEA Annual Report 2003

35

Laura Larson . . . . . . . . . . . . . . . . . . . . . Program Support Assistant

Thu Nguyen. . . . . . . . . . . . . . . . . . . . . . Lead Program Support Assistant

Lalita Palekar, Ph.D. . . . . . . . . . . . . . . . Scientific Review Administrator

Joyce Pegues, Ph.D. . . . . . . . . . . . . . . . Scientific Review Administrator

Phuong Pham . . . . . . . . . . . . . . . . . . . . Program Analyst

Mary Jane Slesinsky, Ph.D. . . . . . . . . . . Scientific Review Administrator

Denise Santeufemio‡ . . . . . . . . . . . . . . . . Review Technical Assistant

Review Processing and Distribution Unit

Adrian Bishop . . . . . . . . . . . . . . . . . . . . Mail and File Clerk

Angela Gantt‡ . . . . . . . . . . . . . . . . . . . . Mail and File Clerk

Marcus Johnson‡ . . . . . . . . . . . . . . . . . . Mail and File Clerk

Greg Jones‡. . . . . . . . . . . . . . . . . . . . . . Mail and File Clerk

Robert Kruth . . . . . . . . . . . . . . . . . . . . . Mail and File Clerk

Latasha Stevens‡ . . . . . . . . . . . . . . . . . . Mail and File Clerk

Clara Murphy. . . . . . . . . . . . . . . . . . . . . Program Assistant

Michael Shatarsky. . . . . . . . . . . . . . . . . . Grants Management Analyst

‡ Contractor.
NCI/DEA Annual Report 2003

36

Program Coordination and Referral Branch

y Serves as the information and coordinating point within the NCI for the clearance and tracking

of all NCI extramural program initiatives.

y Coordinates the shared interests of all trans-NCI program initiatives through the CSR and other

NIH Institutes and Centers.

y Coordinates clearance and publication of all RFAs, PAs, and Notices in the NIH Guide for Grants

and Contracts.

y Coordinates the clearance of all NCI grant mechanism guidelines and policies through the NIH

Office of Extramural Research.

y Serves as the NCI contact point for approval of the use of cooperative agreement mechanisms

and for conversion of grants to cooperative agreements.

y Serves as liaison to the CSR, NIH, to ensure appropriate referral of applications to the Institute

and their distribution and assignment to appropriate program units within the NCI.

y Coordinates development of referral guidelines within the NCI for internal and external use.

y Receives and distributes advance copies of applications for Program Project grants and applications submitted in response to RFAs and PAs, and coordinates this information with review and

program staff.

y Receives Letters of Intent from principal investigators intending to submit large budget grants

and from prospective R13 (conference grants applicants). Maintains a database of prospective

large budget grants applicants.

y Processes ARAs (Awaiting Receipt of Application) through the NOW system to CSR.

y Automatically refers amended and competing continuation (Type 2) applications to the cancer

activity that accepted the previously submitted application.

y Serves as the primary NCI information referral point for the extramural scientific community on

a broad range of subjects, including grant guidelines, application information, new initiatives

announced as RFAs or PAs, and the review process.

y Assists the extramural community in navigating the NIH and NCI Web pages, to help users

obtain current information, forms, and guidelines.

y Directs applicants to the appropriate Program Directors and SRAs for information regarding the

status of the review and award of their grant applications.

y Tracks and analyzes trends of CSR referral to study sections and resultant review outcomes.

y Works with NCI program staff to address unresolved review and referral issues with the CSR and

other Institutes and Centers.

y Coordinates requests from program staff for application status changes and for acceptance of

grant assignments.
NCI/DEA Annual Report 2003

37

Ray Bramhall, Ph.D.* . . . . . . . . . . . . . . Chief

Christopher Hatch, Ph.D.† . . . . . . . . . . . Acting Chief, CSR Referral Liaison

David Contois. . . . . . . . . . . . . . . . . . . . Referral Officer

Leota Hall . . . . . . . . . . . . . . . . . . . . . . Referral Officer, RFA/PA Co-Coordinator

Florence Pedersen . . . . . . . . . . . . . . . . . Referral Officer (CSR Referral Liaison)

Natacha P. Lassègue . . . . . . . . . . . . . . . Program Analyst

Kimberly Morris† . . . . . . . . . . . . . . . . . Program Support Assistant

Deborah Bielat . . . . . . . . . . . . . . . . . . . Program Support Assistant

Sonya Roberson, Ph.D.† . . . . . . . . . . . . RFA/PA Coordinator

* Left in 2003.

† Joined in 2003.
NCI/DEA Annual Report 2003

38

Research Analysis and Evaluation Branch

y Serves as the Institute’s officially designated, centralized source of scientific information and science-based budget information on NCI-supported research projects.

y Analyzes and classifies the science content of all Institute-supported projects.

y Prepares analyses comparing the distribution of funds among research areas; these analyses serve

as a basis for budget projections.

y Prepares special and routine reports and analyses and answers inquiries concerning the scientific and budgetary aspects of Institute-funded research, including research grants, center grants,

and research contracts.

y Maintains liaisons with other organizations involved in related classification activities.

y Documents the need for proposed RFAs by comparing RFA concepts with existing NCI-supported research and with unsolicited applications.

Rosemary Cuddy*. . . . . . . . . . . . . . . . . . Branch Chief

Marilyn Gaston . . . . . . . . . . . . . . . . . . . Acting Branch Chief

Inquiry and Reporting Team

y Responds to generalized data requests.

y Plans, coordinates, and evaluates dissemination of extramural and intramural research data.

y Conducts in-depth analyses of extramural research data.

y Answers inquiries from Congress, the public, the press, and others concerning any phase of

Institute-supported work.

y Identifies emerging priority areas for data collection and analysis.

y Conducts economic analysis of funded research; establishes consensus-building processes with

programs, financial data operations, and others, including the private sector; identifies priority

data gaps on funded research activities; and recommends solutions to fill these gaps.

y Evaluates user needs, conducts formalized user surveys, as needed, and translates these needs

into NCI research reports and dissemination plans.

y Provides specialized data querying, archiving, and reporting functions for the Division, the

Financial Management Branch, and the Institute.

y Directs and conducts the grant, contract, and reporting data file release program, including data

editing, review, and documentation.

y Provides consultation services and writes scientific search formulation instructions to customers’

specifications to facilitate standardized data preparation.

y Coordinates the design, development, and implementation of automated systems for award data

dissemination.

* Left in 2003.
NCI/DEA Annual Report 2003

39

Marilyn Gaston . . . . . . . . . . . . . . . . . . . Team Leader

Stacy Harper-Avilla . . . . . . . . . . . . . . . . . Technical Information Specialist

Research Documentation Team

y Analyzes and indexes grants and contracts for the Branch’s computerized systems.

y Ensures that terms and categories for indexing are updated and reflect current trends in cancer

research, and maintains a thesaurus of term definitions.

y Analyzes extramural projects for relevance to SICs and Anatomic Sites to determine the officially reported figures for Institute support and provide a basis for budget projections.

y Maintains liaison with other offices within the Institute to ensure consistent reporting of data.

y Monitors the results of Institute grant-supported research through the literature surveillance program.

Edward Kyle . . . . . . . . . . . . . . . . . . . . . . Team Leader

Lisa Krueger . . . . . . . . . . . . . . . . . . . . . . Biologist

Nancy Lohrey . . . . . . . . . . . . . . . . . . . . . Biologist

Tyrone Wilson . . . . . . . . . . . . . . . . . . . . . Biologist

Technical Operations Team

y Oversees Information Resource Management (IRM) for the Branch.

y Manages RAEB’s FLARE grants documentation and indexing database, ensuring reliability and

completeness of its contents.

y Performs computerized searches for ad hoc information requests to the Branch.

y Tracks documentation for grant applications, summary sheets, contract proposals, etc., in both

physical and computerized formats.

y Prepares documentation for indexing by the Research Documentation Section.

y Maintains and updates archival document files, including transferring physical files to computer

media.

y Serves as the liaison with contractors and the AISB to resolve FLARE computer application

problems for the Branch.

y Works with contractors and AISB to refine RAEB’s computer applications to meet the Branch’s

needs.

y Manages RAEB’s personnel support functions.

Dianne Ostrow . . . . . . . . . . . . . . . . . . . Team Leader

Gail Blaufarb . . . . . . . . . . . . . . . . . . . . . Technical Information Specialist

Linda Brown . . . . . . . . . . . . . . . . . . . . . Computer Assistant

David Hyde* . . . . . . . . . . . . . . . . . . . . . Technical Information Specialist

* Left in 2003.
NCI/DEA Annual Report 2003

40

Applied Information Systems Branch

y Satisfies the information technology (IT) requirements of the Division and coordinates IRM

activities with other relevant NCI and NIH units and provides high-quality information analysis,

design, development, and coordination of applications in support of Divisional business processes.

y Serves as the focal point for the Division in the development, deployment, and application of

specialized software and databases required for the conduct of review, referral, coding, advisory, and other extramural applications.

y Serves as the liaison with NCI Information Services Technology Branch (ISTB); other NCI 

computer professionals; other NCI units charged with execution of extramural IRM functions;

other trans-NIH functional units such as the CSR, Office of Policy for Extramural Research

Administration (OPERA), and Office of Extramural Research (OER); and the IMPAC II and

eRA (Electronic Research Administration) systems.

y Supports resources and Internet and Intranet applications connectivity and design.

y Establishes, administers, and monitors contracts to provide design, production, and maintenance

for microcomputer equipment and information storage and retrieval systems not covered by the

NCI’s Core Services.

y Formulates DEA-specific office automation policy.

y Provides staff/lead users with technical support and training for DEA IT applications.

y Coordinates general use/support and training with NCI or NIH Core Services.

y Provides Division-specific applications of video teleconferencing and audiovisual services in

support of review and Board activities.

y Provides management with recommendations for establishing and implementing policies for

conducting Divisional computer-assisted presentations, as necessary.

y Reviews user-created applications and recommends and/or designs changes to improve efficiency and effectiveness.

James W. Seach . . . . . . . . . . . . . . . . . . . Chief

Application Development and Operations Team

y Analyzes and coordinates life-cycle development of software for the Division; develops and

designs applications to support the Division’s business practices, including user guides.

y Develops, administers, and monitors contracts for acquisition, support, and maintenance of database systems.

y Administers office automation contracts as well as DEA-wide Blanket Purchase Agreements for

microcomputer equipment maintenance and supplies.

y Formulates office automation policy, system development, and IMPAC II operations.

y Coordinates internal user groups and the provision of training for specific DEA applications and

the use of office automation equipment technology.
NCI/DEA Annual Report 2003

41

Gregory Fischetti . . . . . . . . . . . . . . . . . . . Team Leader

Deborah Buranich . . . . . . . . . . . . . . . . . . Information Technology Specialist

Charles Conley . . . . . . . . . . . . . . . . . . . . Information Technology Specialist

Lauren Lawson† . . . . . . . . . . . . . . . . . . . . Information Technology Specialist

Teresa Park . . . . . . . . . . . . . . . . . . . . . . . Information Technology Specialist

Hector Reyes . . . . . . . . . . . . . . . . . . . . . Information Technology Specialist

Information Management Team

y Designs and maintains the Division’s Intranet and Internet and identifies documents to be placed

on the NCI Web Site to make Division information more accessible to the public.

y Develops new Web-based software applications that will enhance the productivity and efficiency of extramural processes within the DEA and the distribution of Division information throughout the NCI.

y Establishes partnerships and ongoing communications with staff and external customers to foster openness and collaboration in accomplishing the information initiatives of the Division.

y Works with DEA staff to ensure the current utility and linkages of documents placed on the Web.

Amir Sahar-Khiz . . . . . . . . . . . . . . . . . . . Team Leader

Kichelle Green . . . . . . . . . . . . . . . . . . . . Management Assistant

Lorrie Smith. . . . . . . . . . . . . . . . . . . . . . Information Technology Specialist

Elaine Taylor . . . . . . . . . . . . . . . . . . . . . Information Technology Specialist

† Joined in 2003.
NCI/DEA Annual Report 2003

42

Research Programs Review Branch

y Plans, coordinates, and manages the scientific merit review of program project grants, specialized centers, and other grant mechanisms, as necessary, by chartered review committees and special emphasis panels.

y Arranges for and participates in onsite assessments of the research capabilities and facilities of

selected applicants.

y Identifies and recommends appropriate review committee members and site visitors, as required,

for the review of assigned applications.

y Provides input and advice on grant review policy and procedures, application patterns, research

trends, and other related information, as required.

y Coordinates grant review activities with staff of other NCI Divisions and other DEA Branches.

Olivia Bartlett, Ph.D. . . . . . . . . . . . . . . . Chief

Virginia Wray, Ph.D. . . . . . . . . . . . . . . . Deputy Chief

Shakeel Ahmad, Ph.D. . . . . . . . . . . . . . . Scientific Review Administrator

Courtney Banks . . . . . . . . . . . . . . . . . . . Program Support Assistant

Ashley Church . . . . . . . . . . . . . . . . . . . . Office Automation Clerk

Natasha Copeland . . . . . . . . . . . . . . . . . Program Support Assistant

Mary Fletcher, Ph.D. . . . . . . . . . . . . . . . Scientific Review Administrator

Monica Green . . . . . . . . . . . . . . . . . . . . Program Support Assistant

Michelle Higginbottom‡ . . . . . . . . . . . . . Review Technical Assistant

Tiffany Jenifer . . . . . . . . . . . . . . . . . . . . Program Specialist (Instructor)

Willie Johnson . . . . . . . . . . . . . . . . . . . . Program Specialist

Deneen Mattocks. . . . . . . . . . . . . . . . . . Program Support Assistant

William Merritt, Ph.D. . . . . . . . . . . . . . . Scientific Review Administrator

Bratin Saha, Ph.D. . . . . . . . . . . . . . . . . Scientific Review Administrator

Joyce Simms*. . . . . . . . . . . . . . . . . . . . . Program Support Assistant

Michael Small, Ph.D. . . . . . . . . . . . . . . . Scientific Review Administrator

Cheryl Smith . . . . . . . . . . . . . . . . . . . . . Program Support Assistant

Maliaka Staff‡ . . . . . . . . . . . . . . . . . . . . Review Technical Assistant

Patricia Stream‡ . . . . . . . . . . . . . . . . . . . Review Technical Assistant

Shamala Srinivas, Ph.D. . . . . . . . . . . . . . Scientific Review Administrator

Barbara Thompson . . . . . . . . . . . . . . . . Program Support Assistant

Claudio Dansky Ullman, M.D. . . . . . . . . Scientific Review Administrator

Peter Wirth, Ph.D. . . . . . . . . . . . . . . . . . Scientific Review Administrator

Brian Wojcik, Ph.D. . . . . . . . . . . . . . . . . Scientific Review Administrator

Sunghan Yoo, Ph.D. . . . . . . . . . . . . . . . Scientific Review Administrator

* Left in 2003.

‡ Contractor.
NCI/DEA Annual Report 2003

43

Resources and Training Review Branch

y Plans, coordinates, and manages the scientific merit review of cancer center, clinical cooperative

group, training, and education grant and cooperative agreement applications by chartered review

committees and special emphasis panels.

y Arranges for and participates in onsite assessments of the research capabilities and facilities of

selected applicants.

y Identifies and recommends appropriate review committee members and site visitors, as required,

for the review of assigned applications.

y Provides input and advice on grant review policy and procedures, application patterns, and

research trends and other related information, as required.

y Coordinates grant review activities with staff of other NCI Divisions, other DEA Branches, and

the Center for Scientific Review.

David E. Maslow, Ph.D. . . . . . . . . . . . . . Chief and Scientific Review Administrator

Lynn Amende, Ph.D. . . . . . . . . . . . . . . . Scientific Review Administrator

Robert Bird, Ph.D. . . . . . . . . . . . . . . . . . Scientific Review Administrator

Danielle Brown . . . . . . . . . . . . . . . . . . . . Program Support Assistant

Gail Bryant, M.D. . . . . . . . . . . . . . . . . . Scientific Review Administrator

Linda Edwards . . . . . . . . . . . . . . . . . . . . Grants Technical Assistant

Stephanie Glynn‡ . . . . . . . . . . . . . . . . . . . Review Technical Assistant

Deborah Jaffe, Ph.D. . . . . . . . . . . . . . . . Scientific Review Administrator

Ilda McKenna, Ph.D. . . . . . . . . . . . . . . . Scientific Review Administrator

Raymond Petryshyn, Ph.D. . . . . . . . . . . . Scientific Review Administrator

Linda Southworth . . . . . . . . . . . . . . . . . . Program Support Assistant

Harvey Stein, Ph.D.* . . . . . . . . . . . . . . . . Scientific Review Administrator

Zenia Vilensky . . . . . . . . . . . . . . . . . . . . . Lead Grants Technical Assistant

Chanee Williams . . . . . . . . . . . . . . . . . . . Grants Technical Assistant

* Left in 2003.

‡ Contractor.
NCI/DEA Annual Report 2003

44
NCI/DEA Annual Report 2003

45

AISB Applied Information Systems Branch

APR Accelerated Peer Review

ARA Awaiting Receipt of Application

AREA Academic Research Enhancement Award

ATA Academic/Teacher Award

BAA Broad Agency Announcement

BRSG Biomedical Research Support Grant

BSA Board of Scientific Advisors

BSC Board of Scientific Counselors

CARRA Consumer Advocates in Research 

and Related Activities

CCOP Community Clinical Oncology Program

CCR Center for Cancer Research

CCSG Cancer Center Support Grant

CD Compact Disk

CEGP Cancer Education Grant Program

CISNET Cancer Intervention and Surveillance Modeling

Network

CIT Center for Information Technology

CM Committee Management

CM-MAA Committee Management-Master Agreement

Announcement

CMO Committee Management Office

CSR Center for Scientific Review

CTEP Cancer Therapy Evaluation Program

CURE Continuous Umbrella of Research Experience

DARPA Defense Advanced Research Projects Agency

DCB Division of Cancer Biology

DCCPS Division of Cancer Control and Population 

Sciences

DCEG Division of Cancer Epidemiology and Genetics

DCP Division of Cancer Prevention

DCTD Division of Cancer Treatment and Diagnosis

DEA Division of Extramural Activities

DHHS Department of Health and Human Services

EDRN Early Detection Research Network

eRA Electronic Research Administration

ESATTS Extramural Science Administrator Training 

Tracking System

FACA Federal Advisory Committee Act

FDA Food and Drug Administration

FLAIR Flexible System to Advance Innovative Research

FLARE Fiscal Linked Analysis of Research Emphasis

FOP Financial Operating Plan

GRB Grants Review Branch

HIPPA Health Insurance Portability and Accountability

Act

HPV Human Papilloma Virus

IC Institute/Center

ICMIC In Vivo Cellular and Molecular Imaging Center

IDeA Institutional Development Award

IMAT Innovative Molecular Analysis Technologies

IMPAC Information for Management, Planning, 

Analysis, and Coordination - database

IOM Institute of Medicine

IRG Initial Review Group

IRM Information Resources Management

ISTB Information Services Technology Branch

IT Information Technology

Appendix A: Glossary of Acronyms
NCI/DEA Annual Report 2003

46

JAD Joint Application and Development

LRP Loan Repayment Program

MBCCOP Minority-Based Community Clinical Oncology

Program

MBRS Minority Biomedical Research Support

MERIT Method to Extend Research in Time

MMHCC Mouse Models of Human Cancers Consortium

NCAB National Cancer Advisory Board

NCDDG National Cooperative Drug Discovery Group

NCI National Cancer Institute

NCBP National Cancer Policy Board

NCRR National Center for Research Resources

NIA National Institute on Aging

NIH National Institutes of Health

NOW NCI Online Workplace

NRSA National Research Service Award

NTROI Network for Translational Research in Optical 

Imaging

OD Office of the Director

OER Office of Extramural Research

OPERA Office of Policy for Extramural Research 

Administration

ORRPC Office of Referral, Review, and Program 

Coordination

PA Program Announcement

PAR Reviewed Program Announcement

PCPT Prostate Cancer Prevention Trial

PCRB Program Coordination and Referral Branch

PHS Public Health Service (DHHS)

PRG Progress Review Group

RAEB Research Analysis and Evaluation Branch

RAID Rapid Access to Intervention Development

REAP Research Enhancement Awards Program

RFA Request for Applications

RFP Request for Proposals

RO Referral Office

RPG Research Program Grant

RPRB Research Programs Review Branch

RTRB Resources and Training Review Branch

RUG Review Users’ Group

SAIRP Small Animal Imaging Research Program

SBIR Small Business Innovation Research

SEP Special Emphasis Panel

SGE Special Government Employee

SIC Special Interest Category

SIG Shared Instramentation Grant

SOP Standard Operating Procedure

SPORE Specialized Program of Research Excellence

SRA Scientific Review Administrator

SREA Scientific Review and Evaluation Award

SRLB Special Review and Logistics Branch

STTR Small Business Technology Transfer Research

TRIO Translating Research Into Improved Outcomes

TTURCs Transdisciplinary Tobacco Use Research Centers

Appendix A: Glossary of Acronyms
NCI/DEA Annual Report 2003

47

President’s Cancer Panel

Chair

LaSalle D. Leffall, Jr., M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Howard University College of Medicine

Members

Lance E. Armstrong . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Lance Armstrong Foundation

Harold P. Freeman, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .North General Hospital

Margaret L. Kripke, Ph.D. . . . . . . . . . . . . . . . . . . . . . .University of Texas M.D. Anderson Cancer Center

Executive Secretary

Maureen O. Wilson, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .National Cancer Institute

National Cancer Advisory Board

Chair

John E. Niederhuber, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . .University of Wisconsin School of Medicine

Members

Samir Abu-Ghazaleh, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Avera Cancer Institute

James O. Armitage, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .University of Nebraska

Moon S. Chen, Jr., M.P.H., Ph.D. . . . . . . . . . . . . . . . . . . . .University of California, Davis Cancer Center

Kenneth H. Cowan, M.D., Ph.D. . . . . . . . . . .University of Nebraska, Eppley Institute for Cancer Research

Jean B. deKernion, M.D. . . . . . . . . . . . . . . . . .University of California at Los Angeles, School of Medicine

Stephen C. Duffy . . . . . . . . . . . . . . . . . . .American Academy of Facial Plastic and Reconstructive Surgery

Ralph S. Freedman, M.B.B.Ch., Ph.D. . . . . . . . . . . . . . .University of Texas M.D. Anderson Cancer Center

James H. French, Jr., M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .The Center for Plastic Surgery

Elmer E. Huerta, M.D., M.P.H. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Washington Hospital Center

Eric S. Lander, Ph.D. . . . . . . . . . . . . . . . . . . .Whitehead Institute, Massachusetts Institute of Technology

Susan M. Love, M.D. . . . . . . . . . . . . . . . . . . .University of California at Los Angeles, School of Medicine

Arthur W. Nienhuis, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .St. Jude Children’s Research Hospital

Larry Norton, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Memorial Sloan-Kettering Cancer Center

Marlys Popma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Independent Consultant

Franklyn Prendergast, M.D., Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . .Mayo Comprehensive Cancer Center

Amelie G. Ramirez, Dr.P.H. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Baylor College of Medicine

Lydia G. Ryan, M.S.N., P.N.P. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .AFLAC Cancer Center

Ex Officio Members of the National Cancer Advisory Board

The Honorable Elaine Chao, M.B.A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .U.S. Department of Labor

Marianne Lamont Horinko . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .U.S. Environmental Protection Agency

John Howard, M.D., M.P.H., J.D., LL.M. . . . . . . . . .National Institute for Occupational Safety and Health

Rachel Levinson . . . . . . . . . . . . . . . . . . . . . . . .Office of Science and Technology Policy, The White House

Appendix B: List of Chartered Committees, FY2003
NCI/DEA Annual Report 2003

48

Mark B. McClellan, M.D., Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . .U.S. Food and Drug Administration

Kenneth Olden, Ph.D. . . . . . . . . . . . . . . . . . . . .National Institute of Environmental Health Sciences, NIH

Ari Patrinos, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .U.S. Department of Energy

The Honorable Dr. Robert H. Roswell . . . . . . . . . . . . . . . . . . . . . . . .U.S. Department of Veterans Affairs

Hal Stratton . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Consumer Product Safety Commission

The Honorable Tommy Thompson . . . . . . . . . . . . . . . . . . . . . .Department of Health and Human Services

The Honorable Dr. William Winkwerder, Jr. . . . . . . . . . . . . . . . . . . . . . . . . . .U.S. Department of Defense

Elias A. Zerhouni, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .National Institutes of Health

Alternates to Ex Officio Members of the National Cancer Advisory Board

Stephen K. Akiyama, Ph.D. . . . . . . . . . . . . . . . .National Institute of Environmental Health Sciences, NIH

Michael A. Babich, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . .U.S. Consumer Product Safety Commission

Raye-Ann Dorn, M.P.H. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .U.S. Department of Veterans Affairs

Raynard Kington, M.D., Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .National Institutes of Health

Peter Kirchner, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .U.S. Department of Energy

Hugh W. McKinnon, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .U.S. Environmental Protection Agency

T. G. Patel, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .U.S. Department of Veterans Affairs

Richard Pazdur, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .U.S. Food and Drug Administration

John F. Potter, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .U.S. Department of Defense

George Ruby, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .U.S. Department of Labor

Anita L. Schill, Ph.D., M.P.H., M.A., R.N. . . . . . . . .National Institute for Occupational Safety and Health

Past Executive Secretary

Marvin R. Kalt, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .National Cancer Institute

Executive Secretary

Paulette S. Gray, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .National Cancer Institute

Appendix B: List of Chartered Committees, FY2003
NCI/DEA Annual Report 2003

49

NCI Advisory Committee to the Director

Chair

Andrew C. von Eschenbach, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .National Cancer Institute

Members

Frederick R. Appelbaum, M.D. . . . . . . . . . . . . . . . . . . . . . . . . .Fred Hutchinson Cancer Research Center

Michael B. Kastan, Jr., M.D., Ph.D. . . . . . . . . . . . . . . . . . . . . . . . .St. Jude Children’s Research Hospital

Thomas J. Kelly, Jr., M.D., Ph.D. . . . . . . . . . . . . . . . . . . . . . . . .Memorial Sloan-Kettering Cancer Center

Barbara K. LeStage, M.S.H.P. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .American Cancer Society

John E. Niederhuber, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . .University of Wisconsin School of Medicine

Craig A. Thompson, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .University of Pennsylvania

Ex Officio Members

Paulette S. Gray, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .National Cancer Institute

Marvin R. Kalt, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .National Cancer Institute

Alan S. Rabson, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .National Cancer Institute

Executive Secretary

Cherie Nichols, M.B.A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .National Cancer Institute

Appendix B: List of Chartered Committees, FY2003
NCI/DEA Annual Report 2003

50 Appendix B: List of Chartered Committees, FY2003

NCI Board of Scientific Advisors

Chair

Frederick R. Appelbaum, M.D. . . . . . . . . . . . . . . . . . . . . . . . . .Fred Hutchinson Cancer Research Center

Members

David B. Abrams, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . The Miriam Hospital, Brown University 

David S. Alberts, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . .The University of Arizona College of Medicine

Hoda A. Anton-Culver, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .University of California at Irvine

Esther H. Chang, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Georgetown University Medical Center

Neil J. Clendeninn, M.D., Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Drug Development Consultant

Tom M. Curran, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .St. Jude Children’s Research Hospital

Mary Beryl Daly, M.D., Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Fox Chase Cancer Center

Raymond N. DuBois, M.D., Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . .Vanderbilt University Medical Center

Shelton H. Earp, III, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . .Lineberger Comprehensive Cancer Center

Patricia A. Ganz, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . .UCLA, Jonsson Comprehensive Cancer Center

Susan B. Horwitz, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Albert Einstein College of Medicine

Hedvig Hricak, M.D., Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . .Memorial Sloan-Kettering Cancer Center

Eric Hunter, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .University of Alabama

William G. Kaelin, Jr., M.D. . . . . . . . . . . . . . . .Dana-Farber Cancer Institute and Harvard Medical School

Paula Kim . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Pancreatic Cancer Action Network, Inc.

Kenneth W. Kinzler, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Johns Hopkins Oncology Center

Herbert Kressel, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Beth Israel Deaconess Medical Center

Michael P. Link, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Stanford University School of Medicine

Lynn M. Matrisian, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . .Vanderbilt University School of Medicine

W. Gilles McKenna, M.D., Ph.D. . . . . . . . . . . . . . . . . . . . .University of Pennsylvania School of Medicine

Christine A. Miaskowski, R.N., Ph.D., F.A.A.N. . . . . . . . . . . . . . .University of California at San Francisco

Enrico Mihich, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Roswell Park Cancer Institute

John D. Minna, M.D. . . . . . . . . . . . . . . . . . . . . . . . . .University of Texas Southwestern Medical Center

Nancy E. Mueller, Sc.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Harvard School of Public Health

Mack Roach, III, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .University of California at San Francisco

Richard L. Schilsky, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .University of Chicago

Ellen Sigal, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Friends of Cancer Research

Margaret R. Spitz, M.D., M.P.H. . . . . . . . . . . . . . . . . .University of Texas M.D. Anderson Cancer Center

William C. Wood, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Emory University Hospital

Robert C. Young, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Fox Chase Cancer Center

Executive Secretary

Paulette S. Gray, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .National Cancer Institute
NCI/DEA Annual Report 2003

51

NCI Listens: BSA at National Association Meetings

Oncology Nursing Society (ONS)

San Diego, CA, February 6-8, 2003

NCI Listens, Friday, February 7, 2003

Christine Miaskowski, R.N., Ph.D., F.A.A.N. (Chair) . . . . . . . . . . . . . . . . . . . .University of California at San Francisco

Paulette S. Gray, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .National Cancer Institute

Society of Behavioral Medicine (SBM)

Salt Lake City, UT, March 19-22, 2003

NCI Listens, Friday, March 21, 2003

David Abrams, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Brown University

Paulette S. Gray, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .National Cancer Institute

Oncology Nursing Society (ONS)

Denver, CO, May 1-4, 2003

NCI Listens, Friday, May 2, 2003

Paula Kim . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Pancreatic Cancer Action Network, Inc.

Paulette S. Gray, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .National Cancer Institute

American Association for Cancer Research (AACR)

Washington, DC, July 11-14, 2003

NCI Listens, Monday, July 14, 2003

Tom Curran, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .St. Jude Children’s Research Hospital

H. Shelton Earp, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Lineberger Comprehensive Cancer Center

Enrico Mihich, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Roswell Park Cancer Institute

Paulette S. Gray, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .National Cancer Institute

Appendix B: List of Chartered Committees, FY2003
NCI/DEA Annual Report 2003

52

NCI Board of Scientific Counselors

NCI/BSC Subcommittee A—Clinical Sciences and Epidemiology

Chair

Michael B. Kastan, M.D., Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . .St. Jude Children’s Research Hospital

Members

Carlos L. Arteaga, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Vanderbilt University

Leslie Bernstein, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .University of Southern California

Martin A. Cheever, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Corixa Corporation

Michael L. Cleary, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Stanford University School of Medicine

Deborah E. Collyar . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Patient Advocates in Research (PAIR)

Chi V. Dang, M.D., Ph.D. . . . . . . . . . . . . . . . . . . . . . .The Johns Hopkins University School of Medicine

Timothy Eberlein, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Washington University School of Medicine

Elizabeth T. Fontham, Dr.P.H. . . . . . . . . . . . . . . . . . . . .Louisiana State University Health Sciences Center

Stanley R. Hamilton, M.D. . . . . . . . . . . . . . . . . . . . . .University of Texas M.D. Anderson Cancer Center

Elizabeth Holly, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .University of California at San Francisco

David J. Hunter, Sc.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Harvard School of Public Health

Laurence N. Kolonel, M.D., Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .University of Hawaii

Frank McCormick, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .University of California at San Francisco

Daniel M. Medina, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Baylor College of Medicine

Beverly S. Mitchell, M.D. . . . . . . . . . . . . .University of North Carolina at Chapel Hill, School of Medicine

James J. Mule, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .University of Michigan Medical Center

Olufunmilayo F. Olopade, M.B.B.S. . . . . . . . . . . . . . . . . . . . . . . . .University of Chicago Medical Center

Richard J. O’Reilly, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Memorial Sloan-Kettering Cancer Center

Alice P. Pentland, M.D. . . . . . . . . . . . . . . . . . .University of Rochester School of Medicine and Dentistry

Arthur T. Porter, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . .Wayne State University, Detroit Medical Center

David A. Savitz, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .University of North Carolina

David T. Scadden, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Harvard Medical School

Steven G. Self, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Fred Hutchinson Cancer Research Center

Margaret A. Tempero, M.D. . . . . . . . . . . . . . . . . . .University of California, San Francisco Cancer Center

Michael Thun, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .American Cancer Society

Executive Secretary

Abby B. Sandler, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .National Cancer Institute

Appendix B: List of Chartered Committees, FY2003
NCI/DEA Annual Report 2003

53

NCI/BSC Subcommittee B—Basic Sciences

Chair

Thomas J. Kelly, M.D., Ph.D . . . . . . . . . . . . . . . . . . . . . . . . . . .Memorial Sloan-Kettering Cancer Center

Past Chair and Member

Craig B. Thompson, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . .University of Pennsylvania Cancer Center

Members

Rafi Ahmed, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Emory University School of Medicine

Frederick W. Alt, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .The Children’s Hospital

Jon C. Clardy, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Cornell University 

Gideon Dreyfuss, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . .University of Pennsylvania School of Medicine

E. Peter Geiduschek, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .University of California at San Diego

Sankar Ghosh, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Yale University School of Medicine

Stephen S. Hecht, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .University of Minnesota Cancer Center

Nouria T. Hernandez, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Cold Spring Harbor Laboratory

David Housman, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Massachusetts Institute of Technology

Richard D. Kolodner, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .University of California at San Diego

John Kuriyan, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .University of California at Berkeley

Dan R. Littman, M.D., Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .New York University Medical Center

Guillermina Lozano, Ph.D. . . . . . . . . . . . . . . . . . . . . .University of Texas M.D. Anderson Cancer Center

Brooke T. Mossman, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . .University of Vermont, College of Medicine

Dinshaw J. Patel, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Memorial Sloan-Kettering Cancer Center

Suzanne B. Sandmeyer, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .University of California at Irvine

Andrey S. Shaw, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Washington University

Harinder Singh, Ph.D. . . . . . . . . . . . . . . . . . . . .University of Chicago, Howard Hughes Medical Institute

Ronald I. Swanstrom, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . .University of North Carolina at Chapel Hill

Thea D. Tlsty, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .University of California at San Francisco

Gregory L. Verdine, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Harvard University

Inder M. Verma, M.S.C., Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Salk Institute for Biological Studies

Cheryl L. Walker, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . .Univerity of Texas M.D. Anderson Cancer Center

Eileen White, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Howard Hughes Medical Institute

Executive Secretary

Florence E. Farber, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .National Cancer Institute

Appendix B: List of Chartered Committees, FY2003
NCI/DEA Annual Report 2003

54

NCI Director’s Consumer Liaison Group

Chair

Barbara K. LeStage, M.S.H.P. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .American Cancer Society

Members

Vernal Branch . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Y-Me National Breast Cancer Organization

Susan Lowell Butler, M.P.H., Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . .Ovarian Cancer National Alliance

Kathy Giusti, M.B.A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Multiple Myeloma Research Foundation

Michael Katz, M.B.A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .International Myeloma Foundation

Ruth Lin, R.N. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Morristown Memorial Hospital

Gena Love . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .People Living Through Cancer, Inc.

Christopher Pablo . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Kaiser Foundation Health Plan

Karen G. Packer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Marshalltown Cancer Research Center

Henry A. Porterfield . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Alliance for Prostate Cancer Prevention

Nyrvah Richard . . . . . . . . . . . . . . . . . . . . . . . . . . . .Self-Help for Women With Breast or Ovarian Cancer

Doug E. Ulman . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Lance Armstrong Foundation

Marissa Weiss, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Living Beyond Breast Cancer

Executive Secretary

Nancy Caliman . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .National Cancer Institute

Appendix B: List of Chartered Committees, FY2003
NCI/DEA Annual Report 2003

55

NCI Initial Review Group Scientific Review Committees

Subcommittee A—Cancer Centers

Chair

James K. Willson, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Case Western Reserve University

Past Chair

Harold L. Moses, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Vanderbilt-Ingram Cancer Center

Members

Leonard H. Augenlicht, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Albert Einstein College of Medicine

Stephen B. Baylin, M.D. . . . . . . . . . . . . . . . . . . . . . . . .The Johns Hopkins University School of Medicine

George J. Bosl, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Memorial Sloan-Kettering Cancer Center

Michael A. Caligiuri, M.D. . . . . . . . . . . . . . . . . . . . .Ohio State University Comprehensive Cancer Center

William L. Carroll, M.D. . . . . . . . . . . . . . . . . . . . . . .Ohio State University Comprehensive Cancer Center

Graham A. Colditz, M.D., Ph.D. . . . . . . . . . . . . . . . . . . . .Harvard Medical School, Channing Laboratory

Walter J. Curran, Jr., M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Thomas Jefferson University 

Julie Y. Djeu, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . .University of South Florida College of Medicine

Michele F. Follen, M.D., Ph.D. . . . . . . . . . . . . . . . . . . .University of Texas M.D. Anderson Cancer Center

William N. Hait, M.D., Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .The Cancer Institute of New Jersey

Janet A. Houghton, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .St. Jude Children’s Research Hospital

Candace S. Johnson, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . .University of Pittsburgh Cancer Institute

Debra G. Lillegard, M.A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Park Nicollet Health Services

Robin J. Mermelstein, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .University of Illinois at Chicago

Raymond E. Meyn, Jr., Ph.D. . . . . . . . . . . . . . . . . . . .University of Texas M.D. Anderson Cancer Center

David M. Ota, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Medical College of Wisconsin

Electra D. Paskett, M.P.H., Ph.D. . . . . . . . . . . . . . . .Ohio State University Comprehensive Cancer Center

Jill C. Pelling, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .University of Kansas Medical Center

Peggy L. Porter, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Fred Hutchinson Cancer Research Center

Nancy J. Raab-Traub, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . .University of North Carolina at Chapel Hill

Derek Raghavan, M.D., Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .University of Southern California

Catalina Ramos, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Y-ME National Breast Cancer Organization 

Joan H. Schiller, M.D. . . . . . . . . . . . . . . . . . . . . .University of Wisconsin, Comprehensive Cancer Center

Thomas A. Sellers, Ph.D. . . . . . . . . . . . . . . . . . . . . . . Mayo Cancer Center, Mayo Clinic and Foundation

Marc A. Shuman, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .University of California at San Francisco

Daniel D. Von Hoff, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . .University of Arizona College of Medicine

Jean Y. Wang, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .University of California at San Diego

Louella S. Wilburn . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .People Living Through Cancer

David A. Williams, M.D. . . . . . . . . . . . . . . . . . . . . .Indiana University Cancer Center, Indiana University

David W. Yandell, Sc.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .University of Vermont

Scientific Review Administrator

David Maslow, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .National Cancer Institute

Appendix B: List of Chartered Committees, FY2003
NCI/DEA Annual Report 2003

56

Subcommittee C—Basic and Preclinical

Chair

Donald J. Tindall, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Mayo Clinic and Foundation

Past Chair

William F. Morgan, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . .University of Maryland School of Medicine

Members

Dafna Bar-Sagi, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . .State University of New York at Stony Brook

Denise A. Galloway, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . .Fred Hutchinson Cancer Research Center

Dave S. Hoon, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .John Wayne Cancer Institute

Mien-Chie Hung, Ph.D. . . . . . . . . . . . . . . . . . . . . . . .University of Texas M.D. Anderson Cancer Center

Ronald C. Kennedy, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . .Texas Tech University Health Sciences Center

Eva Y. Lee, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .University of California at Irvine

Howard B. Lieberman, Ph.D. . . . . . . . . . . . . . . .Columbia University College of Physicians and Surgeons

Scott W. Lowe, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Cold Spring Harbor Laboratory

Ruth J. Muschel, M.D., Ph.D. . . . . . . . . . . . . . . . . . . . . . .University of Pennsylvania School of Medicine

Harvey L. Ozer, M.D. . . . . . . . . . . . .University of Medicine and Dentistry of New Jersey Medical School

Maria G. Pallavicini, Ph.D. . . . . . . . . . . . . . . . . . . .University of California, San Franciscio Cancer Center

Angel G. Pellicer, M.D., Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . .New York University Medical Center

Salvatore V. Pizzo, M.D., Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Duke University Medical Center

Peter J. Polverini, D.D.S., D.M.S.C. . . . . . . . . . . . . . . . . . . .University of Minnesota School of Dentistry

Garth Powis, D.Phil. . . . . . . . . . . . . . . University of Arizona College of Medicine, Arizona Cancer Center 

Vito Quaranta, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .The Scripps Research Institute

Eddie Reed, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .West Virgina University

Alan G. Rosmarin, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Brown University School of Medicine

Kathleen M. Rundell, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . .Northwestern University Cancer Center

Gary S. Stein, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .University of Massachusetts Medical School

Bill M. Sugden, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .University of Wisconsin at Madison

Philip N. Tsichlis, M.D, Ph.D. . . . . . . . . . . . . . . . . . .Thomas Jefferson University, Kimmel Cancer Center

Louis M. Weiner, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Fox Chase Cancer Center

Bernard E. Weissman, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .University of North Carolina

Scientific Review Administrator

Michael Small, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .National Cancer Institute

Appendix B: List of Chartered Committees, FY2003
NCI/DEA Annual Report 2003

57

Subcommittee D—Clinical Studies

Chair

Philip B. McGlave, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .University of Minnesota Medical School

Members

William T. Beck, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . .University of Illinois at Chicago Cancer Center

Mitchel S. Berger, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .University of California at San Francisco

David P. Carbone, M.D., Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . .Vanderbilt University Cancer Center

Richard E. Champlin, M.D. . . . . . . . . . . . . . . . . . . . . .University of Texas M.D. Anderson Cancer Center

Jose C. Costa, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Yale University School of Medicine

Robert B. Diasio, M.D. . . . . . . . . . . . . . . . . . . . . . .University of Alabama Comprehensive Cancer Center

Harriett B. Eggert, B.S. . . . . . . . . . . . . . . . . . . . . . . . . . . . .Susan G. Komen Breast Cancer Foundation

Soldano Ferrone, M.D., Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Roswell Park Cancer Institute

Karen King-Wah Fu, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .University of California at San Francisco

Stanton L. Gerson, M.D. . . . . . . . . . . . . . . . . . . . . .Case Western Reserve University School of Medicine

Steven J. Grant, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Virginia Commonwealth University

John G. Gribben, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Dana-Farber Cancer Institute

Barbara W. Henderson, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Roswell Park Cancer Institute

Elizabeth M. Jaffee, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .The Johns Hopkins Oncology Center

Roy B. Jones, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . .Health Sciences Center, University of Colorado

Jae H. Kim, M.D., Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Henry Ford Hospital

Gloria C. Li, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Memorial Sloan-Kettering Cancer Center

Patricia M. Lorusso, D.O. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Wayne State University

Lawrence G. Lum, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Roger Williams Cancer Center

Herbert K. Lyerly, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Duke University Medical Center

Dana C. Matthews, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .University of Washington

Mark D. Minden, M.D., Ph.D. . . . . . . . . . . . . . . . .Ontario Cancer Institute, Princess Margaret Hospital

Robert S. Negrin, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Stanford University School of Medicine

Stephen D. Nimer, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Memorial Sloan-Kettering Cancer Center

James Lloyd Omel, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Physician (Retired)

Raphael E. Pollock, M.D., Ph.D. . . . . . . . . . . . . . . . . .University of Texas M.D. Anderson Cancer Center

Carol K. Redmond, Ph.D. . . . . . . . . . . . . . . . . .University of Pittsburgh Graduate School of Public Health

Rupert K. Schmidt-Ullrich, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . .Virginia Commonwealth University

Keith A. Stewart, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Princess Margaret Hospital

Herman D. Suit, M.D., Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Massachusetts General Hospital

Donald L. Trump, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Roswell Park Cancer Institute

Scientific Review Administrator

William Merritt, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .National Cancer Institute

Appendix B: List of Chartered Committees, FY2003
NCI/DEA Annual Report 2003

58

Subcommittee E—Cancer Epidemiology, Prevention, and Control

Chair

Doris M. Benbrook, Ph.D. . . . . . . . . . . . . . . . . . . . . . . .University of Oklahoma Health Sciences Center

Past Chair

Paul F. Engstrom, Ph.D., M.D. . . . . . . . . . . . . . . . . . . . . . . .Fox Chase Cancer Center, Sciences Division

Members

Marianne Berwick, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Memorial Sloan-Kettering Cancer Center

William L. Bigbee, Ph.D. . . . . . . . . . . . . . . . . .University of Pittsburgh, Graduate School of Public Health

Tim E. Byers, M.P.H., M.D. . . . . . . . . . . . . . . . . . . . . . . .University of Colorado Health Sciences Center

Karen M. Emmons, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Dana-Farber Cancer Institute

Gary E. Fraser, M.B., C.H.B. . . . . . . . . . . . . . . . . . . . .Loma Linda University School of Health Research

Kyungmann Kim, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .University of Wisconsin Medical School

Patrick M. Lynch, M.D. . . . . . . . . . . . . . . . . . . . . . . .University of Texas M.D. Anderson Cancer Center

Jeanne S. Mandelblatt, M.D., M.P.H. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Lombardi Cancer Center

Ann E. McNeil, R.N. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .University of Miami

Charles R. Meyer, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .University of Michigan Medical School

Henry R. Pacheco, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .National Council of La Raza

Barbara C. Pence, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . .Texas Tech University Health Sciences Center

Douglas E. Peterson, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . .University of Connecticut Health Center

John M. Pezzuto, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Purdue University

Noma L. Roberson, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Roberson Consulting International

Michael B. Sporn, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Dartmouth Medical School

Terry M. Therneau, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Mayo Clinic and Foundation

Paolo G. Toniolo, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .New York University School of Medicine

Michael J. Welch, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . .Washington University School of Medicine

Scientific Review Administrator

Mary Fletcher, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .National Cancer Institute

Appendix B: List of Chartered Committees, FY2003
NCI/DEA Annual Report 2003

59

Subcommittee F—Manpower and Training

Chair

James S. Economou, M.D., Ph.D. . . . . . . . . . . . . . . .University of California, Los Angeles Medical Center

Members

Judy A. Bean, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Children’s Hospital Medical Center

Powel H. Brown, M.D., Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Baylor College of Medicine

Amy H. Bouton, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .University of Virginia School of Medicine

Helen M. Chamberlin, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .The Ohio State University

Malaya Chatterjee, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .University of Cincinnati Medical Center

Edward A. Copelan, M.D. . . . . . . . . . . . . . .Ohio State University College of Medicine and Public Health

Marila Cordeiro-Stone, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .University of North Carolina

Denis F. Deen, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .University of California at San Francisco

Soldano Ferrone, M.D., Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Roswell Park Cancer Institute

James W. Freeman, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . .University of Texas Health Science Center

Michael R. Freeman, Ph.D. . . . . . . . . . . . . . . . . . .Harvard Medical School, Enders Research Laboratories

David A. Gewirtz, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Virginia Commonwealth University

Michael M. Graham, M.D., Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .University of Iowa

Marc F. Hansen, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . .University of Connecticut Health Science Center

Jeffrey T. Holt, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . .University of Colorado Health Sciences Center

P. Jack Hoopes, Ph.D., D.V.M. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Dartmouth Medical School

Ronald E. Kalil, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .University of Wisconsin

Jeffrey P. Krischer, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .University of South Florida

Diana E. Lake, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Memorial Sloan-Kettering Cancer Center

Timothy W. McKeithan, M.D., Ph.D. . . . . . . . . . . . . . . . . . . . . . .University of Nebraska Medical Center

Steven B. McMahon, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .The Wistar Institute

Maureen E. Murphy, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Fox Chase Cancer Center

Mary Ann Osley, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . .University of New Mexico Health Science Center

Gary R. Pasternack, M.D., Ph.D. . . . . . . . . . . . . . . . . .The Johns Hopkins University School of Medicine

Ann Roman, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Indiana University School of Medicine

John E. Shively, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .City of Hope National Medical Center

Douglas Yee, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .University of Minnesota Cancer Center

Alice Yu, M.D., Ph.D. . . . . . . . . . . . . . . . . . . . . . . . .University of California, San Diego Medical Center

Scientific Review Administrator

Lynn M. Amende, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .National Cancer Institute

Appendix B: List of Chartered Committees, FY2003
NCI/DEA Annual Report 2003

60

Subcommittee G—Education

Chair

Steven M. Grunberg, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .University of Vermont

Members

Andrea M. Barsevick, R.N. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Fox Chase Cancer Center

Jose M. Esteban, M.D., Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Providence Hospital Cancer Center

Richard E. Gallagher, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . .Wayne State University School of Medicine

Jeffrey J. Guidry, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Texas A&M University

Lynn C. Hartmann, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Mayo Clinic and Foundation

Joel B. Mason, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Tufts University

Curtis J. Mettlin, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Roswell Park Cancer Institute

Patricia Dolan Mullen, Dr.P.H. . . . . . . . . . . . . . . . .University of Texas Health Science Center at Houston

Ana M. Navarro, Ph.D. . . . . . . . . . . . . . . . . . .University of California at San Diego, School of Medicine

Billy U. Philips, Jr., M.P.H., Ph.D. . . . . . . . . . . . . . . . . .University of Texas Medical Branch at Galveston

William H. Redd, Ph.D. . . . . . . . . . . . . . . . . .Mount Sinai School of Medicine, Ruttenberg Cancer Center

Douglas Ross, M.D., Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . .University of Maryland School of Medicine

Vernon K. Sondak, M.D. . . . . . . . . . . . . .University of Michigan Comprehensive Cancer/Geriatrics Center

Cameron K. Tebbi, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Tampa Children’s Hospital

John T. Vetto, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Oregon Health and Science University

Scott A. Waldman, M.D., Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Thomas Jefferson University

Sandra E. Ward, Ph.D., R.N. . . . . . . . . . . . . . . . . . . . . . . . . .University of Wisconsin School of Nursing

Jeffrey N. Weitzel, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .City of Hope National Medical Center

Katharine A. Whartenby, Ph.D. . . . . . . . . . . . . . . . . . . The Johns Hopkins University School of Medicine

Scientific Review Administrator

Ilda M. McKenna, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .National Cancer Institute

Past Scientific Review Administrator

Harvey Stein, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .National Cancer Institute

Appendix B: List of Chartered Committees, FY2003
NCI/DEA Annual Report 2003

61

Subcommittee H—Clinical Trials

Chair

Daniel J. Sargent, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Mayo Clinic

Past Chair

Leslie J. Kohman, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .SUNY Health Science Center

Members

James R. Anderson, M.D., Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . .University of Nebraska Medical School

Constance Baird, R.N. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Healthcare Association of New York State

John C. Byrd, M.D. . . . . . . . . . . . . . . . . . . .Ohio State University School of Medicine and Public Health

Robert A Chapman, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Josephine Ford Cancer Center

Carolyn C. Compton, M.D., Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .McGill University

Walter M. Cronin, M.P.H. . . . . . . . . . . . . . . . . . . . .University of Pittsburgh, NSABP Biostatistical Center

Martin J. Edelman, M.D. . . . . . . . . . . . . . . . . . . . . . .University of Maryland Greenebaum Cancer Center

Lawrence E. Flaherty, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Wayne State University

Laurie E. Gaspar, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .University of Colorado

Mary K. Gospodarowicz, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Princess Margaret Hospital

Stuart A. Grossman, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Johns Hopkins Oncology Center

William R. Jewell, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .University of Kansas Medical Center

Charles E. Kahn, Jr., M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Medical College of Wisconsin

Ann Marilyn Leitch, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . .University of Texas Health Science Center

Kevin T. Lewis, M.B.A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .The Colon Cancer Alliance

Neal J. Meropol, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Fox Chase Cancer Center

Judith A. Miller, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Emory University

George L. Mutter, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Brigham and Women’s Hospital

Lisa A. Newman, M.D. . . . . . . . . . . . . . . . . . . . . .University of Michigan Comprehensive Cancer Center

Craig R. Nichols, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Oregon Health Sciences University

Roman Perez-Soler, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Montefiore Medical Center

Carolyn D. Runowicz, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .St. Luke Roosevelt Hospital Center

Marilyn L. Slovak, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .City of Hope National Medical Center

Eric J. Small, M.D. . . . . . . . . . . . .University of California at San Francisco Comprehensive Cancer Center

James A. Stewart, M.D. . . . . . . . . . . . . .University of Wisconsin, Madison Comprehensive Cancer Center

Marilyn Stromborg, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . .Northern Illinois University School of Nursing

Everett E. Vokes, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .University of Chicago Medical Center

Steven Weitman, M.D., Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Ilex Oncology, Inc.

Andrew M. Yeager, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . .University of Pittsburgh School of Medicine

Scientific Review Administrator

Deborah R. Jaffe, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .National Cancer Institute

Appendix B: List of Chartered Committees, FY2003
NCI/DEA Annual Report 2003

62

Subcommittee I—Career Development

Chair

Dennis F. Deen, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .University of California at San Francisco

Members

Deepak Bastia, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Medical University of South Carolina

Mary-Ann Bjornsti, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .St. Jude Children’s Research Hospital

Powel Brown, M.D., Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Baylor College of Medicine

Malaya B. Chatterjee, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . .University of Cincinnati Medical Center

Edward Copelan, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . .The Ohio State University College of Medicine

Michael R. Freeman, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Harvard Medical School

Rafael A. Fridman, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . .Wayne State University School of Medicine

Marc F. Hansen, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .University of Connecticut Health Center

Jeffrey P. Kirscher, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .University of South Florida

Timothy W. McKeithan, M.D., Ph.D. . . . . . . . . . . . . . . . . . . . . . .University of Nebraska Medical Center

Jeffrey F. Moley, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Washington University School of Medicine

John O. Ojeifo, M.D., Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . .Georgetown University School of Medicine

John E. Shively, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .City of Hope Medical Center

Theresa L. Whiteside, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . .University of Pittsburgh Cancer Institute

Douglas Yee, M.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .University of Minnesota Cancer Center

Scientific Review Administrator

Robert Bird, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .National Cancer Institute

Appendix B: List of Chartered Committees, FY2003
NCI/DEA Annual Report 2003

63

Appendix C: NCI Initial Review Group Consultants, FY2003

1. Consultants Serving as Temporary Members on IRG Subcommittees in

FY2003

A Agarwal, Rajesh, Ph.D. . . . . . . . . . . . . . . . . . . . .American Cancer Research Center

Ahles, Tim A., Ph.D. . . . . . . . . . . . . . . . . . . . . . .Dartmouth College

Akporiaye, Emmanuel T., Ph.D. . . . . . . . . . . . . . .University of Arizona

Ali-Osman, Francis C., Ph.D. . . . . . . . . . . . . . . . .Duke University

Anderson, Carolyn J., Ph.D. . . . . . . . . . . . . . . . .Washington University School of Medicine

Anderson, Wayne F., Ph.D. . . . . . . . . . . . . . . . . .Northwestern University

Andersson, Borje S., M.D., Ph.D. . . . . . . . . . . . . .Sandra Technology, Inc.

Andrykowski, Michael A., Ph.D. . . . . . . . . . . . . . .University of Kentucky

Ashikaga, Takamaru, Ph.D. . . . . . . . . . . . . . . . . .University of Vermont and State Agricultural College

Auerbach, Robert, Ph.D. . . . . . . . . . . . . . . . . . . .University of Wisconsin at Madison

Augenlicht, Leonard H., Ph.D. . . . . . . . . . . . . . . .Montefiore Medical Center (Bronx, NY)

B Baird, Constance, M.S., R.N. . . . . . . . . . . . . . . . .Healthcare Association of New York State

Bajorin, Dean, M.D. . . . . . . . . . . . . . . . . . . . . . .Memorial Sloan-Kettering Cancer Center

Banks, William L., Ph.D. . . . . . . . . . . . . . . . . . . .Virginia Commonwealth University

Barofsky, Ivan, Ph.D. . . . . . . . . . . . . . . . . . . . . .Johns Hopkins Bayview Research Campus

Bastia, Deepak, Ph.D. . . . . . . . . . . . . . . . . . . . .Medical University of South Carolina

Beauchamp, Robert D., M.D. . . . . . . . . . . . . . . .Vanderbilt University

Beckman, Joseph S., Ph.D. . . . . . . . . . . . . . . . . .University of Alabama at Birmingham

Benbrook, Doris M., Ph.D. . . . . . . . . . . . . . . . . .University of Oklahoma Health Sciences Center

Benjamin, Laura E., Ph.D. . . . . . . . . . . . . . . . . . .Beth Israel Deaconess Medical Center

Berger, Carole L., Ph.D. . . . . . . . . . . . . . . . . . . .Yale University School of Medicine

Berger, Mitchel S., M.D. . . . . . . . . . . . . . . . . . . .University of California at San Francisco

Berwick, Marianne, Ph.D. . . . . . . . . . . . . . . . . . .Memorial Sloan-Kettering Cancer Center

Bickers, David R., M.D. . . . . . . . . . . . . . . . . . . .Columbia University Health Sciences

Bieberich, Charles J., Ph.D. . . . . . . . . . . . . . . . . .University of Maryland, Baltimore County

Bjornsti, Mary-Ann, Ph.D. . . . . . . . . . . . . . . . . . .St. Jude Children’s Research Hospital

Blot, William J., Ph.D. . . . . . . . . . . . . . . . . . . . .Vanderbilt University

Blum, Ronald H., M.D., Ph.D. . . . . . . . . . . . . . . .New York University

Bogart, Jeffrey A., M.D. . . . . . . . . . . . . . . . . . . .SUNY Update Medical University

Bogler, Oliver, Ph.D. . . . . . . . . . . . . . . . . . . . . . .Case Western Reserve University

Boothman, David A., Ph.D. . . . . . . . . . . . . . . . . .Case Western Reserve University

Borch, Richard F., M.D., Ph.D. . . . . . . . . . . . . . .Purdue University

Bosl, George J., M.D. . . . . . . . . . . . . . . . . . . . . .University of Medicine/Dentistry of New Jersey

Bostick, Roberd M., M.D., Ph.D. . . . . . . . . . . . . .University of South Carolina at Columbia

Bothwell, Mark A., Ph.D. . . . . . . . . . . . . . . . . . .University of Washington

Bouton, Amy H., Ph.D. . . . . . . . . . . . . . . . . . . . .University of Virginia

Bovbjerg, Dana H., Ph.D. . . . . . . . . . . . . . . . . . .Memorial Sloan-Kettering Cancer Center

Brattain, Michael G., Ph.D. . . . . . . . . . . . . . . . . .Roswell Park Cancer Institute Corporation

Brautigan, David L., Ph.D. . . . . . . . . . . . . . . . . .University of Virginia

Brown, Anthony M., Ph.D. . . . . . . . . . . . . . . . . .Weill Medical College of Cornell University
NCI/DEA Annual Report 2003

64

Buckner, Jan C., M.D., Ph.D. . . . . . . . . . . . . . . .Mayo Clinic, Rochester

Burhansstipanov, Linda, Ph.D. . . . . . . . . . . . . . . .Native American Cancer Research

Burke, Steven D., Ph.D. . . . . . . . . . . . . . . . . . . .University of Wisconsin at Madison

Byers, Tim E., M.D., Ph.D. . . . . . . . . . . . . . . . . .University of Colorado

C Camp, Nicola J., Ph.D. . . . . . . . . . . . . . . . . . . .University of Utah

Campbell, Marci K., Ph.D. . . . . . . . . . . . . . . . . .University of North Carolina

Carver, Charles S., Ph.D. . . . . . . . . . . . . . . . . . .University of Miami and Coral Gables

Casero, Robert A., Ph.D. . . . . . . . . . . . . . . . . . .The Johns Hopkins University

Cella, David E., Ph.D. . . . . . . . . . . . . . . . . . . . . .Evanston Northwestern Healthcare

Chamberlin, Helen M., Ph.D. . . . . . . . . . . . . . . .Ohio State University

Chao, Nelson J., M.D. . . . . . . . . . . . . . . . . . . . .Duke University

Chatterjee, Subroto B., Ph.D. . . . . . . . . . . . . . . .The Johns Hopkins University

Chen, Ching-Shih, Ph.D. . . . . . . . . . . . . . . . . . . .Ohio State University

Chiocca, E. Antonio, M.D., Ph.D. . . . . . . . . . . . .Massachusetts General Hospital

Cibull, Michael L., M.D. . . . . . . . . . . . . . . . . . . .University of Kentucky

Claffey, Kevin P., Ph.D. . . . . . . . . . . . . . . . . . . . .University of Connecticut School of Medicine/Dentistry

Cleveland, John L., Ph.D. . . . . . . . . . . . . . . . . . .St. Jude Children’s Research Hospital

Coetzee, Gerhard A., Ph.D. . . . . . . . . . . . . . . . .University of Southern California

Compton, Carolyn C., M.D., Ph.D. . . . . . . . . . . .McGill University

Compton, Duane A., Ph.D. . . . . . . . . . . . . . . . . .Dartmouth University Medical School

Cora, Elsa M., Ph.D. . . . . . . . . . . . . . . . . . . . . .University of Puerto Rico Medical Sciences

Cordeiro-Stone, Marila, Ph.D. . . . . . . . . . . . . . . .University of North Carolina

Corry, Peter M., Ph.D. . . . . . . . . . . . . . . . . . . . .William Beaumont Hospital

Curiel, Tyler J., M.D. . . . . . . . . . . . . . . . . . . . . .Tulane University

Curtis, Jeffrey L., M.D. . . . . . . . . . . . . . . . . . . .University of Michigan

D Davis, Roger B., Sc.D. . . . . . . . . . . . . . . . . . . . .University of Massachusetts Medical School, Worcester

Davisson, Vincent J., Ph.D. . . . . . . . . . . . . . . . .Purdue University

Deb, Swati P., Ph.D. . . . . . . . . . . . . . . . . . . . . .Wake Forest University Health Sciences

Debinski, Waldemar, M.D., Ph.D. . . . . . . . . . . . .Pennsylvania State University

Degregori, James V., Ph.D. . . . . . . . . . . . . . . . . .University of Colorado

Demayo, Francesco, Ph.D. . . . . . . . . . . . . . . . . .Baylor College of Medicine

Demple, Bruce F., Ph.D. . . . . . . . . . . . . . . . . . . .Harvard University School of Public Health

Dewey, William C., Ph.D. . . . . . . . . . . . . . . . . . .Virginia Commonwealth University

Diaz, Manuel O., M.D. . . . . . . . . . . . . . . . . . . .Loyola University, Chicago

Dickson, Robert B., Ph.D. . . . . . . . . . . . . . . . . .Georgetown University

Dow, Karen H., Ph.D. . . . . . . . . . . . . . . . . . . . .University of Central Florida

Dube, Catherine E., Ph.D. . . . . . . . . . . . . . . . . .Brown University

Durden, Donald L., M.D., Ph.D. . . . . . . . . . . . . .University of Indiana

Dynan, William S., Ph.D. . . . . . . . . . . . . . . . . . .Medical College of Georgia

E Earp, H. Shelton, M.D., Ph.D. . . . . . . . . . . . . . . .University of North Carolina

Eckelman, William C., Ph.D. . . . . . . . . . . . . . . . .National Institutes of Health, Clinical Center

Eckhart, Walter, Ph.D. . . . . . . . . . . . . . . . . . . . .Salk Institute for Biological Studies

Economou, James S., M.D., Ph.D. . . . . . . . . . . . .University of California at Los Angeles

Elder, David E., M.D. . . . . . . . . . . . . . . . . . . . . .University of Pennsylvania School of Medicine

Elliott, Thomas E., M.D., Ph.D. . . . . . . . . . . . . . .Duluth Clinic

Appendix C-1: NCI Initial Review Group Consultants, FY2003
NCI/DEA Annual Report 2003

65

Erdman, John W., Ph.D. . . . . . . . . . . . . . . . . . . .University of Illinois

Erickson, Kent L., Ph.D. . . . . . . . . . . . . . . . . . . .University of California at Davis

Erwin, Deborah O., Ph.D. . . . . . . . . . . . . . . . . . .University of Arkansas Medical Sciences, Little Rock

Evers, Mark B., M.D. . . . . . . . . . . . . . . . . . . . . .University of Texas Medical Branch, Galveston

F Fan, Hung Y., Ph.D. . . . . . . . . . . . . . . . . . . . . . .University of California at Irvine

Felton, James S., Ph.D. . . . . . . . . . . . . . . . . . . .Lawrence Livermore National Laboratory

Fenoglio-Preiser, Cecilia M., M.D. . . . . . . . . . . . .University of Cincinnati

Ferrone, Soldano, M.D., Ph.D. . . . . . . . . . . . . . .Roswell Park Cancer Institute Corporation

Field, Jeffrey M., Ph.D. . . . . . . . . . . . . . . . . . . .University of Pennsylvania

Figlin, Robert, M.D. . . . . . . . . . . . . . . . . . . . . . .University of California at Los Angeles

Finn, Olivera J., Ph.D. . . . . . . . . . . . . . . . . . . . .University of Pittsburgh

Fitzgibbon, Marian L., Ph.D. . . . . . . . . . . . . . . . .Northwestern University

Flaherty, Lawrence E., M.D. . . . . . . . . . . . . . . . .Wayne State University

Flint, Jonathan, M.D. . . . . . . . . . . . . . . . . . . . . .Oxford University

Frank-Stromborg, Marilyn, Ph.D. . . . . . . . . . . . . .Northern Illinois University

Freeman, James W., Ph.D. . . . . . . . . . . . . . . . . .University of Texas Health Sciences Center, San Antonio

Freeman, Michael L., Ph.D. . . . . . . . . . . . . . . . . .Vanderbilt University

Fridman, Rafael A., Ph.D. . . . . . . . . . . . . . . . . . .Wayne State University

Fuchs, Ephraim J., M.D. . . . . . . . . . . . . . . . . . . .The Johns Hopkins University

G Galloway, Denise A., Ph.D. . . . . . . . . . . . . . . . . .Fred Hutchinson Cancer Research Center

Gendler, Sandra J., Ph.D. . . . . . . . . . . . . . . . . . .Mayo Clinic, Rochester

Getzenberg, Robert H., Ph.D. . . . . . . . . . . . . . . .University of Pittsburgh

Ginder, Gordon D., M.D., Ph.D. . . . . . . . . . . . . .Virginia Commonwealth University

Giordano, Thomas J., M.D. . . . . . . . . . . . . . . . .University of Michigan

Given, Barbara A., Ph.D. . . . . . . . . . . . . . . . . . .Michigan State University

Glick, Henry, Ph.D. . . . . . . . . . . . . . . . . . . . . . .University of Pennsylvania School of Medicine

Gomer, Charles J., M.D., Ph.D. . . . . . . . . . . . . . .Children’s Hospital, Los Angeles

Gorbsky, Gary J., Ph.D. . . . . . . . . . . . . . . . . . . .Oklahoma Medical Research Foundation

Graham, Michael M., M.D., Ph.D. . . . . . . . . . . .University of Iowa

Green, Stephanie J., Ph.D. . . . . . . . . . . . . . . . . .Fred Hutchinson Cancer Research Center

Grufferman, Seymour, M.D., Ph.D. . . . . . . . . . . .University of Pittsburgh

Grundfest, Warren S., M.D. . . . . . . . . . . . . . . . .University of California at Los Angeles

H Haan, Mary N., Dr.P.H. . . . . . . . . . . . . . . . . . . .University of Michigan

Hahn, Stephen M., M.D. . . . . . . . . . . . . . . . . . .Hospital of the University of Pennsylvania

Haire-Joshu, Debra, Ph.D. . . . . . . . . . . . . . . . . .St. Louis University

Hann, Danette M., Ph.D. . . . . . . . . . . . . . . . . . .American Cancer Society Behavioral Research Center

Harper, Kimberly, Ph.D. . . . . . . . . . . . . . . . . . . .Florida Agricultural and Mechanical University

Hassell, John A., Ph.D. . . . . . . . . . . . . . . . . . . .McMaster University

Hellstrom, Ingegerd E., M.D., Ph.D. . . . . . . . . . .Pacific Northwest Research Institute

Hendrix, Mary J., Ph.D. . . . . . . . . . . . . . . . . . . .University of Iowa

Herlyn, Meenhard, D.Sc., D.V.M. . . . . . . . . . . . .The Wistar Institute

Hess, Jay L., M.D., Ph.D. . . . . . . . . . . . . . . . . .Washington University

Heston, Warren D., Ph.D. . . . . . . . . . . . . . . . . .Case Western Reserve University

Hill, Richard P., Ph.D. . . . . . . . . . . . . . . . . . . . .University of Toronto

Hinds, Philip W., Ph.D. . . . . . . . . . . . . . . . . . . .Harvard University Medical School

Appendix C-1: NCI Initial Review Group Consultants, FY2003
NCI/DEA Annual Report 2003

66

Hochberg, Fred H., M.D. . . . . . . . . . . . . . . . . . .Massachusetts General Hospital

Holland, Eric C., M.D., Ph.D. . . . . . . . . . . . . . . .Memorial Sloan-Kettering Cancer Center

Honn, Kenneth V., Ph.D. . . . . . . . . . . . . . . . . . . .Biomide Corporation

Hoon, Dave S. B., Ph.D. . . . . . . . . . . . . . . . . . . .John Wayne Cancer Institute

Hope, Thomas J., M.D., Ph.D. . . . . . . . . . . . . . .University of Illinois at Chicago

Howett, Mary K., Ph.D. . . . . . . . . . . . . . . . . . . .Pennsylvania State University Hershey Medical Center

Hughes, Chanita A., Ph.D. . . . . . . . . . . . . . . . . .University of Pennsylvania

Hung, Mien-Chie, Ph.D. . . . . . . . . . . . . . . . . . . .University of Texas M.D. Anderson Cancer Center

Hurwitz, Arthur A., Ph.D. . . . . . . . . . . . . . . . . . .SUNY Upstate Medical University

Huycke, Mark M., M.D. . . . . . . . . . . . . . . . . . . .University of Oklahoma Health Sciences Center

I Iglehart, James D., M.D. . . . . . . . . . . . . . . . . . .Brigham and Women’s Hospital

J Jewell, William R., M.D. . . . . . . . . . . . . . . . . . . .University of Kansas Medical Center

Johnson, Linda B., B.S. . . . . . . . . . . . . . . . . . . .National Coalition for Cancer Survivorship

Jones, Glenville, Ph.D. . . . . . . . . . . . . . . . . . . . .Queen’s University

Jorgensen, Timothy J., Ph.D. . . . . . . . . . . . . . . .Georgetown University

Judy, Philip F., Ph.D. . . . . . . . . . . . . . . . . . . . . . .Brigham and Women’s Hospital

Juliano, Rudolph L., Ph.D. . . . . . . . . . . . . . . . . .University of North Carolina

K Kalil, Ronald E., Ph.D. . . . . . . . . . . . . . . . . . . . .University of Wisconsin at Madison

Kallmerten, James L., Ph.D. . . . . . . . . . . . . . . . .Syracuse University

Kantoff, Phillip, M.D. . . . . . . . . . . . . . . . . . . . . .Harvard University Medical School

Kaplan, Alan M., Ph.D. . . . . . . . . . . . . . . . . . . .Virginia Commonwealth University

Kelly, William K., D.O. . . . . . . . . . . . . . . . . . . . .Memorial Sloan-Kettering Cancer Center

Kenan, Daniel J., M.D., Ph.D. . . . . . . . . . . . . . .Duke University

Kennedy, Ronald C., Ph.D. . . . . . . . . . . . . . . . . .Texas Tech University

Kennelly, Peter J., Ph.D. . . . . . . . . . . . . . . . . . . .Virginia Polytechnic Institute and State University

Khokha, Rama, Ph.D. . . . . . . . . . . . . . . . . . . . .University of Toronto

Kim, Jae Ho H., M.D., Ph.D. . . . . . . . . . . . . . . .Henry Ford Hospital

Kirchen, Dennis J., Ed.D. . . . . . . . . . . . . . . . . . .Dominican University

Kirn, David H., M.D. . . . . . . . . . . . . . . . . . . . . .Jennerex

Kolasa, Kathryn M., Ph.D. . . . . . . . . . . . . . . . . .East Carolina University

Krischer, Jeffrey P., Ph.D. . . . . . . . . . . . . . . . . . .H. Lee Moffitt Cancer Center & Research Institute

Kyprianou, Natasha, Ph.D. . . . . . . . . . . . . . . . . .University of Kentucky

L Lattime, Edmund C., Ph.D. . . . . . . . . . . . . . . . . .University of Medicine/Dentistry of New Jersey

Lee, Eva Y., Ph.D. . . . . . . . . . . . . . . . . . . . . . . .University of California at Irvine

Leeper, Dennis B., M.D., Ph.D. . . . . . . . . . . . . . .Thomas Jefferson University

Lepock, James R., Ph.D. . . . . . . . . . . . . . . . . . .University of Waterloo

Levy, David E., Ph.D. . . . . . . . . . . . . . . . . . . . . .New York University School of Medicine

Lewin, Jonathan S., M.D. . . . . . . . . . . . . . . . . . .University Hospitals of Cleveland

Lewis, Kevin T., M.B.A. . . . . . . . . . . . . . . . . . . .Colon Cancer Alliance

Lieberman, Howard B., Ph.D. . . . . . . . . . . . . . . .Columbia University Health Sciences

Limburg, Paul J., M.D. . . . . . . . . . . . . . . . . . . . .Mayo Clinic, Rochester

Line, Bruce R., M.D. . . . . . . . . . . . . . . . . . . . . .University of Maryland Baltimore Professional School

Link, Charles J., M.D. . . . . . . . . . . . . . . . . . . . .Iowa State University

Lipkus, Isaac M., Ph.D. . . . . . . . . . . . . . . . . . . .Duke University

Appendix C-1: NCI Initial Review Group Consultants, FY2003
NCI/DEA Annual Report 2003

67

Liu, Fei-Fei, M.D. . . . . . . . . . . . . . . . . . . . . . . . .University of Toronto

Lo, David D., M.D., Ph.D. . . . . . . . . . . . . . . . . .Digital Gene Technologies

Longmore, Gregory D., M.D. . . . . . . . . . . . . . . .Washington University School of Medicine

Lord, Edith M., Ph.D. . . . . . . . . . . . . . . . . . . . .University of Rochester

Lorusso, Patricia M., M.D. . . . . . . . . . . . . . . . . .Wayne State University

Lowe, Scott W., Ph.D. . . . . . . . . . . . . . . . . . . . .Cold Spring Harbor Laboratory

Lum, Lawrence G., M.D. . . . . . . . . . . . . . . . . . .Roger Williams Hospital

Lynch, David H., Ph.D. . . . . . . . . . . . . . . . . . . .Immunex

Lynch, Richard G., M.D., Ph.D. . . . . . . . . . . . . . .University of Iowa College of Medicine

M Mak, Tak W., M.D., Ph.D. . . . . . . . . . . . . . . . . .University of Toronto, Princess Margaret Hospital

Margolis, Clorinda G., Ph.D. . . . . . . . . . . . . . . . .Thomas Jefferson University

Mathieu, Rachel, B.S. . . . . . . . . . . . . . . . . . . . . .After Breast Cancer Surgery

Mayer, Joni A., Ph.D. . . . . . . . . . . . . . . . . . . . .San Diego State University

McCarthy-Beckett, Donna O., Ph.D. . . . . . . . . . .University of Wisconsin at Madison

McCaul, Kevin D., Ph.D. . . . . . . . . . . . . . . . . . .North Dakota State University

McGlave, Philip B., M.D. . . . . . . . . . . . . . . . . . .University of Minnesota at Twin Cities

Mcmahon, Steven B., Ph.D. . . . . . . . . . . . . . . . .The Wistar Institute

Medina, Daniel, Ph.D. . . . . . . . . . . . . . . . . . . . .Baylor College of Medicine

Merrill, Alfred H., Ph.D. . . . . . . . . . . . . . . . . . . .Georgia Institute of Technology

Meyn, Raymond E., Ph.D. . . . . . . . . . . . . . . . . .University of Texas M.D. Anderson Cancer Center

Mierke, Dale F., M.D., Ph.D. . . . . . . . . . . . . . . .Brown University

Miller, Donald M., M.D., Ph.D. . . . . . . . . . . . . . .University of Louisville School of Medicine

Minden, Mark D., M.D., Ph.D. . . . . . . . . . . . . . .Princess Margaret Hospital

Molnar-Kimber, Katherine L., Ph.D. . . . . . . . . . . .University of Pennsylvania

Morgan, William F., Ph.D. . . . . . . . . . . . . . . . . . .University of Maryland

Morrow, Jason D., M.D. . . . . . . . . . . . . . . . . . .Vanderbilt University

Motamedi, Massoud, Ph.D. . . . . . . . . . . . . . . . .University of Texas Medical Branch, Galveston

Munn, David H., M.D. . . . . . . . . . . . . . . . . . . . .Medical College of Georgia

Muschel, Ruth J., M.D., Ph.D. . . . . . . . . . . . . . .Children’s Hospital of Philadelphia

Mutter, George L., M.D. . . . . . . . . . . . . . . . . . .Brigham and Women’s Hospital

N Nagle, Raymond B., M.D., Ph.D. . . . . . . . . . . . .University of Arizona

Nalcioglu, Orhan, Ph.D. . . . . . . . . . . . . . . . . . . .University of California at Irvine

Naylor, Susan L., Ph.D. . . . . . . . . . . . . . . . . . . .University of Texas Health Sciences Center

Nedrud, John G., Ph.D. . . . . . . . . . . . . . . . . . . .Case Western Reserve University

Negrin, Robert S., M.D., Ph.D. . . . . . . . . . . . . . .International Society for Hematotherapy and Graft Engineering

Neifeld, James P., M.D. . . . . . . . . . . . . . . . . . . .Virginia Commonwealth University

Newman, Lisa A., M.D. . . . . . . . . . . . . . . . . . . .University of Michigan

Newport, Elissa L., Ph.D. . . . . . . . . . . . . . . . . . .University of Rochester

Nishikawa, Robert M., Ph.D. . . . . . . . . . . . . . . .University of Chicago

Notterman, Daniel A., M.D. . . . . . . . . . . . . . . . .Robert Wood Johnson University Hospital

O Ojeifo, John O., M.D., Ph.D. . . . . . . . . . . . . . . .Georgetown University School of Medicine

Oleinick, Nancy L., Ph.D. . . . . . . . . . . . . . . . . . .Case Western Reserve University

Olson, Sara H., M.D., Ph.D. . . . . . . . . . . . . . . . .Memorial Sloan-Kettering Cancer Center

Omel, James Lloyd, M.D. . . . . . . . . . . . . . . . . . .Physician (Retired)

O’Reilly, Richard J., M.D. . . . . . . . . . . . . . . . . . .Memorial Sloan-Kettering Cancer Center

Appendix C-1: NCI Initial Review Group Consultants, FY2003
NCI/DEA Annual Report 2003

68

Osman, Roman, Ph.D. . . . . . . . . . . . . . . . . . . . .Mount Sinai School of Medicine of New York University

Ostrand-Rosenberg, Suzanne O., Ph.D. . . . . . . . . .University of Maryland, Baltimore County

Ozer, Harvey L., M.D. . . . . . . . . . . . . . . . . . . . .University of Medicine/Dentistry of New Jersey

P Pallavicini, Maria G., Ph.D. . . . . . . . . . . . . . . . . .University of California at San Francisco

Patterson, Thomas F., M.D. . . . . . . . . . . . . . . . . .University of Texas Health Sciences Center

Paulson, David F., M.D. . . . . . . . . . . . . . . . . . . .Duke University Medical Center

Pence, Barbara C., Ph.D. . . . . . . . . . . . . . . . . . .Texas Tech University Health Sciences Center

Peterson, Douglas E., D.D.S., Ph.D. . . . . . . . . . .University of Connecticut Health Center

Pezzuto, John M., Ph.D. . . . . . . . . . . . . . . . . . .Purdue University

Pierce, John P., Ph.D. . . . . . . . . . . . . . . . . . . . . .University of California at San Diego

Pizzo, Salvatore V., M.D., Ph.D. . . . . . . . . . . . . .Duke University Medical Center

Polz, Martin, Ph.D. . . . . . . . . . . . . . . . . . . . . . .Massachusetts Institute of Technology

Pope, Melissa J., M.D., Ph.D. . . . . . . . . . . . . . . .Population Council

Porter, Carl W., Ph.D. . . . . . . . . . . . . . . . . . . . .Roswell Park Cancer Institute Corporation

Powis, Garth, Ph.D. . . . . . . . . . . . . . . . . . . . . . .University of Arkansas Medical Sciences, Little Rock

Prasad, Kedar N., Ph.D. . . . . . . . . . . . . . . . . . . .University of Colorado

Price, Ronald R., Ph.D. . . . . . . . . . . . . . . . . . . .Vanderbilt University

R Raab-Traub, Nancy J., Ph.D. . . . . . . . . . . . . . . . .University of North Carolina

Ramos, Catalina, M.D. . . . . . . . . . . . . . . . . . . . .National Y-Me Breast Cancer Organization

Ransohoff, David F., M.D. . . . . . . . . . . . . . . . . .University of North Carolina

Rebbeck, Timothy R., Ph.D. . . . . . . . . . . . . . . . .University of Pennsylvania School of Medicine

Reddi, A. Hari, Ph.D. . . . . . . . . . . . . . . . . . . . . .The Johns Hopkins University

Reddy, Bandaru S., D.V.M., Ph.D. . . . . . . . . . . . .Institute for Cancer Prevention

Reddy, E. Premkumar, Ph.D. . . . . . . . . . . . . . . . .Temple University

Reid, Mary E., Ph.D. . . . . . . . . . . . . . . . . . . . . .Roswell Park Cancer Institute Corporation

Reisfeld, Ralph A., M.D., Ph.D. . . . . . . . . . . . . .Scripps Research Institute

Ridge, John A., M.D., Ph.D. . . . . . . . . . . . . . . .Fox Chase Cancer Center

Roberson, Noma L., Ph.D. . . . . . . . . . . . . . . . . .Roberson Consulting International

Roberts, Charles T., Ph.D. . . . . . . . . . . . . . . . . .Oregon Health and Science University

Roberts, John D., M.D. . . . . . . . . . . . . . . . . . . .Virginia Commonwealth University

Rodeck, Ulrich, M.D., Ph.D. . . . . . . . . . . . . . . . .The Wistar Institute

Rodgers, William H., M.D., Ph.D. . . . . . . . . . . . .University of Alabama at Birmingham

Rogatko, Andre, Ph.D. . . . . . . . . . . . . . . . . . . . .Fox Chase Cancer Center

Romano, Louis J., Ph.D. . . . . . . . . . . . . . . . . . . .Wayne State University

Rosenzweig, Steven A., M.D., Ph.D. . . . . . . . . . .Medical University of South Carolina

Rosmarin, Alan G., M.D. . . . . . . . . . . . . . . . . . .Miriam Hospital

Rowitch, David H., M.D., Ph.D. . . . . . . . . . . . . .Dana-Farber Cancer Institute

Rowley, David R., Ph.D. . . . . . . . . . . . . . . . . . . .American Urological Association

Royal, Henry Duval, M.D. . . . . . . . . . . . . . . . . .Mallinckrodt Institute of Radiology

Rundell, M. Kathleen, Ph.D. . . . . . . . . . . . . . . . .Northwestern University

Ryan, James C., M.D. . . . . . . . . . . . . . . . . . . . .Northern California Institute for Research and Education

S Sadofsky, Moshe J., M.D., Ph.D. . . . . . . . . . . . .Yeshiva University

Sample, Clare E., Ph.D. . . . . . . . . . . . . . . . . . . .St. Jude Children’s Research Hospital

Samuel, Charles E., Ph.D. . . . . . . . . . . . . . . . . . .University of California at Santa Barbara

Samuels, Robert J., M.B.A. . . . . . . . . . . . . . . . . .National Alliance of Breast Cancer Organizations

Appendix C-1: NCI Initial Review Group Consultants, FY2003
NCI/DEA Annual Report 2003

69

Satariano, William A., Ph.D. . . . . . . . . . . . . . . . .University of California and Berkeley

Scarborough, Mark T., M.D. . . . . . . . . . . . . . . . .University of Florida

Schmidt-Ullrich, Rupert K., M.D. . . . . . . . . . . . . .Virginia Commonwealth University

Schnitzer, Jan E., M.D. . . . . . . . . . . . . . . . . . . . .Sidney Kimmel Cancer Center

Schoenlein, Patricia V., Ph.D. . . . . . . . . . . . . . . .Medical College of Georgia

Schultheiss, Timothy E., Ph.D. . . . . . . . . . . . . . . .Beckman Research Institute of City of Hope

Seiden, Michael V., M.D., Ph.D. . . . . . . . . . . . . .Massachusetts General Hospital

Sellers, Thomas A., M.D., Ph.D. . . . . . . . . . . . . .Mayo Clinic, Rochester

Semmes, Oliver J., Ph.D. . . . . . . . . . . . . . . . . . .University of Virginia

Slocum, Harry K., Ph.D. . . . . . . . . . . . . . . . . . . .Roswell Park Cancer Institute Corporation

Smith, Charles D., Ph.D. . . . . . . . . . . . . . . . . . .Pennsylvania State University Hershey Medical Center

Smith, Eva D., Ph.D. . . . . . . . . . . . . . . . . . . . . .University of Illinois at Chicago

Song, Chang W., Ph.D. . . . . . . . . . . . . . . . . . . .University of Minnesota Medical School

Spatola, Arno F., Ph.D. . . . . . . . . . . . . . . . . . . .University of Louisville

Spencer, Richard P., M.D., Ph.D. . . . . . . . . . . . . .University of Connecticut Health Center

Stein, Cy A., M.D., Ph.D. . . . . . . . . . . . . . . . . .Montefiore Medical Center (Bronx, NY)

Stein, Gary S., Ph.D. . . . . . . . . . . . . . . . . . . . . .University of Massachusetts Medical School, Worcester

Stobaugh, John F., Ph.D. . . . . . . . . . . . . . . . . . .University of Kansas

Storey, C. Porter, M.D. . . . . . . . . . . . . . . . . . . .American Academy/Hospice and Palliative Medicine

Stotts, R. Craig, Ph.D. . . . . . . . . . . . . . . . . . . . .University of Tennessee Health Sciences Center

Stratakis, Constantine A., M.D. . . . . . . . . . . . . .National Institute of Child Health and Human Development

Straus, David J., M.D., Ph.D. . . . . . . . . . . . . . . .Memorial Sloan-Kettering Cancer Center

Strecher, Victor J., Ph.D. . . . . . . . . . . . . . . . . . .University of Michigan

Streeter, Oscar, M.D. . . . . . . . . . . . . . . . . . . . . .Norris Cancer Hospital

Studzinski, George P., M.D., Ph.D. . . . . . . . . . . .University of Medicine/Dentistry of New Jersey

Subramanian, Manny R., Ph.D. . . . . . . . . . . . . . .Best Medical International, Inc.

Sun, Luzhe Z., Ph.D. . . . . . . . . . . . . . . . . . . . . .University of Texas Health Sciences Center, San Antonio

T Talalay, Paul, M.D. . . . . . . . . . . . . . . . . . . . . . . .The Johns Hopkins University

Talmadge, James E., Ph.D. . . . . . . . . . . . . . . . . .University of Nebraska Medical Center

Tanabe, Kenneth K., M.D. . . . . . . . . . . . . . . . . .Massachusetts General Hospital

Taneja, Reshma, Ph.D. . . . . . . . . . . . . . . . . . . . .Mount Sinai School of Medicine of New York University

Tannenbaum, Steven R., Ph.D. . . . . . . . . . . . . . .Massachusetts Institute of Technology

Taub, Dennis D., Ph.D. . . . . . . . . . . . . . . . . . . .National Institute on Aging

Terry, Michael A., Ph.D. . . . . . . . . . . . . . . . . . . .University of Rochester

Tigyi, Gabor J., M.D., Ph.D. . . . . . . . . . . . . . . .Federation of American Societies for Experimental Biology

Triozzi, Pierre L., M.D. . . . . . . . . . . . . . . . . . . . .University of Alabama at Birmingham

True, Lawrence D., M.D. . . . . . . . . . . . . . . . . . .University of Washington

Truitt, Robert L., Ph.D. . . . . . . . . . . . . . . . . . . .University of Chicago Medical Center

Trump, Donald L., M.D. . . . . . . . . . . . . . . . . . . .Roswell Park Cancer Institute Corporation

Tweardy, David J., M.D. . . . . . . . . . . . . . . . . . . .Baylor College of Medicine

V Valiante, Nicholas M., Ph.D. . . . . . . . . . . . . . . .Chiron Corporation

Vannier, Michael W., M.D. . . . . . . . . . . . . . . . . .University of Iowa

Vessella, Robert L., Ph.D. . . . . . . . . . . . . . . . . . .University of Washington

Vokes, Everett E., M.D. . . . . . . . . . . . . . . . . . . .University of Chicago Medical Center

Appendix C-1: NCI Initial Review Group Consultants, FY2003
NCI/DEA Annual Report 2003

70

W Wadler, Scott, M.D., Ph.D. . . . . . . . . . . . . . . . . .Montefiore Medical Center (Bronx, NY)

Wagner, Henry, M.D. . . . . . . . . . . . . . . . . . . . . .University of South Florida

Wahl, Richard L., M.D. . . . . . . . . . . . . . . . . . . .The Johns Hopkins University

Wallack, Marc K., M.D. . . . . . . . . . . . . . . . . . . .St. Vincent’s Hospital

Ward, John H., M.D. . . . . . . . . . . . . . . . . . . . . .University of Utah

Ward, Sandra E., Ph.D. . . . . . . . . . . . . . . . . . . .University of Wisconsin at Madison

Warnecke, Richard B., Ph.D. . . . . . . . . . . . . . . . .University of Illinois at Chicago

Weiner, Louis M., M.D. . . . . . . . . . . . . . . . . . . .Fox Chase Cancer Center

Whiteside, Theresa L., Ph.D. . . . . . . . . . . . . . . . .University of Pittsburgh

Woloschak, Gayle E., Ph.D. . . . . . . . . . . . . . . . .Northwestern University

Woodgett, James R., Ph.D. . . . . . . . . . . . . . . . . .Ontario Cancer Institute

Workman, M. L., Ph.D. . . . . . . . . . . . . . . . . . . .Oncology Nursing Society

Wu, Anna M., Ph.D. . . . . . . . . . . . . . . . . . . . . .University of California at Los Angeles

Wu, Tzyy-Choou C., M.D., Ph.D. . . . . . . . . . . . .The Johns Hopkins University

Y Yancopoulos, George D., M.D., Ph.D. . . . . . . . . .Regeneron Pharmaceuticals, Inc.

Yang, Chung S., Ph.D. . . . . . . . . . . . . . . . . . . . .Rutgers University, New Brunswick

Yannelli, John R., Ph.D. . . . . . . . . . . . . . . . . . . .University of Louisville

Yap, Jeffrey T., Ph.D. . . . . . . . . . . . . . . . . . . . . .University of Tennessee Medical Center

Yeager, Andrew M., M.D. . . . . . . . . . . . . . . . . . .University of Pittsburgh

Yokoyama, Wayne M., M.D. . . . . . . . . . . . . . . . .Barnes-Jewish Hospital

Total Number of Reviewers: 328

Total Number of Times Reviewers Served: 406

Appendix C-1: NCI Initial Review Group Consultants, FY2003
NCI/DEA Annual Report 2003

71

2. Consultants Serving as Ad Hoc Committee Members on IRG Site Visit 

Teams in FY2003

A Abrams, Judith, Ph.D. . . . . . . . . . . . . . . . . . . . .Wayne State University

Achilefu, Samuel, Ph.D. . . . . . . . . . . . . . . . . . . .Washington University

Adams, Kathryn A., M.D. . . . . . . . . . . . . . . . . . .Cure for Lymphoma Foundation

Adashi, Eli Y., M.D. . . . . . . . . . . . . . . . . . . . . . .University of Maryland Baltimore Professional School

Aggarwal, Bharat B., Ph.D. . . . . . . . . . . . . . . . .University of Texas M.D. Anderson Cancer Center

Ahmed, Khalil, Ph.D. . . . . . . . . . . . . . . . . . . . . .University of Minnesota

Aisner, Joseph, M.D. . . . . . . . . . . . . . . . . . . . . .University of Medicine/Dentistry of New Jersey 

Aisner, Seena C., M.D. . . . . . . . . . . . . . . . . . . . .University of Medicine/Dentistry of New Jersey

Akman, Steven A., M.D. . . . . . . . . . . . . . . . . . .Wake Forest University Health Sciences

Akporiaye, Emmanuel T., Ph.D. . . . . . . . . . . . . . .University of Arizona

Albelda, Steven M., M.D. . . . . . . . . . . . . . . . . . .University of Pennsylvania Medical Center

Albertson, Donna G., Ph.D. . . . . . . . . . . . . . . . .University of California at San Francisco

Aldaz, C. Marcelo, M.D., Ph.D. . . . . . . . . . . . . .University of Texas M.D. Anderson Cancer Center

Alexander, Caroline M., Ph.D. . . . . . . . . . . . . . . .University of Wisconsin

Ali-Osman, Francis C., Ph.D. . . . . . . . . . . . . . . . .Duke University

Alsina, Melissa, M.D. . . . . . . . . . . . . . . . . . . . . .H. Lee Moffitt Cancer Center and Research Institute

Altman, Norman Harry, D.V.M. . . . . . . . . . . . . . .University of Miami

Andersen, Janet W., Sc.D. . . . . . . . . . . . . . . . . .Harvard University

Anderson, Garnet L., Ph.D. . . . . . . . . . . . . . . . .Fred Hutchinson Cancer Research Center

Anderson, John P., Ph.D. . . . . . . . . . . . . . . . . . .University of California at San Diego

Anderson, Wayne K., Ph.D. . . . . . . . . . . . . . . . .University of Buffalo

Andrews, Philip C., Ph.D. . . . . . . . . . . . . . . . . . .University of Michigan

Arber, Daniel A., M.D. . . . . . . . . . . . . . . . . . . . .Stanford University Hospital

Arceci, Robert J., M.D., Ph.D. . . . . . . . . . . . . . .Children’s Hospital Medical Center (Cincinnati)

Armstrong, Deborah K., M.D. . . . . . . . . . . . . . .The Johns Hopkins University

Artzt, Karen J., Ph.D. . . . . . . . . . . . . . . . . . . . .University of Texas

Asch, Bonnie B., Ph.D. . . . . . . . . . . . . . . . . . . . .Roswell Park Cancer Institute Corporation

Ashikaga, Takamaru, Ph.D. . . . . . . . . . . . . . . . . .University of Vermont and State Agricultural College

Aster, Jon C., M.D., Ph.D. . . . . . . . . . . . . . . . . .Brigham and Women’s Hospital

Auerbach, Robert, Ph.D. . . . . . . . . . . . . . . . . . .University of Wisconsin

Augenlicht, Leonard H., Ph.D. . . . . . . . . . . . . . .Montefiore Medical Center (Bronx, NY)

Austin, David J., Ph.D. . . . . . . . . . . . . . . . . . . .Yale University

B Baer, Maria R., M.D. . . . . . . . . . . . . . . . . . . . . .Roswell Park Cancer Institute Corporation

Bajorin, Dean, M.D. . . . . . . . . . . . . . . . . . . . . .Memorial Sloan-Kettering Cancer Center

Baker, David C., M.D., Ph.D. . . . . . . . . . . . . . . .Texas A&M University Health Science Center

Baker, Henry J., D.V.M. . . . . . . . . . . . . . . . . . . .Auburn University

Baker, Vicki V., M.D., Ph.D. . . . . . . . . . . . . . . . .University of Michigan Medical Center

Ball, Edward D., M.D. . . . . . . . . . . . . . . . . . . . .University of California at San Diego

Barber, Glen N., Ph.D. . . . . . . . . . . . . . . . . . . . .University of Miami

Barrows, Louis R., Ph.D. . . . . . . . . . . . . . . . . . .University of Utah

Barsevick, Andrea M., D.N.Sc., DOTH, D.Sc. . . . .Fox Chase Cancer Center

Barth, Richard J., M.D. . . . . . . . . . . . . . . . . . . .Dartmouth College

Bastia, Deepak, Ph.D. . . . . . . . . . . . . . . . . . . . .Medical University of South Carolina
NCI/DEA Annual Report 2003

72

Basu, Ashis K., Ph.D. . . . . . . . . . . . . . . . . . . . . .University of Connecticut

Beal, Peter A., Ph.D. . . . . . . . . . . . . . . . . . . . . .University of Utah

Bean, Judy A., Ph.D. . . . . . . . . . . . . . . . . . . . . .Children’s Hospital Medical Center

Becich, Michael J., M.D., Ph.D. . . . . . . . . . . . . .University of Pittsburgh

Beckman, Joseph S., Ph.D. . . . . . . . . . . . . . . . . .University of Alabama at Birmingham

Belinsky, Steven A., Ph.D. . . . . . . . . . . . . . . . . .Lovelace Biomedical & Environmental Research

Belk, Bonnie F., M.A., M.P.A. . . . . . . . . . . . . . . .Private Practice

Bellacosa, Alfonso, M.D. . . . . . . . . . . . . . . . . . .Fox Chase Cancer Center

Benbrook, Doris M., Ph.D. . . . . . . . . . . . . . . . . .University of Oklahoma Health Sciences Center

Benchimol, Samuel, Ph.D. . . . . . . . . . . . . . . . . . .University of Toronto

Bepler, Gerold, M.D., Ph.D. . . . . . . . . . . . . . . . .H. Lee Moffitt Cancer Center and Research Institute

Berger, Carole L., Ph.D. . . . . . . . . . . . . . . . . . . .Yale University School of Medicine

Berger, Mitchel S., M.D. . . . . . . . . . . . . . . . . . .University of California at San Francisco

Bergsagel, Peter L., M.D. . . . . . . . . . . . . . . . . . .Weill Medical College of Cornell University

Bernacki, Ralph J., Ph.D. . . . . . . . . . . . . . . . . . .Roswell Park Cancer Institute Corporation

Bernos, Eve E., B.A. . . . . . . . . . . . . . . . . . . . . . .University of Michigan Medical Center

Berwick, Marianne, Ph.D. . . . . . . . . . . . . . . . . .Memorial Sloan-Kettering Cancer Center

Bevan, Michael J., M.D., Ph.D. . . . . . . . . . . . . .University of Washington

Bhalla, Kapil N., M.D. . . . . . . . . . . . . . . . . . . . .H. Lee Moffitt Cancer Center and Research Institute

Bhat, Krishna, Ph.D. . . . . . . . . . . . . . . . . . . . . .Emory University

Bickers, David R., M.D. . . . . . . . . . . . . . . . . . . .Columbia University Health Sciences

Bieberich, Charles J., Ph.D. . . . . . . . . . . . . . . . .University of Maryland, Baltimore County 

Birk, David E., Ph.D. . . . . . . . . . . . . . . . . . . . . .Jefferson Medical College

Black, Paul N., Ph.D. . . . . . . . . . . . . . . . . . . . . .Ordway Research Institute, Inc.

Blair, Ian A., Ph.D. . . . . . . . . . . . . . . . . . . . . . .Vanderbilt University

Blaner, William S., Ph.D. . . . . . . . . . . . . . . . . . .Federation of American Socities for Experimental Biology

Blasberg, Ronald G., M.D. . . . . . . . . . . . . . . . . .Memorial Sloan-Kettering Cancer Center

Blumenstein, Brent A., Ph.D. . . . . . . . . . . . . . . .American College of Surgeons

Bollag, Gideon E., Ph.D. . . . . . . . . . . . . . . . . . .Plexxikon, Inc.

Boman, Bruce M., M.D., Ph.D. . . . . . . . . . . . . .Thomas Jefferson University

Boothman, David A., Ph.D. . . . . . . . . . . . . . . . .Case Western Reserve University

Boozer, Carol N., D.Sc., MOTH . . . . . . . . . . . . . .St. Luke’s-Roosevelt Institute for Health Sciences

Borch, Richard F., M.D., Ph.D. . . . . . . . . . . . . . .Purdue University

Borden, Katherine L., Ph.D. . . . . . . . . . . . . . . . .Mount Sinai School of Medicine of New York University

Bose, Henry R., Ph.D. . . . . . . . . . . . . . . . . . . . .University of Texas

Bosl, George J., M.D. . . . . . . . . . . . . . . . . . . . .University of Medicine/Dentistry of New Jersey

Bothwell, Mark A., Ph.D. . . . . . . . . . . . . . . . . . .University of Washington

Bourdon, Mario A., Ph.D. . . . . . . . . . . . . . . . . .La Jolla Institute for Molecular Medicine

Bovbjerg, Dana H., Ph.D. . . . . . . . . . . . . . . . . .Memorial Sloan-Kettering Cancer Center

Bowen, Deborah J., Ph.D. . . . . . . . . . . . . . . . . .Fred Hutchinson Cancer Research Center

Boyd, Norman F., M.D. . . . . . . . . . . . . . . . . . . .Ontario Cancer Institute

Bracy, Kathleen R., B.A. . . . . . . . . . . . . . . . . . . .University of Washington School of Medicine

Braden, Carrie Jo, Ph.D. . . . . . . . . . . . . . . . . . .University of Texas Health Sciences Center at San Antonio

Brattain, Michael G., Ph.D. . . . . . . . . . . . . . . . .Roswell Park Cancer Institute Corporation

Braun, Thomas M., Ph.D. . . . . . . . . . . . . . . . . .University of Michigan

Brautigan, David L., Ph.D. . . . . . . . . . . . . . . . . .University of Virginia

Bronson, Roderick T., D.V.M. . . . . . . . . . . . . . . .Tufts University School of Veterinary Medicine

Brown, Anthony M., Ph.D. . . . . . . . . . . . . . . . . .Weill Medical College of Cornell University

Appendix C-2: Consultants Serving as Ad Hoc Committee Members on IRG Site Visit Teams
NCI/DEA Annual Report 2003

73

Brown, Powel, M.D., Ph.D. . . . . . . . . . . . . . . . .Baylor College of Medicine

Brown, Terry R., Ph.D. . . . . . . . . . . . . . . . . . . . .The Johns Hopkins University

Bruner, Janet M., M.D. . . . . . . . . . . . . . . . . . . .University of Texas M.D. Anderson Cancer Center

Bryant, Joseph L., D.V.M. . . . . . . . . . . . . . . . . .University of Maryland

Bryant, Peter J., Ph.D. . . . . . . . . . . . . . . . . . . . .University of California at Irvine

Budinger, Thomas F., M.D., Ph.D. . . . . . . . . . . . .University of California at Berkeley

Buettner, Garry R., Ph.D. . . . . . . . . . . . . . . . . . .University of Iowa College of Medicine

Bull, Joan M., M.D. . . . . . . . . . . . . . . . . . . . . . .University of Texas Health Sciences Center at Houston

Bulun, Serdar E., M.D. . . . . . . . . . . . . . . . . . . . .Northwestern University

Burgess, Kevin, Ph.D. . . . . . . . . . . . . . . . . . . . .Texas A&M University

Burke, Donald H., Ph.D. . . . . . . . . . . . . . . . . . .Indiana University

Burke, Harry B., M.D., Ph.D. . . . . . . . . . . . . . . .George Washington University

Burke, Steven D., Ph.D. . . . . . . . . . . . . . . . . . . .University of Wisconsin

Butel, Janet S., Ph.D. . . . . . . . . . . . . . . . . . . . . .Baylor College of Medicine

Butler, Grace L., Ph.D. . . . . . . . . . . . . . . . . . . . .University of Houston

Byrd, John C., M.D. . . . . . . . . . . . . . . . . . . . . .Ohio State University

Byrne, Celia, Ph.D. . . . . . . . . . . . . . . . . . . . . . .Brigham and Women’s Hospital

C Cairo, Mitchell S., M.D. . . . . . . . . . . . . . . . . . . .Children’s Hospital of Orange County

Campbell, Lisa, B.S. . . . . . . . . . . . . . . . . . . . . . .The Johns Hopkins University

Cannon, Joseph G., M.D., Ph.D. . . . . . . . . . . . . .Medical College of Georgia

Cannon, Martin J., Ph.D. . . . . . . . . . . . . . . . . . .DCV Technologies, Inc.

Cantor, Alan B., M.D., Ph.D. . . . . . . . . . . . . . . .Children’s Hospital (Boston)

Carmichael, Gordon G., Ph.D. . . . . . . . . . . . . . . .University of Connecticut Health Center

Carney, Patricia A., Ph.D. . . . . . . . . . . . . . . . . . .Dartmouth College

Casey, Patrick J., Ph.D. . . . . . . . . . . . . . . . . . . .Duke University

Castagnoli, Neal, Ph.D. . . . . . . . . . . . . . . . . . . .Virginia Technologies, Inc.

Catalano, Paul J., Sc.D. . . . . . . . . . . . . . . . . . . .Dana-Farber Cancer Institute

Cave, William T., M.D. . . . . . . . . . . . . . . . . . . . .University of Rochester School of Medicine

Chambers, Timothy C., Ph.D. . . . . . . . . . . . . . . .University of Arkansas Medical Sciences at Little Rock

Chan, Daniel, Ph.D. . . . . . . . . . . . . . . . . . . . . . .The Johns Hopkins University School of Medicine

Chaney, Stephen G., Ph.D. . . . . . . . . . . . . . . . . .University of North Carolina

Chang, Helena R., M.D., Ph.D. . . . . . . . . . . . . . .University of California at Los Angeles

Chang, Stephen M., Ph.D. . . . . . . . . . . . . . . . . .Chiron Technologie, Center for Gene Therapy

Chao, Nelson J., M.D. . . . . . . . . . . . . . . . . . . . .Duke University Medical Center

Chapkin, Robert S., Ph.D. . . . . . . . . . . . . . . . . .Texas A&M University

Chen, Ching-Shih, Ph.D. . . . . . . . . . . . . . . . . . .Ohio State University

Chen, Shiuan, Ph.D. . . . . . . . . . . . . . . . . . . . . .City of Hope National Medical Center

Chen, Yong Q., Ph.D. . . . . . . . . . . . . . . . . . . . . .Wake Forest University Health Sciences

Chenevert, Thomas L., Ph.D. . . . . . . . . . . . . . . .University of Michigan

Cheng, Leo L., Ph.D. . . . . . . . . . . . . . . . . . . . . .Massachusetts General Hospital

Chiocca, E. Antonio, M.D., Ph.D. . . . . . . . . . . . .Massachusetts General Hospital

Chodosh, Lewis A., M.D., Ph.D. . . . . . . . . . . . . .University of Pennsylvania School of Medicine

Clapper, Margie L., Ph.D. . . . . . . . . . . . . . . . . . .Fox Chase Cancer Center

Cleveland, John L., Ph.D. . . . . . . . . . . . . . . . . . .St. Jude Children’s Research Hospital

Clevenger, Charles V., M.D., Ph.D. . . . . . . . . . . .University of Pennsylvania School of Medicine

Cochran, Alistair J., M.D. . . . . . . . . . . . . . . . . . .University of California at Los Angeles

Cody, Vivian, Ph.D. . . . . . . . . . . . . . . . . . . . . . .Hauptman-Woodward Medical Research Institute

Appendix C-2: Consultants Serving as Ad Hoc Committee Members on IRG Site Visit Teams
NCI/DEA Annual Report 2003

74

Coe, Christopher L., Ph.D. . . . . . . . . . . . . . . . . .University of Wisconsin

Coetzee, Gerhard A., Ph.D. . . . . . . . . . . . . . . . .University of Southern California

Cohen, Cynthia, M.D. . . . . . . . . . . . . . . . . . . . .Emory University

Cohen, Michael B., M.D. . . . . . . . . . . . . . . . . . .University of Iowa

Cohen, Stuart H., M.D., Ph.D. . . . . . . . . . . . . . .University of California at Davis

Cole, David J., M.D. . . . . . . . . . . . . . . . . . . . . .Medical University of South Carolina

Colgan, Sean P., Ph.D. . . . . . . . . . . . . . . . . . . . .Brigham and Women’s Hospital

Comai, Lucio, Ph.D. . . . . . . . . . . . . . . . . . . . . . .University of Southern California

Comenzo, Raymond L., M.D. . . . . . . . . . . . . . . .Memorial Sloan-Kettering Cancer Center

Cominelli, Fabio, M.D., Ph.D. . . . . . . . . . . . . . . .Virginia Commonwealth University

Constantine, Corinne, M.B.A. . . . . . . . . . . . . . . .New York University

Conway, Kathleen, Ph.D. . . . . . . . . . . . . . . . . . .University of North Carolina

Cooper, Cary W., Ph.D. . . . . . . . . . . . . . . . . . . .University of Texas Medical Branch

Courtneidge, Sara A., Ph.D. . . . . . . . . . . . . . . . .Van Andel Research Institute

Cox, Adrienne D., Ph.D. . . . . . . . . . . . . . . . . . .University of North Carolina

Crawford, Susan E., M.D., Ph.D. . . . . . . . . . . . .Northwestern University

Cromack, Keith R., Ph.D. . . . . . . . . . . . . . . . . . .Abbott Laboratories

Cullen, Kevin J., M.D., Ph.D. . . . . . . . . . . . . . . .Georgetown University

Curiel, Tyler J., M.D. . . . . . . . . . . . . . . . . . . . . .Tulane University

Curley, Robert W., Ph.D. . . . . . . . . . . . . . . . . . . .Ohio State University

Czachowski, Ralph E., M.A. . . . . . . . . . . . . . . . .Dartmouth College

Czerniecki, Brian J., M.D., Ph.D. . . . . . . . . . . . .University of Pennsylvania

D Dahiya, Rajvir, Ph.D. . . . . . . . . . . . . . . . . . . . . .Northern California Institute for Research and Education

Daling, Janet R., Ph.D. . . . . . . . . . . . . . . . . . . .Fred Hutchinson Cancer Research Center

Dalton, William S., M.D., Ph.D. . . . . . . . . . . . . .H. Lee Moffitt Cancer Center and Research Institute

Damsky, Caroline H., Ph.D. . . . . . . . . . . . . . . . .University of California at San Francisco

Darling, Michael W., MOTH . . . . . . . . . . . . . . . .Indiana University Cancer Center

Das Gupta, Tapas K., Ph.D. . . . . . . . . . . . . . . . .University of Illinois at Chicago

Davie, James R., Ph.D. . . . . . . . . . . . . . . . . . . .University of Manitoba

Davis, Franklin A., Ph.D. . . . . . . . . . . . . . . . . . .Temple University

Davis, Roger B., Sc.D. . . . . . . . . . . . . . . . . . . . .University of Massachusetts Medical School Worcester

De Lissovoy, Gregory V., Ph.D. . . . . . . . . . . . . . .Medtap International, Inc.

Debinski, Waldemar, M.D., Ph.D. . . . . . . . . . . . .Pennsylvania State University

Defranco, Donald B., Ph.D. . . . . . . . . . . . . . . . .University of Pittsburgh

Degrado, Timothy R., Ph.D. . . . . . . . . . . . . . . . .Indiana University-Purdue University at Indianapolis

Delrow, Jeffrey J., Ph.D. . . . . . . . . . . . . . . . . . .Fred Hutchinson Cancer Research Center

Delucas, Lawrence J., Ph.D. . . . . . . . . . . . . . . . .University of Alabama

Demanincor, Darlene J., Ph.D. . . . . . . . . . . . . . .Earthlink

Demple, Bruce F., Ph.D. . . . . . . . . . . . . . . . . . . .Harvard School of Public Health

Devere White, Ralph W., M.D. . . . . . . . . . . . . . .University of California at Davis

Devins, Gerald Michael, Ph.D. . . . . . . . . . . . . . . .University Health Network

Dewhirst, Mark W., Ph.D. . . . . . . . . . . . . . . . . .Duke University Medical Center

Dewitt, David L., Ph.D. . . . . . . . . . . . . . . . . . . .Michigan State University

Diamond, Don J., Ph.D. . . . . . . . . . . . . . . . . . . .Beckman Research Institute of City of Hope

Diasio, Robert B., M.D. . . . . . . . . . . . . . . . . . . .University of Alabama at Birmingham

Dickersin, Kay P., Ph.D. . . . . . . . . . . . . . . . . . . .Brown University

Diehr, Paula K., Ph.D. . . . . . . . . . . . . . . . . . . . .University of Washington

Appendix C-2: Consultants Serving as Ad Hoc Committee Members on IRG Site Visit Teams
NCI/DEA Annual Report 2003

75

Dipersio, John F., M.D., Ph.D. . . . . . . . . . . . . . .Washington University

Disis, Mary L., M.D. . . . . . . . . . . . . . . . . . . . . .University of Washington

Donahue, April B., OTH . . . . . . . . . . . . . . . . . . .National Ovarian Cancer Coalition

Donnenberg, Albert D., Ph.D. . . . . . . . . . . . . . . .University of Pittsburgh

Dressler, Gregory R., Ph.D. . . . . . . . . . . . . . . . .University of Michigan

Dubeau, Louis, M.D., Ph.D. . . . . . . . . . . . . . . . .University of Southern California

Dubinett, Steven M., M.D. . . . . . . . . . . . . . . . . .University of California at Los Angeles

Dudley, Jacquelyn P., Ph.D. . . . . . . . . . . . . . . . . .University of Texas

Dunbar, Sheri, M.P.A. . . . . . . . . . . . . . . . . . . . . .University of Kansas Medical Center

Dunlap, R. Bruce, Ph.D. . . . . . . . . . . . . . . . . . . .University of South Carolina at Columbia

Dupont, Bo, M.D. . . . . . . . . . . . . . . . . . . . . . . .Memorial Sloan-Kettering Cancer Center

Dupont, William D., Ph.D. . . . . . . . . . . . . . . . . .Vanderbilt University

Dynan, William S., Ph.D. . . . . . . . . . . . . . . . . . .Medical College of Georgia

E Eck, Stephen L., M.D., Ph.D. . . . . . . . . . . . . . . .University of Pennsylvania

Eckhart, Walter, Ph.D. . . . . . . . . . . . . . . . . . . . .Salk Institute for Biological Studies

Edgerton, Mary E., M.D., Ph.D. . . . . . . . . . . . . .Vanderbilt University

Eib, Lynn A., B.A. . . . . . . . . . . . . . . . . . . . . . . .Patient Advocates in Research

Eisenberger, Mario A., M.D. . . . . . . . . . . . . . . . .The Johns Hopkins University

Elder, David E., M.D. . . . . . . . . . . . . . . . . . . . . .University of Pennsylvania School of Medicine

Ellenberger, Tom E., Ph.D. . . . . . . . . . . . . . . . . .Harvard University Medical School

Ellenhorn, Joshua D., M.D. . . . . . . . . . . . . . . . .Beckman Research Institute of City of Hope

Ely, Kathryn R., Ph.D. . . . . . . . . . . . . . . . . . . . .Burnham Institute

Erickson, Leonard C., Ph.D. . . . . . . . . . . . . . . . .Indiana University Cancer Center

Evan, Gerard I., Ph.D. . . . . . . . . . . . . . . . . . . . .University of California at San Francisco

F Fahs, Marianne C., Ph.D. . . . . . . . . . . . . . . . . . .New School University

Fan, Hung Y., Ph.D. . . . . . . . . . . . . . . . . . . . . . .University of California at Irvine

Fan, Weimin, M.D., Ph.D. . . . . . . . . . . . . . . . . .Medical University of South Carolina

Fanning, Ellen H., Ph.D. . . . . . . . . . . . . . . . . . . .Vanderbilt University

Feld, Michael S., Ph.D. . . . . . . . . . . . . . . . . . . . .Massachusetts Institute of Technology

Felsburg, Peter J., M.D., Ph.D. . . . . . . . . . . . . . .University of Pennsylvania

Fenoglio-Preiser, Cecilia M., M.D. . . . . . . . . . . . .University of Cincinnati

Fenton, Robert G., M.D., Ph.D. . . . . . . . . . . . . .University of Maryland Baltimore Professional School

Ferrari, Anna C., M.D. . . . . . . . . . . . . . . . . . . . .Mount Sinai School of Medicine of New York University

Ferrone, Soldano, M.D., Ph.D. . . . . . . . . . . . . . .Roswell Park Cancer Institute Corporation

Field, Jeffrey M., Ph.D. . . . . . . . . . . . . . . . . . . .University of Pennsylvania

Figlin, Robert, M.D. . . . . . . . . . . . . . . . . . . . . . .University of California at Los Angeles

Fischer, James J., M.D., Ph.D. . . . . . . . . . . . . . .Icthyox, Inc.

Flaherty, Lawrence E., M.D. . . . . . . . . . . . . . . . .Wayne State University

Fong, Lawrence H., M.D. . . . . . . . . . . . . . . . . . .University of California at San Francisco

Fox, George E., Ph.D. . . . . . . . . . . . . . . . . . . . .Baylor College of Medicine

Fox, Jay W., Ph.D. . . . . . . . . . . . . . . . . . . . . . .University of Virginia

Franklin, William A., Ph.D. . . . . . . . . . . . . . . . . .Albert Einstein College of Medicine

Franko, Joann C., MOTH . . . . . . . . . . . . . . . . . .Case Western Reserve University

Freedman, Matthew T., M.D. . . . . . . . . . . . . . . .Georgetown University

Freeman, Michael R., Ph.D. . . . . . . . . . . . . . . . .Children’s Hospital (Boston)

Freund, Gregory G., M.D. . . . . . . . . . . . . . . . . .University of Illinois at Chicago

Appendix C-2: Consultants Serving as Ad Hoc Committee Members on IRG Site Visit Teams
NCI/DEA Annual Report 2003

76

Fu, Karen King-Wah, M.D. . . . . . . . . . . . . . . . . .University of California at San Francisco

Fuchs, Ephraim J., M.D. . . . . . . . . . . . . . . . . . . .The Johns Hopkins University

Fulton, Amy M., Ph.D. . . . . . . . . . . . . . . . . . . . .University of Maryland Baltimore Professional School

Furcht, Leo T., M.D. . . . . . . . . . . . . . . . . . . . . . .University of Minnesota at Twin Cities

G Gabrielson, Edward W., M.D. . . . . . . . . . . . . . . .The Johns Hopkins University

Gajewski, Thomas F., M.D., Ph.D. . . . . . . . . . . . .University of Chicago

Gallagher, Grant, Ph.D. . . . . . . . . . . . . . . . . . . .University of Medicine/Dentistry of New Jersey

Gallagher, Robert E., M.D. . . . . . . . . . . . . . . . . .Montefiore Medical Center (Bronx, NY)

Gardner, Paul R., Ph.D. . . . . . . . . . . . . . . . . . . .Children’s Hospital Medical Center (Cincinnati)

Garg, Pradeep K., Ph.D. . . . . . . . . . . . . . . . . . . .Yale University

Gaskins, H. R., Ph.D. . . . . . . . . . . . . . . . . . . . . .Baylor College of Medicine

Geacintov, Nicholas E., Ph.D. . . . . . . . . . . . . . . .New York University

Geller, Berta M., Ph.D. . . . . . . . . . . . . . . . . . . . .University of Vermont and State Agricultural College

Gendler, Sandra J., Ph.D. . . . . . . . . . . . . . . . . . .Mayo Clinic, Rochester

Geraghty, Daniel E., Ph.D. . . . . . . . . . . . . . . . . .Fred Hutchinson Cancer Research Center

Gerlach, Robert, Ph.D. . . . . . . . . . . . . . . . . . . . .Cleveland Clinic Foundation

Getzenberg, Robert H., Ph.D. . . . . . . . . . . . . . . .University of Pittsburgh

Gillespie, G. Yancey, Ph.D. . . . . . . . . . . . . . . . . .University of Alabama at Birmingham

Ginder, Gordon D., M.D., Ph.D. . . . . . . . . . . . . .Virginia Commonwealth University

Giralt, Sergio A., M.D. . . . . . . . . . . . . . . . . . . . .University of Texas M.D. Anderson Cancer Center

Glick, Henry, Ph.D. . . . . . . . . . . . . . . . . . . . . . .University of Pennsylvania School of Medicine

Glickson, Jerry D., Ph.D. . . . . . . . . . . . . . . . . . .University of Pennsylvania

Godfrey, Marjorie A., M.B.A. . . . . . . . . . . . . . . .Southwest Oncology Group

Goedegebuure, Peter S., Ph.D. . . . . . . . . . . . . . .Washington University

Gold, Barry I., M.D., Ph.D. . . . . . . . . . . . . . . . .University of Nebraska Medical Center

Goldberg, Judith D., M.D. . . . . . . . . . . . . . . . . .Bristol-Myers Squibb

Goldowitz, Daniel, Ph.D. . . . . . . . . . . . . . . . . . .University of Tennessee Health Sciences Center

Goldring, Mary B., Ph.D. . . . . . . . . . . . . . . . . . .Beth Israel Deaconess Medical Center

Goldstein, Lori J., M.D. . . . . . . . . . . . . . . . . . . .Fox Chase Cancer Center

Goodman, Mark M., Ph.D. . . . . . . . . . . . . . . . . .Emory University

Gordon, Eric M., Ph.D. . . . . . . . . . . . . . . . . . . .Sunesis Pharmaceuticals

Gosky, David M., M.B.A. . . . . . . . . . . . . . . . . . .Case Western Reserve University School of Medicine

Green, Stephanie J., Ph.D. . . . . . . . . . . . . . . . . .Fred Hutchinson Cancer Research Center

Greene, Warner C., M.D., Ph.D. . . . . . . . . . . . . .J. David Gladstone Institutes

Gricoski, John J., OTH . . . . . . . . . . . . . . . . . . . .Fox Chase Cancer Center

Grimm, Elizabeth A., Ph.D. . . . . . . . . . . . . . . . . .Introgen Therapeutics, Inc.

Groshen, Susan G., Ph.D. . . . . . . . . . . . . . . . . . .University of Souther California

Grosveld, Gerard C., Ph.D. . . . . . . . . . . . . . . . . .St. Jude Children’s Research Hospital

Grubbs, Clinton J., Ph.D. . . . . . . . . . . . . . . . . . .Life Sciences Technologies, Inc.

Guan, Jun-Lin, Ph.D. . . . . . . . . . . . . . . . . . . . . .Cornell University

Gupta, Sanjeev, M.D., Ph.D. . . . . . . . . . . . . . . . .Yeshiva University

Gur, David, Ph.D. . . . . . . . . . . . . . . . . . . . . . . .University of Pittsburgh School of Medicine

Gurney, James G., Ph.D. . . . . . . . . . . . . . . . . . .University of Minnesota at Twin Cities

H Hamel, Paul, Ph.D. . . . . . . . . . . . . . . . . . . . . . .University of Toronto

Hamelburg, Manny, MOTH . . . . . . . . . . . . . . . . .Massachusetts Prostate Cancer Coalition

Hamilton, Thomas A., Ph.D. . . . . . . . . . . . . . . . .Case Western Reserve University

Appendix C-2: Consultants Serving as Ad Hoc Committee Members on IRG Site Visit Teams
NCI/DEA Annual Report 2003

77

Hamkalo, Barbara A., Ph.D. . . . . . . . . . . . . . . . .University of California at Irvine

Hammarskjold, Marie-Louise, M.D., Ph.D. . . . . . .University of Virginia

Hang, Bo, M.D., Ph.D. . . . . . . . . . . . . . . . . . . .University of California at Berkeley

Hardwick, J Marie, Ph.D. . . . . . . . . . . . . . . . . . .The Johns Hopkins University

Harris, Randall E., M.D., Ph.D. . . . . . . . . . . . . . .Ohio State University

Harrison, Anita L., M.A. . . . . . . . . . . . . . . . . . . .Eastern Virginia Medical School

Hartmann, Lynn C., M.D., Ph.D. . . . . . . . . . . . . .Mayo Clinic, Rochester

Hasan, Tayyaba, Ph.D. . . . . . . . . . . . . . . . . . . . .Massachusetts General Hospital

Hassell, John A., Ph.D. . . . . . . . . . . . . . . . . . . .McMaster University

Hasty, Edward P., D.V.M. . . . . . . . . . . . . . . . . . .University of Texas Health Science Center at San Antonio

Havill-Ryan, Diana, OTH . . . . . . . . . . . . . . . . . . .University of Chicago School of Medicine

Hayward, Gary S., Ph.D. . . . . . . . . . . . . . . . . . .The Johns Hopkins University

Heaton, E. Fred, B.S. . . . . . . . . . . . . . . . . . . . . .Scripps Research Institute

Heerema, Nyla A., Ph.D. . . . . . . . . . . . . . . . . . .Ohio State University

Heisler, Jules, Ph.D. . . . . . . . . . . . . . . . . . . . . . .University of Pittsburgh

Held, William A., M.D., Ph.D. . . . . . . . . . . . . . . .Roswell Park Cancer Institute Corporation

Hellstrom, Ingegerd E., M.D., Ph.D. . . . . . . . . . .Pacific Northwest Research Institute

Hendrix, Mary J., Ph.D. . . . . . . . . . . . . . . . . . . .University of Iowa

Herman, James G., M.D. . . . . . . . . . . . . . . . . . .Johns Hopkins University Medical School

Herman, Terence S., M.D. . . . . . . . . . . . . . . . . .University of Texas

Herndon, James E., Ph.D. . . . . . . . . . . . . . . . . . .Duke University Medical Cener

Hess, Jay L., M.D., Ph.D. . . . . . . . . . . . . . . . . . .Washington University

Hess, Kenneth R., Ph.D. . . . . . . . . . . . . . . . . . . .University of Texas M.D. Anderson Cancer Center

Heston, Warren D., Ph.D. . . . . . . . . . . . . . . . . .Case Western Reserve University

Hill, Richard P., Ph.D. . . . . . . . . . . . . . . . . . . . . .University of Toronto

Hilsenbeck, Susan G., Ph.D. . . . . . . . . . . . . . . . .Baylor College of Medicine

Hinds, Pamela S., Ph.D. . . . . . . . . . . . . . . . . . . .Oncology Nursing Society

Hindsgaul, Ole, Ph.D. . . . . . . . . . . . . . . . . . . . .University of Alberta

Hirsch, Fred R., M.D., Ph.D. . . . . . . . . . . . . . . .University of Colorado Health Sciences Center

Hiscott, John, M.D., Ph.D. . . . . . . . . . . . . . . . .McGill University Jewish General Hospital

Hnatowich, Donald J., Ph.D. . . . . . . . . . . . . . . .North Shore-Long Island Jewish Research Institute

Hochberg, Fred H., M.D. . . . . . . . . . . . . . . . . . .Massachusetts General Hospital

Holt, Peter R., M.D. . . . . . . . . . . . . . . . . . . . . .St. Luke’s-Roosevelt Institute for Health Sciences

Honn, Kenneth V., Ph.D. . . . . . . . . . . . . . . . . . .Biomide Corporation

Hoon, Dave S. B., Ph.D. . . . . . . . . . . . . . . . . . .John Wayne Cancer Institute

Hope, Thomas J., M.D., Ph.D. . . . . . . . . . . . . . .University of Illinois at Chicago

Horseman, Nelson D., Ph.D. . . . . . . . . . . . . . . .University of Cincinnati

Howe, Louise R., Ph.D. . . . . . . . . . . . . . . . . . . .Weill Medical College of Cornell University

Hromas, Robert A., M.D. . . . . . . . . . . . . . . . . .University of New Mexico

Huang, Christene A., Ph.D. . . . . . . . . . . . . . . . .Massachusetts General Hospital

Huang, Peng, M.D., Ph.D. . . . . . . . . . . . . . . . . .University of Texas M.D. Anderson Cancer Center

Huang, Tim H., Ph.D. . . . . . . . . . . . . . . . . . . . .Ohio State University

Humphries, Richard Keith, M.D., Ph.D. . . . . . . . .British Columbia Cancer Research Centre

Hurwitz, Arthur A., Ph.D. . . . . . . . . . . . . . . . . .SUNY Upstate Medical University

Huston, James S., Ph.D. . . . . . . . . . . . . . . . . . .Intraimmune Therapies

Huycke, Mark M., M.D. . . . . . . . . . . . . . . . . . .University of Oklahoma Health Sciences Center

Hwang, Daniel H., Ph.D. . . . . . . . . . . . . . . . . . .University of California at Davis

Appendix C-2: Consultants Serving as Ad Hoc Committee Members on IRG Site Visit Teams
NCI/DEA Annual Report 2003

78

I Ikle, David N., Ph.D. . . . . . . . . . . . . . . . . . . . . .City of Hope National Medical Center

Ildstad, Suzanne T., M.D. . . . . . . . . . . . . . . . . . .Regenerex, LLC

J James, Charles D., Ph.D. . . . . . . . . . . . . . . . . . .Mayo Clinic, Rochester

Jenkins, Robert B., M.D., Ph.D. . . . . . . . . . . . . .Mayo Clinic, Rochester

Jensen, Roy A., M.D., Ph.D. . . . . . . . . . . . . . . . .Vanderbilt University

Jewell, William R., M.D. . . . . . . . . . . . . . . . . . . .University of Kansas Medical Center

Johnson, Francis, Ph.D. . . . . . . . . . . . . . . . . . . .State University of New York at Stony Brook

Johnson, Linda B., B.S. . . . . . . . . . . . . . . . . . . . .National Coalition for Cancer Survivorship

Jones, Glenville, Ph.D. . . . . . . . . . . . . . . . . . . . .Queen’s University

Jones, Paul K., Ph.D. . . . . . . . . . . . . . . . . . . . . .Case Western Reserve University

Jorgensen, Timothy J., Ph.D. . . . . . . . . . . . . . . . .Georgetown University

Joshi, Harish C., Ph.D. . . . . . . . . . . . . . . . . . . . .Emory University

Jourd’Heuil, David, Ph.D. . . . . . . . . . . . . . . . . . .Albany Medical College of Union University

K Kacinski, Barry M., M.D., Ph.D. . . . . . . . . . . . . .Yale University School of Medicine

Kadmon, Dov, M.D., Ph.D. . . . . . . . . . . . . . . . . .Baylor College of Medicine

Kallmerten, James L., Ph.D. . . . . . . . . . . . . . . . .Syracuse University

Kalluri, Raghu, M.D., Ph.D. . . . . . . . . . . . . . . . .Beth Israel Deaconess Medical Center

Kantarjian, Hagop M., M.D. . . . . . . . . . . . . . . . .University of Texas M.D. Anderson Cancer Center

Kaplitt, Michael G., M.D., Ph.D. . . . . . . . . . . . . .Weill Medical College of Cornell University

Kapur, Raj P., M.D., Ph.D. . . . . . . . . . . . . . . . . .Children’s Hospital and Regional Medical Center

Karrison, Theodore, M.D., Ph.D. . . . . . . . . . . . . .University of Chicago

Katiyar, Santosh K., Ph.D. . . . . . . . . . . . . . . . . .Drexel University

Katzenellenbogen, Benita S., Ph.D. . . . . . . . . . . .University of Illinois

Kaufman, David G., M.D., Ph.D. . . . . . . . . . . . .University of North Carolina

Keely, Patricia J., Ph.D. . . . . . . . . . . . . . . . . . . .University of Wisconsin

Keller, Evan T., M.D., Ph.D. . . . . . . . . . . . . . . . .University of Michigan

Kenan, Daniel J., M.D., Ph.D. . . . . . . . . . . . . . . .Duke University Medical Center

Kennedy, Ronald C., Ph.D. . . . . . . . . . . . . . . . . .Texas Tech University

Kennelly, Peter J., Ph.D. . . . . . . . . . . . . . . . . . . .Virginia Polytechnic Institute and State University

Kessel, David H., Ph.D. . . . . . . . . . . . . . . . . . . .Wayne State University

Kettler, Stephanie, B.S. . . . . . . . . . . . . . . . . . . . .Washington University

Keyes, Sean M., B.A., B.S. . . . . . . . . . . . . . . . . .Fox Chase Cancer Center

Kidd, Vincent J., Ph.D. . . . . . . . . . . . . . . . . . . .St. Jude Children’s Research Hospital

Kim, Kyungmann, Ph.D. . . . . . . . . . . . . . . . . . . .University of Wisconsin

Kinnally, Kathleen W., Ph.D. . . . . . . . . . . . . . . . .New York University

Kirk, Frank, M.A. . . . . . . . . . . . . . . . . . . . . . . . .Puget Sound Prostate Cancer Work Force

Kirn, David H., M.D. . . . . . . . . . . . . . . . . . . . . .Jennerex

Klein, John P., Ph.D. . . . . . . . . . . . . . . . . . . . . .Medical College of Wisconsin

Klein, Peter S., M.D., Ph.D. . . . . . . . . . . . . . . . .University of Pennsylvania

Kleinberg, David L., M.D. . . . . . . . . . . . . . . . . . .New York University School of Medicine

Kleinman, Nanette, D.V.M. . . . . . . . . . . . . . . . . .Case Western Reserve University

Knowles, Annette M., MOTH . . . . . . . . . . . . . . .The Leukemia and Lymphoma Society

Knowles, Barbara B., M.D., Ph.D. . . . . . . . . . . . .Jackson Laboratory

Knudsen, Erik S., Ph.D. . . . . . . . . . . . . . . . . . . .University of Cincinnati

Kohman, Leslie J., M.D. . . . . . . . . . . . . . . . . . . .SUNY Health Science Center

Appendix C-2: Consultants Serving as Ad Hoc Committee Members on IRG Site Visit Teams
NCI/DEA Annual Report 2003

79

Konigsberg, William H., Ph.D. . . . . . . . . . . . . . . .Yale University

Kornfeld, Gary, J.D. . . . . . . . . . . . . . . . . . . . . . .Florida Brain Tumor Association

Kow, Yoke W., Ph.D. . . . . . . . . . . . . . . . . . . . . . .Emory University

Kreuter, Matthew W., Ph.D. . . . . . . . . . . . . . . . .St. Louis University

Kruh, Gary D., M.D., Ph.D. . . . . . . . . . . . . . . . .Fox Chase Cancer Center

Kuchta, Robert D., Ph.D. . . . . . . . . . . . . . . . . . .University of Colorado

Kukafka, Rita, Ph.D. . . . . . . . . . . . . . . . . . . . . .Columbia University Health Sciences

Kukreja, Subhash C., M.D. . . . . . . . . . . . . . . . . .University of Illinois at Chicago

Kumar, Rakesh F., M.D., Ph.D. . . . . . . . . . . . . . .Pennsylvania State University College of Medicine

Kung, Hsing Jien, Ph.D. . . . . . . . . . . . . . . . . . . .University of California at Davis

Kupfer, Abraham, Ph.D. . . . . . . . . . . . . . . . . . . .National Jewish Medical and Research Center

Kuzel, Timothy M., M.D. . . . . . . . . . . . . . . . . . .Northwestern University

Kyprianou, Natasha, Ph.D. . . . . . . . . . . . . . . . . .University of Kentucky

L Lahue, Robert S., Ph.D. . . . . . . . . . . . . . . . . . . .University of Nebraska Medical Center

Laird, Beverly L., Ph.D. . . . . . . . . . . . . . . . . . . .University of Alabama at Birmingham

Lam, Kit S., M.D., Ph.D. . . . . . . . . . . . . . . . . . .University of California at Davis

Lange, Carol A., Ph.D. . . . . . . . . . . . . . . . . . . . .University of Minnesota at Twin Cities

Languino, Lucia R., Ph.D. . . . . . . . . . . . . . . . . . .University of Massachusetts Medical School at Worcester

Largaespada, David A., Ph.D. . . . . . . . . . . . . . . .University of Minnesota at Twin Cities

Larson, Steven M., M.D., Ph.D. . . . . . . . . . . . . .Memorial Sloan-Kettering Cancer Center

Laterra, John J., M.D., Ph.D. . . . . . . . . . . . . . . .Kennedy Krieger Research Institute, Inc.

Lee, Chung, Ph.D. . . . . . . . . . . . . . . . . . . . . . . .Northwestern University Medical School

Lee, Peter P., M.D. . . . . . . . . . . . . . . . . . . . . . .Stanford University

Leeper, Dennis B., M.D., Ph.D. . . . . . . . . . . . . . .Thomas Jefferson University

Legerski, Randy J., Ph.D. . . . . . . . . . . . . . . . . . .University of Texas M.D. Anderson Cancer Center

Leis, Jonathan P., Ph.D. . . . . . . . . . . . . . . . . . . .Northwestern University

Lemons, Richard S., M.D., Ph.D. . . . . . . . . . . . . .University of Utah

Leong, Stanley P.L., M.D. . . . . . . . . . . . . . . . . . .University of California at San Francisco

Levy, David E., Ph.D. . . . . . . . . . . . . . . . . . . . . .New York University School of Medicine

Lewin, John M., M.D. . . . . . . . . . . . . . . . . . . . .University of Colorado Health Sciences Center

Lewis, Kevin T., M.B.A. . . . . . . . . . . . . . . . . . . . .Colon Cancer Alliance

Lezotte, Dennis C., Ph.D. . . . . . . . . . . . . . . . . . .University of Colorado Health Sciences Center

Li, Gloria C., Ph.D. . . . . . . . . . . . . . . . . . . . . . .Memorial Sloan-Kettering Cancer Center

Li, Guo-Min, Ph.D. . . . . . . . . . . . . . . . . . . . . . .University of Kentucky

Li, William W., M.D. . . . . . . . . . . . . . . . . . . . . .Ohio Aerospace Institute

Libermann, Towia A., Ph.D. . . . . . . . . . . . . . . . .Beth Israel Deaconess Medical Center

Lieberman, Paul M., Ph.D. . . . . . . . . . . . . . . . . .Wistar Institute

Lightdale, Charles J., M.D. . . . . . . . . . . . . . . . . .Columbia University Health Sciences

Lin, Henry J., M.D., Ph.D. . . . . . . . . . . . . . . . . .University of California at Los Angeles

Line, Bruce R., M.D. . . . . . . . . . . . . . . . . . . . . .University of Maryland Baltimore Professional School

Lokeshwar, Balakrishna L., Ph.D. . . . . . . . . . . . . .University of Miami

Lord, Edith M., Ph.D. . . . . . . . . . . . . . . . . . . . .University of Rochester

Lovett, Michael A., M.D., Ph.D. . . . . . . . . . . . . .University of California at Los Angeles

Lowe, Scott W., Ph.D. . . . . . . . . . . . . . . . . . . . .Cold Spring Harbor Laboratory

Lubaroff, David M., Ph.D. . . . . . . . . . . . . . . . . .University of Iowa

Lucito, Robert D., Ph.D. . . . . . . . . . . . . . . . . . .Cold Spring Harbor Laboratory

Lum, Lawrence G., M.D. . . . . . . . . . . . . . . . . . .Roger Williams Hospital

Appendix C-2: Consultants Serving as Ad Hoc Committee Members on IRG Site Visit Teams
NCI/DEA Annual Report 2003

80

Lyden, David C., M.D., Ph.D. . . . . . . . . . . . . . . .Weill Medical College of Cornell University

Lyerly, Herbert K., M.D. . . . . . . . . . . . . . . . . . . .Duke University Medical Center

Lyle, Juanita . . . . . . . . . . . . . . . . . . . . . . . . . . .George Washington University

Lynch, James F., M.B.A. . . . . . . . . . . . . . . . . . . .Fox Chase Cancer Center

Lynch, Richard G., M.D., Ph.D. . . . . . . . . . . . . .University of Iowa College of Medicine

M Macey, Daniel J., Ph.D. . . . . . . . . . . . . . . . . . . .Harrison Medical Corporation

Mack, Thomas M., M.D. . . . . . . . . . . . . . . . . . .University of Southern California

Maihle, Nita J., Ph.D. . . . . . . . . . . . . . . . . . . . .Mayo Clinic, Rochester

Manfredi, James J., Ph.D. . . . . . . . . . . . . . . . . .Mount Sinai School of Medicine of New York University

Manni, Andrea, M.D. . . . . . . . . . . . . . . . . . . . . .Pennsylvania State University

Mariadason, John M., Ph.D. . . . . . . . . . . . . . . . .Montefiore Medical Center (Bronx, NY)

Marks, Jeffrey R., M.D., Ph.D. . . . . . . . . . . . . . .Duke University

Marriott, Susan, Ph.D. . . . . . . . . . . . . . . . . . . . .Baylor College of Medicine

Mathews-Roth, Micheline M., M.D. . . . . . . . . . . .Brigham and Women’s Hospital

Mathieu, Rachel, B.S. . . . . . . . . . . . . . . . . . . . . .After Breast Cancer Surgery

Maurer, Calvin R., Ph.D. . . . . . . . . . . . . . . . . . .Stanford University

Mayer, Joni A., Ph.D. . . . . . . . . . . . . . . . . . . . .San Diego State University

McBride, Colleen M., Ph.D. . . . . . . . . . . . . . . . .Duke University Medical Center

McCance, Dennis J., Ph.D. . . . . . . . . . . . . . . . . .University of Rochester

McCarthy-Beckett, Donna O., Ph.D. . . . . . . . . . .University of Wisconsin

McCormick, Frank, Ph.D. . . . . . . . . . . . . . . . . . .University of California at San Francisco

McDermott, Harrold G., OTH . . . . . . . . . . . . . . .University of Oklahoma

McEwan, Alexander J., M.B.B.S. . . . . . . . . . . . . .University of Alberta School of Medicine

McKay, Paul P. . . . . . . . . . . . . . . . . . . . . . . . . . .Patient Advocate

McKinnon, Peter J., Ph.D. . . . . . . . . . . . . . . . . .St. Jude Children’s Research Hospital

McQuaid, John R., Ph.D. . . . . . . . . . . . . . . . . . .Veterans Medical Research Foundation at San Diego

Meares, Claude F., Ph.D. . . . . . . . . . . . . . . . . . .University of California at Davis

Medina, Daniel, Ph.D. . . . . . . . . . . . . . . . . . . . .Baylor College of Medicine

Mellon, Isabel W., Ph.D. . . . . . . . . . . . . . . . . . . .University of Kentucky

Melnick, Ari M., M.D. . . . . . . . . . . . . . . . . . . . .Yeshiva University

Meyer, Charles R., Ph.D. . . . . . . . . . . . . . . . . . .University of Michigan

Meyer, Laurence J., M.D., Ph.D. . . . . . . . . . . . . .University of Utah

Meyers, Craig M., Ph.D. . . . . . . . . . . . . . . . . . .Pennsylvania State University

Mihm, Jr., Martin C., OTH . . . . . . . . . . . . . . . . .Harvard Medical School

Miller, Donald M., M.D., Ph.D. . . . . . . . . . . . . . .University of Louisville School of Medicine

Mills, Susan S., B.S. . . . . . . . . . . . . . . . . . . . . . .Vanderbilt University

Minden, Mark D., M.D., Ph.D. . . . . . . . . . . . . .Princess Margaret Hospital

Mishra, Bhubaneswar, Ph.D. . . . . . . . . . . . . . . . .New York University

Mitchell, Janet B., M.D. . . . . . . . . . . . . . . . . . . .Research Triangle Institute

Mitra, Nandita, Ph.D. . . . . . . . . . . . . . . . . . . . .Memorial Sloan-Kettering Cancer Center

Molnar-Kimber, Katherine L., Ph.D. . . . . . . . . . . .University of Pennsylvania

Monteiro, Alvaro N., Ph.D. . . . . . . . . . . . . . . . . .Strang Cancer Prevention Center

Moon, Randall T., Ph.D. . . . . . . . . . . . . . . . . . . .University of Washington

Moorman, Patricia G., Ph.D. . . . . . . . . . . . . . . . .Duke University

Morgan, Jennifer, MOTH . . . . . . . . . . . . . . . . . . .Medical University of South Carolina

Morgan, Timothy M., Ph.D. . . . . . . . . . . . . . . . .Wake Forest University

Morgan, William F., Ph.D. . . . . . . . . . . . . . . . . . .University of Maryland

Appendix C-2: Consultants Serving as Ad Hoc Committee Members on IRG Site Visit Teams
NCI/DEA Annual Report 2003

81

Mori, Motomi, Ph.D. . . . . . . . . . . . . . . . . . . . . .Oregon Health and Science University

Moriya, Masaaki, Ph.D. . . . . . . . . . . . . . . . . . . .SUNY at Stony Brook

Morrow, Charles S., M.D., Ph.D. . . . . . . . . . . . . .Wake Forest University Health Sciences

Mossman, Brooke T., Ph.D. . . . . . . . . . . . . . . . . .University of Vermont

Mueller, Barbara M., Ph.D. . . . . . . . . . . . . . . . . .La Jolla Institute for Molecular Medicine

Mukhtar, Hasan, Ph.D. . . . . . . . . . . . . . . . . . . . .University of Wisconsin

Mulder, Kathleen M., Ph.D. . . . . . . . . . . . . . . . .Pennsylvania State University

Mullins, Meredith, M.B.A. . . . . . . . . . . . . . . . . . .H. Lee Moffitt Cancer Center

Mulvihill, John J., M.D. . . . . . . . . . . . . . . . . . . .Medical College of Ohio at Toledo

Munger, Karl, Ph.D. . . . . . . . . . . . . . . . . . . . . . .Harvard University Medical School

Munn, David H., M.D. . . . . . . . . . . . . . . . . . . . .Medical College of Georgia

Murphy, James R., Ph.D. . . . . . . . . . . . . . . . . . .National Jewish Medical and Research Center

Murphy, William J., Ph.D. . . . . . . . . . . . . . . . . .Temple University

Murti, Kuruganti G., Ph.D. . . . . . . . . . . . . . . . .St. Jude Children’s Research Hospital

Mutch, David, M.D. . . . . . . . . . . . . . . . . . . . . .Washington University School of Medicine

N Nademanee, Auayporn, M.D. . . . . . . . . . . . . . . .City of Hope National Medical Center

Naeve, Clayton W., Ph.D. . . . . . . . . . . . . . . . . . .St. Jude Children’s Research Hospital

Nagarajan, Lalitha, Ph.D. . . . . . . . . . . . . . . . . . .University of Texas M.D. Anderson Cancer Center

Nail, Lillian M., Ph.D. . . . . . . . . . . . . . . . . . . . .Oregon Health and Science University

Nairn, Rodney S., Ph.D. . . . . . . . . . . . . . . . . . . .University of Texas M.D. Anderson Cancer Center

Nalcioglu, Orhan, Ph.D. . . . . . . . . . . . . . . . . . . .University of California at Irvine

Narayanan, Ramaswamy, Ph.D. . . . . . . . . . . . . . .Florida Atlantic University

Naylor, Susan L., Ph.D. . . . . . . . . . . . . . . . . . . .University of Texas Health Science Center

Negrin, Robert S., M.D., Ph.D. . . . . . . . . . . . . . .International Society for Hematotherapy and Graft Engineering

Nelson, Karen E., Ph.D. . . . . . . . . . . . . . . . . . . .Institute for Genomic Research

Nephew, Kenneth P., Ph.D. . . . . . . . . . . . . . . . . .Indiana University-Purdue University at Indianapolis

Neuhauser, Linda, Dr.P.H. . . . . . . . . . . . . . . . . . .University of California at Berkeley

Neuwelt, Edward A., M.D. . . . . . . . . . . . . . . . . .Oregon Health and Science University

Nicosia, Santo V., M.D. . . . . . . . . . . . . . . . . . . .University of South Florida

Niland, Joyce C., Ph.D. . . . . . . . . . . . . . . . . . . .Beckman Research Institute of City of Hope

Nishikawa, Robert M., Ph.D. . . . . . . . . . . . . . . .University of Chicago

Nissenberg, Merel, J.D. . . . . . . . . . . . . . . . . . . .Consumer Advocate

Noelle, Randolph J., Ph.D. . . . . . . . . . . . . . . . . .Dartmouth College

Norkin, Leonard C., Ph.D. . . . . . . . . . . . . . . . . .University of Massachusetts

Norris, James S., M.D., Ph.D. . . . . . . . . . . . . . . .Medical University of South Carolina

Notterman, Daniel A., M.D. . . . . . . . . . . . . . . . .Robert Wood Johnson University Hospital

Nusse, Roel, Ph.D. . . . . . . . . . . . . . . . . . . . . . .Keystone Symposia

O O’Connor, Timothy R., Ph.D. . . . . . . . . . . . . . . .City of Hope National Medical Center

Ogden, Bryan E., D.V.M. . . . . . . . . . . . . . . . . . .Oregon Health and Science University

Oleinick, Nancy L., Ph.D. . . . . . . . . . . . . . . . . . .Case Western Reserve University

Ondrey, Frank G., M.D., Ph.D. . . . . . . . . . . . . . .University of Minnesota at Twin Cities

Ornitz, David M., M.D., Ph.D. . . . . . . . . . . . . . .Washington University

Osman, Roman, Ph.D. . . . . . . . . . . . . . . . . . . . .Mount Sinai School of Medicine of New York University

Otey, Carol A., Ph.D. . . . . . . . . . . . . . . . . . . . . .University of North Carolina

Appendix C-2: Consultants Serving as Ad Hoc Committee Members on IRG Site Visit Teams
NCI/DEA Annual Report 2003

82

P Pace, Lorraine, M.S. . . . . . . . . . . . . . . . . . . . . . .Patient Advocate Foundation

Pallas, David C., Ph.D. . . . . . . . . . . . . . . . . . . . .Emory University Medical School

Pardue, Mary-Lou L., Ph.D. . . . . . . . . . . . . . . . .Massachusetts Institute of Technology

Park, Morag, Ph.D. . . . . . . . . . . . . . . . . . . . . . .McGill University

Parvin, Jeffrey D., M.D., Ph.D. . . . . . . . . . . . . . .Brigham and Women’s Hospital

Pasqualini, Renata R., Ph.D. . . . . . . . . . . . . . . . .University of Texas M.D. Anderson Cancer Center

Pento, J. Thomas, Ph.D. . . . . . . . . . . . . . . . . . . .University of Oklahoma Health Sciences Center

Perkins, Archibald S., M.D., Ph.D. . . . . . . . . . . . .Yale University

Petasis, Nicos A., Ph.D. . . . . . . . . . . . . . . . . . . .University of Southern California

Pettitt, B. Montgomery, Ph.D. . . . . . . . . . . . . . .University of Houston

Pfenning, Michael A., M.B.A. . . . . . . . . . . . . . . .Mayo Clinic, Rochester

Pieper, Rembert, Ph.D. . . . . . . . . . . . . . . . . . . . .Large Scale Biology Corporation

Pierce, John P., Ph.D. . . . . . . . . . . . . . . . . . . . . .University of California at San Diego

Pirrung, Michael C., Ph.D. . . . . . . . . . . . . . . . . .Duke University

Pitha-Rowe, Paula M., Ph.D. . . . . . . . . . . . . . . . .The Johns Hopkins University

Platanias, Leonidas C., M.D., Ph.D. . . . . . . . . . . .Northwestern University

Plautz, Gregory E., M.D. . . . . . . . . . . . . . . . . . .Cleveland Clinic Foundation

Pleasure, David E., M.D. . . . . . . . . . . . . . . . . . .Children’s Hospital of Philadelphia

Pledger, W. J., Ph.D. . . . . . . . . . . . . . . . . . . . . .H. Lee Moffitt Cancer Center and Research Institute

Polyak, Kornelia, M.D., Ph.D. . . . . . . . . . . . . . . .Dana-Farber Cancer Institute

Polz, Martin, Ph.D. . . . . . . . . . . . . . . . . . . . . . .Massachusetts Institute of Technology

Popel, Aleksander S., Ph.D. . . . . . . . . . . . . . . . . .The Johns Hopkins University

Propert, Kathleen J., D.Sc., Sc.D. . . . . . . . . . . . .University of Pennsylvania

Q Qin, Jun, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . .Case Western Reserve University

R Rafii, Shahin, M.D. . . . . . . . . . . . . . . . . . . . . . . .Weill Medical College of Cornell University

Raleigh, James A., Ph.D. . . . . . . . . . . . . . . . . . .University of North Carolina School of Medicine

Ramakrishnan, Viswanathan, Ph.D. . . . . . . . . . . .Virginia Commonwealth University

Ramanujam, Nimmi, Ph.D. . . . . . . . . . . . . . . . . .University of Wisconsin

Ramotar, Dindial, Ph.D. . . . . . . . . . . . . . . . . . . .Hospital Maisnonneuve-Rosemont

Ramsden, Dale A., Ph.D. . . . . . . . . . . . . . . . . . .University of North Carolina

Rangnekar, Vivek M., Ph.D. . . . . . . . . . . . . . . . .University of Kentucky

Ratliff, Timothy L., Ph.D. . . . . . . . . . . . . . . . . . .Washington University

Rauscher, Frank J., M.D., Ph.D. . . . . . . . . . . . . .Wistar Institute

Ray, Rahul, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . .Boston University School of Medicine

Reddy, Bandaru S., D.V.M., Ph.D. . . . . . . . . . . . .Institute for Cancer Prevention

Reddy, E. Premkumar, Ph.D. . . . . . . . . . . . . . . . .Temple University

Redmond, Carol K., Ph.D. . . . . . . . . . . . . . . . . . .University of Pittsburgh

Reid, Mary E., Ph.D. . . . . . . . . . . . . . . . . . . . . .Roswell Park Cancer Institute Corporation

Repasky, Elizabeth A., Ph.D. . . . . . . . . . . . . . . . .Roswell Park Cancer Institute Corporation

Resing, Katheryn H., Ph.D. . . . . . . . . . . . . . . . . .University of Colorado

Rexer-Bluhm, Mary Katherine, M.A. . . . . . . . . . . .University of Michigan

Rhodes, Kris E., M.S. . . . . . . . . . . . . . . . . . . . . .University of Kentucky

Ribble, Angela, B.A. . . . . . . . . . . . . . . . . . . . . . .Southwest Oncology Group Statistical Center

Ridge, John A., M.D., Ph.D. . . . . . . . . . . . . . . .Fox Chase Cancer Center

Roberson, Noma L., Ph.D. . . . . . . . . . . . . . . . . .Roberson Consulting International

Appendix C-2: Consultants Serving as Ad Hoc Committee Members on IRG Site Visit Teams
NCI/DEA Annual Report 2003

83

Roberson, Paula K., Ph.D. . . . . . . . . . . . . . . . . . .Arkansas Cancer Research Center

Roberts, John D., M.D. . . . . . . . . . . . . . . . . . . .Virginia Commonwealth University

Roberts, R. Michael, Ph.D. . . . . . . . . . . . . . . . . .University of Missouri College of Agriculture

Rogatko, Andre, Ph.D. . . . . . . . . . . . . . . . . . . . .Fox Chase Cancer Center

Romano, Louis J., Ph.D. . . . . . . . . . . . . . . . . . . .Wayne State University

Rosenbaum, Louise M., Ph.D. . . . . . . . . . . . . . . .Dartmouth College

Rosenberg, Susan M., Ph.D. . . . . . . . . . . . . . . . .University of Alberta

Rosenblatt, Joseph D., M.D. . . . . . . . . . . . . . . . .University of Miami

Rosenfeld, Steven S., M.D., Ph.D. . . . . . . . . . . . .University of Alabama at Birmingham

Rosenstein, Barry S., Ph.D. . . . . . . . . . . . . . . . . .Mount Sinai School of Medicine of New York University

Roti Roti, Joseph L., Ph.D. . . . . . . . . . . . . . . . . .Washington University School of Medicine

Roy, Arun K., Ph.D. . . . . . . . . . . . . . . . . . . . . . .University of Texas

Rubin, Mark A., M.D. . . . . . . . . . . . . . . . . . . . .Brigham and Women’s Hospital

Ruckdeschel, John C., M.D., Ph.D. . . . . . . . . . . .University of South Florida

Rundell, M. Kathleen, Ph.D. . . . . . . . . . . . . . . . .Northwestern University

Rutter, Carolyn M., Ph.D. . . . . . . . . . . . . . . . . . .Center for Health Studies

S Sabatini, David M., M.D., Ph.D. . . . . . . . . . . . . .Whitehead Institute for Biomedical Research

Safa, Ahmad R., Ph.D. . . . . . . . . . . . . . . . . . . . .Indiana University-Purdue University at Indianapolis

Saleh, Mansoor N., M.D. . . . . . . . . . . . . . . . . . .University of Alabama at Birmingham

Salisbury, Jeffrey L., Ph.D. . . . . . . . . . . . . . . . . .Mayo Clinic, Rochester

Samuel, Charles E., Ph.D. . . . . . . . . . . . . . . . . . .University of California at Santa Barbara

Sanda, Martin G., M.D. . . . . . . . . . . . . . . . . . . .University of Michigan

Sandri-Goldin, Rozanne M., Ph.D. . . . . . . . . . . . .University of California at Irvine

Santen, Richard J., M.D. . . . . . . . . . . . . . . . . . .University of Virginia

Sassoon, David A., Ph.D. . . . . . . . . . . . . . . . . . .Mount Sinai School of Medicine of New York University

Sauerteig, Antoineta, B.A. . . . . . . . . . . . . . . . . . .University of Miami

Sayre, James W., Ph.D. . . . . . . . . . . . . . . . . . . .University of California at Los Angeles

Schell, Michael J., Ph.D. . . . . . . . . . . . . . . . . . . .University of North Carolina

Schindler, Christian W., M.D., Ph.D. . . . . . . . . . .Columbia University

Schmidt-Ullrich, Rupert K., M.D. . . . . . . . . . . . . .Virginia Commonwealth University

Schnitzer, Jan E., M.D. . . . . . . . . . . . . . . . . . . .Sidney Kimmel Cancer Center

Schoenlein, Patricia V., Ph.D. . . . . . . . . . . . . . . .Medical College of Georgia

Schrag, Deborah, M.D. . . . . . . . . . . . . . . . . . . .Memorial Sloan-Kettering Cancer Center

Schwaiger, Markus, M.D. . . . . . . . . . . . . . . . . . .Universitaet Muenchen

Schwartz, Ann G., Ph.D. . . . . . . . . . . . . . . . . . .Wayne State University

Schwartz, Charles E., Ph.D. . . . . . . . . . . . . . . . .Greenwood Genetic Center

Seiden, Michael V., M.D., Ph.D. . . . . . . . . . . . . .Massachusetts General Hospital

Semmes, Oliver J., Ph.D. . . . . . . . . . . . . . . . . . .University of Virginia

Sgroi, Dennis C., M.D. . . . . . . . . . . . . . . . . . . .Massachusetts General Hospital

Shaw, Chris C., Ph.D. . . . . . . . . . . . . . . . . . . . .University of Texas M.D. Anderson Cancer Center

Shaw, Edward G., M.D. . . . . . . . . . . . . . . . . . . .Wake Forest University Health Sciences

Shilatifard, Ari, Ph.D. . . . . . . . . . . . . . . . . . . . . .St. Louis University School of Medicine

Shokat, Kevan M., Ph.D. . . . . . . . . . . . . . . . . . .University of California at San Francisco

Shulkin, Barry L., M.D. . . . . . . . . . . . . . . . . . . .University of Michigan

Shyr, Yu, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . .Vanderbilt University Medical School

Siemann, Dietmar W., Ph.D. . . . . . . . . . . . . . . . .University of Florida

Simons, Jonathan W., M.D. . . . . . . . . . . . . . . . .Emory University

Appendix C-2: Consultants Serving as Ad Hoc Committee Members on IRG Site Visit Teams
NCI/DEA Annual Report 2003

84

Sirica, Alphonse E., Ph.D. . . . . . . . . . . . . . . . . . .Federation of American Societies for Experimental Biology

Sirover, Michael A., Ph.D. . . . . . . . . . . . . . . . . . .Temple University

Slingluff, Craig L., M.D. . . . . . . . . . . . . . . . . . . .University of Virginia

Smith, Charles D., Ph.D. . . . . . . . . . . . . . . . . . . .Pennsylvania State University

Smith, George P., Ph.D. . . . . . . . . . . . . . . . . . . .University of Missouri

Smith, Gilbert P., DOTH . . . . . . . . . . . . . . . . . . .Children’s Cancer Ombudsman Program

Sondel, Paul M., M.D., Ph.D. . . . . . . . . . . . . . . .University of Wisconsin

Song, Chang W., Ph.D. . . . . . . . . . . . . . . . . . . .University of Minnesota Medical School

Soprano, Dianne R., Ph.D. . . . . . . . . . . . . . . . . .Temple University School of Medicine

Spallone, Robert E., B.A. . . . . . . . . . . . . . . . . . . .Fox Chase Cancer Center

Spatola, Arno F., Ph.D. . . . . . . . . . . . . . . . . . . . .University of Louisville

Speicher, David W., Ph.D. . . . . . . . . . . . . . . . . . .Wistar Institute

Spitz, Douglas R., Ph.D. . . . . . . . . . . . . . . . . . . .University of Iowa

Splitter, Gary A., D.V.M., Ph.D. . . . . . . . . . . . . .University of Wisconsin

Srivastava, Deo Kumar S., Ph.D. . . . . . . . . . . . . .St. Jude Children’s Research Hospital

St. Clair, Daret K., Ph.D. . . . . . . . . . . . . . . . . . .University of Kentucky

Stahl, Douglas, Ph.D. . . . . . . . . . . . . . . . . . . . .City of Hope National Medical Center

Stambrook, Peter J., Ph.D. . . . . . . . . . . . . . . . . .University of Cincinnati

Stanbridge, Eric J., Ph.D. . . . . . . . . . . . . . . . . . .University of California at Irvine

Stenzel, Timothy T., M.D., Ph.D. . . . . . . . . . . . . .Duke University

Storkus, Walter J., M.D., Ph.D. . . . . . . . . . . . . . .University of Pittsburgh

Stotts, R. Craig, Ph.D. . . . . . . . . . . . . . . . . . . . .University of Tennessee Health Sciences Center

Struck, Robert F., Ph.D. . . . . . . . . . . . . . . . . . . .Southern Research Institute

Studzinski, George P., M.D., Ph.D. . . . . . . . . . . .University of Medicine/Dentistry of New Jersey

Sugden, William M., Ph.D. . . . . . . . . . . . . . . . . .University of Wisconsin

Symons, Marc H., Ph.D. . . . . . . . . . . . . . . . . . .North Shore-Long Island Jewish Research Institute

Szyf, Moshe, Ph.D. . . . . . . . . . . . . . . . . . . . . . .McGill University

T Tai, Hsin-Hsiung, Ph.D. . . . . . . . . . . . . . . . . . . . .University of Kentucky

Tainsky, Michael A., Ph.D. . . . . . . . . . . . . . . . . .University of Alabama at Birmingham

Tamayo, Pablo, Ph.D. . . . . . . . . . . . . . . . . . . . . .Massachusetts Institute of Technology

Tanabe, Kenneth K., M.D. . . . . . . . . . . . . . . . . .Massachusetts General Hospital

Tang, Dean G., M.D., Ph.D. . . . . . . . . . . . . . . . .University of Texas M.D. Anderson Cancer Center

Tannishtha, Reya, Ph.D. . . . . . . . . . . . . . . . . . . .Duke Univeristy

Tarin, David, M.D., Ph.D. . . . . . . . . . . . . . . . . .University of California at San Diego

Teebor, George W., M.D. . . . . . . . . . . . . . . . . . .New York University School of Medicine

Templeton, Dennis J., M.D., Ph.D. . . . . . . . . . . .University of Virginia

Terry, Michael A., M.B.A., Ph.D. . . . . . . . . . . . . .University of Rochester

Thigpen, James T., M.D. . . . . . . . . . . . . . . . . . .University of Mississippi Medical Center

Thompson, Lawrence H., Ph.D. . . . . . . . . . . . . . .Lawrence Livermore National Laboratory

Threadgill, David W., Ph.D. . . . . . . . . . . . . . . . . .University of North Carolina

Tlsty, Thea D., Ph.D. . . . . . . . . . . . . . . . . . . . . .University of California at San Diego

Tober-Meyer, Brunhilde, D.V.M. . . . . . . . . . . . . . .East Tennessee State University

Tofani, Susan Higman, B.A. . . . . . . . . . . . . . . . . .Fox Chase Cancer Center

Tomkinson, Alan E., Ph.D. . . . . . . . . . . . . . . . . .University of Texas Health Sciences Center

Tonellato, Peter J., Ph.D. . . . . . . . . . . . . . . . . . . .Medical College of Wisconsin

Tonetti, Debra A., Ph.D. . . . . . . . . . . . . . . . . . . .University of Illinois at Chicago

Triche, Timothy J., M.D., Ph.D. . . . . . . . . . . . . .Children’s Hospital, Los Angeles

Appendix C-2: Consultants Serving as Ad Hoc Committee Members on IRG Site Visit Teams
NCI/DEA Annual Report 2003

85

Tricot, Guido J., M.D., Ph.D. . . . . . . . . . . . . . . .University of Arkansas Medical Sciences at Little Rock

Triozzi, Pierre L., M.D. . . . . . . . . . . . . . . . . . . . .University of Alabama at Birmingham

True, Lawrence D., M.D. . . . . . . . . . . . . . . . . . .University of Washington

Tsodikov, Alexander, Ph.D. . . . . . . . . . . . . . . . . .University of Utah

Turnbull, Daniel H., Ph.D. . . . . . . . . . . . . . . . . . .New York University School of Medicine

Turner, Larry W., B.S. . . . . . . . . . . . . . . . . . . . . .Emory University

Tweardy, David J., M.D. . . . . . . . . . . . . . . . . . . .Baylor College of Medicine

U Ubel, Peter A., M.D. . . . . . . . . . . . . . . . . . . . . .University of Michigan

V Van Kaer, Luc, Ph.D. . . . . . . . . . . . . . . . . . . . . .Vanderbilt University

Van Lier, Johan, Ph.D. . . . . . . . . . . . . . . . . . . . .University of Sherbrooke

Vanin, Elio F., Ph.D. . . . . . . . . . . . . . . . . . . . . . .St. Jude Children’s Research Hospital

Varella-Garcia, Marileila, Ph.D. . . . . . . . . . . . . . .University of Colorado Health Sciences Center

Vats, Abhay N., M.D. . . . . . . . . . . . . . . . . . . . .Children’s Hospital, Pittsburgh

Vaughan, Thomas L., M.D. . . . . . . . . . . . . . . . . .Fred Hutchinson Cancer Research Center

Verma, Ajit K., Ph.D. . . . . . . . . . . . . . . . . . . . . .University of Wisconsin

Vessella, Robert L., Ph.D. . . . . . . . . . . . . . . . . . .University of Washington

Vesselle, Hubert J., M.D., Ph.D. . . . . . . . . . . . . .University of Washington

Vicente, Maria Da Graca, Ph.D. . . . . . . . . . . . . .Louisiana State University A&M at Baton Rouge

Vose, Julie M., M.D., Ph.D. . . . . . . . . . . . . . . . .University of Nebraska Medical Center

W Wachsman, William, M.D., Ph.D. . . . . . . . . . . . .University of California San Diego School of Medicine

Wade, Amy B., M.B.A. . . . . . . . . . . . . . . . . . . . .University of Michigan

Wahl, Richard L., M.D. . . . . . . . . . . . . . . . . . . .The Johns Hopkins University

Walters, Gayle, MOTH . . . . . . . . . . . . . . . . . . . .University of Maryland Baltimore Professional School

Wan, Yinsheng, Ph.D. . . . . . . . . . . . . . . . . . . . .Providence College

Wang, Chyung-Ru, Ph.D. . . . . . . . . . . . . . . . . . .University of Chicago

Weaver, Valerie M., Ph.D. . . . . . . . . . . . . . . . . . .University of Pennsylvania

Weber, Richard J., Ph.D. . . . . . . . . . . . . . . . . . . .University of Illinois College of Medicine

Weick, Martin P., Ph.D. . . . . . . . . . . . . . . . . . . .Baylor College of Medicine

Weigel, Nancy, Ph.D. . . . . . . . . . . . . . . . . . . . . .Baylor College of Medicine

Weinberg, Andrew D., Ph.D. . . . . . . . . . . . . . . .Providence Portland Medical Center

Weinberg, Jay N., M.A. . . . . . . . . . . . . . . . . . . .Hospitality for Family and Friends

Weiner, George J., M.D. . . . . . . . . . . . . . . . . . . .University of Iowa

Weissman, Bernard E., M.D., Ph.D. . . . . . . . . . . .University of North Carolina

Welch, Danny R., Ph.D. . . . . . . . . . . . . . . . . . . .University of Alabama at Birmingham

Wells, K. Sam, Ph.D. . . . . . . . . . . . . . . . . . . . . .Vanderbilt University

Whittemore, Scott R., Ph.D. . . . . . . . . . . . . . . . .University of Louisville

Wicha, Max S., M.D. . . . . . . . . . . . . . . . . . . . . .University of Michigan

Wilburn, Louella S., MOTH . . . . . . . . . . . . . . . . .People Living with Cancer

Wilkins, Linda S., A.A.S., OTH . . . . . . . . . . . . . . .Duke University Medical Center

Williard, Paul G., Ph.D. . . . . . . . . . . . . . . . . . . .Neutron Technology

Wilson-Sanders, Susan E., D.V.M. . . . . . . . . . . . .University of Arizona

Winey, Mark E., Ph.D. . . . . . . . . . . . . . . . . . . . .University of Colorado

Wingard, John R., M.D. . . . . . . . . . . . . . . . . . . .University of Florida

Witmer, Kim E., OTH . . . . . . . . . . . . . . . . . . . . .Salk Institute for Biological Studies

Witzig, Thomas E., M.D. . . . . . . . . . . . . . . . . . .Mayo Clinic, Rochester

Appendix C-2: Consultants Serving as Ad Hoc Committee Members on IRG Site Visit Teams
NCI/DEA Annual Report 2003

86

Woodgett, James R., Ph.D. . . . . . . . . . . . . . . . . .Ontario Cancer Institute

Wronski, Thomas J., Ph.D. . . . . . . . . . . . . . . . . .University of Florida

Wu, Anna M., Ph.D. . . . . . . . . . . . . . . . . . . . . .University of California at Los Angeles

Wu, Jie, M.D., Ph.D. . . . . . . . . . . . . . . . . . . . . .University of South Florida

Wu, Tzyy-Choou C., M.D., Ph.D. . . . . . . . . . . . .The Johns Hopkins University

X Xu, Yan, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . .Cleveland State University

Y Yancopoulos, George D., M.D., Ph.D. . . . . . . . . .Regeneron Pharmaceuticals, Inc.

Yannelli, John R., Ph.D. . . . . . . . . . . . . . . . . . . .University of Louisville

Yap, Jeffrey T., Ph.D. . . . . . . . . . . . . . . . . . . . . .University of Tennessee Medical Center

Yeatman, Timothy J., M.D. . . . . . . . . . . . . . . . . .H. Lee Moffitt Cancer Center and Research Institute

Young, Donn C., M.D., Ph.D. . . . . . . . . . . . . . . .Ohio State University

Young, James W., M.D. . . . . . . . . . . . . . . . . . . .Memorial Sloan-Kettering Cancer Center

Young, Jeanne, B.A. . . . . . . . . . . . . . . . . . . . . . .Childhood Brain Tumor Foundation

Yu, Dihua, M.D., Ph.D. . . . . . . . . . . . . . . . . . . .Texas Tech University Health Sciences Center

Yu, Hongtao, Ph.D. . . . . . . . . . . . . . . . . . . . . . .University of Texas Southwest Medical Center at Dallas

Z Zelterman, Daniel, Ph.D. . . . . . . . . . . . . . . . . . .Yale Cancer Center

Zetter, Bruce R., Ph.D. . . . . . . . . . . . . . . . . . . .Children’s Hospital, Boston

Zhang, Zhong-Yin, Ph.D. . . . . . . . . . . . . . . . . . .Albert Einstein College of Medicine

Zhou, Renping, Ph.D. . . . . . . . . . . . . . . . . . . . .Rutgers University, New Brunswick

Zimbrick, John D., Ph.D. . . . . . . . . . . . . . . . . . .University of Kansas

Zutter, Mary M., M.D. . . . . . . . . . . . . . . . . . . .Vanderbilt University

Total Number of Reviewers: 712

Total Number of Times Reviewers Served: 834

Appendix C-2: Consultants Serving as Ad Hoc Committee Members on IRG Site Visit Teams
NCI/DEA Annual Report 2003

87

3. Consultants Serving on Special Emphasis Panels (SEPs) in FY2003

A Abdel-Nabi, Hani H., Ph.D. . . . . . . . . . . . . . . . .State University of New York at Buffalo

Abraham, George N., M.D. . . . . . . . . . . . . . . . .University of Rochester Medical Center

Abrams, Judith, Ph.D. . . . . . . . . . . . . . . . . . . . .Wayne State University

Adams-Campbell, Lucile L., Ph.D. . . . . . . . . . . . .Howard University

Agarwal, Rajesh, Ph.D. . . . . . . . . . . . . . . . . . . .AMC Cancer Research Center

Agnew, Brian J., Ph.D. . . . . . . . . . . . . . . . . . . .Molecular Probes, Inc.

Agus, David, M.D. . . . . . . . . . . . . . . . . . . . . . .Cedars-Sinai Medical Center

Ahles, Tim A., Ph.D. . . . . . . . . . . . . . . . . . . . . .Dartmouth College

Ahluwalia, Jasjit S., M.D. . . . . . . . . . . . . . . . . . .University of Kansas Medical Center

Ahmed, Khalil, Ph.D. . . . . . . . . . . . . . . . . . . . . .University of Minnesota

Ahsan, Habibul, M.D. . . . . . . . . . . . . . . . . . . . .Columbia University New York

Aisner, Seena C., M.D. . . . . . . . . . . . . . . . . . . .University of Medicine and Dentistry of New Jersey

Akhurst, Rosemary J., Ph.D. . . . . . . . . . . . . . . .University of California at San Francisco

Albain, Kathy S., M.D. . . . . . . . . . . . . . . . . . . .Loyola University Medical Center

Albelda, Steven M., M.D. . . . . . . . . . . . . . . . . . .University of Pennsylvania Medical Center

Albino, Anthony P., Ph.D. . . . . . . . . . . . . . . . . .Institute for Cancer Prevention

Albrecht, Terrance L., Ph.D. . . . . . . . . . . . . . . . .Wayne State University

Aldaz, C. Marcelo, M.D., Ph.D. . . . . . . . . . . . . .University of Texas M.D. Anderson Cancer Center

Ali-Osman, Francis C., Ph.D. . . . . . . . . . . . . . . .Duke University

Allen, Peter S., Ph.D. . . . . . . . . . . . . . . . . . . . . .University of Alberta

Ambinder, Richard F., Ph.D. . . . . . . . . . . . . . . . .The Johns Hopkins University

Ambrosone, Christine B., Ph.D. . . . . . . . . . . . . . .Roswell Park Cancer Institute Corporation

Amin, Viren, Ph.D. . . . . . . . . . . . . . . . . . . . . . .Iowa State University of Science and Technology

Anders, Marion W., D.V.M., Ph.D. . . . . . . . . . . .University of Rochester

Anderson, Carolyn J., Ph.D. . . . . . . . . . . . . . . . .Washington University School of Medicine

Anderson, Garth R., Ph.D. . . . . . . . . . . . . . . . . .Roswell Park Cancer Institute Corporation

Anderson, Graham, Ph.D. . . . . . . . . . . . . . . . . .University of Birmingham

Anderson, Marshall W., M.D., Ph.D. . . . . . . . . . .University of Cincinnati

Andrews, Philip C., Ph.D. . . . . . . . . . . . . . . . . .University of Michigan at Ann Arbor

Andrykowski, Michael A., Ph.D. . . . . . . . . . . . . .University of Kentucky College of Medicine

Aplenc, Richard, M.D. . . . . . . . . . . . . . . . . . . . .Children’s Hospital, Philadelphia

Arab, Lenore, Ph.D. . . . . . . . . . . . . . . . . . . . . .University of North Carolina

Arap, Wadih, M.D., Ph.D. . . . . . . . . . . . . . . . . .University of Texas M.D. Anderson Cancer Center

Arbuckle, Tye E., Ph.D. . . . . . . . . . . . . . . . . . . .Health Canada

Archer, Michael C., Ph.D. . . . . . . . . . . . . . . . . .University of Toronto

Arenaz, Pablo, Ph.D. . . . . . . . . . . . . . . . . . . . . .University of Texas

Armstrong, Deborah K., M.D. . . . . . . . . . . . . . .The Johns Hopkins University

Armstrong, F. Daniel, Ph.D. . . . . . . . . . . . . . . . .Iowa State University of Science 

Aronow, Bruce J., Ph.D. . . . . . . . . . . . . . . . . . .Children’s Hospital Medical Center, Cincinnati

Aronsky, Dominik, M.D., Ph.D. . . . . . . . . . . . . .University of Utah

Ascensao, Joao L., M.D., Ph.D. . . . . . . . . . . . . .Sierra Biomedical Research Corporation

Ashton, Carol M., M.D., M.P.H. . . . . . . . . . . . . .Baylor College of Medicine

Atkins, Michael B., M.D. . . . . . . . . . . . . . . . . . .Beth Israel Deaconess Medical Center

Au, William W., Ph.D. . . . . . . . . . . . . . . . . . . . .University of Texas Medical Branch at Galveston

Auborn, Karen J., Ph.D. . . . . . . . . . . . . . . . . . . .North Shore-Long Island Jewish Research Institute

Augenlicht, Leonard H., Ph.D. . . . . . . . . . . . . . .Montefiore Medical Center 
NCI/DEA Annual Report 2003

88

B Badger, Thomas M., Ph.D. . . . . . . . . . . . . . . . . .University of Arkansas for Medical Sciences

Bafna, Vineet, Ph.D. . . . . . . . . . . . . . . . . . . . . .The Center for Advancement of Genomics

Baile, Walter F., M.D. . . . . . . . . . . . . . . . . . . . .University of Texas M.D. Anderson Cancer Center

Baillargeon, Jacques G., Ph.D. . . . . . . . . . . . . . .University of Texas Health Science Center 

Bains, Yadvindera, M.D. . . . . . . . . . . . . . . . . . . .Mercy Health Center

Baker, Henry J., D.V.M. . . . . . . . . . . . . . . . . . . .Auburn University at Auburn

Baker, James R., M.D. . . . . . . . . . . . . . . . . . . . .University of Michigan at Ann Arbor

Baker, Vicki V., M.D., Ph.D. . . . . . . . . . . . . . . . .University of Michigan Medical Center

Bakken, Suzanne, R.N. . . . . . . . . . . . . . . . . . . .American Medical Informatics Association

Balaban, Barbara J., M.D., Ph.D. . . . . . . . . . . . .West Islip Cancer Coalition

Balducci, Lodovico, M.D. . . . . . . . . . . . . . . . . . .H. Lee Moffitt Cancer Center and Research Institute

Ballman, Karla, Ph.D. . . . . . . . . . . . . . . . . . . . . .Mayo Clinic, Rochester

Banks, William L., Ph.D. . . . . . . . . . . . . . . . . . .Virginia Commonwealth University

Baquet, Claudia R., M.D., Ph.D. . . . . . . . . . . . .University of Maryland School of Medicine

Barbeau, Elizabeth M., M.P.H. . . . . . . . . . . . . . .Dana-Farber Cancer Institute

Barnes, Stephen, Ph.D. . . . . . . . . . . . . . . . . . . .University of Alabama at Birmingham

Barnett, John B., Ph.D. . . . . . . . . . . . . . . . . . . .West Virginia University

Baron, Richard, M.D. . . . . . . . . . . . . . . . . . . . .University of Chicago

Barr, Roger C., Ph.D. . . . . . . . . . . . . . . . . . . . .Duke University

Barredo, Julio C., M.D. . . . . . . . . . . . . . . . . . . .Medical University of South Carolina

Barrett, Harrison H., Ph.D. . . . . . . . . . . . . . . . .University of Arizona

Barron, Annelise E., Ph.D. . . . . . . . . . . . . . . . . .Northwestern University

Bar-Sagi, Dafna, Ph.D. . . . . . . . . . . . . . . . . . . .State University of New York at Stony Brook

Bartolucci, Alfred A., Ph.D. . . . . . . . . . . . . . . . .University of Alabama School of Public Health

Barton, Debra L., R.N. . . . . . . . . . . . . . . . . . . .Mayo Clinic, Rochester

Basen-Engquist, Karen M., Ph.D. . . . . . . . . . . . .University of Texas M.D. Anderson Cancer Center

Bastani, Roshan, Ph.D. . . . . . . . . . . . . . . . . . . .University of California at Los Angeles

Bastian, Boris C., M.D. . . . . . . . . . . . . . . . . . . .University of California at San Francisco

Baum, Stanley, M.D. . . . . . . . . . . . . . . . . . . . . .University of Pennsylvania

Bayliss, Frank T., Ph.D. . . . . . . . . . . . . . . . . . . .San Francisco State University

Bean, Judy A., M.P.H., Ph.D. . . . . . . . . . . . . . . .Children’s Hospital Medical Center

Bear, Harry D., M.D., Ph.D. . . . . . . . . . . . . . . .Virginia Commonwealth University

Becerra, Carlos, M.D. . . . . . . . . . . . . . . . . . . . .University of Texas Southwestern Medical Center

Becker, Lee B., M.D., Ph.D. . . . . . . . . . . . . . . . .University of Georgia

Bedi, Atul, M.D. . . . . . . . . . . . . . . . . . . . . . . . .The Johns Hopkins University

Bedrick, Edward J., Ph.D. . . . . . . . . . . . . . . . . .University of New Mexico

Beenken, Samuel W., M.D. . . . . . . . . . . . . . . . . .Neo Gen Screening, Inc.

Beitz, Alvin J., Ph.D. . . . . . . . . . . . . . . . . . . . . .University of Minnesota at Twin Cities

Belk, Bonnie F., M.P.A. . . . . . . . . . . . . . . . . . . . .Private Practice

Bell, Thomas W., Ph.D. . . . . . . . . . . . . . . . . . . .University of Nevada at Reno

Benaron, David A., M.D. . . . . . . . . . . . . . . . . . .Spectros Corporation

Benkeser, Paul J., Ph.D. . . . . . . . . . . . . . . . . . . .Georgia Institute of Technology

Bennett, John M., M.D. . . . . . . . . . . . . . . . . . .University of Rochester School of Medicine

Benni, Paul B., Ph.D. . . . . . . . . . . . . . . . . . . . .Cas Medical Systems, Inc.

Bensimon, Aaron, Ph.D. . . . . . . . . . . . . . . . . . .Pasteur Institute

Bensinger, William I., M.D. . . . . . . . . . . . . . . . .Fred Hutchinson Cancer Research Center

Benson, Mitchell C., M.D. . . . . . . . . . . . . . . . . .Columbia Presbyterian Medical Center

Appendix C-3: Consultants Serving on SEPs
NCI/DEA Annual Report 2003

89

Bepler, Gerold , M.D., Ph.D. . . . . . . . . . . . . . . .H. Lee Moffitt Cancer Center and Research Institute 

Beresford, Shirley A., Ph.D. . . . . . . . . . . . . . . . .Fred Hutchinson Cancer Research Center

Bergan, Raymond C., M.D. . . . . . . . . . . . . . . . .Northwestern University

Berger, Mitchel S., M.D. . . . . . . . . . . . . . . . . . .University of California at San Francisco

Berget, Peter B., Ph.D. . . . . . . . . . . . . . . . . . . .Carnegie-Mellon University

Bertram, John S., Ph.D. . . . . . . . . . . . . . . . . . . .University of Hawaii Cancer Research Center

Bestor, Timothy H., Ph.D. . . . . . . . . . . . . . . . . .Columbia University Health Sciences

Bettencourt, B., Ph.D. . . . . . . . . . . . . . . . . . . . .University of Missouri at Columbia

Bhattacharyya, Maryka H., Ph.D. . . . . . . . . . . .University of Chicago

Bird, Richard C., Ph.D. . . . . . . . . . . . . . . . . . . .Auburn University at Auburn

Bittner, Michael L., Ph.D. . . . . . . . . . . . . . . . . .TGen

Bjeldanes, Leonard F., Ph.D. . . . . . . . . . . . . . . . .University of California at Berkeley

Blackburn, George L., M.D., Ph.D. . . . . . . . . . . .Beth Israel-Deaconess Medical Center

Blair, William, B.A. . . . . . . . . . . . . . . . . . . . . . .US TOO International, Inc.

Blanchard, Chris, Ph.D. . . . . . . . . . . . . . . . . . . .American Cancer Society

Blaner, William S., Ph.D. . . . . . . . . . . . . . . . . . .Federation of American Society for Experimental Biology

Blaney, Susan, M.D. . . . . . . . . . . . . . . . . . . . . .Baylor College of Medicine

Blankenberg, Francis G., M.D. . . . . . . . . . . . . . .Stanford University

Blatt, Julie, M.D. . . . . . . . . . . . . . . . . . . . . . . .University of North Carolina at Chapel Hill

Bleyer, W. Archie, M.D. . . . . . . . . . . . . . . . . . . .University of Texas M.D. Anderson Cancer Center

Blobe, Gerard C., M.D., Ph.D. . . . . . . . . . . . . . .Duke University

Blocker, Deborah E., M.P.H. . . . . . . . . . . . . . . . .University of North Carolina

Bloom, Joan R, M.P.H., Ph.D. . . . . . . . . . . . . . . .University of California at Berkeley

Blumenstein, Brent A., Ph.D. . . . . . . . . . . . . . . .American College of Surgeons

Boerrigter, Michael E., Ph.D. . . . . . . . . . . . . . . .Leven, Inc.

Bogdanov, Alexei A., Ph.D. . . . . . . . . . . . . . . . .Massachusetts General Hospital

Bogen, Steven A., M.D., Ph.D. . . . . . . . . . . . . . .Medical Discovery Partners, LLC.

Bolinger, Lizann, M.D., Ph.D. . . . . . . . . . . . . . . .University of Iowa

Bolton, Judy L., Ph.D. . . . . . . . . . . . . . . . . . . . .University of Chicago at Illinois

Bond, John H., M.D. . . . . . . . . . . . . . . . . . . . . .Veteran’s Administration Medical Center

Boppart, Stephen A., M.D., Ph.D. . . . . . . . . . . .University of Illinois at Urbana-Champaign

Bornhop, Darryl J., Ph.D. . . . . . . . . . . . . . . . . .Vanderbilt University

Borowsky, Alexander D., M.D. . . . . . . . . . . . . . .University of California at Davis

Bottiglieri, Teodoro, Ph.D. . . . . . . . . . . . . . . . . .Baylor Research Institute

Boudreau, Nancy J., Ph.D. . . . . . . . . . . . . . . . . .University of California at San Francisco

Bouton, Amy H., Ph.D. . . . . . . . . . . . . . . . . . . .University of Virginia at Charlottesville

Bowden, George T., Ph.D. . . . . . . . . . . . . . . . . .University of Arizona College of Medicine

Bowen, Deborah J., Ph.D. . . . . . . . . . . . . . . . . .Fred Hutchinson Cancer Research Center

Bower, Julienne E., Ph.D. . . . . . . . . . . . . . . . . . .University of California at Los Angeles

Boyajian, Richard, M.S.N. . . . . . . . . . . . . . . . . . .Dana-Farber Cancer Institute

Boyce, Brendan F., M.D. . . . . . . . . . . . . . . . . . .University of Texas Health Science Center at San Antonio

Boyd, Jeff A., Ph.D. . . . . . . . . . . . . . . . . . . . . .Memorial Sloan-Kettering Cancer Center

Boyd, Norman F., M.D. . . . . . . . . . . . . . . . . . . .Ontario Cancer Institute

Boyle, Jay O., M.D. . . . . . . . . . . . . . . . . . . . . .Memorial Sloan-Kettering Cancer Center

Brash, Douglas E., Ph.D. . . . . . . . . . . . . . . . . . .Yale University

Brem, Rachel F., M.D. . . . . . . . . . . . . . . . . . . . .George Washington University

Brenan, Colin J. H., Ph.D. . . . . . . . . . . . . . . . . .Biotech Research Laboratories 

Brenner, Dean E., M.D. . . . . . . . . . . . . . . . . . . .University of Michigan at Ann Arbor

Appendix C-3: Consultants Serving on SEPs
NCI/DEA Annual Report 2003

90

Brewer, Molly A., M.D. . . . . . . . . . . . . . . . . . . .Polytechnic University

Briggs, James M., Ph.D. . . . . . . . . . . . . . . . . . .University of Houston

Bromberg, Jonas I., DOTH . . . . . . . . . . . . . . . . .Inflexxion, Inc.

Brown, Alan P., Ph.D. . . . . . . . . . . . . . . . . . . . .Michigan State University

Brown, Anthony M., Ph.D. . . . . . . . . . . . . . . . .Weill Medical College of Cornell University

Brown, C. Perry, Ph.D. . . . . . . . . . . . . . . . . . . .Florida Agricultural and Mechanical University

Brown, Helene G., B.S. . . . . . . . . . . . . . . . . . . .University of California at Los Angeles

Brownson, Delia, Ph.D. . . . . . . . . . . . . . . . . . . .University of Texas

Bruchez, Marcel P., Ph.D. . . . . . . . . . . . . . . . . .Quantum Dot Corporation

Brunicardi, F. Charles, M.D. . . . . . . . . . . . . . . . .Baylor College of Medicine

Bryant, John L., M.D., Ph.D. . . . . . . . . . . . . . . .University of Pittsburgh at Pittsburgh

Buchsbaum, Donald J., Ph.D. . . . . . . . . . . . . . . .University of Alabama at Birmingham

Buerk, Donald G., Ph.D. . . . . . . . . . . . . . . . . . .University of Pennsylvania

Buka, Stephen L., M.D., Ph.D. . . . . . . . . . . . . . .Harvard University School of Public Health

Bullitt, Elizabeth, M.D. . . . . . . . . . . . . . . . . . . .University of North Carolina at Chapel Hill

Buncher, Charles R., Sc.D. . . . . . . . . . . . . . . . . .University of Cincinnati

Burchiel, Scott W., Ph.D. . . . . . . . . . . . . . . . . . .University of New Mexico at Albuquerque

Burdette, Everette C., Ph.D. . . . . . . . . . . . . . . . .Computerized Medical Systems, Inc.

Burgess, Arthur E., Ph.D. . . . . . . . . . . . . . . . . . .Brigham And Women’s Hospital

Burk, Robert D., M.D. . . . . . . . . . . . . . . . . . . . .University of Massachusetts Medical School at Worcester

Burke, Harry B., M.D., Ph.D. . . . . . . . . . . . . . . .George Washington University

Burns, David M., M.D. . . . . . . . . . . . . . . . . . . .University of California at San Diego

Butler, Robert W., Ph.D. . . . . . . . . . . . . . . . . . . .Oregon Health & Science University

Butler, Susan L., M.P.H., Ph.D. . . . . . . . . . . . . . .Ovarian Cancer National Alliance

C Cable, Michael, Ph.D. . . . . . . . . . . . . . . . . . . . .Xenogen Corporation

Calabretta, Bruno, M.D., Ph.D. . . . . . . . . . . . . .Thomas Jefferson University

Caldwell, Charles W., M.D., Ph.D. . . . . . . . . . . .Ellis Fischel Cancer Center

Campana, Dario, M.D., Ph.D. . . . . . . . . . . . . . .St. Jude Children’s Research Hospital

Campbell, Marci K., Ph.D. . . . . . . . . . . . . . . . . .University of North Carolina at Chapel Hill

Cannon Albright, Lisa A., Ph.D. . . . . . . . . . . . . .Intermountain Health Care

Caprioli, Richard M., Ph.D. . . . . . . . . . . . . . . . .Vanderbilt University

Carmichael, Gordon G., Ph.D. . . . . . . . . . . . . . .University of Connecticut Health Center

Carnesecca, Enes, B.A. . . . . . . . . . . . . . . . . . . .Lustgarten Foundation

Carpenter, Janet S., Ph.D. . . . . . . . . . . . . . . . . .Indiana University-Purdue University at Indianapolis

Carroll, William L., M.D. . . . . . . . . . . . . . . . . . .National Childhood Cancer Foundation

Carson, Johnny L., Ph.D. . . . . . . . . . . . . . . . . . .University of North Carolina at Chapel Hill

Carter, Christopher A., Ph.D. . . . . . . . . . . . . . . .Southern Research Institute

Carter, Darryl, M.D. . . . . . . . . . . . . . . . . . . . . .Yale University

Casagrande, John, M.P.H. . . . . . . . . . . . . . . . . .University of Southern California

Castleberry, Robert P., M.D. . . . . . . . . . . . . . . . .University of Alabama at Birmingham

Cegala, Donald J., Ph.D. . . . . . . . . . . . . . . . . . .Ohio State University

Chabner, Bruce A., M.D. . . . . . . . . . . . . . . . . . .Massachusetts General Hospital

Chafin, David R., Ph.D. . . . . . . . . . . . . . . . . . . .Integrated Nano-Technologies, LLC.

Chaillet, John R., M.D., Ph.D. . . . . . . . . . . . . . .Children’s Hospital Pittsburgh

Chamberlain, Marc C., M.D. . . . . . . . . . . . . . . .University of Southern California

Chamberlain, Robert M., Ph.D. . . . . . . . . . . . . . .University of Texas M.D. Anderson Cancer Center

Chamberlin, Helen M., Ph.D. . . . . . . . . . . . . . . .Ohio State University

Appendix C-3: Consultants Serving on SEPs
NCI/DEA Annual Report 2003

91

Champion, Victoria, Ph.D. . . . . . . . . . . . . . . . . .Indiana University School of Nursing

Champlin, Richard E., M.D. . . . . . . . . . . . . . . . .University of Texas M.D. Anderson Cancer Center

Chan, Wing C., M.D., Ph.D. . . . . . . . . . . . . . . .University of Nebraska Medical Center

Chang, Betty L., Ph.D. . . . . . . . . . . . . . . . . . . .American Medical Informatics Association

Chao, Nelson J., M.D. . . . . . . . . . . . . . . . . . . . .Duke University Medical Center

Chen, Christopher S., M.D., Ph.D. . . . . . . . . . . .The Johns Hopkins University

Chen, Wen-Tien, Ph.D. . . . . . . . . . . . . . . . . . . . .Vitatex, Inc.

Chen, Yong Q., Ph.D. . . . . . . . . . . . . . . . . . . . .Wake Forest University Health Sciences

Chen, Zhongping, Ph.D. . . . . . . . . . . . . . . . . . .University of California at Irvine

Cheng, Keith C., M.D., Ph.D. . . . . . . . . . . . . . .Pennsylvania State University, Hershey Medical Center

Cherry, Simon R., Ph.D. . . . . . . . . . . . . . . . . . . .University of California at Davis

Chirikos, Thomas N., Ph.D. . . . . . . . . . . . . . . . .University of South Florida

Chlebowski, Rowan T., M.D., Ph.D. . . . . . . . . . .Harbor-UCLA Research and Education Institute

Christakos, Sylvia S., Ph.D. . . . . . . . . . . . . . . . .University of Medicine and Dentistry of New Jersey

Christie, Debra W., Ph.D. . . . . . . . . . . . . . . . . .University of Mississippi Medical Center

Christman, Judith K., Ph.D. . . . . . . . . . . . . . . . .Federation of American Society for Experimental Biology

Chung, Daniel C., M.D. . . . . . . . . . . . . . . . . . .Massachusetts General Hospital

Chung, Fung-Lung, Ph.D. . . . . . . . . . . . . . . . . .Institute for Cancer Prevention

Chung, Leland W., Ph.D. . . . . . . . . . . . . . . . . . .Emory University

Chute, Christopher G., M.D., Ph.D. . . . . . . . . . .Mayo Clinic, Rochester

Clarke, Robert L., Ph.D. . . . . . . . . . . . . . . . . . .North Carolina State University at Raleigh

Clarke, Robert R., Ph.D. . . . . . . . . . . . . . . . . . .Georgetown University

Clarke-Tasker, Veronica A., Ph.D. . . . . . . . . . . . .Howard University

Cline, Rebecca J., Ph.D. . . . . . . . . . . . . . . . . . .University of Florida

Clohisy, Denis R., M.D. . . . . . . . . . . . . . . . . . .University of Minnesota

Cobau, Charles D., M.D. . . . . . . . . . . . . . . . . . .Toledo Clinic, Inc.

Cochran, Alistair J., M.D. . . . . . . . . . . . . . . . . .University of California at Los Angeles

Coetzee, Gerhard A., Ph.D. . . . . . . . . . . . . . . . .University of Southern California

Cohen, Michael B., M.D. . . . . . . . . . . . . . . . . . .University of Iowa

Cohen, Samuel M., M.D., Ph.D. . . . . . . . . . . . . .University of Nebraska Medical Center

Cokkinides, Vilma, Ph.D. . . . . . . . . . . . . . . . . . .American Cancer Society

Cole, Bernard F., Ph.D. . . . . . . . . . . . . . . . . . . .Dartmouth College

Colvin, Oliver M., M.D. . . . . . . . . . . . . . . . . . . .Duke University Medical Center

Colwell, Brian, Ph.D. . . . . . . . . . . . . . . . . . . . . .Texas A&M University Health Science Center

Conaway, Mark R., Ph.D. . . . . . . . . . . . . . . . . .Duke University

Conover, Cheryl A., Ph.D. . . . . . . . . . . . . . . . . .Mayo Clinic, Rochester

Constatinidis, Ioannis, Ph.D. . . . . . . . . . . . . . . .University of Florida

Conti, Peter S., M.D., Ph.D. . . . . . . . . . . . . . . .University of Southern California

Cook, Thomas J., Ph.D. . . . . . . . . . . . . . . . . . .Rutgers The State University of New Jersey at New Brunswick

Copelan, Edward A., M.D. . . . . . . . . . . . . . . . . .Ohio State University

Correa, Pelayo, M.D. . . . . . . . . . . . . . . . . . . . . .Prospect Associates, Ltd.

Corton, J. Chris, Ph.D. . . . . . . . . . . . . . . . . . . .ToxicoGenomics

Costello, Joseph F., Ph.D. . . . . . . . . . . . . . . . . .University of California at San Francisco

Counter, Christopher M., Ph.D. . . . . . . . . . . . . .Duke Medical Center

Cozen, Wendy, M.P.H. . . . . . . . . . . . . . . . . . . . .University of Southern California

Crair, Michael, Ph.D. . . . . . . . . . . . . . . . . . . . . .Baylor College of Medicine

Crano, William D., Ph.D. . . . . . . . . . . . . . . . . . .Claremont Graduate School

Cravatt, Benjamin F., Ph.D. . . . . . . . . . . . . . . . .Scripps Research Institute

Appendix C-3: Consultants Serving on SEPs
NCI/DEA Annual Report 2003

92

Crawford, Susan E., M.D., Ph.D. . . . . . . . . . . . .Northwestern University

Creek, Kim E., Ph.D. . . . . . . . . . . . . . . . . . . . . .University of South Carolina at Aiken

Cress, Anne E., Ph.D. . . . . . . . . . . . . . . . . . . . .University of Arizona

Crippen, Gordon M., Ph.D. . . . . . . . . . . . . . . . .University of Michigan at Ann Arbor

Cromack, Keith R., Ph.D. . . . . . . . . . . . . . . . . .Abbott Laboratories

Crosby, Margaree S., Ed.D. . . . . . . . . . . . . . . . .Clemson University

Crowell, Pamela L., Ph.D. . . . . . . . . . . . . . . . . .Indiana University-Purdue University at Indianapolis

Cumberlin, Richard L., M.D. . . . . . . . . . . . . . . .George Washington University

Cummings, Richard D., Ph.D. . . . . . . . . . . . . . .University of Oklahoma Health Sciences Center

Cunningham, Ian A., Ph.D. . . . . . . . . . . . . . . . .Robards Research Institute

Curbow, Barbara Ann, Ph.D. . . . . . . . . . . . . . . .Hopkins University School of Hygiene/Public Health

D Dahiya, Rajvir, Ph.D. . . . . . . . . . . . . . . . . . . . . .Northern California Institute Research and Education

Dahl, Alan R., Ph.D. . . . . . . . . . . . . . . . . . . . . .Ohio State University

Dalton, Madeline A., Ph.D. . . . . . . . . . . . . . . . .Dartmouth College

Daly, Mary B., M.D., Ph.D. . . . . . . . . . . . . . . . .Fox Chase Cancer Center

Daryoush, Afshin S., Ph.D. . . . . . . . . . . . . . . . .Drexel University

Daskalakis, Constantine, Sc.D. . . . . . . . . . . . . . .Thomas Jefferson University

David, Prabu, Ph.D. . . . . . . . . . . . . . . . . . . . . .Ohio State University

Davies, Stella, M.D., Ph.D. . . . . . . . . . . . . . . . .Children’s Hospital Medical Center at Cincinnati

Davis, Scott, Ph.D. . . . . . . . . . . . . . . . . . . . . . .Fred Hutchinson Cancer Research Center

Davis-King, Donna T., Ph.D. . . . . . . . . . . . . . . . .Charles Drew Medical Clinic, Inc.

Day, Billy W., Ph.D. . . . . . . . . . . . . . . . . . . . . .University of Pittsburgh at Pittsburgh

Day, John K., Ph.D. . . . . . . . . . . . . . . . . . . . . .Epigenomics, Inc.

De Leon, Daisy D., Ph.D. . . . . . . . . . . . . . . . . .Loma Linda University

Deapen, Dennis M., Dr.P.H. . . . . . . . . . . . . . . . .University of Southern California

Dejesus, Onofre T., Ph.D. . . . . . . . . . . . . . . . . .University of Wisconsin

Del Junco, Deborah J., Ph.D. . . . . . . . . . . . . . . .University of Texas Health Science Center at Houston

Delano, Mark C., M.D. . . . . . . . . . . . . . . . . . . .Michigan State University

Deleo, Albert, Ph.D. . . . . . . . . . . . . . . . . . . . . .University of Pittsburgh at Pittsburgh

Delipkau, Sally A., B.S. . . . . . . . . . . . . . . . . . . .Harvard Hughes Medical Institute

Delong, David M., Ph.D. . . . . . . . . . . . . . . . . . .Duke University

Delucchi, Kevin L., Ph.D. . . . . . . . . . . . . . . . . . .University of California at San Francisco

Demark-Wahnefried, Wendy, Ph.D. . . . . . . . . . . .Duke University

Denison, Michael S., Ph.D. . . . . . . . . . . . . . . . .University of California at Davis

Descour, Michael R., Ph.D. . . . . . . . . . . . . . . . .University of Arizona

Dewanjee, Mrinal K., Ph.D. . . . . . . . . . . . . . . . .Applied Molecular Probes, Inc.

Dewhirst, Mark W., D.V.M., Ph.D. . . . . . . . . . . .Duke University

Diamond, Alan M., Ph.D. . . . . . . . . . . . . . . . . .University of Illinois at Chicago

Dicioccio, Richard A., Ph.D. . . . . . . . . . . . . . . . .Roswell Park Cancer Institute

Dicker, Adam P., M.D., Ph.D. . . . . . . . . . . . . . . .Thomas Jefferson University

Dietrich, Allen, M.D. . . . . . . . . . . . . . . . . . . . . .Dartmouth College

Dignan, Mark B., Ph.D. . . . . . . . . . . . . . . . . . .AMC Cancer Research Center

Distefano, Peter S., Ph.D. . . . . . . . . . . . . . . . . .Elixir Pharmaceuticals, Inc.

Dix, Kelly D., Ph.D. . . . . . . . . . . . . . . . . . . . . . .Lovelace Respiratory Research Institute

Djuric, Zora, Ph.D. . . . . . . . . . . . . . . . . . . . . . .Wayne State University

Dolnick, Bruce J., Ph.D. . . . . . . . . . . . . . . . . . .Roswell Park Cancer Institute Corporation

Domann, Frederick E., Ph.D. . . . . . . . . . . . . . . .University of Iowa

Appendix C-3: Consultants Serving on SEPs
NCI/DEA Annual Report 2003

93

Donahue, April B., OTH . . . . . . . . . . . . . . . . . . .National Ovarian Cancer Coalition

Dong, Chunming, M.D. . . . . . . . . . . . . . . . . . . .Duke University

D’Onofrio, Carol N., Ph.D. . . . . . . . . . . . . . . . .University of California at Berkeley

Dorshow, Richard B., Ph.D. . . . . . . . . . . . . . . . .Shurjo Medical Technologies, Inc.

Dow, Karen H., Ph.D. . . . . . . . . . . . . . . . . . . . .University of Central Florida

Drake, Richard R., Ph.D. . . . . . . . . . . . . . . . . . .Eastern Virginia Medical School

Drees, Beth E., Ph.D. . . . . . . . . . . . . . . . . . . . .Echelon Biosciences, Inc.

Drezek, Rebekah A., Ph.D. . . . . . . . . . . . . . . . . .Rice University

Dubbs, Robert J., M.B.A., J.D. . . . . . . . . . . . . . .Thomas Jefferson University

Dubeau, Louis, M.D., Ph.D. . . . . . . . . . . . . . . . .University of Southern California

Duntsch, Carney, B.S. . . . . . . . . . . . . . . . . . . . .American Cancer Society

Dupont, William D., Ph.D. . . . . . . . . . . . . . . . . .Vanderbilt University

Durden, Donald L., M.D., Ph.D. . . . . . . . . . . . . .University of Indiana

Dykstra, Mary L., OTH, R.N. . . . . . . . . . . . . . . .Advocate

E Eary, Janet F., M.D. . . . . . . . . . . . . . . . . . . . . . .University of Washington 

Ebbert, Judith Ann, M.P.H. . . . . . . . . . . . . . . . . .Thomas Jefferson University

Eckhart, Walter, Ph.D. . . . . . . . . . . . . . . . . . . . .Salk Institute for Biological Studies

Edelman, Martin J., M.D. . . . . . . . . . . . . . . . . . .University of Maryland

Edgerton, Mary E., M.D., Ph.D. . . . . . . . . . . . . .Vanderbilt University

Ehrich, Marion F., Ph.D. . . . . . . . . . . . . . . . . . . .Virginia Polytechnic Institute and State University

Einspahr, Janine, Ph.D. . . . . . . . . . . . . . . . . . . .University of Arizona Cancer Center

Ekker, Stephen C., Ph.D. . . . . . . . . . . . . . . . . . .University of Minnesota

El Kouni, Mahmoud H., Ph.D. . . . . . . . . . . . . . .University of Alabama at Birmingham

Elashoff, Robert M., Ph.D. . . . . . . . . . . . . . . . . .University of California at Los Angeles

El-Bayoumy, Karam E., Ph.D. . . . . . . . . . . . . . . .Institute for Cancer Prevention

Elder, John P., Ph.D. . . . . . . . . . . . . . . . . . . . . .San Diego State University

Ellerton, John A., M.D. . . . . . . . . . . . . . . . . . . .Southern Nevada Cancer Research Foundation

Emmons, Karen M., Ph.D. . . . . . . . . . . . . . . . . .Dana-Farber Cancer Institute

Enders, Greg H., M.D., Ph.D. . . . . . . . . . . . . . .University of Pennsylvania

Ernst, Thomas, Ph.D. . . . . . . . . . . . . . . . . . . . .Brookhaven Science Association-Brookhaven Laboratory

Ershler, William B., M.D. . . . . . . . . . . . . . . . . . .Institute of Advanced Studies Aging and Geriatric Medicine

Erwin, Deborah O., Ph.D. . . . . . . . . . . . . . . . . .University of Arkansas Medical School

Esterowitz, Leon, Ph.D. . . . . . . . . . . . . . . . . . . .National Science Foundation

Evans, Thomas G., M.D. . . . . . . . . . . . . . . . . . .Vical, Inc.

Evelhoch, Jeffrey L., Ph.D. . . . . . . . . . . . . . . . . .Pharmacia Corporation

F Fahs, Marianne C., Ph.D. . . . . . . . . . . . . . . . . . .New York School University

Fajardo, Laurie L., M.D. . . . . . . . . . . . . . . . . . . .University of Iowa

Farber, Rosann A., Ph.D. . . . . . . . . . . . . . . . . . .University of North Carolina

Farr, Andrew G., Ph.D. . . . . . . . . . . . . . . . . . . .University of Washington

Fenoglio-Preiser, Cecilia M., M.D. . . . . . . . . . . . .University of Cincinnati

Fenyo, David, Ph.D. . . . . . . . . . . . . . . . . . . . . .Genomic Solutions, Inc.

Ferrell, Betty R., Ph.D. . . . . . . . . . . . . . . . . . . .Beckman Research Institute of City of Hope

Ferrone, Soldano, M.D., Ph.D. . . . . . . . . . . . . . .Roswell Park Cancer Institute Corporation

Finer-Moore, Janet S., Ph.D. . . . . . . . . . . . . . . .University of California at San Francisco

Finn, Paul, M.D. . . . . . . . . . . . . . . . . . . . . . . . .University California at Los Angeles, David Geffen School of Medicine

Fishbein, James C., Ph.D. . . . . . . . . . . . . . . . . .University of Maryland

Appendix C-3: Consultants Serving on SEPs
NCI/DEA Annual Report 2003

94

Fishbein, Michael C., M.D. . . . . . . . . . . . . . . . . .University of California at Los Angeles

Fisher, David E., M.D., Ph.D. . . . . . . . . . . . . . . .Dana-Farber Cancer Institute

Fisher, Edwin B., Ph.D. . . . . . . . . . . . . . . . . . . .Washington University

Fleming, Jason B., M.D. . . . . . . . . . . . . . . . . . .University of Texas Southwest Medical Center at Dallas

Flocke, Susan A., Ph.D. . . . . . . . . . . . . . . . . . . .Case Western Reserve University

Flotte, Thomas J., M.D. . . . . . . . . . . . . . . . . . . .Massachusetts General Hospital

Floyd, Carey E., M.D., Ph.D. . . . . . . . . . . . . . . .Duke University

Flynn, Brian S., Ph.D. . . . . . . . . . . . . . . . . . . . .University of Vermont

Fontham, Elizabeth, Ph.D. . . . . . . . . . . . . . . . . .Louisiana State University Medical Center

Forster, Jean L., Ph.D. . . . . . . . . . . . . . . . . . . . .University of Minnesota

Fowler, Bruce A., Ph.D. . . . . . . . . . . . . . . . . . . .University of Maryland

Frankel, Arthur E., M.D. . . . . . . . . . . . . . . . . . .Wake Forest University Health Sciences

Frank-Kamenetskii, Maxim D., Ph.D. . . . . . . . . . .Boston University Charles River Campus

Franklin, Wilbur A., M.D. . . . . . . . . . . . . . . . . .University of Colorado Health Science Center

Franko, Joann C., MOTH . . . . . . . . . . . . . . . . . .Case Western Reserve University

Freeman, James W., Ph.D. . . . . . . . . . . . . . . . . .University of Texas Health Science Center

Fresco, Jacques R., Ph.D. . . . . . . . . . . . . . . . . .Princeton University

Frey, Eric C., Ph.D. . . . . . . . . . . . . . . . . . . . . . .The Johns Hopkins University

Freytag, Svend O., Ph.D. . . . . . . . . . . . . . . . . . .Henry Ford Health System

Fridman, Rafael A., Ph.D. . . . . . . . . . . . . . . . . . .Wayne State University

Fu, Xiang-Dong, Ph.D. . . . . . . . . . . . . . . . . . . .University of California at San Diego

Furge, Kyle A., Ph.D. . . . . . . . . . . . . . . . . . . . . .Van Andel Research Institute

Futcher, A. Bruce, Ph.D. . . . . . . . . . . . . . . . . . .State University of New York at Stony Brook

Futscher, Bernard W., Ph.D. . . . . . . . . . . . . . . . .University of Arizona

G Gabrielson, Edward W., M.D. . . . . . . . . . . . . . . .The Johns Hopkins University

Gabrilove, Janice L., M.D. . . . . . . . . . . . . . . . . .Mount Sinai Medical Center

Gaeta, Alexander L., Ph.D. . . . . . . . . . . . . . . . .Cornell University

Gaitan, Michael, Ph.D. . . . . . . . . . . . . . . . . . . .National Institutes of Standards and Technology

Gajewski, Thomas F., M.D., Ph.D. . . . . . . . . . . .University of Chicago

Gale, James M., Ph.D. . . . . . . . . . . . . . . . . . . .University of New Mexico

Gallinger, Steven, M.D. . . . . . . . . . . . . . . . . . . .Mount Sinai Hospital (Toronto)

Gallo, James M., Ph.D. . . . . . . . . . . . . . . . . . . .Fox Chase Cancer Center

Gange, Stephen J., Ph.D. . . . . . . . . . . . . . . . . . .The Johns Hopkins University

Ganiats, Ted George, M.D. . . . . . . . . . . . . . . . . .University of California

Gann, Peter H., M.D. . . . . . . . . . . . . . . . . . . . .Northwestern University

Gao, Allen C., M.D., Ph.D. . . . . . . . . . . . . . . . .Roswell Park Cancer Institute Corporation

Garewal, Harinder S., M.D., Ph.D. . . . . . . . . . . .University of Arizona

Garlich, Joseph R., Ph.D. . . . . . . . . . . . . . . . . . .Comchem Technologies, Inc.

Gasson, Judith C., M.D., Ph.D. . . . . . . . . . . . . .University of California at Los Angeles

Gaston, Sandra M., Ph.D. . . . . . . . . . . . . . . . . .Beth Israel Deaconess Medical Center

Gatley, Samuel J., Ph.D. . . . . . . . . . . . . . . . . . . .Brookhaven Science Association-Brookhaven Laboratory

Gau, Vincent J., Ph.D. . . . . . . . . . . . . . . . . . . . .Genefluidics, Inc.

Gehan, Edmund A., Ph.D. . . . . . . . . . . . . . . . . .Georgetown University

George, John S., Ph.D. . . . . . . . . . . . . . . . . . . .Los Alamos Scientific Laboratories

Gerner, Eugene W., M.D., Ph.D. . . . . . . . . . . . . .University of Arizona

Gewirtz, David A., Ph.D. . . . . . . . . . . . . . . . . . .Virginia Commonwealth University

Giaccia, Amato J., Ph.D. . . . . . . . . . . . . . . . . . .Stanford University

Appendix C-3: Consultants Serving on SEPs
NCI/DEA Annual Report 2003

95

Giardina, Charles A., Ph.D. . . . . . . . . . . . . . . . .University of Connecticut

Gibson, Raymond E., Ph.D. . . . . . . . . . . . . . . . .Merck Research Laboratories

Gilliam, Anita C., M.D., Ph.D. . . . . . . . . . . . . . .Case Western Reserve University

Gillis, Kevin D., Ph.D. . . . . . . . . . . . . . . . . . . . .University of Missouri

Gimotty, Phyllis A., Ph.D. . . . . . . . . . . . . . . . . .University of Pennsylvania

Giordano, Antonio, M.D., Ph.D. . . . . . . . . . . . . .Sbarro Institute for Cancer Research

Given, Barbara A., Ph.D. . . . . . . . . . . . . . . . . . .Michigan State University

Gleave, Martin, M.D. . . . . . . . . . . . . . . . . . . . .Vancouver Memorial Hospital

Glinsky, Gennadi V., M.D., Ph.D. . . . . . . . . . . . .Sidney Kimmel Cancer Center

Gmitro, Arthur F., Ph.D. . . . . . . . . . . . . . . . . . . .University of Arizona

Gobbel, Glenn T., D.V.M., Ph.D. . . . . . . . . . . . . .University of Pittsburgh

Gogal, Robert M., D.V.M. . . . . . . . . . . . . . . . . .Virginia College of Osteopathic Medicine

Goggins, Michael G., M.D. . . . . . . . . . . . . . . . .The Johns Hopkins University

Gold, Barry I., M.D., Ph.D. . . . . . . . . . . . . . . . .University of Nebraska

Gold, David V., Ph.D. . . . . . . . . . . . . . . . . . . . .Garden State Cancer Center

Gold, Robert S., Ph.D. . . . . . . . . . . . . . . . . . . . .University of Maryland College Park Campus

Goldrick, Marianna M., Ph.D. . . . . . . . . . . . . . .Ambion, Inc.

Goldsmith, Denise, M.P.H. . . . . . . . . . . . . . . . . .Clinician Support Technology, Inc.

Goldson, Alfred L., M.D. . . . . . . . . . . . . . . . . . .Howard University Hospital

Golovlev, Val V., Ph.D. . . . . . . . . . . . . . . . . . . . .Sci-Tec, Inc.

Golub, Todd R., M.D. . . . . . . . . . . . . . . . . . . . .Dana-Farber Cancer Institute

Gomer, Charles J., M.D., Ph.D. . . . . . . . . . . . . .Children’s Hospital, Los Angeles

Goodlett, David R., Ph.D. . . . . . . . . . . . . . . . . .Institute for Systems Biology

Goodwin, J. Wendall, M.D. . . . . . . . . . . . . . . . .Cox Health Systems

Goodwin, James S., M.D. . . . . . . . . . . . . . . . . .University of Texas Medical Branch

Goodwin, Pamela J., M.D. . . . . . . . . . . . . . . . . .Samuel Lunenfeld Research Institute

Goss, Bill . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Bill Goss, Inc.

Gotay, Carolyn C., Ph.D. . . . . . . . . . . . . . . . . . .University of Hawaii

Gottlieb, Nell H., Ph.D. . . . . . . . . . . . . . . . . . . .University of Texas at Austin

Gould, Michael N., M.D., Ph.D. . . . . . . . . . . . . .University of Wisconsin at Madison

Graham, Michael M., M.D., Ph.D. . . . . . . . . . . .University of Iowa

Gralow, Julie R., M.D. . . . . . . . . . . . . . . . . . . . .University of Washington

Grant, Marcia L., Ph.D. . . . . . . . . . . . . . . . . . . .Beckman Research Institute of City of Hope

Greco, William R., Ph.D. . . . . . . . . . . . . . . . . . .Roswell Park Cancer Institute Corporation

Green, B. Lee, Ph.D. . . . . . . . . . . . . . . . . . . . . .Texas A&M University System

Green, Daniel M., M.D. . . . . . . . . . . . . . . . . . . .Roswell Park Cancer Institute Corporation

Green, Mark A., Ph.D. . . . . . . . . . . . . . . . . . . . .Purdue University at West Lafayette

Green, Sidney, Ph.D. . . . . . . . . . . . . . . . . . . . . .Howard University

Greene, Geoffrey W., Ph.D. . . . . . . . . . . . . . . . .University of Rhode Island

Greene, John M., Ph.D. . . . . . . . . . . . . . . . . . . .SRA International

Greene, Paul G., Ph.D. . . . . . . . . . . . . . . . . . . .University of Alabama at Birmingham

Greenleaf, James F., Ph.D. . . . . . . . . . . . . . . . . .Mayo Clinic, Rochester

Greiner, Timothy C., M.D. . . . . . . . . . . . . . . . . .University of Nebraska Medical Center

Gricoski, John J., M.B.A. . . . . . . . . . . . . . . . . . .Fox Chase Cancer Center

Griffith, Jeffrey K., Ph.D. . . . . . . . . . . . . . . . . . .University of New Mexico at Albuquerque

Grigsby, Perry W., M.D. . . . . . . . . . . . . . . . . . .Washington University

Grizzle, William E., M.D., Ph.D. . . . . . . . . . . . . .University of Alabama at Birmingham

Groden, Joanna L., Ph.D. . . . . . . . . . . . . . . . . .University of Cincinnati

Appendix C-3: Consultants Serving on SEPs
NCI/DEA Annual Report 2003

96

Groshen, Susan G., Ph.D. . . . . . . . . . . . . . . . . . .University Southern California

Grossman, Zachary D., M.D. . . . . . . . . . . . . . . .Roswell Park Cancer Institute Corporation

Grubbs, Clinton J., Ph.D. . . . . . . . . . . . . . . . . . .Life Sciences Technologies, Inc.

Grufferman, Seymour, M.D., Ph.D. . . . . . . . . . . .University of Pittsburgh

Grundfest, Warren S., M.D. . . . . . . . . . . . . . . . .University of California at Los Angeles

Guidry, Jeffery J., Ph.D. . . . . . . . . . . . . . . . . . . .Texas A&M University System

Gullberg, Grant T., Ph.D. . . . . . . . . . . . . . . . . . .University of California 

Gum, James R., Ph.D. . . . . . . . . . . . . . . . . . . . .Northern California Institute Research

Gumerlock, Paul H., Ph.D. . . . . . . . . . . . . . . . . .University of California, Davis Cancer Center

Gupta, Alok, Ph.D. . . . . . . . . . . . . . . . . . . . . . .Siemens Corporate Research, Inc.

Gupta, Sanjay, Ph.D. . . . . . . . . . . . . . . . . . . . . .Case Western Reserve University

Gupta, Sudhir, M.D., Ph.D. . . . . . . . . . . . . . . . .American Association for Chronic Fatigue Syndrome

Gur, David, Ph.D. . . . . . . . . . . . . . . . . . . . . . . .University of Pittsburgh School of Medicine

Gutierrez, Peter L., Ph.D. . . . . . . . . . . . . . . . . . .University of Maryland Cancer Center

Gygi, Steven P., Ph.D. . . . . . . . . . . . . . . . . . . . .Harvard University Medical School

H Haffty, Bruce G., M.D. . . . . . . . . . . . . . . . . . . .Yale University

Halas, Nancy Naomi, J., Ph.D. . . . . . . . . . . . . . .Rice University

Haley, Nancy Jean, Ph.D. . . . . . . . . . . . . . . . . . .Metlife

Hallahan, Dennis E., M.D., Ph.D. . . . . . . . . . . . .Vanderbilt University

Hamilton, Ann S., Ph.D. . . . . . . . . . . . . . . . . . . .University of Southern California

Hamilton, Marit Nilsen, Ph.D. . . . . . . . . . . . . . .Iowa State University

Hamilton, Thomas C., Ph.D. . . . . . . . . . . . . . . .Fox Chase Cancer Center

Hammons, George J., Ph.D. . . . . . . . . . . . . . . . .Philander Smith College

Hande, Kenneth R., M.D. . . . . . . . . . . . . . . . . . .Vanderbilt University

Handgretinger, Rupert, M.D., Ph.D. . . . . . . . . . .St. Jude Children’s Research Hospital

Hannink, Mark, Ph.D. . . . . . . . . . . . . . . . . . . . .University of Missouri at Columbia

Hannon, Sandra W., Ph.D. . . . . . . . . . . . . . . . . .The Hannon Group, LLC.

Hansen, Christine M., Ph.D. . . . . . . . . . . . . . . . .Iowa State University

Hansen, John A., M.D. . . . . . . . . . . . . . . . . . . .Fred Hutchinson Cancer Research Center

Hansen, Marc F., Ph.D. . . . . . . . . . . . . . . . . . . .University of Connecticut School of Medicine and Dentistry

Haque, Syed S., Ph.D. . . . . . . . . . . . . . . . . . . . .University of Medicine and Dentistry of New Jersey

Harper, Jeffrey, Ph.D. . . . . . . . . . . . . . . . . . . . .Harvard University Medical School

Harris, Lyndsay N., M.D. . . . . . . . . . . . . . . . . . .Dana-Farber Cancer Institute

Harris, Randall E., M.D., Ph.D. . . . . . . . . . . . . .Ohio State University

Harris, Robin B., Ph.D. . . . . . . . . . . . . . . . . . . .University of Arizona

Harrison, David E., Ph.D. . . . . . . . . . . . . . . . . .University of Vermont and State Agriculture College

Harvey, Jennifer Ann, M.D. . . . . . . . . . . . . . . . .University of Virginia at Charlottesville

Haselgrove, John C., Ph.D. . . . . . . . . . . . . . . . .Children’s Hospital of Philadelphia

Hasty, Jeff M., Ph.D. . . . . . . . . . . . . . . . . . . . .University of California at San Diego

Hatsukami, Dorothy K., Ph.D. . . . . . . . . . . . . . .University of Minnesota Medical School

Havill-Ryan, Diana, M.B. . . . . . . . . . . . . . . . . . .University of Chicago Pritzker Medical School

Hawkes, Wayne C., Ph.D. . . . . . . . . . . . . . . . . .University of California at Davis

Hazan, Rachel B., Ph.D. . . . . . . . . . . . . . . . . . .Yeshiva University

Hazle, John D., Ph.D. . . . . . . . . . . . . . . . . . . . .University of Texas M.D. Anderson Cancer Center

Head, Kathleen, DOTH . . . . . . . . . . . . . . . . . . . .Alternative Medicine Review

Heber, David, M.D., Ph.D. . . . . . . . . . . . . . . . . .University of California at Los Angeles

Heid, Kermit K., BOTH . . . . . . . . . . . . . . . . . . . .Patient Advocate

Appendix C-3: Consultants Serving on SEPs
NCI/DEA Annual Report 2003

97

Hellstrom, Ingegerd E., M.D., Ph.D. . . . . . . . . . .Pacific Northwest Research Institute

Helpern, Joseph A., Ph.D. . . . . . . . . . . . . . . . . .New York University School of Medicine

Hemstreet, George P., M.D., Ph.D. . . . . . . . . . . .H and B Medical Technology

Herman, Brian A., M.D., Ph.D. . . . . . . . . . . . . . .University of Texas Health Science Center

Herman, James G., M.D. . . . . . . . . . . . . . . . . . .The Johns Hopkins University Medical School

Herschman, Harvey R., Ph.D. . . . . . . . . . . . . . . .University of California at Los Angeles

Heslop, Helen E., M.D. . . . . . . . . . . . . . . . . . . .Baylor College of Medicine

Hess, Kenneth R, Ph.D. . . . . . . . . . . . . . . . . . . .University of Texas M.D. Anderson Cancer Center

Heston, Warren D., Ph.D. . . . . . . . . . . . . . . . . .Cleveland Clinic Foundation - Lerner Research Institute

Hettich, Robert L., Ph.D. . . . . . . . . . . . . . . . . . .UT-Battelle, LLC-Oak Ridge National Laboratory

Hickman, James J., Ph.D. . . . . . . . . . . . . . . . . .Hesperosa, LLC.

Hielscher, Andreas H., Ph.D. . . . . . . . . . . . . . . .Columbia University at New York

Hight-Walker, Angela, Ph.D. . . . . . . . . . . . . . . . .National Institutes of Standards and Technology

Hilakivi-Clarke, Leena A., Ph.D. . . . . . . . . . . . . .Lombardi Cancer Research Center

Hill, Christopher P., M.D., Ph.D. . . . . . . . . . . . . .University of Utah

Hill, David E., Ph.D. . . . . . . . . . . . . . . . . . . . . .Dana-Farber Cancer Institute

Hinders, Mark K., Ph.D. . . . . . . . . . . . . . . . . . .College of William and Mary

Hinds, Philip W., Ph.D. . . . . . . . . . . . . . . . . . . .Harvard University

Hine, R. Jean, Ph.D. . . . . . . . . . . . . . . . . . . . . .University of Arkansas

Hittelman, Walter N., Ph.D. . . . . . . . . . . . . . . . .University of Texas M.D. Anderson Cancer Center

Ho, Peter T. C., M.D., Ph.D. . . . . . . . . . . . . . . . .GlaxoSmithKline

Hobart, Peter M., Ph.D. . . . . . . . . . . . . . . . . . .Vical, Inc

Hodge, Felicia S., Ph.D. . . . . . . . . . . . . . . . . . . .University of Minnesota at Twin Cities

Holiday, David B., Ph.D. . . . . . . . . . . . . . . . . . .University of Texas Health Center at Tyler

Holmes-McNary, Minnie Q., Ph.D. . . . . . . . . . . .University of North Carolina at Chapel Hill

Holt, Jeffrey T., M.D. . . . . . . . . . . . . . . . . . . . .University of Colorado Health Sciences Center

Hom, David J., B.S. . . . . . . . . . . . . . . . . . . . . . .Baylor College of Medicine

Honn, Kenneth V., Ph.D. . . . . . . . . . . . . . . . . . .Biomide Corporation

Hoon, Dave S., Ph.D. . . . . . . . . . . . . . . . . . . . .John Wayne Cancer Institute

Horne, Donald W., Ph.D. . . . . . . . . . . . . . . . . . .Vanderbilt University

Hortobagyi, Gabriel N., M.D. . . . . . . . . . . . . . . .University of Texas M.D. Anderson Cancer Center

Horton, John, M.D. . . . . . . . . . . . . . . . . . . . . .University of South Florida

Hosking, James D., Ph.D. . . . . . . . . . . . . . . . . .University of North Carolina at Chapel Hill

Hoskins, William J., M.D. . . . . . . . . . . . . . . . . .Memorial Sloan-Kettering Cancer Center

Hotchkiss, John M., B.A. . . . . . . . . . . . . . . . . . .Anvil Informatics, Inc.

Houghton, Raymond L., Ph.D. . . . . . . . . . . . . . .Corixa Corporation

Howell, Gillian M., Ph.D. . . . . . . . . . . . . . . . . . .University of Texas Health Science Center

Howett, Mary K., Ph.D. . . . . . . . . . . . . . . . . . .Pennsylvania State University Hershey Medical Center

Hromas, Robert A., M.D. . . . . . . . . . . . . . . . . .University of New Mexico at Albuquerque

Hsieh, Chung-Cheng, Sc.D. . . . . . . . . . . . . . . . .University of Massachusetts Medical School

Hsu, Edward W., Ph.D. . . . . . . . . . . . . . . . . . . .Duke University

Hu, Ming, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . .Washington State University

Huang, Tim H., Ph.D. . . . . . . . . . . . . . . . . . . . .Ohio State University

Hudson, Courtney, M.B.A. . . . . . . . . . . . . . . . . .EmergingMed

Huff, Vicki D., Ph.D. . . . . . . . . . . . . . . . . . . . . .University of Texas M.D. Anderson Cancer Center

Hughes, Chanita A., Ph.D. . . . . . . . . . . . . . . . . .Tobacco Research Center

Humphrey, Peter A., M.D., Ph.D. . . . . . . . . . . . .Washington University

Hung, Mien-Chie, Ph.D. . . . . . . . . . . . . . . . . . . .University of Texas M.D. Anderson Cancer Center

Appendix C-3: Consultants Serving on SEPs
NCI/DEA Annual Report 2003

98

Hurt, Richard D., M.D. . . . . . . . . . . . . . . . . . . .Mayo Clinic, Rochester

Hurwitz, Aryeh A., M.D. . . . . . . . . . . . . . . . . . .University of Kansas Medical Center

Hussein, Mohamad, M.D. . . . . . . . . . . . . . . . . .Cleveland Clinic Foundation

Hyland, Andrew, Ph.D. . . . . . . . . . . . . . . . . . . .Roswell Park Cancer Institute Corporation

Hymowitz, Norman, Ph.D. . . . . . . . . . . . . . . . . .University of Medicine and Dentistry of New Jersey 

I Ikle, David N., Ph.D. . . . . . . . . . . . . . . . . . . . . .City of Hope

Ilaria, Robert L., M.D. . . . . . . . . . . . . . . . . . . . .University of Texas Southwest Medical Center/Dallas

Isaacson, David, Ph.D. . . . . . . . . . . . . . . . . . . .Rensselaer Polytechnic Institute

Issa, Jean-Pierre J., M.D. . . . . . . . . . . . . . . . . . .University of Texas M.D. Anderson Cancer Center

Ittmann, Michael M., M.D., Ph.D. . . . . . . . . . . .New York University

J Jackson-Grusby, Laurie, Ph.D. . . . . . . . . . . . . . .Whitehead Institute

Jacobellis, Jillian, Ph.D. . . . . . . . . . . . . . . . . . . .Colorado State Department/Public Health Environment

Jacobs, David R., Ph.D. . . . . . . . . . . . . . . . . . . .University of Minnesota at Twin Cities

Jacobsen, Donald W., Ph.D. . . . . . . . . . . . . . . . .Cleveland Clinic Foundation

Jacobson, Elaine L., Ph.D. . . . . . . . . . . . . . . . . .University of Arizona

Jacquez, Geoffrey M., Ph.D. . . . . . . . . . . . . . . .BioMedware

Jaen, Carlos R., M.D., Ph.D. . . . . . . . . . . . . . . .State University of New York at Buffalo

Jaffee, Elizabeth M., M.D., Ph.D. . . . . . . . . . . . .The Johns Hopkins University School of Medicine

Jain, Ajay N., Ph.D. . . . . . . . . . . . . . . . . . . . . .University of California at San Francisco

Jansen, E. Duco, Ph.D. . . . . . . . . . . . . . . . . . . .Vanderbilt University

Jatoi, Aminah, M.D. . . . . . . . . . . . . . . . . . . . . .Mayo Clinic, Rochester

Jay, Daniel G., Ph.D. . . . . . . . . . . . . . . . . . . . . .Tufts University at Boston

Jaye, David L., M.D. . . . . . . . . . . . . . . . . . . . . .Emory University

Jelinek, Diane F., Ph.D. . . . . . . . . . . . . . . . . . . .Mayo Clinic, Rochester

Jenkins, Robert B., M.D., Ph.D. . . . . . . . . . . . . .Mayo Clinic, Rochester

Jiang, Huabei, Ph.D. . . . . . . . . . . . . . . . . . . . . .Clemson University

Jibaja-Weiss, Maria L., Ed.D. . . . . . . . . . . . . . . .Baylor College of Medicine

Johnson, Bruce E., M.D. . . . . . . . . . . . . . . . . . .Dana-Farber Cancer Institute

Johnson, Bryon D., Ph.D. . . . . . . . . . . . . . . . . .Medical College of Wisconsin

Johnson, Candace S., M.D., Ph.D. . . . . . . . . . . .Roswell Park Cancer Institute Corporation

Johnson, Linda B., B.S. . . . . . . . . . . . . . . . . . . .National Coalition For Cancer Survivorship

Jones, Glenville, Ph.D. . . . . . . . . . . . . . . . . . . . .Queen’s University

June, Carl H., M.D., Ph.D. . . . . . . . . . . . . . . . .University of Pennsylvania

Jung, Mira O., Ph.D. . . . . . . . . . . . . . . . . . . . .Georgetown University

K Kacinski, Barry M., M.D., Ph.D. . . . . . . . . . . . . .Yale University School of Medicine

Kaiser, Larry R., M.D. . . . . . . . . . . . . . . . . . . . .University of Pennsylvania

Kamat, Ashish, M.D. . . . . . . . . . . . . . . . . . . . . .University of Texas M.D. Anderson Cancer Center

Kantoff, Phillip, M.D. . . . . . . . . . . . . . . . . . . . .Harvard University Medical School

Kao, Joseph P., Ph.D. . . . . . . . . . . . . . . . . . . . .University of Maryland

Kaplan, Alan M., Ph.D. . . . . . . . . . . . . . . . . . . .Virginia Commonwealth University

Kappler, John W., Ph.D. . . . . . . . . . . . . . . . . . .National Jewish Medical and Research Center

Karagas, Margaret R., Ph.D. . . . . . . . . . . . . . . .Dartmouth College

Karellas, Andrew, Ph.D. . . . . . . . . . . . . . . . . . . .University of Massachusetts Medical School

Karlan, Beth Y., M.D. . . . . . . . . . . . . . . . . . . . .Cedars-Sinai Medical Center

Karliner, Joel S., M.D., Ph.D. . . . . . . . . . . . . . . .University of California at San Francisco

Appendix C-3: Consultants Serving on SEPs
NCI/DEA Annual Report 2003

99

Kasid, Usha N., Ph.D. . . . . . . . . . . . . . . . . . . . .Georgetown University

Kaufman, Howard L., M.D., Ph.D. . . . . . . . . . . .Columbia University Health Sciences

Kaul, Karen L., M.D., Ph.D. . . . . . . . . . . . . . . . .Evanston Hospital

Kay, Neil E., M.D. . . . . . . . . . . . . . . . . . . . . . . .Mayo Clinic, Rochester

Keever-Taylor, Carolyn Anne, Ph.D. . . . . . . . . . . .Froedtert East

Kelcz, Frederick , M.D., Ph.D. . . . . . . . . . . . . . .University of Wisconsin at Madison

Keller, Steven M., M.D., Ph.D. . . . . . . . . . . . . . .Albert Einstein College of Medicine

Kelley, Mark R., Ph.D. . . . . . . . . . . . . . . . . . . . .Indiana University-Purdue University 

Kelley, Michael J., M.D. . . . . . . . . . . . . . . . . . . .Duke University

Kemeny, Margaret E., Ph.D. . . . . . . . . . . . . . . . .University California at Los Angeles

Kenan, Daniel J., M.D., Ph.D. . . . . . . . . . . . . . .Duke University Medical Center

Khalkhali-Ellis, Zhila, Ph.D. . . . . . . . . . . . . . . . . .University of Iowa

Khokha, Rama, Ph.D. . . . . . . . . . . . . . . . . . . . .University of Toronto

Kiecolt-Glaser, Janice K., Ph.D. . . . . . . . . . . . . . .Ohio State University

Kie, Merrill S., M.D. . . . . . . . . . . . . . . . . . . . . .University of Texas M.D. Anderson Cancer Center

Killackey, Maureen A., M.D., Ph.D. . . . . . . . . . . .Bassett Cancer Center

Kim, Kyungmann, Ph.D. . . . . . . . . . . . . . . . . . .University of Wisconsin at Madison

Kim, Young-In J., M.D. . . . . . . . . . . . . . . . . . . . .University of Toronto

Kimler, Bruce F., Ph.D. . . . . . . . . . . . . . . . . . . . .University of Kansas Medical Center

Kipp, Thomas J., M.D., Ph.D. . . . . . . . . . . . . . .University of California at San Diego

Kirschner, Marvin A., M.D. . . . . . . . . . . . . . . . .University of Medicine and Dentistry at New Jersey

Kittle, Rick, Ph.D. . . . . . . . . . . . . . . . . . . . . . . .Howard University

Kiviat, Nancy B., M.D. . . . . . . . . . . . . . . . . . . .University of Washington

Klein, John P., Ph.D. . . . . . . . . . . . . . . . . . . . . .Medical College of Wisconsin

Klein-Szanto, Andres J., M.D. . . . . . . . . . . . . . . .Fox Chase Cancer Center

Klesge, Lisa M., Ph.D. . . . . . . . . . . . . . . . . . . . .University of Tennessee Health Science Center

Kline, Kimberly, Ph.D. . . . . . . . . . . . . . . . . . . . .University of Texas at Austin

Klotz, Laurence, M.D. . . . . . . . . . . . . . . . . . . . .Sunnybrook & Women’s College Health Sciences Center

Knipp, Gregory T., Ph.D. . . . . . . . . . . . . . . . . . .Rutgers State University of New Jersey

Knoell, Daren L., Ph.D. . . . . . . . . . . . . . . . . . . .Ohio State University

Knopp, Michael, M.D., Ph.D. . . . . . . . . . . . . . .Ohio State University

Knowles, David W., M.D., Ph.D. . . . . . . . . . . . .Mother Assumpta Health for All, Inc.

Kolega, John P., Ph.D. . . . . . . . . . . . . . . . . . . . .State University of New York at Buffalo

Kong, Tony Ah-Ng, Ph.D. . . . . . . . . . . . . . . . . .Rutgers University College of Pharmacy

Konto, Christopher D., M.D. . . . . . . . . . . . . . . .Duke University

Koo, Robert D., Ph.D. . . . . . . . . . . . . . . . . . . .University of Maryland

Kopecky, Kenneth J., Ph.D. . . . . . . . . . . . . . . . .Fred Hutchinson Cancer Research Center

Kornblith, Alice B., Ph.D. . . . . . . . . . . . . . . . . .Dana-Farber Cancer Institute

Kotchen, Jane M., M.D. . . . . . . . . . . . . . . . . . .Medical College of Wisconsin

Koutcher, Jason A., M.D., Ph.D. . . . . . . . . . . . .Memorial Sloan-Kettering Cancer Center

Koval, Charles F., Ph.D. . . . . . . . . . . . . . . . . . . .University of Wisconsin

Krailo, Mark D., Ph.D. . . . . . . . . . . . . . . . . . . .National Childhood Cancer Foundation

Krasnykh, Victor N., Ph.D. . . . . . . . . . . . . . . . .Vectorlogics, Inc.

Kraut, Robert, Ph.D. . . . . . . . . . . . . . . . . . . . . .Carnegie-Mellon University

Krischer, Jeffrey P., Ph.D. . . . . . . . . . . . . . . . . .H. Lee Moffitt Cancer Center and Research Institute

Krizman, David B., Ph.D. . . . . . . . . . . . . . . . . .Expression Pathology, Inc.

Krohn, Kenneth A., Ph.D. . . . . . . . . . . . . . . . . .University of Washington

Krolewski, John J., M.D., Ph.D. . . . . . . . . . . . . .University of California at Irvine

Appendix C-3: Consultants Serving on SEPs
NCI/DEA Annual Report 2003

100

Kron, Stephen J., M.D., Ph.D. . . . . . . . . . . . . . .University of Chicago

Krupinski, Elizabeth A., Ph.D. . . . . . . . . . . . . . . .University of Arizona

Kucuk, Omer J., M.D., Ph.D. . . . . . . . . . . . . . . .Wayne State University

Kuebler, Philip, M.D., Ph.D. . . . . . . . . . . . . . . . .Columbus CCOP

Kukafka, Rita, Ph.D. . . . . . . . . . . . . . . . . . . . . .Columbia University Health Sciences

Kulkarni, Amit, Ph.D. . . . . . . . . . . . . . . . . . . . . .Molecular Simulations, Inc.

Kung, Hank F., Ph.D. . . . . . . . . . . . . . . . . . . . . .University of Pennsylvania

Kurfess, James Daniel, Ph.D. . . . . . . . . . . . . . . .Naval Research Laboratories

Kurhanewicz, John, Ph.D. . . . . . . . . . . . . . . . . .University of California at San Francisco

Kurman, Robert J., M.D. . . . . . . . . . . . . . . . . . .The Johns Hopkins University

Kushi, Lawrence H., Ph.D. . . . . . . . . . . . . . . . . .Kaiser Foundation Research Institute

Kwock, Lester, Ph.D. . . . . . . . . . . . . . . . . . . . . .University of North Carolina at Chapel Hill

L Ladner, Robert D., Ph.D. . . . . . . . . . . . . . . . . . .University Medicine and Dentistry at New Jersey

Laird, Dale W., Ph.D. . . . . . . . . . . . . . . . . . . . . .University of Western Ontario

Lance, Peter, M.D. . . . . . . . . . . . . . . . . . . . . . .Arizona Cancer Center

Landsittel, Douglas P., Ph.D. . . . . . . . . . . . . . . .University of Pittsburgh

Lane, Richard W., Ph.D. . . . . . . . . . . . . . . . . . . .Unilever Bestfoods North America

Langer, Mark, M.D. . . . . . . . . . . . . . . . . . . . . .Advanced Process Combinatorics

Larson, Steven M., M.D., Ph.D. . . . . . . . . . . . . .Memorial Sloan-Kettering Cancer Center

Lasater, Thomas M., Ph.D. . . . . . . . . . . . . . . . . .Brown University

Layne, Elizabeth L., D.D.S. . . . . . . . . . . . . . . . . .Alliance/Lung Cancer Advocacy, Support and Education

Lazovich, Deann, Ph.D. . . . . . . . . . . . . . . . . . . .University of Minnesota

Leary, James F., Ph.D. . . . . . . . . . . . . . . . . . . . .University of Texas Medical Branch at Galveston

Lebien, Tucker W., Ph.D. . . . . . . . . . . . . . . . . . .University of Minnesota Cancer Center

Lee, Chung, Ph.D. . . . . . . . . . . . . . . . . . . . . . .Northwestern University

Lee, Jeannette Y., Ph.D. . . . . . . . . . . . . . . . . . . .University of Alabama at Birmingham

Lee, Luke P., Ph.D. . . . . . . . . . . . . . . . . . . . . . .University of California at Berkeley

Lee, Marion M., Ph.D. . . . . . . . . . . . . . . . . . . . .University of California at San Francisco

Lee, Robert J., Ph.D. . . . . . . . . . . . . . . . . . . . . .Ohio State University

Lee, Stephen C., Ph.D. . . . . . . . . . . . . . . . . . . .Ohio State University

Lefebvre, R. Craig, Ph.D. . . . . . . . . . . . . . . . . . .Prospect Associates, Ltd.

Lehman, Constance D., M.D., Ph.D. . . . . . . . . . .University of Washington

Leigh, Susan A., R.N. . . . . . . . . . . . . . . . . . . . . .Cancer Survivorship

Lentz, Steven R., M.D., Ph.D. . . . . . . . . . . . . . .University of Iowa

Lerner, Seth P., M.D. . . . . . . . . . . . . . . . . . . . . .Baylor College of Medicine

Lesley, Scott A., Ph.D. . . . . . . . . . . . . . . . . . . . .Genomics Institute of the Novartis Research Foundation

Leslie-Pelecky, Diandra L., Ph.D. . . . . . . . . . . . . .University of Nebraska

Lesser, Martin L., Ph.D. . . . . . . . . . . . . . . . . . . .New York University

Levenson, Richard M., M.D., Ph.D. . . . . . . . . . . .Cambridge Research and Instrumentation

Lever, Susan Z., Ph.D. . . . . . . . . . . . . . . . . . . . .University of Missouri at Columbia

Levin, Bernard, M.D. . . . . . . . . . . . . . . . . . . . . .University of Texas M.D. Anderson Cancer Center

Lewellen, Thomas K., Ph.D. . . . . . . . . . . . . . . . .University of Washington

Lewin, John M., M.D. . . . . . . . . . . . . . . . . . . . .University of Colorado Health Sciences Center

Li, King C., M.D. . . . . . . . . . . . . . . . . . . . . . . .Stanford University

Li, Sara, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . .University of Kansas Medical Center

Liang, Peng, Ph.D. . . . . . . . . . . . . . . . . . . . . . .Vanderbilt University

Liang, Zhi-Pei, Ph.D. . . . . . . . . . . . . . . . . . . . . .University of Illinois at Urbana-Champaign

Appendix C-3: Consultants Serving on SEPs
NCI/DEA Annual Report 2003

101

Liao, Shutsung, Ph.D. . . . . . . . . . . . . . . . . . . . .University of Illinois

Lichtenstein, Alan K., M.D. . . . . . . . . . . . . . . . .Brentwood Biomedical Research Institute

Lieberman, David A., M.D. . . . . . . . . . . . . . . . .Portland Veteran’s Administration Medical Center

Lieberman, Howard B., Ph.D. . . . . . . . . . . . . . . .Columbia University Health Sciences Center

Liebman, Michael N., Ph.D. . . . . . . . . . . . . . . . .University of Pennsylvania Cancer Center

Lillegard, Debra G., M.A. . . . . . . . . . . . . . . . . . .Methodist Hospital Cancer Center

Lin, Henry J., M.D., Ph.D. . . . . . . . . . . . . . . . . .Harbor-UCLA Medical Center

Link, Charles J., M.D. . . . . . . . . . . . . . . . . . . . .Iowa State University

Linney, Elwood A., Ph.D. . . . . . . . . . . . . . . . . . .Duke University Medical Center

Linton, Marigold L., Ph.D. . . . . . . . . . . . . . . . . .University of Kansas

Linville, Linda H., Ph.D. . . . . . . . . . . . . . . . . . . .University of Kentucky

Lipkus, Isaac M., Ph.D. . . . . . . . . . . . . . . . . . . .Duke University

Liu, Fei-Fei, M.D. . . . . . . . . . . . . . . . . . . . . . . .University of Toronto

Liu, Hong, Ph.D. . . . . . . . . . . . . . . . . . . . . . . .University of Oklahoma at Norman

Livolsi, Virginia A., M.D. . . . . . . . . . . . . . . . . . .University of Pittsburgh

Lo, David D., M.D., Ph.D. . . . . . . . . . . . . . . . . .Digital Gene Technologies

Lo, Joseph Y., Ph.D. . . . . . . . . . . . . . . . . . . . . .Duke University

Lo, Shih-Chung B., Ph.D. . . . . . . . . . . . . . . . . . .Georgetown University

Locascio, Laurie E., Ph.D. . . . . . . . . . . . . . . . . . .National Institute of Standards and Technology

Logothetis, Christopher J., M.D. . . . . . . . . . . . .University of Texas M.D. Anderson Cancer Center

Logsdon, Craig D., Ph.D. . . . . . . . . . . . . . . . . . .University of Michigan at Ann Arbor

London, Jack W., Ph.D. . . . . . . . . . . . . . . . . . . .Thomas Jefferson University, Kimmel Cancer Center

Longnecker, Daniel S., M.D. . . . . . . . . . . . . . . . .Dartmouth Medical School

Lopez, Alfredo, M.D., Ph.D. . . . . . . . . . . . . . . .Louisiana State University

Lopez, Manuel M., Ph.D. . . . . . . . . . . . . . . . . .Minnesota State Colleges and University

Loprinzi, Charles L., M.D. . . . . . . . . . . . . . . . . .Mayo Clinic, Rochester

Lotze, Michael T., M.D., Ph.D. . . . . . . . . . . . . . .University of Pittsburgh at Pittsburgh

Lu, Junxuan, Ph.D. . . . . . . . . . . . . . . . . . . . . . .University of Minnesota at Twin Cities

Lund, Jim, M.S. . . . . . . . . . . . . . . . . . . . . . . . . .Sandia National Laboratories

Lyerly, Herbert K., M.D. . . . . . . . . . . . . . . . . . .Duke University Medical Center

Lynch, James C., Ph.D. . . . . . . . . . . . . . . . . . . .University of Nebraska

Lynch, Kevin R., Ph.D. . . . . . . . . . . . . . . . . . . . .University of Virginia Medical School

Lynch, Patrick M., M.D. . . . . . . . . . . . . . . . . . .University of Alabama at Birmingham

Lyn-Cook, Beverly D., Ph.D. . . . . . . . . . . . . . . . .FDA-National Center for Toxicological Research

M Macapinlac, Homer A., M.D. . . . . . . . . . . . . . . .Memorial Sloan-Kettering Cancer Center

MacArthur, Robert, DOTH . . . . . . . . . . . . . . . . .Columbia University

MaCrae, Calum A., M.D. . . . . . . . . . . . . . . . . . .Massachusetts General Hospital

Mahadevan-Jasen, Anita, Ph.D. . . . . . . . . . . . . .Vanderbilt University

Maher, Veronica M., Ph.D. . . . . . . . . . . . . . . . .Karmanos Cancer Institute

Mahvi, David M., M.D., Ph.D. . . . . . . . . . . . . . .University of Wisconsin Hospitals

Maier, John S., M.D., Ph.D. . . . . . . . . . . . . . . . .Chemimage, Inc.

Majumdar, Arun, Ph.D. . . . . . . . . . . . . . . . . . . .University of California

Makrigiorgos, G. M., Ph.D. . . . . . . . . . . . . . . . .Dana-Farber Cancer Institute

Malkhosyan, Sergei R., Ph.D. . . . . . . . . . . . . . . .Burnham Institute

Malone, John B., Ph.D. . . . . . . . . . . . . . . . . . . .Louisiana State University A&M College

Maloney, David G., M.D., Ph.D. . . . . . . . . . . . . .Fred Hutchinson Cancer Research Center

Manautou, Jose E., Ph.D. . . . . . . . . . . . . . . . . . .University of Connecticut

Appendix C-3: Consultants Serving on SEPs
NCI/DEA Annual Report 2003

102

Manion, Frank J., MOTH . . . . . . . . . . . . . . . . . .Fox Chase Cancer Center

Mansfield, Carl, M.D. . . . . . . . . . . . . . . . . . . . .University of Maryland at Baltimore 

Mao, Li, M.D. . . . . . . . . . . . . . . . . . . . . . . . . .University of Texas M.D. Anderson Cancer Center

Marcantonio, Eugene E., M.D., Ph.D. . . . . . . . . .Columbia University at New York 

Markland, Francis S., Ph.D. . . . . . . . . . . . . . . . .Pivotal Biosciences, Inc.

Marrangoni, James . . . . . . . . . . . . . . . . . . . . . . .Advocate

Marsh, James D., M.D. . . . . . . . . . . . . . . . . . . .Wayne State University

Marton, Laurence J., M.D. . . . . . . . . . . . . . . . . .Slil Biomedical Corporation

Mason, Joel B., M.D. . . . . . . . . . . . . . . . . . . . .Tufts University at Boston

Mason, Ralph P., Ph.D. . . . . . . . . . . . . . . . . . . .University of Texas Southwestern Medical Center

Mattoussi, Hedi, Ph.D. . . . . . . . . . . . . . . . . . . .Naval Research Laboratory

Mc Clure, Jennifer B., Ph.D. . . . . . . . . . . . . . . .Group Health Cooperative of Puget Sound

Mc Cubrey, James A., Ph.D. . . . . . . . . . . . . . . . .East Carolina University

Mc Donald, Paige A., Ph.D. . . . . . . . . . . . . . . . .Howard University

Mc Garrity, Gerard J., Ph.D. . . . . . . . . . . . . . . . .Genetic Therapy, Inc.

McBride, William H., Ph.D. . . . . . . . . . . . . . . . .University of California at Los Angeles

McCaul, Kevin D., Ph.D. . . . . . . . . . . . . . . . . . .North Dakota University

McDonald, Jamie M., MOTH . . . . . . . . . . . . . . .Presbyterian Hospital

McDonnell, Timothy J., M.D., Ph.D. . . . . . . . . . .University of Texas M.D. Anderson Cancer Center

McGlave, Philip B., M.D. . . . . . . . . . . . . . . . . . .University of Minnesota

McLennan, Ian J., Ph.D. . . . . . . . . . . . . . . . . . .Ecosynthetix, Inc.

McMahon, Steven B., Ph.D. . . . . . . . . . . . . . . . .Wistar Institute

McQueen, Charlene A., Ph.D. . . . . . . . . . . . . . .University of Arizona

McWeeney, Shannon K., Ph.D. . . . . . . . . . . . . . .Oregon Health and Science University

Mehta, Rajendra G., Ph.D. . . . . . . . . . . . . . . . . .University of Illinois at Chicago

Meldrum, Deirdre R., Ph.D. . . . . . . . . . . . . . . . .University of Washington

Mendonca, Paulo Ricardo, Ph.D. . . . . . . . . . . . . .GE Global Research

Meropol, Neal J., M.D. . . . . . . . . . . . . . . . . . . .Fox Chase Cancer Center

Merriman, Ronald L., Ph.D. . . . . . . . . . . . . . . . .Parke Davis Pharmaceutical Research Institute

Metz, Charles E., Ph.D. . . . . . . . . . . . . . . . . . . .University of Utah

Meyer, Laurence J., M.D., Ph.D. . . . . . . . . . . . .University of Utah

Meyers, Christina A., Ph.D. . . . . . . . . . . . . . . . .University of Texas M.D. Anderson Cancer Center

Meyn, Raymond E., Ph.D. . . . . . . . . . . . . . . . . .University of Texas M.D. Anderson Cancer Center

Meyskens, Frank L., M.D. . . . . . . . . . . . . . . . . .SRI International

Mezrich, Reuben S., M.D., Ph.D. . . . . . . . . . . . .Brigham and Women’s Hospital

Miller, Donald M., M.D., Ph.D. . . . . . . . . . . . . .James Graham Brown Cancer Center

Miller, Jeffrey E., Ph.D. . . . . . . . . . . . . . . . . . . .Ivs Technologies, LLC.

Miller, Richard G., Ph.D. . . . . . . . . . . . . . . . . . .Ontario Cancer Institute

Milliken, George A., Ph.D. . . . . . . . . . . . . . . . . .Kansas State University

Mills, Sherry L., M.D. . . . . . . . . . . . . . . . . . . . .Abt Associates, Inc.

Minden, Mark D., M.D., Ph.D. . . . . . . . . . . . . .Princess Margaret Hospital

Mirand, Amy L., Ph.D. . . . . . . . . . . . . . . . . . . .Roswell Park Cancer Institute Corporation

Miyamoto, Suzanne, Ph.D. . . . . . . . . . . . . . . . . .University of California at Davis

Mizaikoff, Boris, Ph.D. . . . . . . . . . . . . . . . . . . .Georgia Institute of Technology

Modugno, Francesmary, Ph.D. . . . . . . . . . . . . . .University of Pittsburgh at Pittsburgh

Moen, Phillip T., Ph.D. . . . . . . . . . . . . . . . . . . . .One Cell Systems, Inc.

Moin, Kamiar, Ph.D. . . . . . . . . . . . . . . . . . . . . .Wayne State University

Moinpour, Carol, Ph.D. . . . . . . . . . . . . . . . . . . .Fred Hutchinson Cancer Center

Appendix C-3: Consultants Serving on SEPs
NCI/DEA Annual Report 2003

103

Moore, Bartlett D., M.D., Ph.D. . . . . . . . . . . . .University of Texas

Moorman, Patricia G., Ph.D. . . . . . . . . . . . . . . .Duke University

Moran, Richard G., Ph.D. . . . . . . . . . . . . . . . . .Virginia Commonwealth University

Morgan, Jennifer, MOTH . . . . . . . . . . . . . . . . . .Medical University of South Carolina

Morgan, Lee Roy R., M.D., Ph.D. . . . . . . . . . . . .Dekk-Tec, Inc.

Morgan, William F., Ph.D. . . . . . . . . . . . . . . . . .University of Maryland

Morre, Dorothy M., Ph.D. . . . . . . . . . . . . . . . . .Purdue University at West Lafayette

Morris, Marilyn E., Ph.D. . . . . . . . . . . . . . . . . . .State University of New York at Buffalo

Morris, Michael D., Ph.D. . . . . . . . . . . . . . . . . .University of Michigan

Morris, Selma J., Ph.D. . . . . . . . . . . . . . . . . . . .Grady Health System

Morrow, Gary R., Ph.D. . . . . . . . . . . . . . . . . . . .University of Rochester

Morse, Edward V., Ph.D. . . . . . . . . . . . . . . . . . .Tulane University

Moses, William W., Ph.D. . . . . . . . . . . . . . . . . . .University of California-Lawrence Berkeley Laboratory

Moyer, James D., Ph.D. . . . . . . . . . . . . . . . . . .Pfizer Central Research

Moysich, Kirsten B., Ph.D. . . . . . . . . . . . . . . . .Roswell Park Cancer Institute Corporation

Muddiman, David C., Ph.D. . . . . . . . . . . . . . . . .Mayo Clinic, Rochester

Muggia, Franco M., M.D. . . . . . . . . . . . . . . . . .New York University

Mukhtar, Hasan, Ph.D. . . . . . . . . . . . . . . . . . . .University of Wisconsin at Madison

Mulder, Kathleen M., Ph.D. . . . . . . . . . . . . . . . .Pennsylvania State

Mulvihill, John J., M.D. . . . . . . . . . . . . . . . . . . .Medical College of Ohio

Murphy, Maureen E., Ph.D. . . . . . . . . . . . . . . . .Fox Chase Cancer Center

Muschler, George F., M.D. . . . . . . . . . . . . . . . . .Cleveland Clinic Lerner College

Musgrove, Lewis C., B.A. . . . . . . . . . . . . . . . . . .Us Too International, Inc.

Mycek, Mary-Ann, Ph.D. . . . . . . . . . . . . . . . . . .University of Michigan

Myers, Ronald E., Ph.D. . . . . . . . . . . . . . . . . . .Thomas Jefferson University

Myszka, David G., Ph.D. . . . . . . . . . . . . . . . . . .University of Utah

N Nace, G. Stephen, M.D. . . . . . . . . . . . . . . . . . . .University of Illinois College of Medicine

Naughton, Michelle J., Ph.D. . . . . . . . . . . . . . . .Wake Forest University

Navone, Nora M., M.D., Ph.D. . . . . . . . . . . . . .University of Texas M.D. Anderson Cancer Center

Nazarian, Levon N., M.D. . . . . . . . . . . . . . . . . .Thomas Jefferson University

Nedelkov, Dobrin, Ph.D. . . . . . . . . . . . . . . . . . .Intrinsic Bioprobes, Inc.

Nelson, David., Ph.D. . . . . . . . . . . . . . . . . . . . .Medical College of Ohio at Toledo

Nelson, Peter S., M.D. . . . . . . . . . . . . . . . . . . . .Fred Hutchinson Cancer Research Center

Nelson, Richard L., M.D. . . . . . . . . . . . . . . . . . .University of Illinois at Chicago

Nelson, Sarah J., Ph.D. . . . . . . . . . . . . . . . . . . .University of California at San Francisco

Nemerow, Glen R., Ph.D. . . . . . . . . . . . . . . . . . .Scripps Research Institute

Neoptolemos, John, M.D. . . . . . . . . . . . . . . . . .Royal Liverpool University

Nephew, Kenneth, Ph.D. . . . . . . . . . . . . . . . . . .Indiana University-Purdue University at Indianapolis

Newbold, Susan K., R.N. . . . . . . . . . . . . . . . . . .University of Maryland

Newcomer, Marcia E., Ph.D. . . . . . . . . . . . . . . .Louisiana State University A&M College

Niaura, Raymond S., M.D., Ph.D. . . . . . . . . . . .Miriam Hospital

Nicholas, Barbara L., R.N. . . . . . . . . . . . . . . . . .Baptist Hospital East

Nichols, Craig R., M.D. . . . . . . . . . . . . . . . . . . .Oregon Health and Science University

Nicholson, Henry Stacy, M.D. . . . . . . . . . . . . . .Oregon Health and Science University

Nickoloff, Brian J., M.D., Ph.D. . . . . . . . . . . . . .Loyola University of Chicago

Nicosia, Santo V., M.D. . . . . . . . . . . . . . . . . . . .University of South Florida

Nilan, Michael S. . . . . . . . . . . . . . . . . . . . . . . . .Syracuse University

Appendix C-3: Consultants Serving on SEPs
NCI/DEA Annual Report 2003

104

Niles, Richard M., Ph.D. . . . . . . . . . . . . . . . . . .Marshall University

Ning, Ruola, Ph.D. . . . . . . . . . . . . . . . . . . . . . .University of Rochester

Nitiss, John L., Ph.D. . . . . . . . . . . . . . . . . . . . .St. Jude Children’s Research Hospital

Noring, Lois E., R.N. . . . . . . . . . . . . . . . . . . . . .American Cancer Society

Norman, Sandra A., Ph.D. . . . . . . . . . . . . . . . . .University of Pennsylvania

Normolle, Daniel P., Ph.D. . . . . . . . . . . . . . . . . .University of Michigan

North, William G., Ph.D. . . . . . . . . . . . . . . . . . .Dartmouth College

Nowak, Norma J., Ph.D. . . . . . . . . . . . . . . . . . .Roswell Park Cancer Institute Corporation

O O’Brien, Charles A., Ph.D. . . . . . . . . . . . . . . . . .University of Arkansas Medical Sciences at Little Rock

Obuchowski, Nancy, Ph.D. . . . . . . . . . . . . . . . . .Cleveland Clinic Lerner College

Okunieff, Paul, M.D., Ph.D. . . . . . . . . . . . . . . . .University of Rochester

Olivares, Jose A., Ph.D. . . . . . . . . . . . . . . . . . . .Los Alamos Scientific Laboratory

Olive, Peggy L., Ph.D. . . . . . . . . . . . . . . . . . . . .British Columbia Cancer Research Centre

Oliver, M. Norman, M.D. . . . . . . . . . . . . . . . . . .University of Virginia at Charlottesville

Olsen, Nancy J., M.D. . . . . . . . . . . . . . . . . . . . .Vanderbilt University

Olshan, Andrew F., Ph.D. . . . . . . . . . . . . . . . . . .University of North Carolina at Chapel Hill

Olson, Sara H., M.D., Ph.D. . . . . . . . . . . . . . . .Memorial Sloan-Kettering Cancer Center

Omel, James Lloyd, M.D. . . . . . . . . . . . . . . . . . .Advocate

Omenn, Gilbert S., M.D., Ph.D. . . . . . . . . . . . . .University of Michigan

Omiecinski, Curtis J., Ph.D. . . . . . . . . . . . . . . . .Pennsylvania State University at University Park

Onaral, Banu, Ph.D. . . . . . . . . . . . . . . . . . . . . .Drexel University

Ondrey, Frank G., M.D., Ph.D. . . . . . . . . . . . . . .University of Minnesota at Twin Cities

Opperman, Lynne A., Ph.D. . . . . . . . . . . . . . . . .Texas A&M Baylor College of Dentistry

Oraevsky, Alexander A., Ph.D. . . . . . . . . . . . . . .Fairway Medical Technologies, Inc.

Orlowski, Robert Z., M.D., Ph.D. . . . . . . . . . . . .University of North Carolina at Chapel Hill

Orthner, Helmuth F., Ph.D. . . . . . . . . . . . . . . . . .University of Alabama at Birmingham

Osley, Mary A., Ph.D. . . . . . . . . . . . . . . . . . . . .Memorial Sloan-Kettering Cancer Center

Ossowski, Liliana, Ph.D. . . . . . . . . . . . . . . . . . .Mount Sinai School of Medicine of New York University

Ota, David M., M.D. . . . . . . . . . . . . . . . . . . . .University of Missouri, Ellis Fischel Cancer Center

Otterson, Gregory A., M.D. . . . . . . . . . . . . . . . .Ohio State University

Ou, Jing-Hsiung J., Ph.D. . . . . . . . . . . . . . . . . .University California at Los Angeles

P Pallavicini, Maria G., Ph.D. . . . . . . . . . . . . . . . .University of California at San Francisco

Pamer, Eric G., M.D. . . . . . . . . . . . . . . . . . . . . .Memorial Sloan-Kettering Cancer Center

Pan, Dongfeng, Ph.D. . . . . . . . . . . . . . . . . . . . .University of Virginia at Charlottesville

Pan, Yingtian, Ph.D. . . . . . . . . . . . . . . . . . . . . .State University of New York at Stony Brook

Paquette, Ronald L., M.D. . . . . . . . . . . . . . . . . .University California at Los Angeles

Pardo, Francisco S., M.D., Ph.D. . . . . . . . . . . . .New York Medical College

Parent, Richard A., Ph.D. . . . . . . . . . . . . . . . . .Consultox, Ltd.

Parquette, Jonathan R., Ph.D. . . . . . . . . . . . . . .Ohio State University

Parrish, Alan R., Ph.D. . . . . . . . . . . . . . . . . . . .Texas A&M University

Pasick, Rena J., M.D., Ph.D. . . . . . . . . . . . . . . .University of California at San Francisco

Paskett, Electra D., M.D., Ph.D. . . . . . . . . . . . .Ohio State University

Pasqualini, Renata R., Ph.D. . . . . . . . . . . . . . . . .University of Texas M.D. Anderson Cancer Center

Patchell, Roy A., M.D., Ph.D. . . . . . . . . . . . . . .University of Kentucky

Patel, Dhavalkumar D., M.D., Ph.D. . . . . . . . . . .University of North Carolina at Chapel Hill

Patriotis, Christos F., Ph.D. . . . . . . . . . . . . . . . .Fox Chase Cancer Center

Appendix C-3: Consultants Serving on SEPs
NCI/DEA Annual Report 2003

105

Patt, Bradley E., Ph.D. . . . . . . . . . . . . . . . . . . . .Photon Imaging, Inc.

Patterson, Ruth E., Ph.D. . . . . . . . . . . . . . . . . . .Fred Hutchinson Cancer Research Center

Paulsen, Keith D., Ph.D. . . . . . . . . . . . . . . . . . . .Dartmouth College

Pearse, Roger N., M.D., Ph.D. . . . . . . . . . . . . . .Cornell University Medical College

Peehl, Donna M., Ph.D. . . . . . . . . . . . . . . . . . . .Stanford University

Pelus, Louis M., Ph.D. . . . . . . . . . . . . . . . . . . . .Indiana-Perdue University

Penedo, Frank J., Ph.D. . . . . . . . . . . . . . . . . . . .University of Miami at Coral Gables

Pereira, Michael A., Ph.D. . . . . . . . . . . . . . . . . .Medical College of Ohio at Toledo

Perkel, Sara J., M.B.A. . . . . . . . . . . . . . . . . . . . .National Comprehensive Cancer Network

Perkins, Kenneth A., Ph.D. . . . . . . . . . . . . . . . . .Society for Research on Nicotine/Tobacco

Petereit, Daniel G., M.D. . . . . . . . . . . . . . . . . . .Cancer Care Institute

Petersen, Gloria M., Ph.D. . . . . . . . . . . . . . . . . .Mayo Clinic, Rochester

Peterson, Leif E., Ph.D. . . . . . . . . . . . . . . . . . . .Baylor College of Medicine

Petrick, Nicholas, Ph.D. . . . . . . . . . . . . . . . . . . .Food and Drug Administration

Petrucelli, Nancie, M.S. . . . . . . . . . . . . . . . . . . .Karmanos Cancer Institute

Petsko, Gregory A., Ph.D. . . . . . . . . . . . . . . . . .Brandeis University

Pettitt, B. Montgomery, Ph.D. . . . . . . . . . . . . . .University of Houston

Pfefer, Josh, Ph.D. . . . . . . . . . . . . . . . . . . . . . .Food and Drug Administration

Philips, Billy U., Ph.D. . . . . . . . . . . . . . . . . . . . .University of Texas Medical Branch at Galveston

Piazza, Gary A., Ph.D. . . . . . . . . . . . . . . . . . . .Southern Research Institute

Piccirillo, Jay F., M.D. . . . . . . . . . . . . . . . . . . . .Washington University

Pienta, Kenneth J., M.D. . . . . . . . . . . . . . . . . . .University of Michigan at Ann Arbor

Pieper, Rembert, Ph.D. . . . . . . . . . . . . . . . . . . . .Large Scale Biology Corporation

Piepmeier, Joseph M., M.D. . . . . . . . . . . . . . . . .Yale University School of Medicine

Pinkas, Jan, Ph.D. . . . . . . . . . . . . . . . . . . . . . . .Genzyme Corporation

Pinto, Harlan A., M.D., Ph.D. . . . . . . . . . . . . . .Stanford University Medical Center

Piwnica-Worms, David R., M.D., Ph.D. . . . . . . . .Washington University

Plymate, Stephen R., M.D. . . . . . . . . . . . . . . . . .University of Washington

Pogribny, Igor P., Ph.D. . . . . . . . . . . . . . . . . . . .Food and Drug Administration

Pogue, Brian W., Ph.D. . . . . . . . . . . . . . . . . . . .Dartmouth College

Poland, Alan P., M.D., Ph.D. . . . . . . . . . . . . . . .University of Wisconsin at Madison

Pollenz, Richard S., Ph.D. . . . . . . . . . . . . . . . . .University of South Florida

Pollock, Brad H., Ph.D. . . . . . . . . . . . . . . . . . . .National Childhood Cancer Foundation

Pomper, Martin G., M.D., Ph.D. . . . . . . . . . . . . .The Johns Hopkins University

Portenoy, Russell K., M.D. . . . . . . . . . . . . . . . . .Beth Israel Medical Center

Porter, David L., M.D. . . . . . . . . . . . . . . . . . . . .University of Pennsylvania

Powe, Barbara D., Ph.D. . . . . . . . . . . . . . . . . . .American Cancer Society

Powell, Steven M., M.D. . . . . . . . . . . . . . . . . . .University of Virginia

Prokhorov, Alexander V., M.D., Ph.D. . . . . . . . . .University of Texas M.D. Anderson Cancer Center

Pumiglia, Kevin M., Ph.D. . . . . . . . . . . . . . . . . .Albany Medical College

Q Qian, Jianzhong, Ph.D. . . . . . . . . . . . . . . . . . . .Edda Technology, Inc.

Qian, Wei, Ph.D. . . . . . . . . . . . . . . . . . . . . . . .University of South Florida

Quaranta, Vito, M.D. . . . . . . . . . . . . . . . . . . . .Vanderbilt University

R Rabinowitz, Daniel, Ph.D. . . . . . . . . . . . . . . . . .Columbia University at New York

Rader, Jeanne I., Ph.D. . . . . . . . . . . . . . . . . . . .Food and Drug Administration

Raghavan, Derek, M.D., Ph.D. . . . . . . . . . . . . .University of Southern California, Norris Comprehensive Cancer Center

Appendix C-3: Consultants Serving on SEPs
NCI/DEA Annual Report 2003

106

Rai, Shesh, Ph.D. . . . . . . . . . . . . . . . . . . . . . . .St. Jude Children’s Research Hospital

Rajagopalan, Raghavan, Ph.D. . . . . . . . . . . . . . .Bioflexis, LLC.

Ramos, Catalina, M.D. . . . . . . . . . . . . . . . . . . .National Y-Me Breast Cancer Organization

Ramsey, Scott D., M.D., Ph.D. . . . . . . . . . . . . . .Fred Hutchinson Cancer Research Center

Rao, Chintalapally V., Ph.D. . . . . . . . . . . . . . . . .American Health Foundation

Raubitschek, Andrew A., M.D., Ph.D. . . . . . . . . .Beckman Research Institute of City of Hope

Rawl, Susan M., Ph.D. . . . . . . . . . . . . . . . . . . . .Indiana University

Read, George S., Ph.D. . . . . . . . . . . . . . . . . . . .University of Missouri at Kansas City

Reader, Steven, Ph.D. . . . . . . . . . . . . . . . . . . . .University of South Florida

Reber, Howard A., M.D. . . . . . . . . . . . . . . . . . .University of California at Los Angeles

Recht, Lawrence D., M.D., Ph.D. . . . . . . . . . . . .University of Massachusetts Medical School at Worcester

Recklitis, Christopher J., Ph.D. . . . . . . . . . . . . . .Dana-Farber Cancer Institute

Redd, William H., Ph.D. . . . . . . . . . . . . . . . . . . .Mount Sinai School of Medicine of New York University

Reddi, A. Hari, Ph.D. . . . . . . . . . . . . . . . . . . . .The Johns Hopkins University

Redston, Mark, M.D. . . . . . . . . . . . . . . . . . . . .Brigham and Women’s Hospital, Harvard Medical School

Reed, Gregory A., Ph.D. . . . . . . . . . . . . . . . . . .University of Kansas Medical Center

Reese-Coulbourne, Jane . . . . . . . . . . . . . . . . . . .RC Consulting

Reichert, David E., Ph.D. . . . . . . . . . . . . . . . . .Washington University

Reitz, Marvin S., Ph.D. . . . . . . . . . . . . . . . . . . .University of Maryland

Rhodus, Nelson L., M.P.H., M.S. . . . . . . . . . . . . .University of Minnesota at Twin Cities

Rice, Michael J., B.S. . . . . . . . . . . . . . . . . . . . . .Advocate

Rice, Ronald E., Ph.D. . . . . . . . . . . . . . . . . . . . .Rutgers University

Riddell, Stanely R., M.D. . . . . . . . . . . . . . . . . . . .Fred Hutchinson Cancer Research Center

Rimer, Barbara K., D.P.H. . . . . . . . . . . . . . . . . . .University of North Carolina at Chapel Hill

Rindfleisch, Thomas C., Ph.D. . . . . . . . . . . . . . . .Skolar, Inc.

Rinker-Schaeffer, Carrie W., M.D., Ph.D. . . . . . . .University of Chicago

Risch, Harvey A., M.D., Ph.D. . . . . . . . . . . . . . .Yale University

Risendal, Betsy C., Ph.D. . . . . . . . . . . . . . . . . . .University of Colorado Health Sciences Center

Ritenbaugh, Cheryl K., Ph.D. . . . . . . . . . . . . . . .Kaiser Foundation Research Institute

Ritz, Jerome, M.D. . . . . . . . . . . . . . . . . . . . . . .Dana-Farber Cancer Institute

Roberson, Noma L., Ph.D. . . . . . . . . . . . . . . . . .Roberson Consulting International

Roberson, Paula K., Ph.D. . . . . . . . . . . . . . . . . .Arkansas Cancer Research Center

Roberts, John D., M.D. . . . . . . . . . . . . . . . . . . .Virginia Commonwealth University/Medical College of Virginia

Roberts-Gray, Cynthia R., Ph.D. . . . . . . . . . . . . .Resource Network

Robertson, Erle S., Ph.D. . . . . . . . . . . . . . . . . . .University of Pennsylvania

Robinson, Dan, Ph.D. . . . . . . . . . . . . . . . . . . . .University of California at Davis

Robinson, Daniel R., Ph.D. . . . . . . . . . . . . . . . . .University of California at Davis

Robinson, Leslie A., Ph.D. . . . . . . . . . . . . . . . . .University of Tennessee

Roden, Richard B., Ph.D. . . . . . . . . . . . . . . . . . .The Johns Hopkins University

Rodgers, William H., M.D., Ph.D. . . . . . . . . . . . .University of Alabama at Birmingham

Rodin, Miriam B., M.D., Ph.D. . . . . . . . . . . . . . .University of Chicago Cancer Research Center

Rodriguez, Ronald, M.D., Ph.D. . . . . . . . . . . . . .The Johns Hopkins University

Rodriquez-Bigas, Miguel, M.D. . . . . . . . . . . . . . .University of Texas M.D. Anderson Cancer Center

Roemer, Peter B., Ph.D. . . . . . . . . . . . . . . . . . . .Oni, Inc.

Roetzheim, Richard G., M.D. . . . . . . . . . . . . . . .University of South Florida

Rogers, Adrianne E., M.D. . . . . . . . . . . . . . . . . .Boston University Medical Campus

Rogers, Everett M., Ph.D. . . . . . . . . . . . . . . . . . .University of New Mexico

Rogler, Charles E., Ph.D. . . . . . . . . . . . . . . . . . .Yeshiva University

Appendix C-3: Consultants Serving on SEPs
NCI/DEA Annual Report 2003

107

Rollins, Andrew M., Ph.D. . . . . . . . . . . . . . . . . .Case Western Reserve University

Romkes, Marjorie, Ph.D. . . . . . . . . . . . . . . . . . .University of Pittsburgh

Rosenberg, Carol L., M.D. . . . . . . . . . . . . . . . . .Boston University Medical Campus

Rosenberg, Michael, Ph.D. . . . . . . . . . . . . . . . . .Biogen, Inc.

Rosenberg, Naomi E., Ph.D. . . . . . . . . . . . . . . . .Tufts University 

Rosenblatt, David S., M.D. . . . . . . . . . . . . . . . . .McGill University Hospital Centre

Rosenman, Julian G., M.D., Ph.D. . . . . . . . . . . .University of North Carolina

Ross, Jeffrey S., M.D. . . . . . . . . . . . . . . . . . . . .Albany Medical College of Union University

Ross, Mark M., Ph.D. . . . . . . . . . . . . . . . . . . . .Argonex, Inc.

Roth, Jack A., M.D. . . . . . . . . . . . . . . . . . . . . .University of Texas

Rothman, Douglas L., Ph.D. . . . . . . . . . . . . . . . .Yale University

Roti Roti, Joseph L., Ph.D. . . . . . . . . . . . . . . . . .Washington University School of Medicine

Royak-Schaler, Renee, Ph.D. . . . . . . . . . . . . . . . .Institute for Cancer Prevention

Roychoudhuri, Chandrasekhar, Ph.D. . . . . . . . . . .University of Connecticut at Storrs

Ruccione, Kathy, R.N. . . . . . . . . . . . . . . . . . . . . .Children’s Hospital, Los Angeles

Ruffin, Mack T., M.D. . . . . . . . . . . . . . . . . . . . .University of Michigan at Ann Arbor

Rundell, M. Kathleen, Ph.D. . . . . . . . . . . . . . . . .Northwestern University

Runowicz, Carolyn D., M.D. . . . . . . . . . . . . . . .University of Connecticut Health Center

Rush, Laura J., D.V.M., Ph.D. . . . . . . . . . . . . . .Ohio State University

Rutner, Herman, M.S. . . . . . . . . . . . . . . . . . . . .Immunicon Corporation

Ryan, James C., M.D. . . . . . . . . . . . . . . . . . . . .Northern California Institute Research and Education

S Said, Jonathan W., M.D., Ph.D. . . . . . . . . . . . . .University of California at Los Angeles

Saigal, Christopher, M.D. . . . . . . . . . . . . . . . . . .University of California at Los Angeles

Saleh, Mansoor N., M.D. . . . . . . . . . . . . . . . . . .University of Alabama at Birmingham

Saltz, Frances M., BOTH . . . . . . . . . . . . . . . . . . .Cancer Hope Network

Sandersc, Jean E., M.D. . . . . . . . . . . . . . . . . . . .University of Washington School of Medicine

Sartell, Karen, M.A. . . . . . . . . . . . . . . . . . . . . . .University of Chicago

Sartor, Oliver, M.D. . . . . . . . . . . . . . . . . . . . . . .Louisiana State University Health Science Center at New Orleans

Satariano, William A., Ph.D. . . . . . . . . . . . . . . . .University of California at Berkeley

Sauerteig, Antoineta, B.A. . . . . . . . . . . . . . . . . . .University of Miami

Savary, Priscilla A., B.A. . . . . . . . . . . . . . . . . . . .Colorectal Cancer Network

Sawaya, Raymond E., M.D. . . . . . . . . . . . . . . . .University of Texas M.D. Anderson Cancer Center

Scardino, Peter T., M.D. . . . . . . . . . . . . . . . . . . .Memorial Sloan-Kettering Cancer Center

Schaffer, James David, Ph.D. . . . . . . . . . . . . . . .Phillips Research

Scheinberg, David A., M.D., Ph.D. . . . . . . . . . . .Memorial Sloan-Kettering Cancer Center

Schellhase, Kenneth G., M.D. . . . . . . . . . . . . . . .Medical College of Wisconsin

Schiemann, William P., Ph.D. . . . . . . . . . . . . . . .National Jewish Medical and Research Center

Schlegel, Richard R., M.D., Ph.D. . . . . . . . . . . . .Georgetown University

Schnitzer, Jan E., M.D. . . . . . . . . . . . . . . . . . . .Sidney Kimmel Cancer Center

Schnoll, Robert A., Ph.D. . . . . . . . . . . . . . . . . . .Fox Chase Cancer Center

Schoenberg, Mark P., M.D. . . . . . . . . . . . . . . . .The Johns Hopkins University

Schwartz, Ann G., Ph.D. . . . . . . . . . . . . . . . . . .Wayne State University

Schwartz, Anna L., Ph.D. . . . . . . . . . . . . . . . . . .University of Washington

Schwartz, David H., M.D., Ph.D. . . . . . . . . . . . .The Johns Hopkins University

Schwartz, Gary G., M.D., Ph.D. . . . . . . . . . . . . .Wake Forest University Health Sciences

Schwartz, Gary K., M.D. . . . . . . . . . . . . . . . . . .Memorial Sloan-Kettering Cancer Center

Schwartz, Joel L., DOTH . . . . . . . . . . . . . . . . . . .Institute for Cancer Prevention

Appendix C-3: Consultants Serving on SEPs
NCI/DEA Annual Report 2003

108

Schwartz, Marc D., Ph.D. . . . . . . . . . . . . . . . . .Lombardi Cancer Center

Schwartz, Stuart, M.D., Ph.D. . . . . . . . . . . . . . .University of Medicine and Dentistry of New Jersey

Scott, Charles B., Ph.D. . . . . . . . . . . . . . . . . . . .American College of Radiology

Scully, Sean P., M.D., Ph.D. . . . . . . . . . . . . . . . .Mayo Clinic, Rochester

Selhub, Jacob, Ph.D. . . . . . . . . . . . . . . . . . . . . .Tufts University

Sellers, Thomas A., M.D., Ph.D. . . . . . . . . . . . . .Mayo Clinic, Rochester

Semenov, Serguei Y., Ph.D. . . . . . . . . . . . . . . . . .Carolinas Medical Center

Serody, Jonathan S., M.D., Ph.D. . . . . . . . . . . . .University of North Carolina at Chapel Hill

Shabot, Michael M., M.D. . . . . . . . . . . . . . . . . .Cedars-Sinai Medical Center

Shahidi, Mahnaz, M.D., Ph.D. . . . . . . . . . . . . . .University of Illinois

Shannon, Jackilen, Ph.D. . . . . . . . . . . . . . . . . . .Oregon Health and Science University

Shapiro, Charles L., M.D. . . . . . . . . . . . . . . . . .Ohio State University

Sharlow, Elizabeth R., Ph.D. . . . . . . . . . . . . . . . .Prolx Pharmaceuticals Corporation

Sharp, John G., Ph.D. . . . . . . . . . . . . . . . . . . . .University of Nebraska

Shibata, Darryl K., M.D., Ph.D. . . . . . . . . . . . . .University of Southern California

Shiff, Steven J., M.D. . . . . . . . . . . . . . . . . . . . .University of Medicine and Dentistry of New Jersey

Shively, John E., Ph.D. . . . . . . . . . . . . . . . . . . . .City of Hope National Medical Center

Shore, Roy E., Ph.D. . . . . . . . . . . . . . . . . . . . . .New York University School of Medicine

Showe, Louise C., Ph.D. . . . . . . . . . . . . . . . . . .Wistar Institute

Shrieve, Dennis C., M.D., Ph.D. . . . . . . . . . . . . .University of Utah

Shultz, Terry D., Ph.D. . . . . . . . . . . . . . . . . . . .Washington State University

Shyr, Yu, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . .Vanderbilt University Medical School

Siegfried, Jill M., Ph.D. . . . . . . . . . . . . . . . . . . .University of Pittsburgh

Signorielli, Nancy, Ph.D. . . . . . . . . . . . . . . . . . . .University of Delaware

Sikic, Branimir I., M.D., Ph.D. . . . . . . . . . . . . . .Stanford University

Silver, Richard T., M.D. . . . . . . . . . . . . . . . . . . .Cornell University Medical Center

Silver, Robert B., Ph.D. . . . . . . . . . . . . . . . . . . .Marine Biological Laboratory

Simon, Tom . . . . . . . . . . . . . . . . . . . . . . . . . . . .Caring Ambassadors Program

Simoneau, Anne R., M.D. . . . . . . . . . . . . . . . . .University of California at Irvine

Simons, Jonathan W., M.D. . . . . . . . . . . . . . . . .Emory University

Simpson, Pippa M., Ph.D. . . . . . . . . . . . . . . . . .University of Arkansas

Singh, Gurmit, Ph.D. . . . . . . . . . . . . . . . . . . . .McMaster University

Singh, Manbir, Ph.D. . . . . . . . . . . . . . . . . . . . .University of Southern California

Sinko, Patrick J., Ph.D. . . . . . . . . . . . . . . . . . . .Rutgers University

Sison, Cristina P., Ph.D. . . . . . . . . . . . . . . . . . . .North Shore-Long Island Jewish Research Institute

Sixbey, John W., M.D. . . . . . . . . . . . . . . . . . . . .Louisiana State University Health Science Center of New Orleans

Skinner, Celette S., Ph.D. . . . . . . . . . . . . . . . . . .Duke University

Sklar, Charles A., M.D. . . . . . . . . . . . . . . . . . . .Memorial Sloan-Kettering Cancer Center

Slaga, Thomas J., Ph.D. . . . . . . . . . . . . . . . . . .University of Texas M.D. Anderson Cancer Center

Slater, Michael D., Ph.D. . . . . . . . . . . . . . . . . . .Colorado State University

Sliva, Daniel, Ph.D. . . . . . . . . . . . . . . . . . . . . . .Clarian Health Partners

Smirniotopoulos, James G., M.D. . . . . . . . . . . . .Uniformed Services University

Smit, Ellen, Ph.D. . . . . . . . . . . . . . . . . . . . . . . .State University of New York at Buffalo

Smith, Darrell N., M.D. . . . . . . . . . . . . . . . . . . .Brigham and Women’s Hospital

Smith, David I., Ph.D. . . . . . . . . . . . . . . . . . . . .Mayo Clinic, Rochester

Smith, Eva D., Ph.D. . . . . . . . . . . . . . . . . . . . . .University of Illinois at Chicago

Smith, Gary J., Ph.D. . . . . . . . . . . . . . . . . . . . . .University of North Carolina at Chapel Hill

Appendix C-3: Consultants Serving on SEPs
NCI/DEA Annual Report 2003

109

Smith, Theresa J., Ph.D. . . . . . . . . . . . . . . . . . . .University of South Carolina at Columbia

Smolen, Paul D., Ph.D. . . . . . . . . . . . . . . . . . . .University of Texas

Snedeker, Suzanne M., Ph.D. . . . . . . . . . . . . . . .Cornell University

So, Peter T., Ph.D. . . . . . . . . . . . . . . . . . . . . . . .Massachusetts Institute of Technology

Solomon, Alan, M.D. . . . . . . . . . . . . . . . . . . . . .University of Tennessee

Sondak, Vernon K., M.D. . . . . . . . . . . . . . . . . . .University of Michigan

Sorger, Peter K., Ph.D. . . . . . . . . . . . . . . . . . . . .Massachusetts Institute of Technology

Sotomayor, Eduardo M., M.D. . . . . . . . . . . . . . .University of South Florida

Spencer, David M., Ph.D. . . . . . . . . . . . . . . . . . .Baylor College of Medicine

Sporn, Michael B., M.D. . . . . . . . . . . . . . . . . . .Dartmouth College

Spriggs, David R., M.D. . . . . . . . . . . . . . . . . . .Memorial Sloan-Kettering Cancer Center

Srour, Edward F., Ph.D. . . . . . . . . . . . . . . . . . . .Indiana University

Stadler, Walter M., M.D. . . . . . . . . . . . . . . . . . .University of Chicago

Stahl, Douglas, Ph.D. . . . . . . . . . . . . . . . . . . . .City of Hope National Medical Center

Staib, Lawrence H., Ph.D. . . . . . . . . . . . . . . . . .Yale University

Stamnes, Knut, Ph.D. . . . . . . . . . . . . . . . . . . . .Stevens Institute of Technology

Stanbridge, Eric J., Ph.D. . . . . . . . . . . . . . . . . .University of California

Stashenko, Philip P., Ph.D. . . . . . . . . . . . . . . . . .Forsyth Institute

Stavri, P. Zoe, Ph.D. . . . . . . . . . . . . . . . . . . . . .Oregon Health and Science University

Stein, Gary S., Ph.D. . . . . . . . . . . . . . . . . . . . . .University of Massachusetts Medical School

Steinherz, Laurel, M.D. . . . . . . . . . . . . . . . . . . .Memorial Sloan-Kettering Cancer Center

Stemmermann, Grant N., M.D. . . . . . . . . . . . . . .University of Cincinnati

Sternick, Edward S., Ph.D. . . . . . . . . . . . . . . . . .Tufts-New England Medical Center

Stevens, Richard G., Ph.D. . . . . . . . . . . . . . . . . .University of Connecticut School of Medicine and Dentistry

Stevens, Victoria L., Ph.D. . . . . . . . . . . . . . . . . .Emory University

Stewart, Carleton C., Ph.D. . . . . . . . . . . . . . . . .Roswell Park Cancer Institute Corporation

Stewart, Clinton F., DOTH. . . . . . . . . . . . . . . . . .St. Jude Children’s Research Hospital

Stewart, Keith A., M.D. . . . . . . . . . . . . . . . . . . .University of Toronto

Stick, Roberta S., DOTH. . . . . . . . . . . . . . . . . . .Leukemia and Lymphoma Society

Stoner, Gary D., Ph.D. . . . . . . . . . . . . . . . . . . .Ohio State University

Stott, William, Ph.D. . . . . . . . . . . . . . . . . . . . . .Dow Chemical Company

Stotts, R. Craig, Ph.D. . . . . . . . . . . . . . . . . . . .University of Tennessee Health Science Center

Stover, Patrick J., Ph.D. . . . . . . . . . . . . . . . . . . .Federation of American Society for Experimental Biology

Strecher, Victor J., Ph.D. . . . . . . . . . . . . . . . . . .University of Michigan at Ann Arbor

Streeter, Oscar, M.D. . . . . . . . . . . . . . . . . . . . . .Norris Cancer Hospital

Streeter, Philip R., Ph.D. . . . . . . . . . . . . . . . . . .Oregon Health and Science University

Strom, Sara S., Ph.D. . . . . . . . . . . . . . . . . . . . .University of Texas M.D. Anderson Cancer Center

Studts, Jamie L., Ph.D. . . . . . . . . . . . . . . . . . . .University of Louisville

Stuhldreher, Wendy L., Ph.D. . . . . . . . . . . . . . . .Slippery Rock University

Su, Yan A., M.D., Ph.D. . . . . . . . . . . . . . . . . . .Georgetown University

Sukumar, Saraswati, Ph.D. . . . . . . . . . . . . . . . . .The Johns Hopkins University

Sumner, II, Walton, M.D. . . . . . . . . . . . . . . . . . .Barnes-Jewish Hospital

Sutphen, Rebecca , M.D. . . . . . . . . . . . . . . . . . .University of South Florida

Sutter, Thomas R., Ph.D. . . . . . . . . . . . . . . . . . .University of Memphis

Swaan, Peter W., Ph.D. . . . . . . . . . . . . . . . . . . .University of Maryland Baltimore School of Pharmacy

Swanson, Basil I., M.D., Ph.D. . . . . . . . . . . . . . .University of California-Los Alamos National Laboratory

Szabo, Csaba, M.D., Ph.D. . . . . . . . . . . . . . . . . .Inotek Pharmaceuticals Corporation

Appendix C-3: Consultants Serving on SEPs
NCI/DEA Annual Report 2003

110

T Talavera, Gregory A., M.D., Ph.D. . . . . . . . . . . .San Diego State University

Talcott, James A., M.D. . . . . . . . . . . . . . . . . . . .Massachusetts General Hospital

Tamura, Tsunenobu, M.D. . . . . . . . . . . . . . . . . .University of Alabama at Birmingham

Tan, Lee K., M.D. . . . . . . . . . . . . . . . . . . . . . . .Memorial Sloan-Kettering Cancer Center

Tang, Cha-Mei, Ph.D. . . . . . . . . . . . . . . . . . . . .Creatv Microtech, Inc.

Tatum, James L., M.D. . . . . . . . . . . . . . . . . . . .Virginia Commonwealth University

Taylor, Jeremy M., Ph.D. . . . . . . . . . . . . . . . . . .University California at Los Angeles

Taylor, Kathryn L., Ph.D. . . . . . . . . . . . . . . . . .Georgetown University

Telang, Nitin T., Ph.D. . . . . . . . . . . . . . . . . . . . .Strang Cancer Prevention Center

Templeton, Dennis J., M.D., Ph.D. . . . . . . . . . . .University of Virginia at Charlottesville

Tengs, Tammy O., Sc.D. . . . . . . . . . . . . . . . . . . .University of California at Irvine

Tercyak, Kenneth P., Ph.D. . . . . . . . . . . . . . . . . .Georgetown University

Terrian, David M., Ph.D. . . . . . . . . . . . . . . . . . .East Carolina University

Teruel, Mary N., Ph.D. . . . . . . . . . . . . . . . . . . .Stanford University

Tew, Kenneth D., Ph.D. . . . . . . . . . . . . . . . . . . .Fox Chase Cancer Center

Therneau, Terry M., Ph.D. . . . . . . . . . . . . . . . . .Mayo Clinic and Foundation

Thomas, Jerry A., M.S. . . . . . . . . . . . . . . . . . . .Uniformed Services University

Thomas, Judith M., Ph.D. . . . . . . . . . . . . . . . . .University of Alabama at Birmingham

Thomenius, Kai E., Ph.D. . . . . . . . . . . . . . . . . . .General Electric Co. Corporate Research and Development Center

Tockman, Melvyn S., M.D., Ph.D. . . . . . . . . . . . .University of South Florida

Toledano, Alicia Y., Sc.D. . . . . . . . . . . . . . . . . . .Brown University

Tomlinson, Gail E., M.D., Ph.D. . . . . . . . . . . . . .University of Texas Southwest Medical Center

Toole, Bryan P., Ph.D. . . . . . . . . . . . . . . . . . . . .Medical University of South Carolina

Tornos, Carmen, M.D. . . . . . . . . . . . . . . . . . . . .Memorial Sloan-Kettering Cancer Center

Torti, Frank M., M.D., Ph.D. . . . . . . . . . . . . . . .Wake Forest University Health Sciences

Tosteson, Tor D., Ph.D. . . . . . . . . . . . . . . . . . . .Dartmouth College

Trasler, Jacquetta M., M.D., Ph.D. . . . . . . . . . . .McGill University

Trimble, Cornelia L., M.D. . . . . . . . . . . . . . . . . .The Johns Hopkins University

Trinidad, Dennis R., Ph.D. . . . . . . . . . . . . . . . . .University of California at San Diego

True, Lawrence D., M.D. . . . . . . . . . . . . . . . . . .University of Washington

Truitt, Robert L., Ph.D. . . . . . . . . . . . . . . . . . . .Medical College of Wisconsin

Tsao, Ming-Sound S., M.D. . . . . . . . . . . . . . . . .Princess Margaret Hospital

Ts’O, Paul O., Ph.D. . . . . . . . . . . . . . . . . . . . . .Cell Works, Inc.

Tung, Ching-Hsuan, Ph.D. . . . . . . . . . . . . . . . . .Massachusetts General Hospital

Turkson, James K., Ph.D. . . . . . . . . . . . . . . . . . .H. Lee Moffitt Cancer Center and Research Institute

Turner, Larry W., B.S. . . . . . . . . . . . . . . . . . . . . .Emory University

Tycko, Benjamin, M.D., Ph.D. . . . . . . . . . . . . . .Institute for Cancer Genetics

U Unger, Elizabeth R., M.D., Ph.D. . . . . . . . . . . . .Centers for Disease Control and Prevention

Urnov, Fyodor D., Ph.D. . . . . . . . . . . . . . . . . . .Sangamo Biosciences, Inc.

Uthus, Eric O., Ph.D. . . . . . . . . . . . . . . . . . . . .USDA, Grand Forks 

V Valentino, Daniel J., Ph.D. . . . . . . . . . . . . . . . . .University California at Los Angeles

Valentovic, Monica A., Ph.D. . . . . . . . . . . . . . . .Marshall University School of Medicine

Van Aelst, Linda Van, Ph.D. . . . . . . . . . . . . . . . .Cold Spring Harbor Laboratory

Van Breemen, Richard B., Ph.D. . . . . . . . . . . . . .University of Illinois at Chicago

Van Etten, Richard A., M.D., Ph.D. . . . . . . . . . .Center for Blood Research, Inc.

Vannier, Michael W., M.D. . . . . . . . . . . . . . . . . .University of Iowa

Appendix C-3: Consultants Serving on SEPs
NCI/DEA Annual Report 2003

111

Varella-Garcia, Marileila, Ph.D. . . . . . . . . . . . . . .University of Colorado Health Sciences Center

Veltri, Robert W., Ph.D. . . . . . . . . . . . . . . . . . . .Urocor, Inc.

Verlee, Donald, Ph.D. . . . . . . . . . . . . . . . . . . . .Hospital Products Division

Verma, Ajit K., Ph.D. . . . . . . . . . . . . . . . . . . . . .University of Wisconsin at Madison

Vessella, Robert L., Ph.D. . . . . . . . . . . . . . . . . . .University of Washington

Vignali, Dario A., Ph.D. . . . . . . . . . . . . . . . . . . .St. Jude Children’s Research Hospital

Villalona, Miguel A., M.D. . . . . . . . . . . . . . . . . .Ohio State University

Villarreal, Roberto, M.D., Ph.D. . . . . . . . . . . . . .University of Texas Health Science Center at San Antonio

Visuri, Steven R., Ph.D. . . . . . . . . . . . . . . . . . . .University of California-Lawrence Livermore National Laboratory

Vitkin, Alex, Ph.D. . . . . . . . . . . . . . . . . . . . . . .Ontario Cancer Institute

Vo-Dinh, Tuan, Ph.D. . . . . . . . . . . . . . . . . . . . .UT-Battelle, LLC-Oak Ridge National Laboratory

Vogel, John S., Ph.D. . . . . . . . . . . . . . . . . . . . .University of California

Votaw, John R., Ph.D. . . . . . . . . . . . . . . . . . . . .Emory University

W Wagner, Henry, M.D. . . . . . . . . . . . . . . . . . . . . .University of South Florida

Wagner, Kay-Uwe, Ph.D. . . . . . . . . . . . . . . . . . .University of Nebraska Medical Center

Walczak, Irene M., M.A. . . . . . . . . . . . . . . . . . .Imagine Sensor Possibilities

Walker, Bailus, Ph.D. . . . . . . . . . . . . . . . . . . . . .Howard University

Waller, Edmund K., M.D., Ph.D. . . . . . . . . . . . . .Cerus Corporation

Walsh, Judith, M.D. . . . . . . . . . . . . . . . . . . . . .University of California at San Francisco

Wang, Lihong, Ph.D. . . . . . . . . . . . . . . . . . . . . .Texas Engineering Experiment Station

Wang, Yue J., Ph.D. . . . . . . . . . . . . . . . . . . . . .Virginia Polytechnic Institute and State University

Wang, Zhigang, Ph.D. . . . . . . . . . . . . . . . . . . . .University of Kentucky

Wang, Zhou, Ph.D. . . . . . . . . . . . . . . . . . . . . . .Northwestern University

Wangsness, Lori A. . . . . . . . . . . . . . . . . . . . . . .Mayo Foundation

Warburton, William K., Ph.D. . . . . . . . . . . . . . . .X-Ray Instrumentation Associates

Ward, John H., M.D. . . . . . . . . . . . . . . . . . . . . .University of Utah

Ward, Pamela, Ph.D. . . . . . . . . . . . . . . . . . . . . .University of California at Irvine

Wargovich, Michael J., Ph.D. . . . . . . . . . . . . . . .University of South Carolina at Columbia

Warren, Mary E., Ph.D. . . . . . . . . . . . . . . . . . . .Genpathway, Inc.

Washington, Mary K., M.D., Ph.D. . . . . . . . . . . .Vanderbilt University

Wasserman, Linda M., M.D., Ph.D. . . . . . . . . . . .University of California at San Diego

Watkins, Simon C., Ph.D. . . . . . . . . . . . . . . . . . .Essex Corporation

Wear, Keith A., Ph.D. . . . . . . . . . . . . . . . . . . . .Food and Drug Administration

Webb, Kevin, Ph.D. . . . . . . . . . . . . . . . . . . . . . .Massachusetts Institute of Technology

Weber, Jeffrey S., M.D., Ph.D. . . . . . . . . . . . . . .University of Southern California

Weber, Michael J., Ph.D. . . . . . . . . . . . . . . . . . .University of Illinois

Wei, Alexander, Ph.D. . . . . . . . . . . . . . . . . . . . .Purdue University at West Lafayette

Wei, Jeanne Y., M.D., Ph.D. . . . . . . . . . . . . . . . .University of Arkansas Medical School at Little Rock

Weichert, Jamey P., Ph.D. . . . . . . . . . . . . . . . . .University of Wisconsin

Weick, Martin P., Ph.D. . . . . . . . . . . . . . . . . . . .Baylor College of Medicine

Weier, Heinz-Ulrich G., Ph.D. . . . . . . . . . . . . . . .Lawrence Berkeley National Laboratory

Weinberg, Irving N., M.D., Ph.D. . . . . . . . . . . . .Naviscan Pet Systems, Inc.

Weinberger, Scot, Ph.D. . . . . . . . . . . . . . . . . . . .Ciphergen Biosystems, Inc.

Weiner, George J., M.D. . . . . . . . . . . . . . . . . . .University of Iowa

Weiner, Roy S., M.D. . . . . . . . . . . . . . . . . . . . .Tulane University Medical Center

Weiner, Susan L., Ph.D. . . . . . . . . . . . . . . . . . . .The Children’s Cause, Inc.

Weir, Gordon C., M.D. . . . . . . . . . . . . . . . . . . .Joslin Diabetes Center

Appendix C-3: Consultants Serving on SEPs
NCI/DEA Annual Report 2003

112

Weis, Marcia R., B.S. . . . . . . . . . . . . . . . . . . . . .Washington University

Weiss, Geoffrey R., M.D. . . . . . . . . . . . . . . . . . .University of Texas Health Science Center at San Antonio

Weissman, Bernard E., M.D., Ph.D. . . . . . . . . . .University of North Carolina

Weissman, Sherman M., M.D. . . . . . . . . . . . . . .Yale University

Welch, Gisele, Ph.D. . . . . . . . . . . . . . . . . . . . . .Georgia Institute of Technology

Welsh, Joellen E., Ph.D. . . . . . . . . . . . . . . . . . . .University of Notre Dame

Wender, Richard, M.D. . . . . . . . . . . . . . . . . . . . .Jefferson Medical College

Wenger, Neil S., M.D. . . . . . . . . . . . . . . . . . . . .University of California at Los Angeles

Weston, Allan, M.D. . . . . . . . . . . . . . . . . . . . . .Kansas Veteran’s Administration Medical Center

Westphall, Michael S., Ph.D. . . . . . . . . . . . . . . .University of Wisconsin at Madison

Wetzel, Arthur W., Ph.D. . . . . . . . . . . . . . . . . . .Pittsburgh Supercomputing Center

Wewers, Mary Ellen, Ph.D. . . . . . . . . . . . . . . . . .Ohio State University

White, Lisa L., Ph.D. . . . . . . . . . . . . . . . . . . . . .Rock Against Cancer

Whitten, Pamela S., Ph.D. . . . . . . . . . . . . . . . . .Michigan State University

Wieand, Samuel H., M.D., Ph.D. . . . . . . . . . . . .University of Pittsburgh

Wiernik, Peter H., M.D. . . . . . . . . . . . . . . . . . . .Our Lady of Mercy Medical Center

Wilding, George A., M.D. . . . . . . . . . . . . . . . . .University of Wisconsin at Madison

Willey, James C., M.D. . . . . . . . . . . . . . . . . . . .Medical College of Ohio at Toledo

Williams, Daniel B., Ph.D. . . . . . . . . . . . . . . . . .New Mexico Highlands University

Willson, Richard C., Ph.D. . . . . . . . . . . . . . . . . .University of Houston

Wilson, Brian C., Ph.D. . . . . . . . . . . . . . . . . . . .University of Toronto

Wilson, Thaddeus Andrew, Ph.D. . . . . . . . . . . . . .University of Tennessee Health Science Center

Wingard, John R., M.D. . . . . . . . . . . . . . . . . . . .University of Florida

Winn, Robert J., M.D. . . . . . . . . . . . . . . . . . . . .Thomas Jefferson University

Winzelberg, Andrew, Ph.D. . . . . . . . . . . . . . . . . .Stanford University

Wishnok, John S., Ph.D. . . . . . . . . . . . . . . . . . .Massachusetts Institute of Technology

Witherspoon, Yvonne, B.A. . . . . . . . . . . . . . . . . .Dana-Farber Cancer Institute

Wolf, Randi L., Ph.D. . . . . . . . . . . . . . . . . . . . .Columbia University Teachers College

Wong, Albert J., M.D. . . . . . . . . . . . . . . . . . . . .Thomas Jefferson University

Woo, Elizabeth S., Ph.D. . . . . . . . . . . . . . . . . . .Cellomics, Inc.

Wood, Marie E., M.D., Ph.D. . . . . . . . . . . . . . . .University of Vermont and State Agriculture College

Woodgett, James R., Ph.D. . . . . . . . . . . . . . . . .Ontario Cancer Institute

Woods, Virgil L., M.D. . . . . . . . . . . . . . . . . . . .University of California at San Diego

Wu, Joseph M., Ph.D. . . . . . . . . . . . . . . . . . . . .New York Medical College

Wu, Xifeng, M.D., Ph.D. . . . . . . . . . . . . . . . . . .University of Texas M.D. Anderson Cancer Center

Y Yaffe, Martin J., Ph.D. . . . . . . . . . . . . . . . . . . . .Sunnybrook and Women’s College Health Sciences Center

Yamamoto, Monica E., Ph.D. . . . . . . . . . . . . . . .University of Pittsburgh at Pittsburgh

Yan, Lin, Ph.D. . . . . . . . . . . . . . . . . . . . . . . . . .Protein Technologies International

Yancey, Antronette K., M.D., Ph.D. . . . . . . . . . .University of California at Los Angeles

Yandell, David W., M.D. . . . . . . . . . . . . . . . . . . .University of Vermont

Yang, Chung S., Ph.D. . . . . . . . . . . . . . . . . . . . .Rutgers The State University of New Jersey at New Brunswick

Yang, Raymond S., Ph.D. . . . . . . . . . . . . . . . . . .Colorado State University

Yannelli, John R., Ph.D. . . . . . . . . . . . . . . . . . . .University of Louisville

Yates, Jerome W., M.D., Ph.D. . . . . . . . . . . . . . .Roswell Park Cancer Institute

Yawn, Barbara P., M.D. . . . . . . . . . . . . . . . . . . .Olmsted Medical Group

Yee, Amy S., Ph.D. . . . . . . . . . . . . . . . . . . . . . .Tufts University at Boston

Yee, Douglas, M.D. . . . . . . . . . . . . . . . . . . . . . .University of Minnesota

Appendix C-3: Consultants Serving on SEPs
NCI/DEA Annual Report 2003

113

Yeung, Edward F., Ph.D. . . . . . . . . . . . . . . . . . . .Iowa State University

Yih, Tachung C., Ph.D. . . . . . . . . . . . . . . . . . . . .University of Texas at Arlington

Yu, Herbert H., M.D., Ph.D. . . . . . . . . . . . . . . . .Yale University

Yueh, Bevan, M.D. . . . . . . . . . . . . . . . . . . . . . .University of Washington

Z Zabriskie, Mark, Ph.D. . . . . . . . . . . . . . . . . . . . .Oregon State University

Zagzebski, James A., Ph.D. . . . . . . . . . . . . . . . .University of Wisconsin at Madison

Zahrbock, Cary, MOTH . . . . . . . . . . . . . . . . . . . .National Coalition/Cancer Survivorship

Zangar, Richard C., Ph.D. . . . . . . . . . . . . . . . . .Battelle Pacific Northwest Laboratories

Zavislan, James M., Ph.D. . . . . . . . . . . . . . . . . .Lucid Technologies, Inc.

Zebala, John A., M.D., Ph.D. . . . . . . . . . . . . . . .Syntrix Biosystems, Inc.

Zebrack, Brad J., Ph.D. . . . . . . . . . . . . . . . . . . .University of Southern California

Zemel, Richard S., Ph.D. . . . . . . . . . . . . . . . . . .University of Arizona

Zeng, Jianchao, Ph.D. . . . . . . . . . . . . . . . . . . . .Georgetown University

Zeng, Qing, Ph.D. . . . . . . . . . . . . . . . . . . . . . .Brigham and Women’s Hospital

Zhang, Xiao-Kun, Ph.D. . . . . . . . . . . . . . . . . . . .Burnham Institute

Zhang, Zuo-Feng, M.D., Ph.D. . . . . . . . . . . . . . .University of California at Los Angeles

Zhao, Yingming, Ph.D. . . . . . . . . . . . . . . . . . . .University of Texas

Zhou, Jin-Rong, Ph.D. . . . . . . . . . . . . . . . . . . . .Beth Israel Deaconess Medical Center

Zinn, Kurt R., Ph.D. . . . . . . . . . . . . . . . . . . . . .University of Alabama at Birmingham

Zuckerman, Kenneth S., M.D., Ph.D. . . . . . . . . .H. Lee Moffitt Cancer Center and Research Institute

Total Number of Reviewers: 1,274

Total Number of Times Reviewers Served: 1,659

Appendix C-3: Consultants Serving on SEPs
NCI/DEA Annual Report 2003

114
NCI/DEA Annual Report 2003

115

Appendix D: Activities of the National Cancer Advisory Board

Originally established as the National Advisory Cancer Council in 1937, the NCAB consists of 18

members who are appointed by the President and 12 nonvoting ex officio members. The NCAB

advises, assists, consults with, and makes recommendations to the Secretary, DHHS, and to the NCI

Director with respect to the activities carried out by and through the Institute and on policies pertaining to these activities. It is authorized to recommend support for grants and cooperative agreements,

following technical and scientific peer review. The Director of the DEA serves as Executive

Secretary of the NCAB. In fulfilling its role as the locus for second-level review of all peer-reviewed

applications involving requests for more than $50,000 in direct costs, the Board reviewed a total of

6,178 applications in FY2003.

The Board heard presentations, discussed, and provided advice on a variety of topics and NCI activities in FY2003, such as:

y Tumor Immunology and Immunotherapy Workshop Report

y NCI Tumor Immunology and Immunotherapy Strategic Initiatives

y NIH Reorganization Committee Report

y Update on NIH Loan Repayment Program

y Impact of HIPAA on Oncology Research

y P01 Process Review Report

y Current Issues in Tobacco Control

y NCI Training Commission

y Obesity—Cancer Risk and Prognosis

y Cancer Trends and Statistics Update

y NCAB Retreat Report and Future Directions

y Overview of Center to Reduce Cancer Health Disparities

y NCI/FDA Partnerships and the Use of Serum Proteomic Patterns for Cancer Detection

y Establishing the NCI Vocabulary and Bioinformatics Initiative

y Subcommittee on Planning and Budget: Bypass Budget Update

y Plans for Cancer Information Service

y Annual Delegations of Authority/New Business I

y P30/P50 Working Group Report

y American Association for Cancer Research Update

y Stomach and Esophageal Cancer Progress Review Group Report
NCI/DEA Annual Report 2003

116

y MERIT Awardee Presentation: Modulators of Prostate Cancer Metastasis

y NCI Director’s Report

y President’s Cancer Panel Report

y NIH Director’s Report

y Legislative Update

y Gene Expression Profiles Predict Survival of Lymphoma Patients After Chemotherapy

y Program Review of Division of Cancer Epidemiology and Genetics

y Program Review of Division of Cancer Prevention

y Transdivisional Research on Human Papilloma Virus (HPV): Definition and Intervention of a

Cancer-Causing Agent

As part of its mandate for oversight of NCI activities, the NCAB receives regular updates from the

NCI Director, the NCI Office of Legislation and Congressional Activities, the President’s Cancer

Panel, and the National Cancer Policy Board.

Another major role of the Board is to monitor the overall advisory and oversight activities of the NCI

as a whole. In that regard, it annually reviews the site visit outcomes of intramural review and the

extramural RFA and RFP concepts acted upon by the BSA. The NCAB also participates in the framing of the annual NCI Bypass Budget and considers the impact of actualized priorities as expressed

by the allocation of the annual operating budget.

The full text of recent NCAB meeting summaries is available on the NCI Web site at: http://

deaifo.nci.nih.gov/advisory/ncabminmenu.htm.

Appendix D: Activities of the NCAB
NCI/DEA Annual Report 2003

117

Appendix E: Activities of the Board of Scientific Advisors

The BSA provides scientific advice on a wide variety of matters concerning scientific program policy, progress, and future direction of NCI’s extramural research programs, and concept review of

extramural program initiatives.

In addition to approving a number of extramural program initiatives (see below), the BSA also heard

presentations on the following in FY2003:

• NCI Director’s Report

• Future Directions for NCI Imaging

• IOM/NCPB Report: Fulfilling the Potential of Cancer Prevention and Early Detection

• NCI/Congressional Relations

• NCI’s 2015 Challenge Goal: Enabling Technologies

• Cancer Genetics Network Progress Report

• Status Report: NCI Bypass Budget

• Prostate Cancer Prevention Trial (PCPT) Results

• Report of the Deputy Director, NCI

• BSA at National Meetings

• Translating Research Into Improved Outcomes (TRIO) Program Progress Report

• Cancer Regression in Patients Following Clonal Repopulation With Antitumor Lymphocytes

• Transdisciplinary Tobacco Use Research Centers Update: Development of New Methods for

Measuring the Impact of Scientific Initiatives

• Annual RFA Report

• Status Report: CTEP Concept Evaluation Panels

• Early Detection Research Network (EDRN) Progress Report

• Mouse Models of Human Cancers Consortium (MMHCC) Update

• NCAB P30/P50 Working Group Report—Advancing Translational Cancer Research: A Vision

of the Cancer Center and SPORE Programs of the Future

• Peer Review System for Program Project Grants

• Mini-Symposia: Transdisciplinary Tobacco Use Research Centers (TTURCs)

• Division of Cancer Control and Population Sciences: Program Status Reports 
NCI/DEA Annual Report 2003

118

RFA Concepts Approved

Office of the Director 

• Innovative Molecular Analysis Technologies (IMAT) Program

Division of Cancer Biology

• Integrative Cancer Biology Programs

Division of Cancer Control and Population Sciences

• Transdisciplinary Tobacco Use Research Centers (TTURCs)

• Long-Term Cancer Survivors: Research Initiatives

• Understanding Mechanisms of Physical Activity Behavior Change

Division of Cancer Treatment and Diagnosis

• National Cooperative Drug Discovery Groups (NCDDGs) for Cancer

• Academic Public-Private Partnership Program/Academic Public-Private Partnership Planning Grant

Cooperative Agreements Approved

Division of Cancer Treatment and Diagnosis

• Strategic Partnering To Evaluate Cancer Signature

• Small Animal Imaging Research Program (SAIRP)

• Pediatric Preclinical Testing Program

• Pediatric Brain Tumor Consortium 

Division of Cancer Control and Population Sciences

• Cancer Intervention and Surveillance Modeling Network (CISNET)

Division of Cancer Prevention

• Community Clinical Oncology Program (CCOP)/Minority-Based Clinical Oncology Program

(MBCCOP)

• Early Detection Research Network (EDRN)

The full text of recent BSA meeting summaries is available on the NCI Web site at: http://deainfo.

nci.nih.gov/advisory/bsaminmenu.htm.

Appendix E: Activities of the Board of Scientific Advisors
NCI/DEA Annual Report 2003

119

Appendix F: NCI Grant Guidelines and Descriptions

Below is a brief description of NIH grants, contracts, and extramural policy notices. Additional

information about these and other administrative supplements to research grants, guidelines, study

section rosters, and information on the Center for Scientific Review, NIH, may be obtained by contacting the Referral Office, Division of Research, or see the DEA Web page on Grants Guidelines

and Descriptions at http://deainfo.nci.nih.gov/flash/awards.htm.

C Series: Research Construction Programs

C06 Research Facilities Construction Grants

To provide matching Federal funds, up to 75 percent, for construction or major remodeling

to create new research facilities. In addition to basic research laboratories, this may include,

under certain circumstances, animal facilities and/or limited clinical facilities where they are

an integral part of an overall research effort.

F Series: Fellowship Programs

F31 Predoctoral Individual National Research Service Award (NRSA)

To provide predoctoral individuals with supervised research training in specified health and

health-related areas leading toward a research degree (e.g., Ph.D.).

F31 Predoctoral Fellowship—Minority Students

A fellowship award that provides predoctoral minority students with supervised research

training in specified health and health-related areas leading toward the research degree (e.g.,

Ph.D.).

F31 Predoctoral Fellowship—Students with Disabilities

A fellowship award that provides predoctoral students with disabilities with supervised

research training in specified health and health-related areas leading toward the research

degree (e.g., Ph.D.).

F32 National Research Service Award for Individual Postdoctoral Fellows

To provide postdoctoral research training to individuals to broaden their scientific background and extend their potential for research in specified health-related areas.

F33 National Research Service Award for Senior Fellows

To provide opportunities for experienced scientists to make major changes in the direction

of research careers, broaden scientific backgrounds, acquire new research capabilities,

enlarge command of an allied research field, or take time from regular professional responsibilities to increase capabilities to engage in health-related research.

K Series: Career Development Programs

K01 The Howard Temin Award

An NCI-specific variant of the NIH Mentored Research Scientist Development Award that

is designed to provide research scientists with an additional period of sponsored research

experience as a way to gain expertise in a research area new to the applicant or in an area

that would demonstrably enhance the applicant’s scientific career.
NCI/DEA Annual Report 2003

120

K01 Mentored Career Development Award for Underrepresented Minorities

To support scientists committed to research who are in need of both advanced research training and additional experience.

K05 Established Investigator Award in Cancer Prevention, Control, Behavioral, and Population

Research

To support scientists qualified to pursue independent research that would extend the research

program of the sponsoring institution, or to direct an essential part of this program.

K07 Cancer Prevention, Control, Behavioral, and Population Sciences Career Development Award

To support the postdoctoral career development of investigators who are committed to academic research careers in cancer prevention, control, behavioral, epidemiological, and/or the

population sciences. It supports up to 5 years of combined didactic and supervised (i.e.,

mentored) research experiences to acquire the methodological and theoretical research skills

needed to become an independent scientist. The very broad nature of the prevention, control, and population sciences makes it applicable to those individuals doctorally trained in

the basic sciences, medicine, behavioral sciences, and public health. The K07 award has

been expanded from a scope limited to “preventive oncology” to include the entire spectrum

of fields that are of vital importance to cancer prevention and control such as nutrition, epidemiology, and behavioral sciences.

K08 Mentored Clinical Scientists Development Award

To provide the opportunity for promising medical scientists with demonstrated aptitude to

develop into independent investigators, or for faculty members to pursue research in categorical areas applicable to the awarding unit, and to aid in filling the academic faculty gap

in specific shortage areas within U.S. health professions institutions.

K08 Mentored Clinical Scientists Development Award—Minorities in Clinical Oncology

A specialized type of Mentored Clinical Scientist Developmental Awards (K08s) that support the development of outstanding clinical research scientists, with this type being

reserved for qualified individuals from under-represented minority groups. Both types of

K08 awards support periods of specialized study for clinically trained professionals who are

committed to careers in research and who have the potential to develop into independent

investigators. The K08 awards for Minorities in Clinical Oncology are distinct and important because they provide opportunities for promising medical scientists with demonstrated

aptitudes who belong to under-represented minority groups to develop into independent

investigators, or for faculty members who belong to under-represented minority groups to

pursue research aspects of categorical areas applicable to the awarding unit(s), and aid in

filling the academic faculty gaps in these shortage areas within health professions institutions in the United States.

K12 Institutional Clinical Oncology Research Career Development Award

To support a newly trained clinician appointed by an institution for development of independent research skills and experience in a fundamental science within the framework of an

interdisciplinary research and development program.

K22 The NCI Transition Career Development Award for Underrepresented Minorities

To provide support to outstanding newly trained basic or clinical investigators to develop their

independent research skills through a two-phase program: an initial period involving an intramural appointment at the NIH and a final period of support at an extramural institution. The

Appendix F: NCI Grant Guidelines and Descriptions
NCI/DEA Annual Report 2003

121

award is intended to facilitate the establishment of a record of independent research by the

investigator to sustain or promote a successful research career.

K22 The NCI Scholars Program

To provide an opportunity for outstanding new investigators to begin their independent

research careers, first within the special environment of the National Cancer Institute and

then at an institution of their choice. Specifically, this Program provides necessary resources

to initiate an independent research program of 3 to 4 years at the NCI followed by an extramural funding mechanism (K22) to support their research program for 2 years at the extramural institution to which they are recruited.

K23 Mentored Patient-Oriented Research Career Development Award

To provide support for the career development of investigators who have made a commitment to focus their research endeavors on patient-oriented research. This mechanism provides support for a 3-year minimum up to 5-year period of supervised study and research for

clinically trained professionals who have the potential to develop into productive clinical

investigators.

K23 Mentored Patient-Oriented Research Career Development Award for Underrepresented

Minorities

To support the career development of investigators who have made a commitment to focus

their research on patient-oriented research. This mechanism provides support for a period of

supervised study and research for clinically trained professionals who have the potential to

develop into productive clinical investigators in patient-oriented research.

K24 Mid-Career Investigator Award in Patient-Oriented Research

To provide support for clinicians to allow them protected time to devote to patient-oriented

research and to act as mentors for beginning clinical investigators. The target candidates are

outstanding clinical scientists engaged in patient-oriented research who are within 15 years

of their specialty training, who can demonstrate the need for a period of intensive research

focus as a means of enhancing their clinical research careers, and who are committed to

mentoring the next generation of clinical investigators in patient-oriented research.

K25 Mentored Quantitative Research Career Development Award

This award allows an independent scientist in a highly technical field of research to identify an appropriate mentor with extensive experience in cancer research and to receive the

necessary training and career development required to become involved in multidisciplinary

cancer research.

P Series: Research Program Projects and Centers

P01 Research Program Projects

To support multidisciplinary or multifaceted research programs that have a focused theme.

Each component project should be directly related to and contribute to the common theme.

P20 Exploratory Grants

To support planning for new programs, expansion or modification of existing resources, and

feasibility studies to explore various approaches to the development of interdisciplinary programs that offer potential solutions to problems of special significance to the mission of the

NIH. These exploratory studies may lead to specialized or comprehensive centers.

Appendix F: NCI Grant Guidelines and Descriptions
NCI/DEA Annual Report 2003

122

P30 Center Core Grants

To support shared use of resources and facilities for categorical research by investigators

from different disciplines who provide a multidisciplinary approach to a joint research

effort, or by investigators from the same discipline who focus on a common research problem. The core grant is integrated with the Center’s component projects or Program Projects,

though funded independently from them. This support, by providing more accessible

resources, is expected to assure greater productivity than that provided through the separate

projects and Program Projects.

P50 Specialized Center Grants

To support any part of the full range of research and development from very basic to clinical; may involve ancillary supportive activities such as protracted patient care necessary to

the primary research or R&D effort. This spectrum of activities comprises a multidisciplinary attack on a specific disease or biomedical problem area. These grants differ from

Program Project grants in that they are usually developed in response to an announcement

of the programmatic needs of an Institute or Division, and subsequently receive continuous

attention from its staff. Centers also may serve as regional or national resources for special

research purposes.

R Series: Research Projects

R01 Research Project

Grants are awarded to institutions to allow a Principal Investigator to pursue a scientific

focus or objective in his or her area of interest and competence. Institutional sponsorship

assures the NIH that the institution will provide facilities necessary to conduct the research

and will be accountable for the grant funds. Applications are accepted for health-related

research and development in all areas within the scope of the NIH’s mission.

R03 Small Research Grants

Small grants provide research support, specifically limited in time and amount, for activities

such as pilot projects, testing of new techniques, or feasibility studies of innovative, highrisk research, which would provide a basis for more extended research.

R13 Conferences

The NIH provides funding for conferences to coordinate, exchange, and disseminate information related to its program interests. Generally, such awards are limited to participation

with other organizations in supporting conferences rather than provision of sole support.

Costs eligible for support include salaries, consultant services, equipment rental, travel, supplies, conference services, and publications. Prospective applicants are encouraged to

inquire in advance concerning possible interest on the part of an awarding Institute/Center

(IC), and to obtain more information on application procedures and costs.

R15 The NIH Academic Research Enhancement Awards (AREA)

To enhance the research environment of educational institutions that have not been traditional recipients of NIH research funds, this award provides limited funds to those institutions’

faculty members to develop new research projects or expand ongoing research activities in

health sciences and to encourage students to participate in the research activity. As funds are

anticipated to continue to be available each year, the NIH is now inviting applications for

AREA grants through a standing, ongoing Program Announcement.

Appendix F: NCI Grant Guidelines and Descriptions
NCI/DEA Annual Report 2003

123

R21 Exploratory/Developmental Grants

To encourage the development of new research activities in categorical program areas.

(Support generally is restricted in level of support and duration.)

R24 Resource-Related Research Projects

To support research projects that will enhance the capability of resources to serve bio-medical research.

R25E Cancer Education Grant Program (CEGP)

A flexible, curriculum-driven program aimed at developing and sustaining innovative educational approaches that ultimately will have an impact on reducing cancer incidence, mortality, and morbidity, as well as on improving the quality of life of cancer patients. The

CEGP accepts investigator-initiated grant applications that pursue a wide spectrum of objectives ranging from short courses; to the development of new curriculum in academic institutions; to national forums and seminar series; to hands-on workshop experiences for the

continuing education of health care professionals, biomedical researchers, and the lay community; to structured short-term research experiences designed to motivate high school, college, medical, dental, and other health professional students to pursue careers in cancer

research. Education grants can focus on education activities before, during, and after the

completion of a doctoral level degree, as long as they address a need that is not fulfilled adequately by any other grant mechanism available at the NIH, and are dedicated to areas of

particular concern to the National Cancer Program.

R25T Cancer Education and Career Development Program

To support development and/or implementation of a program related to a category in one or

more of the areas of education, information, training, technical assistance, coordination, or

evaluation.

R33 Exploratory/Developmental Grants, Phase II

To provide a second phase for support of innovative exploratory and developmental research

activities initiated under the R21 mechanism. Although only R21 awardees are generally eligible to apply for R33 support, specific program initiatives may establish eligibility criteria

under which applications could be accepted from applicants who demonstrate program competency equivalent to that expected under R33.

R37 Method to Extend Research in Time (MERIT) Award

To provide long-term grant support to investigators whose research competence and productivity are distinctly superior and who are highly likely to continue to perform in an outstanding manner. Investigators may not apply for a MERIT Award. Program staff and/or members of the cognizant National Advisory Council/Board will identify candidates for the

MERIT Award during the course of review of competing research grant applications prepared and submitted in accordance with regular PHS requirements.

Small Business Innovation Research (SBIR) and Small Business Technology Transfer

(STTR) Programs

The NIH welcomes grant applications from small businesses in any biomedical or behavioral research area as described in the solicitations below. Support under the SBIR program

is normally provided for 6 months/$100,000 for Phase I, and 2 years/$500,000 for Phase II.

However, applicants may propose longer periods of time and greater amounts of funds necessary for completion of the project.

Appendix F: NCI Grant Guidelines and Descriptions
NCI/DEA Annual Report 2003

124

R41 STTR Grants, Phase I

To support cooperative R&D projects between small business concerns and research institutions, limited in time and amount; to establish the technical merit and feasibility of ideas

that have potential for commercialization.

R42 STTR Grants, Phase II

To support in-depth development of cooperative R&D projects between small business concerns and research institutions, limited in time and amount, whose feasibility has been established in Phase I and that have potential for commercial products or services.

R43 SBIR Grants, Phase I

To support projects, limited in time and amount, to establish the technical merit and feasibility of R&D ideas that may ultimately lead to commercial products or services.

R44 SBIR Grants, Phase II

To support in-depth development of R&D ideas whose feasibility have been established in

Phase I that are likely to result in commercial products or services.

R55 James A. Shannon Director’s Awards; Guidelines

To provide a limited award to investigators to further develop, test, and refine research techniques; perform secondary analysis of available data sets; test the feasibility of innovative

and creative approaches; and conduct other discrete projects that can demonstrate their

research capabilities and lend additional weight to their already meritorious applications.

S Series: Research-Related Programs

S06 Minority Biomedical Research Support (MBRS)

To strengthen the biomedical research and research training capability of ethnic minority

institutions, and thus establish a more favorable milieu for increasing the involvement of

minority faculty and students in biomedical research.

S07 Biomedical Research Support Grants (NCRR BRSG)

As an example of this funding mechanism, the NIH issued a Request for Applications (RFA)

in FY2003 to provide short-term interim support for institutional activities that will strengthen oversight of human subjects research at institutions that receive significant NIH support

for clinical research. Although there is considerable flexibility in the types of activities that

could be supported under the BRSG program, this RFA emphasized the importance of

efforts to enhance the protection of research subjects by means that will be sustained by the

recipient institution after the award period ends. Awardees are also required to collaborate

with other institutions conducting human subjects research and are not currently funded

under this program, to share educational resources, computer technologies, best practices,

etc. Although all NIH components supporting clinical research (including the NCI) are providing support for this program, it will be administered by the National Center for Research

Resources (NCRR).

S10 Biomedical Research Support Shared Instrumentation Grants (NCRR SIG)

The National Center for Research Resources (NCRR) initiated its competitive Shared

Instrumentation Grant (SIG) Program in FY 1982. Shared Instrumentation Grants provide

support for expensive state-of-the-art instruments utilized in both basic and clinical research.

This program is designed to meet the special problems of acquisition and updating of expensive shared-use instruments that are not generally available through other NIH funding

Appendix F: NCI Grant Guidelines and Descriptions
NCI/DEA Annual Report 2003

125

mechanisms, such as the regular research project, program project, or center grant programs.

Applications for funds to design or to advance the design of new instruments are not accepted. The objective of the program is to make available to institutions with a high concentration of NIH-supported biomedical investigators expensive research instruments that can

only be justified on a shared-use basis and for which meritorious research projects are

described.

T Series: Training Programs

T15 Continuing Education Training Grants

To assist professional schools and other public and nonprofit institutions in the establishment, expansion, or improvement of programs of continuing professional education, especially for programs of extensive continuation, extension, or refresher education dealing with

new developments in the science and technology of the profession.

T32 NIH National Research Service Award—Institutional Research Training Grants

To enable institutions to make National Research Service Awards to individuals selected by

them for predoctoral and postdoctoral research training in specified shortage areas.

U Series: Cooperative Agreements

U01 Research Projects

To support a discrete, specified, circumscribed project to be performed by the named investigators in an area representing their specific interests and competencies.

U10 Cooperative Clinical Research—Cooperative Agreements

To support clinical evaluation of various methods of therapy and/or prevention in specific

disease areas. These represent cooperative programs between participating institutions and

Principal Investigators, and are usually conducted under established protocols.

U13 Conference—Cooperative Agreements

In order to coordinate, exchange, and disseminate information related to its program interests, an NIH Institute or Center can use this type of award to provide funding and direction

for appropriate scientific conferences. These cooperative agreements allow the NCI to partner with one or more outside organizations to support international, national, or regional

meetings, conferences, and workshops that are of value in promoting the goals of the

National Cancer Program.

U19 Research Program—Cooperative Agreements

To support a research program of multiple projects directed toward a specific major objective, basic theme, or program goal, requiring a broadly based, multidisciplinary, and often

long-term approach. 

U24 Resource-Related Research Projects—Cooperative Agreements 

To support research projects contributing to improvement of the capability of resources to

serve biomedical research.

Appendix F: NCI Grant Guidelines and Descriptions
NCI/DEA Annual Report 2003

126

U54 Specialized Center—Cooperative Agreements

To support any part of the full range of research and development from very basic to clinical;

may involve ancillary supportive activities such as protracted patient care necessary to the

primary research or R&D effort. The spectrum of activities comprises a multidisciplinary

attack on a specific disease entity or biomedical problem area. These differ from program

projects in that they are usually developed in response to an announcement of the programmatic needs of an Institute or Division and subsequently receive continual attention from its

staff. Centers may also serve as regional or national resources for special research purposes, with assistance from staff of the funding component in identifying appropriate priority

needs.

U56 Exploratory Grants—Cooperative Agreements

To support planning for new programs, expansion or modification of existing resources, and

feasibility studies to explore various approaches to the development of interdisciplinary programs that offer potential solutions to problems of special significance to the mission of the

NIH. These exploratory studies may lead to specialized or comprehensive centers. Substantial

Federal programmatic staff involvement is intended to assist investigators during performance

of the research activities, as defined in the terms and conditions of award.

Appendix F: NCI Grant Guidelines and Descriptions
NCI/DEA Annual Report 2003

127

Appendix G: Cancer Information Sources on the Internet

DEA Web Sites

The following Web sites are maintained by the DEA to provide detailed information to researchers

and the public about NCI funding opportunities and the Advisory Boards and groups supported by

the DEA.

http://deainfo.nci.nih.gov/index.htm

DEA home page. Links to the individual DEA Web pages listed below; mission of the

Division; contact information for DEA staff.

http://deainfo.nci.nih.gov/advisory/Boards.htm

Links to the home pages of NCI’s Advisory Boards.

http://deainfo.nci.nih.gov/advisory/pcp/pcp.htm

Charter of the President’s Cancer Panel; meeting agendas; meeting minutes; annual reports.

http://deainfo.nci.nih.gov/advisory/ncab.htm

Charter of the National Cancer Advisory Board; members of subcommittees; meeting agendas.

http://deainfo.nci.nih.gov/advisory/ncabminmenu.htm

Full text of NCAB meeting summaries.

http://deainfo.nci.nih.gov/advisory/bsa.htm

Charter of the Board of Scientific Advisors; members of subcommittees; meeting agendas.

http://deainfo.nci.nih.gov/advisory/bsaminmenu.htm

Full text of BSA meeting summaries.

http://deainfo.nci.nih.gov/advisory/bsa/bsa_program/bsaprgr.htm

Program Review Group reports.

http://deainfo.nci.nih.gov/advisory/bsc.htm

Charter of the Board of Scientific Counselors; members of subcommittees.

http://deainfo.nci.nih.gov/advisory/irg.htm

Charter of the Initial Review Group; members of subcommittees.

http://deainfo.nci.nih.gov/advisory/sep.htm

Charter of the Special Emphasis Panel; rosters of recent meetings.

http://deainfo.nci.nih.gov/advisory/joint.htm

Charter of the Advisory Committee to the Director; meeting schedules, agendas, and minutes; members of NCI Director’s Working Groups, Program Review Working Groups, and

Progress Working Groups.
NCI/DEA Annual Report 2003

128

http://deainfo.nci.nih.gov/advisory/pog/progress/index.htm

Function and organization of Progress Review Groups, PRG reports and meeting schedules;

members of PRGs.

http://deainfo.nci.nih.gov/advisory/dclg/dclg.htm

Charter of the NCI Director’s Consumer Liaison Group; meeting schedules, agendas, minutes, and meeting summaries.

http://deainfo.nci.nih.gov/funding.htm

Comprehensive information about funding for cancer research; lists of active PAs and RFAs;

and also recently cleared concepts; grant policies and guidelines; downloadable application

forms.

http://deainfo.nci.nih.gov/extra/pa/all_pa.htm

Active PAs, with links to detailed descriptions.

http://deainfo.nci.nih.gov/extra/rfa/index.htm

Active RFAs, with links to detailed descriptions.

http://deainfo.nci.nih.gov/grantspolicies/index.htm

Links to full-text NCI and NIH policies related to grants and grant review (e.g., Guidelines

on the Inclusion of Women and Minorities as Subjects in Clinical Research and Instructions

to Reviewers for Evaluating Research Involving Human Subjects in Grant and Cooperative

Agreement Applications).

http://deainfo.nci.nih.gov/flash/awards.htm

Grants Guidelines and Descriptions (descriptions of NCI funding mechanisms, with links to

PAs, RFAs, guidelines, and supplemental materials).

http://deais.nci.nih.gov/Query/QueryForm

NCI’s Funded Research Portfolio database contains information about research grant and

contract awards for the current and past five fiscal years. Searchable by text words contained

in project abstracts and by Special Interest Category (SIC) and anatomic site codes.

http://deainfo.nci.nih.gov/whatsnew/news.htm

Extramural events and updates.

NCI Web Sites

The National Cancer Institute maintains a number of Web sites containing information about

the Institute and its programs. All NCI Web sites, including those designed to provide cancer-related information to the general public and physicians, can be reached from the NCI

home page at http://cancer.gov/.

Appendix G: Cancer Information Sources on the Internet
NCI/DEA Annual Report 2003

129

Applications by Board

Activity Totals 

Mechanism Code by Activity Jan May Sep

Research Facilities Construction Grants C06 1 0 0 1

International Training Grants in Epidemiology (FIC) D43 26 0 0 26

Predoctoral Individual National Research Service Award F31 51 0 37 14

Postdoctoral Individual National Research Service Award F32 441 146 138 157

National Research Service Award for Senior Fellows F33 3 3 0 0

Research Scientist Development Award - 

Research and Training K01 108 30 48 30

Research Scientist Award K05 8 3 1 4

Academic/Teacher Award K07 73 27 27 19

Clinical Investigator Award K08 144 46 53 45

Physician Scientist Award (Program) K12 13 13 0 0

Career Transition Award K22 53 12 25 16

Mentored Patient-Oriented Research Development Award K23 60 19 27 14

Midcareer Investigator Award in Patient-Oriented Research K24 9 4 1 4

Mentored Quantitative Research Career Development K25 8 1 2 5

Loan Repayment Program for Clinical Researchers L30 3 0 0 3

Loan Repayment Program for Pediatric Researchers L40 5 0 0 5

Research Program Projects P01 141 46 48 47

Exploratory Grants P20 52 15 13 24

Center Core Grants P30 17 9 6 2

Animal (Mammalian and Nonmammalian) Model,

and Animal and Biological Material Resource Grants (NCRR) P40 1 1 0 0

Biotechnology Resource Grant Program P41 4 0 2 2

Specialized Center P50 88 11 61 16

Research Project R01 5,655 1,720 1,843 2,092

Small Research Grants R03 287 80 110 97

(Continued)

*Source: IMPACII. Includes NCI Primary and Secondary assigned applications and withdrawn applications. Excludes deleted applications. Of the 11,144 applications received during the year, 3,615 were not recommended for further consideration by the initial

review committee, and an additional 3,966 received scores in the bottom 33 percent and were not submitted for NCAB action.

Table 1. Applications Received for Referral by the NCI/DEA 

(by Mechanism), FY2003*
NCI/DEA Annual Report 2003

130

Applications by Board

Activity Totals 

Mechanism Code by Activity Jan May Sep

Conferences R13 150 53 45 52

Academic Research Enhancement Awards (AREA) R15 86 35 30 21

Research Demonstration and Dissemination Projects R18 1 0 0 1

Exploratory/Developmental Grants R21 1,532 374 452 706

Resource-Related Research Projects R24 1 1 0 0

Education Projects R25 90 30 33 27

Exploratory/Developmental Grants Phase II R33 83 34 33 16

Method to Extend Research in Time (MERIT) Award R37 25 12 3 10

Small Business Technology Transfer (STTR) Grants - Phase I R41 126 28 52 46

*Small Business Technology Transfer (STTR) Grants - Phase II R42 16 5 5 6

Small Business Innovation Research Grants (SBIR) - Phase I R43 1,218 353 457 408

Small Business Innovation Research Grants (SBIR) - Phase II R44 295 88 126 81

Minority Biomedical Research Support (MBRS) S06 7 2 5 0

Biomedical Research Support Grants (NCRR) S07 23 0 0 23

Continuing Education Training Program T15 7 7 0 0

Institutional National Research Service Award T32 64 27 22 15

Institutional National Research Service Award 

with Involvement of NIH Intramural Faculty TU2 2 0 0 2

Research Project (Cooperative Agreements) U01 58 9 5 44

Cooperative Clinical Research (Cooperative Agreements) U10 54 36 2 16

Conference (Cooperative Agreements) U13 2 2 0 0

Research Program (Cooperative Agreements) U19 1 0 0 1

Resource-Related Research Project (Cooperative Agreements) U24 1 0 1 0

Specialized Center (Cooperative Agreements) U54 33 16 0 17

Exploratory Grants - Cooperative Agreement (NCI) U56 18 10 0 8

Overall Totals 11,144 3,308 3,713 4,123

*Source: IMPACII. Includes NCI Primary and Secondary assigned applications and withdrawn applications. Excludes deleted applications. Of the 11144 applications received during the year, 3615 were not recommended for further consideration by initial review

committee, and an additional 3966 received scores in the bottom 33 percent and were not submitted for NCAB action.

Table 1. Applications Received for Referral by the NCI/DEA 

(by Mechanism), FY2003* (Continued)
NCI/DEA Annual Report 2003

131

Applications by Board

Activity Totals 

Mechanism Code by Activity Jan May Sep

Research Scientist Development Award - 

Research and Training K01 105 30 47 28

Research Scientist Award K05 8 3 1 4

Academic/Teacher Award K07 73 27 27 19

Clinical Investigator Award K08 114 38 34 42

Physician Scientist Award (Program) K12 13 13 0 0

Career Transition Award K22 53 12 25 16

Mentored Patient-Oriented Research Development Award K23 48 16 23 9

Midcareer Investigator Award in Patient-Oriented Research K24 9 4 1 4

Mentored Quantitative Research Career Development K25 7 1 2 4

Loan Repayment Program for Clinical Researchers L30 199 0 0 0

Loan Repayment Program for Pediatric Researchers L40 44 0 0 0

Research Program Projects P01 138 44 48 46

Exploratory Grants P20 49 15 10 24

Center Core Grants P30 11 3 6 2

Specialized Center P50 77 11 50 16

Research Project R01 211 108 62 41

Small Research Grants R03 276 77 107 92

Conferences R13 80 38 22 20

Exploratory/Developmental Grants R21 287 121 96 70

Education Projects R25 90 30 33 27

Exploratory/Developmental Grants - Phase II R33 66 30 23 13

Small Business Technology Transfer (STTR) Grants - Phase I R41 20 6 12 2

*Small Business Technology Transfer (STTR) Grants - Phase II R42 1 0 1 0

Small Business Innovation Research Grants (SBIR) - Phase I R43 152 58 61 33

Small Business Innovation Research Grants (SBIR) - Phase II R44 67 30 21 16

Continuing Education Training Program T15 1 1 0 0

(Continued)

*Source: IMPACII. Includes NCI Primary and Secondary assigned applications and withdrawn applications. Excludes deleted applications. Of the 2,164 applications reviewed during the year, 482 were not recommended for further consideration by the initial

review committee, and an additional 779 received scores in the bottom 33 percent and were not submitted for NCAB action.

Table 2. Applications Reviewed by the NCI/DEA (by Mechanism), FY2003*
NCI/DEA Annual Report 2003

132

Applications by Board

Activity Totals 

Mechanism Code by Activity Jan May Sep

Institutional National Research Service Award T32 64 27 22 15

Institutional National Research Service Award 

with Involvement of NIH Intramural Faculty TU2 2 0 0 2

Research Project (Cooperative Agreements) U01 36 9 5 22

Cooperative Clinical Research (Cooperative Agreements) U10 54 36 2 16

Resource-Related Research Project (Cooperative Agreements) U24 1 0 1 0

Specialized Center (Cooperative Agreements) U54 33 16 0 17

Exploratory Grants - Cooperative Agreement (NCI) U56 18 10 0 8

Overall Totals 2,164 814 742 608 

Total Costs

NCI IRG Types of Applications Number of Requested Requested

Subcommittee Reviewed Applications First Year All Years

A—Cancer Centers P20, P30 17 $56,150,261 $300,951,157 

C—Basic and Preclinical P01, R13 71 122,734,299 639,999,237 

D—Clinical Studies P01 36 76,680,688 389,701,989 

E—Cancer Epidemiology, 

Prevention and Control P01, R01, U01, U24 28 60,023,323 290,660,175 

F—Manpower and Training K01, K08, K22, K25, 

R25, T15, T32, TU2 274 46,129,074 241,014,234 

G—Education K01, K05, K07, K12, 

K22, K23, K24, R25 243 50,843,360 251,600,489 

H—Clinical Groups R01, U10 34 91,425,940 586,258,599

I—Career Development K08, K22 54 7,117,310 32,674,311

Grand Totals 757 $511,104,255 $2,732,860,191 

Table 3: Applications Reviewed by NCI IRG Subcommittees for NCAB

Meetings, FY2003

Table 2. Applications Reviewed by the NCI/DEA (by Mechanism), FY2003*

(Continued)
NCI/DEA Annual Report 2003

133

Jan 2003 May 2003 Sep 2003 Total for

Type of Application NCAB NCAB NCAB FY2003

New 12 15 12 39

New Amended 8 13 8 29

Recompeting 13 7 12 32

Recompeting Amended 8 10 13 31

Supplement 2 2 0 4

Totals 43 47 45 135

Table 4. Summary of Investigator-Initiated P01 Applications Reviewed 

for Each NCAB Meeting, FY2003

NCAB Number of SRG SEP Site Telephone Applicant

Meeting Applications Review Review Visit Conference Interview Committee

January 2003 43 39 4 25 15 3 0

May 2003 47 43 4 22 24 1 0

September 2003 45 41 4 26 18 1 0

Totals 135 123 12 73 57 5 0

Table 5. Summary of Review Formats for Unsolicited Program Project

Applications Reviewed, FY2003

Total Costs

Number of Requested Requested

Program Division Applications First Year All Years

Division of Cancer Biology (DCB) 48 $85,751,081 $445,823,279

Division of Cancer Control and 

Population Sciences (DCCPS) 8 20,489,351 100,332,903

Division of Cancer Prevention (DCP) 9 24,575,814 128,386,293

Division of Cancer Treatment and Diagnosis (DCTD) 70 151,754,858 784,342,782

Grand Totals 135 $282,571,104 $1,458,885,257

Table 6. Summary of Unsolicited P01 Applications Reviewed by NCI

Program Division, FY2003
NCI/DEA Annual Report 2003

134

Date of 

PAR Mechanism Title Division Publication

CA03-017 TU2 NCI Institutional Pre-Doctoral Research 

Training Partnership Award ODDES, CTB 10/10/2002

CA04-002 U01 Mouse Models of Human Cancers Consortium DCB 10/10/2002

TW03-006 R01, U01 Global Health Research Initiative Program

for New Foreign Investigators DCB 11/4/2002

ES03-001 U01 Breast Cancer and the Environment Research Centers DCCPS 11/11/2002

DK03-011 R01, R21 Hepatitis C: Natural History, Pathogenesis, 

Therapy and Prevention DCB 1/6/2003

OB03-001 R01 Pathway Linking Education To Health DCCPS 1/8/2003

OB03-004 R24 Mind-Body Interactions and Health: 

Research Infrastructure Program DCCPS 1/9/2003

OB03-005 R21 Mind-Body Interactions and Health: 

Exploratory/Developmental Research DCCPS 1/9/2003

OB03-003 R01 Maintenance of Long-Term Behavioral Change DCCPS 1/15/2003

CA04-001 U01 Consortium of Therapeutic Studies of 

Primary Central Nervous System DCTD 1/16/2003

CA04-003 R01, R03, R21 Long-Term Cancer Survivors: Research Initiatives DCCPS 4/7/2003

CA04-004 R01 Molecular Targets for Nutrients in Prostate DCP 4/24/2003

CA04-007 U10 Minority-Based Community Clinical Oncology Program DCP 5/16/2003

CA04-008 U10 Community Clinical Oncology Program DCP 5/19/2003

CA04-009 R01, R21 Mechanisms of Physical Activity Behavior Change DCCPS 6/23/2003

CA04-005 U56 Academic Public-Private Partnership Program (AP4) Planning Grant DCTD 7/30/2003

CA04-006 U01 The Early Detection Research Network: 

Biomarker Developmental Laboratories DCP 9/22/2003

Table 7. Requests for Applications (RFAs) Published by the NCI, FY2003
NCI/DEA Annual Report 2003

135

Date of 

PA Mechanism Title Division Publication

PA03-003 R21 Exploratory Studies in Cancer Detection,

Prognosis and Prediction DCTD 10/3/2002

PA03-020 R21 Molecular Targets for Cancer Drug Discovery:

Exploratory Grants DCTD 11/7/2002

PA03-021 R41, R42, Molecular Targets for Cancer Drug Discovery: 

R43, R44 SBIR/STTR DCTD 11/7/2002

PA03-024 R01 Molecular Epidemiology of HIV Associated Cancer DCCPS 11/7/2002

Table 8. Program Announcements (PAs) Published by the NCI, FY2003
NCI/DEA Annual Report 2003

136

Table 9. Program Announcements with Special Referral (PARs) Published

by the NCI, FY2003

Date of 

PAR Mechanism Title Division Publication

PAR03-002 K08 Mentored Clinical Scientist Award 

for Underrepresented Minorities ODDES, CMBB 10/3/2002

PAR03-005 R21 Quick Trials for Novel Cancer Therapies DCTD 10/7/2002

PAR03-006 K23 Mentored Patient-Oriented Research 

for Underrepresented Minorities ODDES, CMBB 10/7/2002

PAR03-009 R01 Improving Diet and Physical

Activity Assessment DCCPS 10/10/2002

PAR03-010 R03 Small Grants Program for 

Cancer Epidemiology DCCPS 10/16/2002

PAR03-013 R41, R42, Small Business Grants for Identifying 

R43, R44 Molecular Signatures of Cancer DCTD 10/22/2002

PAR03-016 K01 NCI Mentored Career Development 

Award for Underrepresented Minorities DCCPS 10/30/2002

PAR03-022 P20 Planning Grants for NCI Research Centers DDES 11/8/2002

PAR03-093 R25 Cancer Education Grant Program DCP 4/3/2003

PAR03-098 R21, R33 Phased Application Awards in 

Cancer Prognosis and Prediction DCTD 4/8/2003

PAR03-099 R41, R42, Cancer Prognosis and Prediction: 

R43, R44 SBIR/STTR Initiative DCTD 4/8/2003

PAR03-104 K01 The Howard Temin Award DCTD 4/15/2003

PAR03-124 R21, R33 Development of Novel Technologies 

for In Vivo Imaging DCTD 5/19/2003

PAR03-149 K05 Established Investigator Award in Cancer Prevention,

Control, Behavioral, and Population Sciences ODDES, CTB 7/8/2003

PAR03-148 R25 Cancer Education and Career 

Development Program ODDES, CTB 7/16/2003

PAR03-157 R21 Industry-Academic Partnerships for 

Development of Biomedical Imaging Systems DCTD 7/29/2003

PAR03-158 P50 Specialized Programs of Research Excellence (SPOREs) in Human Cancer for the Year 2003 ODDES, OSB 8/4/2003
NCI/DEA Annual Report 2003

137

Total Costs

Applications by NCAB Round

RFA Activity Requested Requested

Title of Initiative Initiative Number Codes Totals Jan May Sep First Year All Years

Cooperative Grants for Nutritional 

Modulation of Genetic Pathways 

Leading to Cancer 01 CA03-001 R01 1 1 0 0 $379,575 $1,899,575 

Cooperative Grants for Nutritional 

Modulation of Genetic Pathways 

Leading to Cancer 01 CA03-001 U54 14 14 0 0 25,381,945 132,277,848 

Network for Translational Research: 

Optical Imaging 02 CA03-002 U54 17 0 0 17 23,904,142 136,642,879 

Molecular Targets for Nutrients in 

Prostate Cancer Prevention 04 CA03-003 R01 60 60 0 0 20,327,722 97,287,571 

Chemoprevention of TobaccoRelated Cancers in Former 

Smokers: Preclinical Studies 05 CA03-004 R01 17 17 0 0 6,847,143 20,577,263 

Chemoprevention of TobaccoRelated Cancers in Former

Smokers: Preclinical Studies 05 CA03-004 R21 1 1 0 0 200,000 400,000 

Chemoprevention of Estrogen 

Receptor (ER) Negative Breast 

Cancer Preclinical Studies 04 CA03-005 R01 24 24 0 0 9,045,128 42,901,030 

Chemoprevention of TobaccoRelated Cancers in Former 

Smokers: Clinical Studies 05 CA03-006 U01 8 8 0 0 6,259,577 30,542,140 

Centers of Excellence in Cancer 

Communications Research 06 CA03-007 P50 16 0 16 0 35,951,183 181,334,443 

Cooperative Planning Grant for 

Comprehensive Minority Institution/

Cancer Center Partnership C2 CA03-008 U56 10 10 0 0 3,555,838 18,288,638 

Planning Grant for Minority Institution/

Cancer Center Collaboration C2 CA03-009 P20 14 14 0 0 2,310,003 6,808,835 

Comprehensive Minority Institution/

Cancer Center Partnership C2 CA03-010 U54 2 2 0 0 2,034,809 10,467,696 

Community Clinical Oncology Program C3 CA03-011 U10 16 16 0 0 12,820,584 62,770,992

Minority-Based Community Clinical 

Oncology Program C3 CA03-012 U10 4 4 0 0 1,993,104 8,068,625 

Molecular Interactions Between 

Tumor Cells and Bone C1 CA03-013 R01 54 0 54 0 17,279,075 82,426,536 

Molecular Interactions Between 

Tumor Cells and Bone C1 CA03-013 R21 44 0 44 0 6,473,851 12,756,874 

In Vivo Cellular and Molecular 

Imaging Centers (ICMICs) 02 CA03-015 P50 9 0 9 0 $17,922,379 $89,934,917 

(Continued)

Table 10. Requests for Applications (RFAs) Reviewed by the NCI/DEA,

FY2003

Bypass†

† The designation refers to a Bypass “opportunity” or “challenge” initiative as noted on p. 6.
NCI/DEA Annual Report 2003

138

Total Costs

Applications by NCAB Round

RFA Activity Requested Requested

Title of Initiative Initiative Number Codes Totals Jan May Sep First Year All Years

Diet, DNA Methylation and 

Other Epigenetic Events, 

and Cancer Prevention 03 CA03-016 R01 37 0 0 37 $13,189,817 53,570,671 

Diet, DNA Methylation and 

Other Epigenetic Events, 

and Cancer Prevention 03 CA03-016 R21 14 0 0 14 2,064,259 4,136,233 

Cooperative Planning Grant for 

Cancer Disparities Research 

Partnership Program C6 CA03-018 U56 8 0 0 8 6,450,611 26,570,465 

Exploratory/Developmental 

Grants: Overcoming Barriers 

to Early Phase Clinical Trials C3 CA03-501 R21 18 18 0 0 10,091,706 20,098,835 

Cooperative Trials in Diagnostic 

Imaging 02 CA03-502 U01 2 0 0 2 6,736,922 34,104,450 

Cooperative Breast Cancer Tissue 

Resource C2 CA03-503 U01 4 0 4 0 1,123,848 4,494,325 

Integrating Aging and Cancer 

Research in NCI Cancer Centers C2 CA03-504 P20 24 0 0 24 17,531,202 89,848,570 

Consortium of Therapeutic 

Studies of Primary Central 

Nervous System NA CA04-001 U01 19 0 0 19 5,396,107 27,783,899 

Totals 437 189 127 121 $255,270,530 $1,195,993,310

Table 10. Requests for Applications (RFAs) Reviewed by the NCI/DEA,

FY2003 (Continued)

Bypass†
NCI/DEA Annual Report 2003

139

Total Costs

Applications by NCAB Round

RFA Activity Requested Requested

Title of Initiative Number Codes Totals Jan May Sep First Year All Years

Mentored Patient-Oriented 

Research Career 

Development Award C8 PA00-004 K23 1 1 0 0 $113,400 $453,600

Small Grants Program for 

Cancer Epidemiology NA PA01-021 R03 46 15 31 0 3,282,510 6,470,262

Non-Mammalian Organisms 

as Models for Anticancer 

Drug Discovery NA PA01-042 R01 1 1 0 0 327,073 1,662,673

Flexible System to Advance 

Innovative Research (FLAIR) 04 PA01-091 R41 8 0 8 0 0 3,412,175

Flexible System to Advance 

Innovative Research (FLAIR) 04 PA01-091 R42 1 0 1 0 0 1,947,589

Flexible System to Advance 

Innovative Research (FLAIR) 04 PA01-091 R43 36 0 36 0 932,789 14,013,519 

Flexible System to Advance 

Innovative Research (FLAIR) 04 PA01-091 R44 12 0 12 0 4,567,395 23,718,839

Specialized Programs of Research 

Excellence (SPOREs) C2 PA01-110 P50 1 0 1 0 2,749,944 14,079,325 

Innovative Toxicology Models: 

SBIR/STTR NA PA02-075 R41 3 2 0 1 0 1,102,697 

Innovative Toxicology Models: 

SBIR/STTR NA PA02-075 R43 31 12 0 19 250,000 10,157,870 

Innovative Toxicology Models: 

SBIR/STTR NA PA02-075 R44 7 3 0 4 3,132,786 12,704,914 

Development of High-Yield 

Technologies for Isolating 

Exfoliated Cells in Body Fluids 04 PA02-086 R21 15 7 3 5 2,477,787 5,360,437 

Mentored Quantitative Research 

Career Development Award C8 PA02-127 K25 1 0 0 1 119,135 640,898 

Cancer Prevention Research 

Small Grant Program NA PAR00-025 R03 36 36 0 0 2,726,653 5,552,335 

Cancer Education Grant 

Program C6 PAR00-033 R25 3 2 1 0 699,452 4,343,682 

Institutional Clinical Oncology 

Research Career Development 

Program C8 PAR00-063 K12 2 2 0 0 914,787 4,717,842 

Cancer Education and Career 

Development Program C8 PAR00-064 R25 2 0 2 0 1,078,416 5,330,024 

The Howard Temin Award C8 PAR00-066 K01 1 0 1 0 94,213 711,396 

(Continued)

Table 11. PA/PAR Special Emphasis Panel (SEP) Applications Reviewed

by the NCI/DEA, FY2003

Bypass†

Initiative

† The designation refers to a Bypass “opportunity” or “challenge” initiative as noted on p. 6.
NCI/DEA Annual Report 2003

140

Total Costs

Applications by NCAB Round

RFA Activity Requested Requested

Title of Initiative Number Codes Totals Jan May Sep First Year All Years

Specialized Programs 

of Research Excellence 

(SPORE) C2 PAR00-087 P50 1 0 1 0 $2,646,111 $13,904,719 

Cancer Communication and 

Interactive Media Technology 06 PAR00-137 R44 1 0 1 0 149,689 149,689

Small Grant Program for 

Conference Support NA PAR00-141 R13 1 0 1 0 50,000 50,000 

Cancer Prognosis and Prediction: 

Phased Application Awards C4 PAR01-061 R21 24 16 8 0 3,581,475 43,517,162 

Cancer Prognosis and Prediction: 

Phased Application Awards C4 PAR01-061 R33 12 4 8 0 6,011,430 23,572,794 

Cancer Prognosis and Prediction: 

SBIR/STTR Initiative C4 PAR01-062 R41 2 1 1 0 0 273,677 

Cancer Prognosis and Prediction: 

SBIR/STTR Initiative C4 PAR01-062 R43 9 3 6 0 0 1,576,204 

Cancer Prognosis and Prediction:

SBIR/STTR Initiative C4 PAR01-062 R44 4 3 1 0 948,265 10,347,913 

Development of Novel Imaging

Technology (Phased Innov. Award) 02 PAR01-101 R21 26 25 1 0 4,936,019 35,990,009 

Development of Novel Imaging 

Technology (Phased Innov. Award) 02 PAR01-101 R33 11 11 0 0 5,844,761 17,185,284 

Development of Novel Imaging 

Technology (SBIR/STTR) Initiative 02 PAR01-102 R41 1 1 0 0 0 0 

Development of Novel Imaging 

Technology (SBIR/STTR) Initiative 02 PAR01-102 R43 27 27 0 0 179,250 9,134,801 

Development of Novel Imaging 

Technology (SBIR/STTR) Initiative 02 PAR01-102 R44 14 14 0 0 3,272,571 25,500,087 

Innovative Technology for 

Molecular Analysis: Phased 

Innovation Award 04 PAR01-104 R21 31 4 12 15 5,080,553 48,843,758 

Innovative Technology for 

Molecular Analysis: Phased 

Innovation Award 04 PAR01-104 R33 10 2 6 2 6,534,517 19,763,205 

Innovative Technology for 

Molecular Analysis: Phased 

Innovation Award 04 PAR01-104 R44 1 1 0 0 0 995,634 

Innovative Technology for 

Molecular Analysis: SBIR/STTR 04 PAR01-105 R41 2 0 2 0 0 357,437 

(Continued)

Table 11. PA/PAR Special Emphasis Panel (SEP) Applications Reviewed by

the NCI/DEA, FY2003 (Continued)

Bypass†

Initiative
NCI/DEA Annual Report 2003

141

Total Costs

Applications by NCAB Round

RFA Activity Requested Requested

Title of Initiative Number Codes Totals Jan May Sep First Year All Years

Innovative Technology for 

Molecular Analysis: SBIR/STTR 04 PAR01-105 R43 28 9 10 9 $306,040 $8,241,262 

Innovative Technology for 

Molecular Analysis: SBIR/STTR 04 PAR01-105 R44 17 4 4 9 5,524,992 22,196,498

Applications of Innovative 

Technologies: Phased 

Innovation Award 04 PAR01-106 R21 44 14 13 17 6,973,691 73,225,192 

Applications of Innovative 

Technologies: Phased 

Innovation Award 04 PAR01-106 R33 29 10 9 10 21,759,606 64,245,043 

Applications of Innovative 

Technologies: Phased 

Innovation Award 04 PAR01-106 R44 1 1 0 0 486,813 1,391,435 

Applications for Innovative 

Technologies: SBIR/STTR 04 PAR01-107 R41 2 1 1 0 159,756 368,880 

Applications for Innovative 

Technologies: SBIR/STTR 04 PAR01-107 R43 19 7 9 3 0 3,780,785 

Applications for Innovative 

Technologies: SBIR/STTR 04 PAR01-107 R44 6 1 2 3 1,491,952 9,567,719 

Specialized Programs of 

Research Excellence (SPOREs) 

in Human Cancer FY2002 C2 PAR01-110 P20 1 1 0 0 2,749,973 14,416,202 

Specialized Programs of 

Research Excellence (SPOREs) 

in Human Cancer FY2002 C2 PAR01-110 P50 21 11 9 1 55,138,275 291,765,718 

Small Grants Program for 

Behavioral Research in 

Cancer Control NA PAR02-037 R03 63 26 17 20 4,797,618 9,044,634 

Colorectal Cancer Screening 

in Primary Care Practice C3 PAR02-042 R21 48 21 12 15 7,709,093 14,982,497 

Specialized Programs of 

Research Excellence (SPORES) 

in Pancreatic Cancer for the 

Year 2002 C2 PAR02-068 P20 3 0 3 0 8,007,675 41,409,592 

Specialized Programs of 

Research Excellence (SPORES) 

in Pancreatic Cancer for the 

Year 2002 C2 PAR02-068 P50 11 0 11 0 31,388,154 166,804,619 

Innovative Toxicology Models 

for Drug Evaluation: Exploratory/

Developmental Grants and 

Phased Innovation Award NA PAR02-074 R21 14 10 0 4 2,123,053 4,413,339 

(Continued)

Table 11. PA/PAR Special Emphasis Panel (SEP) Applications Reviewed by

the NCI/DEA, FY2003 (Continued)

Bypass†

Initiative
NCI/DEA Annual Report 2003

142

Total Costs

Applications by NCAB Round

RFA Activity Requested Requested

Title of Initiative Number Codes Totals Jan May Sept First Year All Years

Innovative Toxicology Models for 

Drug Evaluation: Exploratory/

Developmental Grants and 

Phased Innovation Award NA PAR02-074 R33 3 2 0 1 $828,916 $3,150,388

Specialized Programs of Research 

Excellence (SPOREs) in Human 

Cancer for the Year 2003 C2 PAR02-126 P50 11 0 0 11 29,750,435 153,214,849 

Diet, DNA Methylation and 

Other Epigenetic Events, and 

Cancer Prevention: Competing 

Supplements NA PAR02-175 R01 1 0 0 1 450,000 1,350,000 

Small Grants Program for 

Research in Cancer Prevention NA PAR02-176 R03 92 0 58 34 6,789,921 13,498,476 

Small Grants Program for 

Cancer Epidemiology C4 PAR03-010 R03 38 0 1 37 2,864,640 5,512,878 

Planning Grants for NCI 

Research Centers C2 PAR03-022 P20 1 0 1 0 340,000 545,000 

Specialized Program of 

Research Excellence in 

Human Cancer (SPORE) C2 PAR99-167 P50 1 0 1 0 2,589,811 13,580,361 

Totals 838 311 305 222 $254,931,395 $1,284,247,817 

Table 11. PA/PAR Special Emphasis Panel (SEP) Applications Reviewed by

the NCI/DEA, FY2003 (Continued)

Bypass†

Initiative
NCI/DEA Annual Report 2003

143

Total Costs

Applications by NCAB Round

Activity Requested Requested 

Mechanism Codes Totals Jan May Sep First Year All Years

Conferences R13 78 38 20 20 $1,882,046 $4,067,087 

Research Project R01 1 0 1 0 0 0 

Specialized Center P50 6 0 2 4 15,001,931 81,883,685 

Small Research Grants R03 1 0 0 1 72,500 145,000 

Research Program Projects P01 14 5 4 5 43,525,697 227,171,080 

Clinical Investigator Award K08 1 0 1 0 151,200 756,000 

Exploratory/Developmental 

Grants R21 1 0 1 0 0 0 

Cooperative Clinical Research 

(Cooperative Agreements) U10 1 1 0 0 545,609 2,880,500 

Small Business Innovation 

Research Grants (SBIR) - Phase II R44 1 0 1 0 450,000 900,000 

Totals 104 44 30 30 $61,628,983 $317,803,352

Table 12. Non-RFA PA SEP Applications Reviewed by NCI/DEA, FY2003

FY1999 FY2000 FY2001 FY2002 FY2003 Percent Change

’99-’03

No. Cost No. Cost No. Cost No. Cost No. Cost No. Cost

R01

NCI 

Overall 2,796 $275,000 3,011 $295,000 3,234 $312,000 3,378 $324,000 3,573 $338,000 27.8% 22.9%

DCB 1,631 253,000 1,780 270,000 1,838 280,000 1,942 298,000 2,028 305,000 24.3 20.5

DCP 80 517,000 65 552,000 122 423,000 126 403,000 151 448,000 88.7 -13.3

DCTD 794 244,000 852 266,000 915 281,000 918 288,000 973 308,000 22.5 26.2

DCCPS 291 411,000 313 449,000 357 494,000 389 497,000 418 512,000 43.6 24.5

P01 

NCI 

Overall 169 1,477,000 179 1,599,000 178 1,692,000 173 1,836,000 178 1,891,000 5.3 28.0

DCB 68 1,236,000 66 1,343,000 61 1,451,000 63 1,571,000 70 1,651,000 2.9 33.6

DCP 7 1,890,000 8 2,076,000 11 1,776,000 13 1,931,000 12 2,014,000 71.4 6.6

DCTD 80 1,615,000 87 1,723,000 91 1,754,000 80 1,995,000 83 1,988,000 3.7 23.1

DCCPS 14 1,612,000 18 1,693,000 15 2,169,000 16 2,015,000 13 2,321,000 -7.1 44.0

Table 13. Average Total Cost and Number of Research Program Grant

Awards by Division, FY1999-FY2003
NCI/DEA Annual Report 2003

144

Dollars in Thousands % of NCI Total

Award Dollar Average Number Dollar Competing Competing Success 

Mechanism Count Cost Requested Awarded Rate

RPG R01 - Traditional 

Research Grants 3,573 1,207,388 338 53.55 39.62 3,543 948 26.8

P01 - Program Reports 178 336,607 1,891 2.67 11.04 115 42 36.5

R03 - Small Grants 203 15,207 75 3.04 0.50 252 107 42.5

R15 - Academic Research 

Enhancement Awards (AREA) 21 3,086 147 0.31 0.10 53 21 39.6

R21 - Exploratory/

Developmental Research 360 67,741 188 5.40 2.22 910 208 22.9

R33 - Phased Innovation 

Grant (Phase 2) 81 37,714 466 1.21 1.24 77 10 13.0

R29 - First Awards 17 1,584 113 0.21 0.05

R37 - Merit Awards 70 35,359 505 1.05 1.16 20 20 100.0

U19, U01 - Cooperative 

Agreements 27 31,127 1,153 0.40 1.02 6 5 83.3

R01 - Program Evaluation 58,721 0.00 1.93

Total for RPG POOL Group 4,527 1,794,534 4,876 67.85 58.88 4,976 1,361 27.4

P01, R01, R03, R21, R33, 

U01 - Request for Applications 81 26,697 330 1.21 0.88 231 39 16.9

U01, U19, U42 - Cooperative 

Agreements - RFA 171 146,645 858 2.56 4.81 42 21 50.0

TOTAL for RFA/

Cooperative Agreement 252 173,342 1,188 3.78 5.69 273 60 22.0

U43, U44, R43, R44 - Small 

Business Innovation Research 328 85,137 260 4.92 2.79 957 227 23.7

R41, R42-Small Business 

Technology Transfer 28 5,720 204 0.42 0.19 92 20 21.7

Total for SBIR/STTR 356 90,857 464 5.34 2.98 1,049 247 23.5

Total for RPG 5,135 2,058,733 6,528 76.96 67.55 6,298 1,668 26.5

CENTERS U54 - Specialized Center 

(Cooperative Agreements) 14 19,166 1,369 0.21 0.63 2 2 100.0

Comprehensive Core Grants 34 153,968 4,528 0.51 5.05 7 7 100.0

P20 - Exploratory Grants 43 10,588 246 0.64 0.35 25 0.0

P30, P40, P41, U42 -

Core Clinical 21 52,517 2,501 0.31 1.72 6 5 83.3

P20, P50 - Spores 53 123,107 2,323 0.79 4.04 56 18 32.1

(Continued)

Table 14. Summary of NCI Grant Awards (by Mechanism), FY2003 
NCI/DEA Annual Report 2003

145

Dollars in Thousands % of NCI Total

Award Dollar Average Number Dollar Competing Competing Success 

Mechanism Count Cost Requested Awarded Rate

P30 - Core Basic 6 15,669 2,612 0.09 0.51 1 1 100.0

Center for AIDS Research 3,064 0.00 0.10

Total for Centers 171 378,079 13,579 2.56 12.41 97 33 34.0

Other U56 - Exploratory Grants -

Research Cooperative Agreement (NCI) 26 11,559 445 0.39 0.38 18 12 66.7 (A)

U10 - Clinical Cooperative Groups 78 158,714 2,035 1.17 5.21 20 19 95.0

R09, U09 - Scientific Evaluation 1 8,085 8,085 0.01 0.27

S06 - Minority Biomedical 

Research Support 3,853 0.00 0.13

R24, U24 - Research/

Resource Grant 54 29,976 555 0.81 0.98 3 3 100.0

T15 - Training Conference Grants 4 340 85 0.06 0.01 2 1 50.0

Biomedical Research 

Support Grant 3,842 0.00 0.13

U13 - Conference 

(Cooperative Agreement) 12 0.00 0.00

D43,R13 - Conference Grants/

International Training Grants 

in Epidemiology 104 2,099 20 1.56 0.07 82 70 85.4

Total for Other Research (A) 267 218,480 11,225 4.00 7.17 125 105 84.0

Other R25 - Cancer Education 102 30,041 295 1.53 0.99 76 24 31.6

Research

(B) K01 - Temin Award K01 105 14,209 135 1.57 0.47 109 35 32.1

K05 - Established Investigator 

Award in Cancer Prevention 

and Control K05 12 1,462 122 0.18 0.05 5 2 40.0

K07 - Preventive 

Oncology Award K07 88 11,243 128 1.32 0.37 67 25 37.3

K08 - Mentored Clinical 

Scientist K08 141 18,512 131 2.11 0.61 101 31 30.7

K25 - Mentored Quantitative 

Research Career Development 

Award K25 2 273 137 0.03 0.01 3 1 33.3

K12, K14 - Mentored 

Career Award K12 15 8,391 559 0.22 0.28 14 5 35.7

K30 - Institutional 

Curriculum Award K30 1,599 0.00 0.05

(Continued)

Table 14. Summary of NCI Grant Awards (by Mechanism), FY2003 

(Continued)
NCI/DEA Annual Report 2003

146

Dollars in Thousands % of NCI Total

Award Dollar Average Number Dollar Competing Competing Success 

Mechanism Count Cost Requested Awarded Rate

K23 - Mentored Patient-Oriented 

Research Career Development 

Award K23 53 6,873 130 0.79 0.23 42 12 28.6

K24 - Mid-Career Investigator

in Patient-Oriented Research 

Award K24 38 4,406 116 0.57 0.14 6 1 16.7

K22 - Clinical Research 

Track K22 32 4,877 152 0.48 0.16 43 12 27.9

Total for Other Research (B)

—Careers 486 71,845 1,610 7.28 2.36 390 124 31.8

Total for Other Research

(A+B) 855 320,366 13,130 12.81 10.51 591 253 42.8

NRSA T32, T34, T35, T36 -

NRSA Institution 182 59,890 329 2.73 1.97 60 30 50.0

F30, F31, F32, F33, F34 -

NRSA Fellowships 138 5,960 43 2.07 0.20 285 72 25.3

Total for NRSA 320 65,850 372 4.80 2.16 345 102 29.6

Cancer Control

Total for Cancer Control 191 221,620 2,130 2.86 7.27 59 36 61.0

Contruction

C06 - Construction 3,000 0.00 0.10

Total NCI Grants 6,672 3,047,648 35,739 100.00 100.00 7,390 2,092 28.3

Table 14. Summary of NCI Grant Awards (by Mechanism), FY2003

(Continued)
NCI/DEA Annual Report 2003

147

Special Interest 2002 2003 Percent 2002 2003 Percent 2002 2003 Percent 

Category (SIC) Grants Grants Change Contracts Contracts Change Totals Totals Change

Adoptive Cell Immunotherapy 62,020,806 65,348,655 5.37 0 0 62,020,806 65,348,655 5.37

Adv. Manufacturing Technology 12,573,059 7,477,696 -40.53 1,698,837 2,364,215 39.17 14,271,896 9,841,911 -31.04

Aging 130,562,127 155,261,752 18.92 8,548,329 10,698,428 25.15 139,110,456 165,960,180 19.30

AIDS 54,639,185 110,670,266 102.55 6,315,417 8,400,382 33.01 60,954,602 119,070,648 95.34

Alternative Medicine, Direct 29,883,761 56,622,885 89.48 3,066,382 859,109 -71.98 32,950,143 57,481,994 74.45

Alternative Medicine, Indirect 28,408,151 28,480,937 0.26 1,277,445 1,566 -99.88 29,685,596 28,482,503 -4.05

Alzheimers Dementia 1,030,384 1,621,994 57.42 0 0 1,030,384 1,621,994 57.42

Arthritis 1,120,913 1,584,332 41.34 0 0 1,120,913 1,584,332 41.34

Asbestos 1,836,892 4,491,877 144.54 0 0 1,836,892 4,491,877 144.54

Ataxis Telangiectasia 7,916,376 6,834,383 -13.67 34,035 2,785 -91.82 7,950,411 6,837,168 -14.00

Autoimmune Diseases 7,067,274 8,686,585 22.91 23 0 -100.00 7,067,297 8,686,585 22.91

Behavior Research, Direct 205,410,803 234,536,774 14.18 4,198,913 6,575,016 56.59 209,609,716 241,111,790 15.03

Bioengineering 248,182,230 249,639,347 0.59 33,279,602 45,020,366 35.28 281,461,832 294,659,713 4.69

Biological Response Modifiers 662,169,054 693,802,345 4.78 39,296,508 47,628,016 21.20 701,465,562 741,430,361 5.70

Biomaterials Research 19,921,311 24,642,591 23.70 4,017,504 8,915,546 121.92 23,938,815 33,558,137 40.18

Birth Defects 8,353,572 8,859,294 6.05 15,035 0 -100.00 8,368,607 8,859,294 5.86

Bone Marrow Transplantation 65,937,038 62,342,401 -5.45 0 0 65,937,038 62,342,401 -5.45

Breast Cancer Detection 85,530,617 87,083,783 1.82 3,115,652 3,109,893 -0.18 88,646,269 90,193,676 1.75

Breast Cancer Education 15,775,726 16,892,672 7.08 539 25,166 4,569.02 15,776,265 16,917,838 7.24

Breast Cancer Epidemiology 64,790,564 68,313,342 5.44 2,996,210 982,938 -67.19 67,786,774 69,296,280 2.23

Breast Cancer Genetics 78,160,277 76,095,610 -2.64 730,266 564,142 -22.75 78,890,543 76,659,752 -2.83

Breast Cancer Prevention 27,877,909 32,648,918 17.11 2,801,617 2,011,223 -28.21 30,679,526 34,660,141 12.97

Breast Cancer Rehabilitation 12,268,949 13,111,191 6.86 25,707 0 -100.00 12,294,656 13,111,191 6.64

Breast Cancer Screening 27,483,358 27,099,723 -1.40 0 74,349 27,483,358 27,174,072 -1.13

Breast Cancer Treatment 139,311,736 145,047,262 4.12 6,481,948 6,749,515 4.13 145,793,684 151,796,777 4.12

Breast Cancer—Basic 124,002,636 140,617,772 13.40 476,244 697,101 46.37 124,478,880 141,314,873 13.53

Cancer Survivorship 121,248,170 155,516,370 28.26 2,402,478 4,012,075 67.00 123,650,648 159,528,445 29.02

Carcinogenesis, Environmental 489,132,687 519,568,630 6.22 30,671,225 15,414,427 -49.74 519,803,912 534,983,057 2.92

Cervical Cancer Education 1,988,194 449,332 -77.40 0 0 1,988,194 449,332 -77.40

Chemoprevention 108,460,873 139,276,608 28.41 29,238,960 31,939,659 9.24 137,699,833 171,216,267 24.34

Chemotherapy 385,496,067 418,100,555 8.46 20,080,145 22,543,090 12.27 405,576,212 440,643,645 8.65

Child Health 42,029,648 46,735,300 11.20 721,264 140,916 -80.46 42,750,912 46,876,216 9.65

Childhood Cancers 134,620,199 145,225,096 7.88 41,915 266,123 534.91 134,662,114 145,491,219 8.04

Clinical Trials, Diagnosis 58,080,246 76,113,941 31.05 33,127,604 54,197,359 63.60 91,207,850 130,311,300 42.87

Clinical Trials, Other 11,304,651 15,472,520 36.87 338,023 90,069 -73.35 11,642,674 15,562,589 33.67

Clinical Trials, Prevention 54,760,830 63,222,364 15.45 10,723,782 16,330,637 52.28 65,484,612 79,553,001 21.48

Clinical Trials, Therapy 376,474,443 394,745,137 4.85 7,440,726 16,942,091 127.69 383,915,169 411,687,228 7.23

Combined Treatment Modalities 242,999,243 233,282,835 -4.00 0 494,586 242,999,243 233,777,421 -3.80

Diabetes 7,215,043 7,548,368 4.62 160,380 0 -100.00 7,375,423 7,548,368 2.34

Diagnosis 457,525,593 495,151,906 8.22 45,212,195 68,869,978 52.33 502,737,788 564,021,884 12.19

Diagnostic Imaging 208,649,190 229,522,569 10.00 28,408,030 47,656,346 67.76 237,057,220 277,178,915 16.92

Diethylstilbestrol 799,254 20,335 -97.46 1,311,257 1,422,768 8.50 2,110,511 1,443,103 -31.62

(Continued)

* Some categories are not mutually exclusive, resulting in overlap in reported funding; dollar totals, therefore, exceed 100 percent of the extramural 

budget.

Table 15. NCI Special Interest Category (SIC) Dollars for FY2003— 

Percent Change from FY2002*
NCI/DEA Annual Report 2003

148

Special Interest 2002 2003 Percent 2002 2003 Percent 2002 2003 Percent 

Category (SIC) Grants Grants Change Contracts Contracts Change Totals Totals Change

Dioxin 1,203,176 1,086,371 -9.71 0 97,991 1,203,176 1,184,362 -1.56

DNA Repair 132,131,096 153,272,564 16.00 1,227,104 142,698 -88.37 133,358,200 153,415,262 15.04

Drug Development 372,377,063 411,687,594 10.56 32,510,368 36,193,414 11.33 404,887,431 447,881,008 10.62

Drug Resistance 91,532,583 106,222,127 16.05 149,743 151,379 1.09 91,682,326 106,373,506 16.02

Drugs—Natural Products 129,558,190 133,489,902 3.03 5,655,782 3,195,322 -43.50 135,213,972 136,685,224 1.09

Endocrinology 156,203,671 182,937,161 17.11 5,205,320 4,031,416 -22.55 161,408,991 186,968,577 15.84

Epidemiology—Biochemical 241,511,924 234,520,510 -2.89 10,454,574 10,820,716 3.50 251,966,498 245,341,226 -2.63

Gene Transfer Clinical 19,026,602 20,278,841 6.58 0 0 19,026,602 20,278,841 6.58

Helicobacter 2,155,965 4,242,773 96.79 0 0 2,155,965 4,242,773 96.79

Hematology 410,583,465 439,919,550 7.14 5,519,782 5,523,293 0.06 416,103,247 445,442,843 7.05

Hematopoietic Stem Cell Research 89,663,101 95,335,267 6.33 0 0 89,663,101 95,335,267 6.33

Hormone Replacement Rx 12,170,912 13,502,323 10.94 0 0 12,170,912 13,502,323 10.94

Hospice 1,554,969 5,429,050 249.14 0 0 1,554,969 5,429,050 249.14

Iatrogenesis 52,363,969 56,747,784 8.37 1,344,565 2,068,617 53.85 53,708,534 58,816,401 9.51

Infant Mortality 415,516 137,648 -66.87 0 0 415,516 137,648 -66.87

Information Dissemination 225,817,314 253,168,775 12.11 101,603,549 111,193,860 9.44 327,420,863 364,362,635 11.28

Interferon 32,284,204 33,908,831 5.03 0 0 32,284,204 33,908,831 5.03

Magnetic Resonance Imaging 66,882,447 78,768,024 17.77 727,054 4,283,466 489.15 67,609,501 83,051,490 22.84

Mammography 34,655,900 35,959,438 3.76 25,707 74,349 189.22 34,681,607 36,033,787 3.90

Metastasis 250,350,433 291,583,495 16.47 3,022,663 4,447,992 47.15 253,373,096 296,031,487 16.84

Mind/Body Research 11,405,866 16,186,181 41.91 0 0 11,405,866 16,186,181 41.91

Molecular Disease 1,158,808,792 1,254,249,336 8.24 11,969,047 7,810,872 -34.74 1,170,777,839 1,262,060,208 7.80

Neurofibromatosis 779,543 895,105 14.82 0 0 779,543 895,105 14.82

Neurofibromatosis, Related 4,941,020 4,401,999 -10.91 0 0 4,941,020 4,401,999 -10.91

Nursing Research 9,702,363 11,916,138 22.82 0 0 9,702,363 11,916,138 22.82

Nutrition 179,032,658 200,562,461 12.03 11,854,416 11,958,656 0.88 190,887,074 212,521,117 11.33

Nutrition Monitoring 38,850,410 36,098,086 -7.08 0 0 38,850,410 36,098,086 -7.08

Obesity 28,475,968 31,377,290 10.19 270 111,701 41,270.74 28,476,238 31,488,991 10.58

Occupational Cancer 12,992,732 13,542,319 4.23 861,012 1,664,027 93.26 13,853,744 15,206,346 9.76

Oncogenes 542,665,620 615,438,803 13.41 8,973,622 5,039,633 -43.84 551,639,242 620,478,436 12.48

Organ Transplant Research 75,564,744 72,356,860 -4.25 0 0 75,564,744 72,356,860 -4.25

Osteoporosis 1,372,960 1,168,234 -14.91 0 0 1,372,960 1,168,234 -14.91

P53 114,641,163 130,311,151 13.67 2,032,371 1,405,304 -30.85 116,673,534 131,716,455 12.89

Pain 9,302,205 14,411,836 54.93 0 0 9,302,205 14,411,836 54.93

Palliative Care 16,548,850 21,296,057 28.69 0 0 16,548,850 21,296,057 28.69

Pap Testing 13,578,109 14,509,718 6.86 76,370 0 -100.00 13,654,479 14,509,718 6.26

Pesticides 3,580,892 3,308,388 -7.61 704,095 823,095 16.90 4,284,987 4,131,483 -3.58

Population Research 10,335,971 10,491,878 1.51 0 0 10,335,971 10,491,878 1.51

Prevention, Primary 286,005,520 325,152,163 13.69 33,630,480 38,607,415 14.80 319,636,000 363,759,578 13.80

Radiation—Electromagnetic Fields 467,375 495,945 6.11 0 0 467,375 495,945 6.11

Radiation—Ionizing 41,945,036 39,053,743 -6.89 156,917 1,821,452 1,060.77 42,101,953 40,875,195 -2.91

Radiation—Low-Level Ionizing 13,877,729 12,100,041 -12.81 0 0 13,877,729 12,100,041 -12.81

Radiation—Non-Ionizing 34,067,458 35,855,310 5.25 173,319 1,038,185 499.00 34,240,777 36,893,495 7.75

Radiation—Non-Ionizing Dx or Rx 87,338,415 94,526,145 8.23 727,054 4,283,466 489.15 88,065,469 98,809,611 12.20

(Continued)

Table 15. NCI Special Interest Category (SIC) Dollars for FY2003— 

Percent Change from FY2002* (Continued)
Special Interest 2002 2003 Percent 2002 2003 Percent 2002 2003 Percent 

Category (SIC) Grants Grants Change Contracts Contracts Change Totals Totals Change

Radiation—UV 31,910,200 33,983,034 6.50 173,319 1,038,185 499.00 32,083,519 35,021,219 9.16

Radiotherapy 215,427,906 201,939,626 -6.26 418,936 1,896,883 352.79 215,846,842 203,836,509 -5.56

Radon 3,062,288 2,247,435 -26.61 0 0 3,062,288 2,247,435 -26.61

Rare Diseases 36,784,776 41,324,416 12.34 1,854,127 516,669 -72.13 38,638,903 41,841,085 8.29

RAS Inhibitors 11,496,118 12,024,328 4.59 419,867 448,444 6.81 11,915,985 12,472,772 4.67

Rehabilitation 21,727,475 23,424,350 7.81 2,270,210 2,133,909 -6.00 23,997,685 25,558,259 6.50

Resources 387,027,189 412,144,493 6.49 137,814,273 165,774,178 20.29 524,841,462 577,918,671 10.11

Rural Populations 26,641,779 30,622,310 14.94 14,940,067 13,160,025 -11.91 41,581,846 43,782,335 5.29

Sexually Transmitted Diseases 40,417,819 43,121,144 6.69 1,443,351 3,669,351 154.22 41,861,170 46,790,495 11.78

Smokeless Tobacco 9,079,157 7,923,647 -12.73 108,451 128,883 18.84 9,187,608 8,052,530 -12.35

Smoking and Health 128,987,933 132,499,349 2.72 3,193,683 4,272,828 33.79 132,181,616 136,772,177 3.47

Smoking Behavior 73,479,632 78,209,883 6.44 898,311 748,181 -16.71 74,377,943 78,958,064 6.16

Smoking, Passive 5,144,280 6,023,879 17.10 85,026 64,442 -24.21 5,229,306 6,088,321 16.43

Structural Biology 300,907,474 338,681,284 12.55 4,909,708 3,199,926 -34.82 305,817,182 341,881,210 11.79

Surgery 139,416,973 135,221,839 -3.01 1,197,577 665,662 -44.42 140,614,550 135,887,501 -3.36

Taxol 73,218,250 71,264,155 -2.67 115,953 374,079 222.61 73,334,203 71,638,234 -2.31

Telehealth 78,386,738 97,153,182 23.94 64,190,845 39,576,797 -38.35 142,577,583 136,729,979 -4.10

Therapy 971,888,124 1,049,142,096 7.95 59,909,897 77,690,439 29.68 1,031,798,021 1,126,832,535 9.21

Tropical Diseases 8,553,908 11,087,651 29.62 684,611 725,000 5.90 9,238,519 11,812,651 27.86

Tumor Markers 411,307,341 471,967,996 14.75 13,043,137 17,146,841 31.46 424,350,478 489,114,837 15.26

Tumor Necrosis Factor 21,666,167 27,597,775 27.38 0 0 21,666,167 27,597,775 27.38

Underserved Populations 87,086,363 112,322,588 28.98 15,811,281 17,821,410 12.71 102,897,644 130,143,998 26.48

Virus Cancer Research 176,999,020 191,710,572 8.31 3,660,942 4,576,971 25.02 180,659,962 196,287,543 8.65

Virus—Epstein-Barr 21,842,219 23,253,988 6.46 0 25,000 21,842,219 23,278,988 6.58

Virus—Genital Herpes 791,268 666,153 -15.81 0 0 791,268 666,153 -15.81

Virus—Hepatitis B 10,892,276 10,387,770 -4.63 335,501 0 -100.00 11,227,777 10,387,770 -7.48

Virus—Hepatitis C 3,411,568 4,640,622 36.03 335,501 74,918 -77.67 3,747,069 4,715,540 25.85

Virus—Herpes 49,648,779 51,753,550 4.24 0 25,000 49,648,779 51,778,550 4.29

Virus—HHV6 48,563 40,917 -15.74 0 0 48,563 40,917 -15.74

Virus—HHV8 12,455,991 17,712,740 42.20 0 74,918 12,455,991 17,787,658 42.80

Virus—HTLV-I 5,817,459 7,718,640 32.68 684,611 725,000 5.90 6,502,070 8,443,640 29.86

Virus—HTLV-II 272,629 15,161 -94.44 0 0 272,629 15,161 -94.44

Virus—HTLV-Unspecified 225,104 69,094 -69.31 0 0 225,104 69,094 -69.31

Virus—Papilloma 38,294,419 46,445,814 21.29 1,203,737 3,424,351 184.48 39,498,156 49,870,165 26.26

Virus—Papova 48,070,872 58,451,388 21.59 1,203,737 3,424,351 184.48 49,274,609 61,875,739 25.57

Virus—SV40 1,813,705 8,645,371 376.67 0 0 1,813,705 8,645,371 376.67

Vitamin A 23,883,101 21,937,835 -8.14 2,123,408 549,010 -74.14 26,006,509 22,486,845 -13.53

Vitamin C 6,379,668 6,809,996 6.75 0 0 6,379,668 6,809,996 6.75

Vitamins, Other 13,073,118 21,047,264 61.00 816,487 26,553 -96.75 13,889,605 21,073,817 51.72

NCI/DEA Annual Report 2003

149

Table 15. NCI Special Interest Category (SIC) Dollars for FY2003— 

Percent Change from FY2002* (Continued)
NCI/DEA Annual Report 2003

150

Special Interest 2002 2003 Percent 2002 2003 Percent 2002 2003 Percent 

Category (SIC) Grants Grants Change Contracts Contracts Change Totals Totals Change

Adrenal 2,461,533 3,960,952 60.91 0 0 2,461,533 3,960,952 60.91

Anus 2,830,955 3,802,505 34.32 0 554,188 2,830,955 4,356,693 53.89

Bladder 26,027,326 28,537,263 9.64 1,274,097 838,168 -34.21 27,301,423 29,375,431 7.60

Blood 973,156 638,763 -34.36 7,518 136,071 1,709.94 980,674 774,834 -20.99

Bone Marrow 19,677,230 18,738,105 -4.77 0 0 19,677,230 18,738,105 -4.77

Bone, Cartilage 17,247,451 22,398,965 29.87 0 0 17,247,451 22,398,965 29.87

Brain 82,797,727 92,635,682 11.88 1,041,891 2,643,784 153.75 83,839,618 95,279,466 13.64

Breast 466,221,807 487,276,101 4.52 15,147,918 11,859,220 -21.71 481,369,725 499,135,321 3.69

Buccal Cavity 4,452,219 5,193,075 16.64 776,646 429,189 -44.74 5,228,865 5,622,264 7.52

Central Nervous System 17,456,905 18,803,554 7.71 155,922 142,785 -8.43 17,612,827 18,946,339 7.57

Cervix 56,185,149 66,450,143 18.27 3,859,186 5,607,727 45.31 60,044,335 72,057,870 20.01

Childhood Leukemia 47,525,099 47,364,916 -0.34 0 25,000 47,525,099 47,389,916 -0.28

Colon, Rectum 222,963,391 222,623,080 -0.15 16,908,463 20,565,109 21.63 239,871,854 243,188,189 1.38

Connective Tissue 7,857,870 7,572,951 -3.63 0 0 7,857,870 7,572,951 -3.63

Embryonic Tissue, Cells 10,165,631 7,746,541 -23.80 0 0 10,165,631 7,746,541 -23.80

Erythrocytes 1,017,898 985,198 -3.21 0 0 1,017,898 985,198 -3.21

Esophagus 15,633,684 18,297,131 17.04 558,406 742,552 32.98 16,192,090 19,039,683 17.59

Eye 2,504,907 2,340,893 -6.55 0 91,795 2,504,907 2,432,688 -2.88

Gall Bladder 222,092 757,328 241.00 0 0 222,092 757,328 241.00

Gastrointestinal Tract 11,463,853 14,090,712 22.91 2,207,704 1,782,279 -19.27 13,671,557 15,872,991 16.10

Genital System, Female 1,699,401 1,224,104 -27.97 655,629 711,385 8.50 2,355,030 1,935,489 -17.81

Genital System, Male 978,638 764,895 -21.84 1,739,438 2,402,836 38.14 2,718,076 3,167,731 16.54

Head and Neck 24,867,379 33,873,712 36.22 1,666,099 1,842,386 10.58 26,533,478 35,716,098 34.61

Heart 6,253,719 6,774,839 8.33 380,408 0 -100.00 6,634,127 6,774,839 2.12

Hodgkins Lymphoma 11,314,840 15,735,723 39.07 4 160,2354,005,775.00 11,314,844 15,895,958 40.49

Invertebrate Tissue, Cells 13,247,408 7,851,614 -40.73 222,251 229,539 3.28 13,469,659 8,081,153 -40.00

Kaposi Sarcoma 16,402,643 18,485,724 12.70 167,574 267,773 59.79 16,570,217 18,753,497 13.18

Kidney 18,754,097 23,012,397 22.71 475,715 0 -100.00 19,229,812 23,012,397 19.67

Larynx 1,538,946 1,239,045 -19.49 0 0 1,538,946 1,239,045 -19.49

Leukemia 167,559,408 190,719,926 13.82 1,851,787 2,021,451 9.16 169,411,195 192,741,377 13.77

Leukocytes 70,161,712 68,432,226 -2.46 1,064,377 1,091,676 2.56 71,226,089 69,523,902 -2.39

Liver 51,157,569 52,377,535 2.38 3,247,716 2,548,304 -21.54 54,405,285 54,925,839 0.96

Lung 206,648,203 233,722,488 13.10 18,114,315 20,281,024 11.96 224,762,518 254,003,512 13.01

Lymph Node 678,029 418,211 -38.32 0 0 678,029 418,211 -38.32

Lymphatic System 2,068,357 1,772,709 -14.29 0 0 2,068,357 1,772,709 -14.29

Melanoma 72,703,068 81,518,973 12.13 2,461,213 1,733,587 -29.56 75,164,281 83,252,560 10.76

Muscle 9,793,642 10,585,789 8.09 0 0 9,793,642 10,585,789 8.09

Myeloma 17,356,968 23,349,917 34.53 761,393 108,120 -85.80 18,118,361 23,458,037 29.47

Nervous System 3,523,660 2,947,832 -16.34 0 0 3,523,660 2,947,832 -16.34

Neuroblastoma 16,908,206 23,084,752 36.53 0 25,000 16,908,206 23,109,752 36.68

Non-Hodgkins Lymphoma 77,141,012 87,043,129 12.84 2,415,160 658,184 -72.75 79,556,172 87,701,313 10.24

(Continued)

* This table reports funding for research grants and contracts only; training grants and intramural projects are excluded.

Table 16. NCI Organ Site-Specific Dollars for FY2003— 

Percent Change from FY2002*
NCI/DEA Annual Report 2003

151

Special Interest 2002 2003 Percent 2002 2003 Percent 2002 2003 Percent 

Category (SIC) Grants Grants Change Contracts Contracts Change Totals Totals Change

Nose, Nasal Passages 2,019,221 1,889,287 -6.43 0 0 2,019,221 1,889,287 -6.43

Ovary 78,133,675 80,445,298 2.96 9,597,944 13,833,083 44.13 87,731,619 94,278,381 7.46

Pancreas 30,643,668 39,271,824 28.16 959,681 1,393,282 45.18 31,603,349 40,665,106 28.67

Parathyroid 144,535 103,368 -28.48 0 0 144,535 103,368 -28.48

Penis 555,233 570,915 2.82 0 0 555,233 570,915 2.82

Pharynx 3,054,679 3,496,979 14.48 0 0 3,054,679 3,496,979 14.48

Pituitary 2,330,309 2,223,903 -4.57 0 0 2,330,309 2,223,903 -4.57

Plant Tissue, Cells 299,402 417,169 39.33 0 0 299,402 417,169 39.33

Platelets 766,283 1,014,760 32.43 0 0 766,283 1,014,760 32.43

Prostate 242,985,186 261,534,830 7.63 16,198,261 20,628,018 27.35 259,183,447 282,162,848 8.87

Reticuloendothelial System 24,077,970 22,633,635 -6.00 934,837 0 -100.00 25,012,807 22,633,635 -9.51

Respiratory System 2,231,189 1,752,342 -21.46 0 0 2,231,189 1,752,342 -21.46

Retinoblastoma 2,013,370 2,275,980 13.04 0 0 2,013,370 2,275,980 13.04

Skin 55,643,355 58,036,360 4.30 2,255,975 2,071,557 -8.17 57,899,330 60,107,917 3.81

Small Intestine 1,940,181 2,744,882 41.48 0 0 1,940,181 2,744,882 41.48

Spleen 334,096 397,133 18.87 0 0 334,096 397,133 18.87

Stomach 6,555,573 9,819,892 49.79 2,097,465 591,103 -71.82 8,653,038 10,410,995 20.32

Testis 5,330,602 5,913,343 10.93 105,039 268,930 156.03 5,435,641 6,182,273 13.74

Thymus 1,011,485 830,245 -17.92 0 0 1,011,485 830,245 -17.92

Thyroid 3,948,141 4,832,175 22.39 0 0 3,948,141 4,832,175 22.39

Trachea, Bronchus 386,225 156,675 -59.43 393,732 0 -100.00 779,957 156,675 -79.91

Urinary System 703,615 540,930 -23.12 0 0 703,615 540,930 -23.12

Uterus 21,336,142 24,291,159 13.85 527,039 108,695 -79.38 21,863,181 24,399,854 11.60

Vagina 690,010 542,925 -21.32 0 0 690,010 542,925 -21.32

Vascular 51,333,578 47,688,318 -7.10 518,142 1,327,432 156.19 51,851,720 49,015,750 -5.47

Wilms Tumor 4,499,303 4,773,264 6.09 0 0 4,499,303 4,773,264 6.09

Table 16. NCI Organ Site-Specific Dollars for FY2003— 

Percent Change from FY2002* (Continued)
NCI/DEA Annual Report 2003

152

Workload

Announcement Number Annoucement Title Round

RFP N01-CN-25000-39 Recompetition: Phase I & Phase II Clinical Studies of Chemopreventive Agents 2/03

RFP N43-CP-31039-66 Particle-Based Assays for Detection and Quantification of Viral Antibodies 5/03

RFP N43-CM-37011-54 New Approaches for the Determination of 3-D Protein Structure 5/03

RFP N43-CM37015-28 Technologies for the Study of Genetic Alterations 5/03

RFP N43-CM-37016-19 New Technologies for Monitoring the Tumor Micro-environment 5/03

RFP N43-CO-31044-64 Development and Application of High-Throughput Proteomics Technology 5/03

RFP N01-CP-31032-66 Development of Oligonucleotide Selection Software for Molecular Genetic Analysis 5/03

RFP N43-CM-37015-28 Biomedical Informatics System for Basic and Clinical Cancer Research 5/03

RFPN01-CO-27042-32(BAA) Initiative: Fundamental Technologies for Development of Bimolecular Sensors 5/03

RFP N01-CO-37007-16(BAA) Novel Technologies for Noninvasive Detection, Diagnosis and Treatment of Cancer 5/03

RFP N43-CM-37012-23 Clinical Trials Data Collection Using Hand-Held Technology 5/03

RFP N01-CP-31012-66 Epidemiological Studies of Cancer Among Atomic Bomb Survivors 5/03

RFP N01-CN-25026-76 Preclinical In Vitro and In Vivo Screening Assays 5/03

RFP N43-CN-35022-61

(Topic 187) Expert- vs. User-Tailored Interactive Media 5/03

Topic 188 Technologies to Promote Best Practice in Data Sharing 5/03

RFP N43-CN-35022-61

(Topic 189) Real-Time Cancer Communications Data Collection 5/03

RFP N43-CM-37018-16 Development of Novel Agents Directed Against Childhood Cancer Molecular Targets 5/03

RFP N01-CM-37008-45 Early Clinical Trials of Imaging Agents 10/03

RFP N01-CP-31006-50 The Agricultural Health Study - Field Stations 10/03

RFP N01-CN-25002-72 Preclinical Toxicology of New Cancer Preventing Agents - 

Using Work Assignment Mechanism 10/03

RFP N01-CP-31018-50 U.S. Radiologic Technologist Cohort: New Strategies for Follow-up

and Detailed Study of Radiation and Genetic Factors 10/03

NOT-OD-03-057 Loan Repayment Program for Clinical Researchers 10/03

NOT-OD-03-058 Loan Repayment Program for Pediatric Researchers

* NCI reviewed a total of 404 proposals. The proposals were in response to RFPs (35), the 2003 SBIR contract solicitations (94),

BAA initiatives (31), and the Loan Repayment Programs (244). 

Table 17. Requests for Proposals (RFPs)* Reviewed by NCI/DEA in FY2003
An electronic version of this document can be viewed and downloaded

from the Internet at http://deainfo.nci.nih.gov/
U.S. DEPARTMENT OF HEALTH

AND HUMAN SERVICES

Public Health Service

National Institutes of Health

September 2004